#term ID	term description	observed gene count	background gene count	strength	false discovery rate	matching proteins in your network (IDs)	matching proteins in your network (labels)
PMID:26655500	(2016) MULTIMERIN2 binds VEGF-A primarily via the carbohydrate chains exerting an angiostatic function and impairing tumor growth.	4	22	2.47	0.0049	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000451040,9606.ENSP00000478570	SPARC,HSPG2,PGF,VEGFA
PMID:16914267	(2006) The vascular endothelial growth factor VEGF165 induces perlecan synthesis via VEGF receptor-2 in cultured human brain microvascular endothelial cells.	3	5	2.99	0.0199	9606.ENSP00000363827,9606.ENSP00000451040,9606.ENSP00000478570	HSPG2,PGF,VEGFA
PMID:34957918	(2022) Long-term in vivo survival of 3D-bioprinted human lipoaspirate-derived adipose tissue: proteomic signature and cellular content.	4	83	1.9	0.0268	9606.ENSP00000231061,9606.ENSP00000362524,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,ANGPTL2,HSPG2,VEGFA
PMID:35160111	(2022) Influence of Cytokines on Inflammatory Eye Diseases: A Citation Network Study.	3	25	2.29	0.0268	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:33413407	(2021) Effective production of human growth factors in Escherichia coli by fusing with small protein 6HFh8.	3	13	2.58	0.0268	9606.ENSP00000231061,9606.ENSP00000451040,9606.ENSP00000478570	SPARC,PGF,VEGFA
PMID:33413646	(2021) Impact of 3D cell culture on bone regeneration potential of mesenchymal stromal cells.	3	23	2.33	0.0268	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:33510227	(2021) Decreased angiogenesis as a possible pathomechanism in cervical degenerative myelopathy.	3	17	2.46	0.0268	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:33680070	(2021) Integrated Learning: Screening Optimal Biomarkers for Identifying Preeclampsia in Placental mRNA Samples.	3	16	2.49	0.0268	9606.ENSP00000276571,9606.ENSP00000451040,9606.ENSP00000478570	CRH,PGF,VEGFA
PMID:33937276	(2021) The Charming World of the Extracellular Matrix: A Dynamic and Protective Network of the Intestinal Wall.	4	72	1.96	0.0268	9606.ENSP00000231061,9606.ENSP00000362524,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,ANGPTL2,HSPG2,VEGFA
PMID:33991464	(2021) Intermittent hypoxia changes the interaction of the kinin-VEGF system and impairs myocardial angiogenesis in the hypertrophic heart.	3	23	2.33	0.0268	9606.ENSP00000450482,9606.ENSP00000451040,9606.ENSP00000478570	BDKRB2,PGF,VEGFA
PMID:34064508	(2021) Vascular Endothelial Growth Factor, a Key Modulator of the Anti-Tumor Immune Response.	4	57	2.06	0.0268	9606.ENSP00000006053,9606.ENSP00000276571,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,CRH,PGF,VEGFA
PMID:34105297	(2021) Physiological and Pathological Factors Affecting Drug Delivery to the Brain by Nanoparticles.	4	74	1.95	0.0268	9606.ENSP00000231061,9606.ENSP00000276571,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,CRH,HSPG2,VEGFA
PMID:34185437	(2021) Targeting neuropilins as a viable SARS-CoV-2 treatment.	3	19	2.41	0.0268	9606.ENSP00000363827,9606.ENSP00000451040,9606.ENSP00000478570	HSPG2,PGF,VEGFA
PMID:34299174	(2021) Cardiovascular and Cerebrovascular Implications of Growth Restriction: Mechanisms and Potential Treatments.	3	7	2.84	0.0268	9606.ENSP00000276571,9606.ENSP00000451040,9606.ENSP00000478570	CRH,PGF,VEGFA
PMID:34440184	(2021) Cortisol Dose-Dependently Impairs Migration and Tube-like Formation in a Trophoblast Cell Line and Modulates Inflammatory and Angiogenic Genes.	3	25	2.29	0.0268	9606.ENSP00000450482,9606.ENSP00000451040,9606.ENSP00000478570	BDKRB2,PGF,VEGFA
PMID:34445299	(2021) Keratin-Alginate Sponges Support Healing of Partial-Thickness Burns.	3	17	2.46	0.0268	9606.ENSP00000231061,9606.ENSP00000451040,9606.ENSP00000478570	SPARC,PGF,VEGFA
PMID:34680449	(2021) Role of the Uteroplacental Renin-Angiotensin System in Placental Development and Function, and Its Implication in the Preeclampsia Pathogenesis.	3	19	2.41	0.0268	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:34681829	(2021) Extracellular Environment-Controlled Angiogenesis, and Potential Application for Peripheral Nerve Regeneration.	3	18	2.43	0.0268	9606.ENSP00000363827,9606.ENSP00000451040,9606.ENSP00000478570	HSPG2,PGF,VEGFA
PMID:34685589	(2021) Pathological AT1R-B2R Protein Aggregation and Preeclampsia.	3	22	2.35	0.0268	9606.ENSP00000450482,9606.ENSP00000451040,9606.ENSP00000478570	BDKRB2,PGF,VEGFA
PMID:34948944	(2021) Physiological Changes and Pathological Pain Associated with Sedentary Lifestyle-Induced Body Systems Fat Accumulation and Their Modulation by Physical Exercise.	4	115	1.75	0.0268	9606.ENSP00000006053,9606.ENSP00000276571,9606.ENSP00000362524,9606.ENSP00000478570	CX3CL1,CRH,ANGPTL2,VEGFA
PMID:34992598	(2021) The Placental Innate Immune System Is Altered in Early-Onset Preeclampsia, but Not in Late-Onset Preeclampsia.	3	24	2.31	0.0268	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:35071362	(2021) Endocan: A Key Player of Cardiovascular Disease.	3	23	2.33	0.0268	9606.ENSP00000363827,9606.ENSP00000451040,9606.ENSP00000478570	HSPG2,PGF,VEGFA
PMID:32485901	(2020) Advances in the Research of Bioinks Based on Natural Collagen, Polysaccharide and Their Derivatives for Skin 3D Bioprinting.	3	22	2.35	0.0268	9606.ENSP00000231061,9606.ENSP00000451040,9606.ENSP00000478570	SPARC,PGF,VEGFA
PMID:32668602	(2020) The Ins and Outs of Cathepsins: Physiological Function and Role in Disease Management.	4	71	1.96	0.0268	9606.ENSP00000006053,9606.ENSP00000220166,9606.ENSP00000231061,9606.ENSP00000363827	CX3CL1,CTSH,SPARC,HSPG2
PMID:32850857	(2020) Laminins Regulate Placentation and Pre-eclampsia: Focus on Trophoblasts and Endothelial Cells.	3	17	2.46	0.0268	9606.ENSP00000363827,9606.ENSP00000451040,9606.ENSP00000478570	HSPG2,PGF,VEGFA
PMID:32879763	(2020) DS-7080a, a Selective Anti-ROBO4 Antibody, Shows Anti-Angiogenic Efficacy with Distinctly Different Profiles from Anti-VEGF Agents.	3	16	2.49	0.0268	9606.ENSP00000334329,9606.ENSP00000451040,9606.ENSP00000478570	UNC5B,PGF,VEGFA
PMID:32995122	(2020) A Biomimetic Approach toward Enhancing Angiogenesis: Recombinantly Expressed Domain V of Human Perlecan Is a Bioactive Molecule That Promotes Angiogenesis and Vascularization of Implanted Biomaterials.	3	10	2.69	0.0268	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:33123472	(2020) Bone Marrow Adipocytes, Adipocytokines, and Breast Cancer Cells: Novel Implications in Bone Metastasis of Breast Cancer.	4	97	1.83	0.0268	9606.ENSP00000006053,9606.ENSP00000231061,9606.ENSP00000362524,9606.ENSP00000478570	CX3CL1,SPARC,ANGPTL2,VEGFA
PMID:33379400	(2020) Hold on or Cut? Integrin- and MMP-Mediated Cell-Matrix Interactions in the Tumor Microenvironment.	4	93	1.85	0.0268	9606.ENSP00000231061,9606.ENSP00000362524,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,ANGPTL2,HSPG2,VEGFA
PMID:30913246	(2019) Socioeconomic status and early blood concentrations of inflammation-related and neurotrophic proteins among extremely preterm newborns.	3	25	2.29	0.0268	9606.ENSP00000276571,9606.ENSP00000451040,9606.ENSP00000478570	CRH,PGF,VEGFA
PMID:31286151	(2019) Role of Macrophages in Pregnancy and Related Complications.	4	87	1.87	0.0268	9606.ENSP00000006053,9606.ENSP00000276571,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,CRH,PGF,VEGFA
PMID:31312121	(2019) Early Post-stroke Activation of Vascular Endothelial Growth Factor Receptor 2 Hinders the Receptor 1-Dependent Neuroprotection Afforded by the Endogenous Ligand.	3	23	2.33	0.0268	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:31359618	(2019) Risk factors for hemorrhage of brain arteriovenous malformation.	3	22	2.35	0.0268	9606.ENSP00000363827,9606.ENSP00000451040,9606.ENSP00000478570	HSPG2,PGF,VEGFA
PMID:31541017	(2019) Perlecan regulates pericyte dynamics in the maintenance and repair of the blood-brain barrier.	3	25	2.29	0.0268	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:31613820	(2019) Secreted modular calcium-binding proteins in pathophysiological processes and embryonic development.	3	24	2.31	0.0268	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:32038609	(2019) Steroids, Pregnancy and Fetal Development.	3	18	2.43	0.0268	9606.ENSP00000276571,9606.ENSP00000451040,9606.ENSP00000478570	CRH,PGF,VEGFA
PMID:27874278	(2018) Placental growth factor and its potential role in diabetic retinopathy and other ocular neovascular diseases.	3	17	2.46	0.0268	9606.ENSP00000334329,9606.ENSP00000451040,9606.ENSP00000478570	UNC5B,PGF,VEGFA
PMID:29467498	(2018) Early Detection of Preeclampsia Using Circulating Small non-coding RNA.	3	7	2.84	0.0268	9606.ENSP00000276571,9606.ENSP00000451040,9606.ENSP00000478570	CRH,PGF,VEGFA
PMID:29594035	(2018) Targeting Macrophages in Cancer: From Bench to Bedside.	4	68	1.98	0.0268	9606.ENSP00000006053,9606.ENSP00000231061,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,SPARC,PGF,VEGFA
PMID:29682574	(2018) Baseline Predictors of Visual Acuity Outcome in Patients with Wet Age-Related Macular Degeneration.	3	20	2.39	0.0268	9606.ENSP00000231061,9606.ENSP00000451040,9606.ENSP00000478570	SPARC,PGF,VEGFA
PMID:29729196	(2018) Potential Clinical Targets in Hepatopulmonary Syndrome: Lessons From Experimental Models.	3	21	2.37	0.0268	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:30332844	(2018) Therapeutic Strategies for Spinal Cord Injury.	3	18	2.43	0.0268	9606.ENSP00000006053,9606.ENSP00000220166,9606.ENSP00000478570	CX3CL1,CTSH,VEGFA
PMID:30518776	(2018) Extracellular Protein Fibulin-7 and Its C-Terminal Fragment Have In Vivo Antiangiogenic Activity.	3	18	2.43	0.0268	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:28337358	(2017) Gastric Cancer and Angiogenesis: Is VEGF a Useful Biomarker to Assess Progression and Remission?	3	25	2.29	0.0268	9606.ENSP00000362524,9606.ENSP00000451040,9606.ENSP00000478570	ANGPTL2,PGF,VEGFA
PMID:26940231	(2016) Taking cues from the extracellular matrix to design bone-mimetic regenerative scaffolds.	3	19	2.41	0.0268	9606.ENSP00000231061,9606.ENSP00000451040,9606.ENSP00000478570	SPARC,PGF,VEGFA
PMID:26959822	(2016) The Vascular Endothelial Growth Factor Inhibitors Ranibizumab and Aflibercept Markedly Increase Expression of Atherosclerosis-Associated Inflammatory Mediators on Vascular Endothelial Cells.	3	13	2.58	0.0268	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:27022202	(2016) Advancing biomaterials of human origin for tissue engineering.	4	53	2.09	0.0268	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000451040,9606.ENSP00000478570	SPARC,HSPG2,PGF,VEGFA
PMID:27050277	(2016) Migration-inducing gene 7 promotes tumorigenesis and angiogenesis and independently predicts poor prognosis of epithelial ovarian cancer.	3	21	2.37	0.0268	9606.ENSP00000231061,9606.ENSP00000451040,9606.ENSP00000478570	SPARC,PGF,VEGFA
PMID:27145079	(2016) Possible Biomarkers of Chronic Stress Induced Exhaustion - A Longitudinal Study.	3	9	2.74	0.0268	9606.ENSP00000276571,9606.ENSP00000451040,9606.ENSP00000478570	CRH,PGF,VEGFA
PMID:27247335	(2016) Novel Biomarkers to Improve the Prediction of Cardiovascular Event Risk in Type 2 Diabetes Mellitus.	3	22	2.35	0.0268	9606.ENSP00000231061,9606.ENSP00000451040,9606.ENSP00000478570	SPARC,PGF,VEGFA
PMID:25626871	(2015) Perlecan deficiency causes endothelial dysfunction by reducing the expression of endothelial nitric oxide synthase.	3	14	2.54	0.0268	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:25634527	(2015) Crosstalk between cancer cells and blood endothelial and lymphatic endothelial cells in tumour and organ microenvironment.	4	60	2.04	0.0268	9606.ENSP00000362524,9606.ENSP00000363827,9606.ENSP00000451040,9606.ENSP00000478570	ANGPTL2,HSPG2,PGF,VEGFA
PMID:26032325	(2015) Correlation between cell-free mRNA expressions and PLGF protein level in severe preeclampsia.	3	10	2.69	0.0268	9606.ENSP00000276571,9606.ENSP00000451040,9606.ENSP00000478570	CRH,PGF,VEGFA
PMID:26071118	(2015) The role of H2S bioavailability in endothelial dysfunction.	3	19	2.41	0.0268	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:26106425	(2015) Recent Advances in Hydroxyapatite Scaffolds Containing Mesenchymal Stem Cells.	3	19	2.41	0.0268	9606.ENSP00000231061,9606.ENSP00000451040,9606.ENSP00000478570	SPARC,PGF,VEGFA
PMID:26236708	(2015) Depot-Based Delivery Systems for Pro-Angiogenic Peptides: A Review.	3	23	2.33	0.0268	9606.ENSP00000231061,9606.ENSP00000451040,9606.ENSP00000478570	SPARC,PGF,VEGFA
PMID:26263555	(2015) LTBP-2 Has a Single High-Affinity Binding Site for FGF-2 and Blocks FGF-2-Induced Cell Proliferation.	3	22	2.35	0.0268	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:26357521	(2015) Antiangiogenic Effect of Ethanol Extract of Vigna angularis via Inhibition of Phosphorylation of VEGFR2, Erk, and Akt.	3	16	2.49	0.0268	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:26406320	(2015) Breeding Strategy Determines Rupture Incidence in Post-Infarct Healing WARPing Cardiovascular Research.	3	14	2.54	0.0268	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:23995988	(2014) De novo hem- and lymphangiogenesis by endothelial progenitor and mesenchymal stem cells in immunocompetent mice.	3	7	2.84	0.0268	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:24451141	(2014) Intravitreal injection of ranibizumab and CTGF shRNA improves retinal gene expression and microvessel ultrastructure in a rodent model of diabetes.	3	14	2.54	0.0268	9606.ENSP00000231061,9606.ENSP00000451040,9606.ENSP00000478570	SPARC,PGF,VEGFA
PMID:24472220	(2014) Netrin-4 promotes mural cell adhesion and recruitment to endothelial cells.	3	15	2.51	0.0268	9606.ENSP00000334329,9606.ENSP00000363827,9606.ENSP00000478570	UNC5B,HSPG2,VEGFA
PMID:24684874	(2014) Immunomodulatory effects of sex hormones: requirements for pregnancy and relevance in melanoma.	4	47	2.14	0.0268	9606.ENSP00000006053,9606.ENSP00000276571,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,CRH,PGF,VEGFA
PMID:24883213	(2014) The maternal brain: an organ with peripartal plasticity.	3	19	2.41	0.0268	9606.ENSP00000276571,9606.ENSP00000451040,9606.ENSP00000478570	CRH,PGF,VEGFA
PMID:24966662	(2014) Anti-vascular endothelial growth factor acts on retinal microgliamacrophage activation in a rat model of ocular inflammation.	3	22	2.35	0.0268	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:25068296	(2014) Lymphatic endothelial cells support tumor growth in breast cancer.	3	23	2.33	0.0268	9606.ENSP00000363827,9606.ENSP00000451040,9606.ENSP00000478570	HSPG2,PGF,VEGFA
PMID:25143950	(2014) Netrins and their roles in placental angiogenesis.	3	13	2.58	0.0268	9606.ENSP00000334329,9606.ENSP00000451040,9606.ENSP00000478570	UNC5B,PGF,VEGFA
PMID:26237384	(2014) The Role of RNAs and microRNAs in Non-Invasive Prenatal Diagnosis.	3	22	2.35	0.0268	9606.ENSP00000276571,9606.ENSP00000451040,9606.ENSP00000478570	CRH,PGF,VEGFA
PMID:26636134	(2014) Deletion of SPARC Enhances Retinal Vaso-Obliteration in Mouse Model of Oxygen-Induced Retinopathy.	3	8	2.79	0.0268	9606.ENSP00000231061,9606.ENSP00000451040,9606.ENSP00000478570	SPARC,PGF,VEGFA
PMID:23092791	(2013) Endothelial tip cells in ocular angiogenesis: potential target for anti-angiogenesis therapy.	4	54	2.08	0.0268	9606.ENSP00000334329,9606.ENSP00000363827,9606.ENSP00000451040,9606.ENSP00000478570	UNC5B,HSPG2,PGF,VEGFA
PMID:23437253	(2013) The heparin-binding activity of secreted modular calcium-binding protein 1 (SMOC-1) modulates its cell adhesion properties.	3	20	2.39	0.0268	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:23739851	(2013) CCL3 and CXCL12 production in vitro by dental pulp fibroblasts from permanent and deciduous teeth stimulated by Porphyromonas gingivalis LPS.	3	18	2.43	0.0268	9606.ENSP00000006053,9606.ENSP00000231061,9606.ENSP00000478570	CX3CL1,SPARC,VEGFA
PMID:23795287	(2013) Photoreceptor avascular privilege is shielded by soluble VEGF receptor-1.	3	14	2.54	0.0268	9606.ENSP00000363827,9606.ENSP00000451040,9606.ENSP00000478570	HSPG2,PGF,VEGFA
PMID:23959079	(2013) Cartilage to bone transitions in health and disease.	3	21	2.37	0.0268	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:21826801	(2012) A systems biology approach to synovial joint lubrication in health, injury, and disease.	4	79	1.92	0.0268	9606.ENSP00000006053,9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	CX3CL1,SPARC,HSPG2,VEGFA
PMID:22363824	(2012) Association of mast cell-derived VEGF and proteases in Dengue shock syndrome.	3	24	2.31	0.0268	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:22558449	(2012) MFG-E8 released by apoptotic endothelial cells triggers anti-inflammatory macrophage reprogramming.	3	17	2.46	0.0268	9606.ENSP00000006053,9606.ENSP00000363827,9606.ENSP00000478570	CX3CL1,HSPG2,VEGFA
PMID:22734666	(2012) Microvascular repair: post-angiogenesis vascular dynamics.	3	20	2.39	0.0268	9606.ENSP00000334329,9606.ENSP00000451040,9606.ENSP00000478570	UNC5B,PGF,VEGFA
PMID:22897854	(2012) Targeted disruption of heparan sulfate interaction with hepatocyte and vascular endothelial growth factors blocks normal and oncogenic signaling.	3	17	2.46	0.0268	9606.ENSP00000363827,9606.ENSP00000451040,9606.ENSP00000478570	HSPG2,PGF,VEGFA
PMID:22982687	(2012) Putative genes mediating the effects of orexins in the posterior paraventricular thalamus on neuroendocrine and behavioral adaptations to repeated stress.	3	20	2.39	0.0268	9606.ENSP00000006053,9606.ENSP00000276571,9606.ENSP00000478570	CX3CL1,CRH,VEGFA
PMID:31380106	(2012) TIMP-2: An Endogenous Angiogenesis Inhibitor with Distinct Antitumoral Properties.	3	25	2.29	0.0268	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:21344348	(2011) Epithelial-mesenchymal interactions in biliary diseases.	4	102	1.81	0.0268	9606.ENSP00000006053,9606.ENSP00000363827,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,HSPG2,PGF,VEGFA
PMID:21547092	(2011) Diagnosis and management of fetal growth restriction.	3	19	2.41	0.0268	9606.ENSP00000276571,9606.ENSP00000451040,9606.ENSP00000478570	CRH,PGF,VEGFA
PMID:21698156	(2011) M402, a novel heparan sulfate mimetic, targets multiple pathways implicated in tumor progression and metastasis.	3	22	2.35	0.0268	9606.ENSP00000363827,9606.ENSP00000451040,9606.ENSP00000478570	HSPG2,PGF,VEGFA
PMID:21822394	(2011) Pre-eclampsia: pathophysiology, diagnosis, and management.	3	19	2.41	0.0268	9606.ENSP00000276571,9606.ENSP00000451040,9606.ENSP00000478570	CRH,PGF,VEGFA
PMID:20212229	(2010) A phase 1 trial of ABT-510 concurrent with standard chemoradiation for patients with newly diagnosed glioblastoma.	3	19	2.41	0.0268	9606.ENSP00000362524,9606.ENSP00000363827,9606.ENSP00000478570	ANGPTL2,HSPG2,VEGFA
PMID:20860549	(2010) Traumatic spinal cord injury alters angiogenic factors and TGF-beta1 that may affect vascular recovery.	3	7	2.84	0.0268	9606.ENSP00000231061,9606.ENSP00000451040,9606.ENSP00000478570	SPARC,PGF,VEGFA
PMID:20932114	(2010) Peroxisome proliferator-activated receptors, metabolic syndrome and cardiovascular disease.	4	67	1.99	0.0268	9606.ENSP00000006053,9606.ENSP00000362524,9606.ENSP00000363827,9606.ENSP00000478570	CX3CL1,ANGPTL2,HSPG2,VEGFA
PMID:18773892	(2009) The lens capsule.	3	22	2.35	0.0268	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:19352513	(2009) A compartment model of VEGF distribution in humans in the presence of soluble VEGF receptor-1 acting as a ligand trap.	3	17	2.46	0.0268	9606.ENSP00000363827,9606.ENSP00000451040,9606.ENSP00000478570	HSPG2,PGF,VEGFA
PMID:19374334	(2009) Molecular regulation of tumor angiogenesis and perfusion via redox signaling.	4	95	1.84	0.0268	9606.ENSP00000362524,9606.ENSP00000363827,9606.ENSP00000451040,9606.ENSP00000478570	ANGPTL2,HSPG2,PGF,VEGFA
PMID:19699244	(2009) Release characteristics and osteogenic activity of recombinant human bone morphogenetic protein-2 grafted to novel self-assembled poly(lactide-co-glycolide fumarate) nanoparticles.	3	7	2.84	0.0268	9606.ENSP00000231061,9606.ENSP00000451040,9606.ENSP00000478570	SPARC,PGF,VEGFA
PMID:18612802	(2008) Inhibition of protein kinase CK2 suppresses angiogenesis and hematopoietic stem cell recruitment to retinal neovascularization sites.	3	16	2.49	0.0268	9606.ENSP00000363827,9606.ENSP00000451040,9606.ENSP00000478570	HSPG2,PGF,VEGFA
PMID:18759329	(2008) Context matters: in vivo and in vitro influences on muscle satellite cell activity.	3	25	2.29	0.0268	9606.ENSP00000006053,9606.ENSP00000363827,9606.ENSP00000478570	CX3CL1,HSPG2,VEGFA
PMID:33125712	(2021) Update of P2X receptor properties and their pharmacology: IUPHAR Review 30.	3	26	2.27	0.0271	9606.ENSP00000276571,9606.ENSP00000304767,9606.ENSP00000478570	CRH,P2RY1,VEGFA
PMID:31754927	(2020) The potassium channel Kcne3 is a VEGFA-inducible gene selectively expressed by vascular endothelial tip cells.	3	26	2.27	0.0271	9606.ENSP00000334329,9606.ENSP00000451040,9606.ENSP00000478570	UNC5B,PGF,VEGFA
PMID:30380785	(2018) Shared Features of Endothelial Dysfunction between Sepsis and Its Preceding Risk Factors (Aging and Chronic Disease).	3	26	2.27	0.0271	9606.ENSP00000006053,9606.ENSP00000363827,9606.ENSP00000478570	CX3CL1,HSPG2,VEGFA
PMID:29276377	(2017) Anti-angiogenic effects of biotechnological therapies in rheumatic diseases.	3	26	2.27	0.0271	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:23601906	(2013) CD39 and CD73 in immunity and inflammation.	3	26	2.27	0.0271	9606.ENSP00000006053,9606.ENSP00000304767,9606.ENSP00000478570	CX3CL1,P2RY1,VEGFA
PMID:22737047	(2012) The effects of extracellular matrix proteins on neutrophil-endothelial interaction--a roadway to multiple therapeutic opportunities.	3	26	2.27	0.0271	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:19926395	(2010) Purinergic mechanisms in breast cancer support intravasation, extravasation and angiogenesis.	3	26	2.27	0.0271	9606.ENSP00000304767,9606.ENSP00000451040,9606.ENSP00000478570	P2RY1,PGF,VEGFA
PMID:30709008	(2019) Innovative Biomaterials for Bone Regrowth.	3	27	2.26	0.0280	9606.ENSP00000231061,9606.ENSP00000451040,9606.ENSP00000478570	SPARC,PGF,VEGFA
PMID:29984111	(2018) Physiological Perspective on Therapies of Lymphatic Vessels.	3	27	2.26	0.0280	9606.ENSP00000006053,9606.ENSP00000363827,9606.ENSP00000478570	CX3CL1,HSPG2,VEGFA
PMID:27148412	(2016) MEK inhibitor can reverse the resistance to bevacizumab in A549 cells harboring Kirsten rat sarcoma oncogene homolog mutation.	3	27	2.26	0.0280	9606.ENSP00000006053,9606.ENSP00000362524,9606.ENSP00000478570	CX3CL1,ANGPTL2,VEGFA
PMID:23374253	(2013) Endorepellin laminin-like globular 12 domains bind Ig3-5 of vascular endothelial growth factor (VEGF) receptor 2 and block pro-angiogenic signaling by VEGFA in endothelial cells.	3	28	2.24	0.0301	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:32879300	(2020) FGFFGFR signaling in health and disease.	4	123	1.72	0.0306	9606.ENSP00000220166,9606.ENSP00000276571,9606.ENSP00000363827,9606.ENSP00000478570	CTSH,CRH,HSPG2,VEGFA
PMID:35095910	(2021) Anti-Inflammatory Effects of Acupuncture at ST36 Point: A Literature Review in Animal Studies.	4	124	1.72	0.0313	9606.ENSP00000006053,9606.ENSP00000276571,9606.ENSP00000304767,9606.ENSP00000478570	CX3CL1,CRH,P2RY1,VEGFA
PMID:34471729	(2021) Personalized Proteomics for Precision Diagnostics in Hearing Loss: Disease-Specific Analysis of Human Perilymph by Mass Spectrometry.	3	29	2.23	0.0323	9606.ENSP00000363827,9606.ENSP00000451040,9606.ENSP00000478570	HSPG2,PGF,VEGFA
PMID:32663498	(2020) Composition, structure and function of the corneal stroma.	3	29	2.23	0.0323	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:33274176	(2020) Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome.	3	29	2.23	0.0323	9606.ENSP00000276571,9606.ENSP00000451040,9606.ENSP00000478570	CRH,PGF,VEGFA
PMID:20222960	(2010) Cell-matrix interactions in dermal repair and scarring.	3	29	2.23	0.0323	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:31615030	(2019) Gene Expression Profiling of the Extracellular Matrix Signature in Macrophages of Different Activation Status: Relevance for Skin Wound Healing.	4	127	1.71	0.0328	9606.ENSP00000220166,9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	CTSH,SPARC,HSPG2,VEGFA
PMID:35154561	(2022) Tissue Kallikrein Protects Rat Prostate against the Inflammatory Damage in a Chronic Autoimmune Prostatitis Model via Restoring Endothelial Function in a Bradykinin Receptor B2-Dependent Way.	3	30	2.21	0.0340	9606.ENSP00000006053,9606.ENSP00000450482,9606.ENSP00000478570	CX3CL1,BDKRB2,VEGFA
PMID:33496844	(2021) The potential association between a new angiogenic marker fractalkine and a placental vascularization in preeclampsia.	3	30	2.21	0.0340	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:29180953	(2017) Roles of Glial Cells in Sculpting Inhibitory Synapses and Neural Circuits.	3	30	2.21	0.0340	9606.ENSP00000006053,9606.ENSP00000231061,9606.ENSP00000304767	CX3CL1,SPARC,P2RY1
PMID:27903606	(2016) EphA2 is a functional receptor for the growth factor progranulin.	3	30	2.21	0.0340	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:28031693	(2016) Intake of dietary salt and drinking water: Implications for the development of age-related macular degeneration.	3	30	2.21	0.0340	9606.ENSP00000304767,9606.ENSP00000451040,9606.ENSP00000478570	P2RY1,PGF,VEGFA
PMID:22848585	(2012) Increased angiogenesis and improved left ventricular function after transplantation of myoblasts lacking the MyoD gene into infarcted myocardium.	3	30	2.21	0.0340	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:24955751	(2012) Extracellular Matrix is an Important Component of Limbal Stem Cell Niche.	3	30	2.21	0.0340	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:21470139	(2011) Anti-angiogenic peptides for cancer therapeutics.	3	30	2.21	0.0340	9606.ENSP00000231061,9606.ENSP00000451040,9606.ENSP00000478570	SPARC,PGF,VEGFA
PMID:33854498	(2021) Direct and Indirect Modulation of T Cells by VEGF-A Counteracted by Anti-Angiogenic Treatment.	3	31	2.2	0.0348	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:35004644	(2021) Preeclamptic Women Have Disrupted Placental microRNA Expression at the Time of Preeclampsia Diagnosis: Meta-Analysis.	3	31	2.2	0.0348	9606.ENSP00000231061,9606.ENSP00000451040,9606.ENSP00000478570	SPARC,PGF,VEGFA
PMID:30537441	(2019) Concise Review: The Endothelial Cell Extracellular Matrix Regulates Tissue Homeostasis and Repair.	3	31	2.2	0.0348	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:28717175	(2017) Snake venom VEGF Vammin induces a highly efficient angiogenic response in skeletal muscle via VEGFR-2NRP specific signaling.	3	31	2.2	0.0348	9606.ENSP00000334329,9606.ENSP00000362524,9606.ENSP00000451040	UNC5B,ANGPTL2,PGF
PMID:25751786	(2015) Can we produce heparinheparan sulfate biomimetics using mother-nature as the gold standard?	3	31	2.2	0.0348	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:25530971	(2014) Prospect of stem cell conditioned medium in regenerative medicine.	3	31	2.2	0.0348	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:23307733	(2013) Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure.	3	31	2.2	0.0348	9606.ENSP00000006053,9606.ENSP00000334329,9606.ENSP00000478570	CX3CL1,UNC5B,VEGFA
PMID:16481221	(2006) Angiogenic transcriptome of human microvascular endothelial cells: Effect of hypoxia, modulation by atorvastatin.	3	31	2.2	0.0348	9606.ENSP00000231061,9606.ENSP00000451040,9606.ENSP00000478570	SPARC,PGF,VEGFA
PMID:35356091	(2022) Recent advance in treatment of atherosclerosis: Key targets and plaque-positioned delivery strategies.	4	134	1.69	0.0351	9606.ENSP00000006053,9606.ENSP00000304767,9606.ENSP00000363827,9606.ENSP00000478570	CX3CL1,P2RY1,HSPG2,VEGFA
PMID:33834155	(2021) Neovascularization of engineered tissues for clinical translation: Where we are, where we should be?	3	32	2.18	0.0354	9606.ENSP00000231061,9606.ENSP00000451040,9606.ENSP00000478570	SPARC,PGF,VEGFA
PMID:34721670	(2021) Novel Cardiovascular Biomarkers Associated with Increased Cardiovascular Risk in Women With Prior PreeclampsiaHELLP Syndrome: A Narrative Review.	3	32	2.18	0.0354	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:32429045	(2020) Eyeing the Extracellular Matrix in Vascular Development and Microvascular Diseases and Bridging the Divide between Vascular Mechanics and Function.	3	32	2.18	0.0354	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:34681861	(2021) Defective Uteroplacental Vascular Remodeling in Preeclampsia: Key Molecular Factors Leading to Long Term Cardiovascular Disease.	3	33	2.17	0.0377	9606.ENSP00000450482,9606.ENSP00000451040,9606.ENSP00000478570	BDKRB2,PGF,VEGFA
PMID:32785136	(2020) Targeting Angiopoietin in Retinal Vascular Diseases: A Literature Review and Summary of Clinical Trials Involving Faricimab.	3	33	2.17	0.0377	9606.ENSP00000362524,9606.ENSP00000451040,9606.ENSP00000478570	ANGPTL2,PGF,VEGFA
PMID:30682077	(2019) Lifelong aerobic exercise protects against inflammaging and cancer.	3	33	2.17	0.0377	9606.ENSP00000006053,9606.ENSP00000231061,9606.ENSP00000478570	CX3CL1,SPARC,VEGFA
PMID:30906828	(2019) Regulation and functions of integrin alpha2 in cell adhesion and disease.	3	33	2.17	0.0377	9606.ENSP00000363827,9606.ENSP00000451040,9606.ENSP00000478570	HSPG2,PGF,VEGFA
PMID:30984014	(2019) Exercise-Induced Myokines With Therapeutic Potential for Muscle Wasting.	3	33	2.17	0.0377	9606.ENSP00000006053,9606.ENSP00000231061,9606.ENSP00000478570	CX3CL1,SPARC,VEGFA
PMID:26926246	(2016) Receptors, channels, and signalling in the urothelial sensory system in the bladder.	3	33	2.17	0.0377	9606.ENSP00000006053,9606.ENSP00000276571,9606.ENSP00000304767	CX3CL1,CRH,P2RY1
PMID:25661523	(2015) Pivotal role for decorin in angiogenesis.	3	33	2.17	0.0377	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:25944985	(2015) Inflammatory response mechanisms exacerbating hypoxemia in coexistent pulmonary fibrosis and sleep apnea.	3	33	2.17	0.0377	9606.ENSP00000006053,9606.ENSP00000231061,9606.ENSP00000478570	CX3CL1,SPARC,VEGFA
PMID:33806335	(2021) Emerging Role of Pericytes and Their Secretome in the Heart.	3	34	2.16	0.0387	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:30410092	(2018) Relationship between aqueous humor cytokine level changes and retinal vascular changes after intravitreal aflibercept for diabetic macular edema.	3	34	2.16	0.0387	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:26136750	(2015) Cellular Regulation of the Uterine Microenvironment That Enables Embryo Implantation.	3	34	2.16	0.0387	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:26651999	(2015) NG2 glia are required for vessel network formation during embryonic development.	3	34	2.16	0.0387	9606.ENSP00000334329,9606.ENSP00000451040,9606.ENSP00000478570	UNC5B,PGF,VEGFA
PMID:24332926	(2014) Extracellular regulation of VEGF: isoforms, proteolysis, and vascular patterning.	3	34	2.16	0.0387	9606.ENSP00000363827,9606.ENSP00000451040,9606.ENSP00000478570	HSPG2,PGF,VEGFA
PMID:24611021	(2014) Inhibition of the methionine aminopeptidase 2 enzyme for the treatment of obesity.	3	34	2.16	0.0387	9606.ENSP00000231061,9606.ENSP00000451040,9606.ENSP00000478570	SPARC,PGF,VEGFA
PMID:23510751	(2013) The uncertain role of unmodified mesenchymal stem cells in tumor progression: what master switch?	3	34	2.16	0.0387	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:24289502	(2013) Neurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidence.	3	34	2.16	0.0387	9606.ENSP00000276571,9606.ENSP00000450482,9606.ENSP00000478570	CRH,BDKRB2,VEGFA
PMID:22153350	(2012) Matrix metalloproteinase-28 deletion amplifies inflammatory and extracellular matrix responses to cardiac aging.	3	34	2.16	0.0387	9606.ENSP00000006053,9606.ENSP00000231061,9606.ENSP00000478570	CX3CL1,SPARC,VEGFA
PMID:21176175	(2010) Breast cancer metastasis to the bone: mechanisms of bone loss.	3	34	2.16	0.0387	9606.ENSP00000231061,9606.ENSP00000451040,9606.ENSP00000478570	SPARC,PGF,VEGFA
PMID:18081553	(2008) Paracrinicity: the story of 30 years of cellular pituitary crosstalk.	4	143	1.66	0.0387	9606.ENSP00000231061,9606.ENSP00000276571,9606.ENSP00000363827,9606.ENSP00000451040	SPARC,CRH,HSPG2,PGF
PMID:32214785	(2020) Osmotic and hypoxic induction of osteopontin in retinal pigment epithelial cells: Involvement of purinergic receptor signaling.	3	35	2.15	0.0390	9606.ENSP00000304767,9606.ENSP00000451040,9606.ENSP00000478570	P2RY1,PGF,VEGFA
PMID:31475143	(2019) Nanotheranostics Targeting the Tumor Microenvironment.	3	35	2.15	0.0390	9606.ENSP00000231061,9606.ENSP00000451040,9606.ENSP00000478570	SPARC,PGF,VEGFA
PMID:33926070	(2021) Exercise Training-Induced Extracellular Matrix Protein Adaptation in Locomotor Muscles: A Systematic Review.	3	36	2.13	0.0417	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:29867149	(2018) Laminin heparin-binding peptides bind to several growth factors and enhance diabetic wound healing.	3	36	2.13	0.0417	9606.ENSP00000363827,9606.ENSP00000451040,9606.ENSP00000478570	HSPG2,PGF,VEGFA
PMID:30400641	(2018) Adipose Stem Cell Translational Applications: From Bench-to-Bedside.	3	36	2.13	0.0417	9606.ENSP00000231061,9606.ENSP00000451040,9606.ENSP00000478570	SPARC,PGF,VEGFA
PMID:23305164	(2013) Modeling the blood-brain barrier using stem cell sources.	3	36	2.13	0.0417	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:21280145	(2011) Mapping structural landmarks, ligand binding sites, and missense mutations to the collagen IV heterotrimers predicts major functional domains, novel interactions, and variation in phenotypes in inherited diseases affecting basement membranes.	3	36	2.13	0.0417	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:19026761	(2009) Molecular pathology of age-related macular degeneration.	3	36	2.13	0.0417	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:20835995	(2009) Regulation of endothelial cell functions by basement membrane- and arachidonic acid-derived products.	3	36	2.13	0.0417	9606.ENSP00000363827,9606.ENSP00000451040,9606.ENSP00000478570	HSPG2,PGF,VEGFA
PMID:33968926	(2021) Rebuilding the Vascular Network: In vivo and in vitro Approaches.	3	37	2.12	0.0431	9606.ENSP00000334329,9606.ENSP00000451040,9606.ENSP00000478570	UNC5B,PGF,VEGFA
PMID:34571920	(2021) Inhibition of Cellular and Animal Inflammatory Disease Models by NF-kappaB Inhibitor DHMEQ.	3	37	2.12	0.0431	9606.ENSP00000006053,9606.ENSP00000362524,9606.ENSP00000478570	CX3CL1,ANGPTL2,VEGFA
PMID:30897858	(2019) Cysteine Cathepsins and their Extracellular Roles: Shaping the Microenvironment.	3	37	2.12	0.0431	9606.ENSP00000006053,9606.ENSP00000231061,9606.ENSP00000363827	CX3CL1,SPARC,HSPG2
PMID:31717621	(2019) Comprehensive In Vitro Testing of Calcium Phosphate-Based Bioceramics with Orthopedic and Dentistry Applications.	3	37	2.12	0.0431	9606.ENSP00000231061,9606.ENSP00000451040,9606.ENSP00000478570	SPARC,PGF,VEGFA
PMID:25258680	(2014) The role of microglia in diabetic retinopathy.	3	37	2.12	0.0431	9606.ENSP00000006053,9606.ENSP00000231061,9606.ENSP00000478570	CX3CL1,SPARC,VEGFA
PMID:20585340	(2010) Cellular and molecular aspects of vascular dysfunction in systemic sclerosis.	3	37	2.12	0.0431	9606.ENSP00000363827,9606.ENSP00000451040,9606.ENSP00000478570	HSPG2,PGF,VEGFA
PMID:18591389	(2008) Neuronatin: a new inflammation gene expressed on the aortic endothelium of diabetic mice.	3	37	2.12	0.0431	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:34831167	(2021) Mechanisms, Diagnosis and Treatment of Bone Metastases.	4	152	1.63	0.0439	9606.ENSP00000006053,9606.ENSP00000231061,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,SPARC,PGF,VEGFA
PMID:34884703	(2021) Effects of Intermittent Hypoxia on Cytokine Expression Involved in Insulin Resistance.	3	38	2.11	0.0443	9606.ENSP00000231061,9606.ENSP00000362524,9606.ENSP00000478570	SPARC,ANGPTL2,VEGFA
PMID:32438055	(2020) Extracellular matrix-derived peptides in tissue remodeling and fibrosis.	3	38	2.11	0.0443	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:28346545	(2017) Aqueous cytokine levels are associated with reduced macular thickness after intravitreal ranibizumab for diabetic macular edema.	3	38	2.11	0.0443	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:27591403	(2016) Redox signaling in cardiovascular pathophysiology: A focus on hydrogen peroxide and vascular smooth muscle cells.	3	38	2.11	0.0443	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:26367079	(2015) Endostatins emerging roles in angiogenesis, lymphangiogenesis, disease, and clinical applications.	3	38	2.11	0.0443	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:21904523	(2011) Vascular growth in health and disease.	3	38	2.11	0.0443	9606.ENSP00000334329,9606.ENSP00000451040,9606.ENSP00000478570	UNC5B,PGF,VEGFA
PMID:32103637	(2020) Endothelial and Inflammation Biomarker Profiles at Diagnosis Reflecting Clinical Heterogeneity and Serving as a Prognostic Tool for Treatment Response in Two Independent Cohorts of Patients With Juvenile Dermatomyositis.	3	39	2.1	0.0460	9606.ENSP00000231061,9606.ENSP00000451040,9606.ENSP00000478570	SPARC,PGF,VEGFA
PMID:29425770	(2018) Scarring vs. functional healing: Matrix-based strategies to regulate tissue repair.	3	39	2.1	0.0460	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:30323895	(2018) SSeCKSAkap12 suppresses metastatic melanoma lung colonization by attenuating Src-mediated pre-metastatic niche crosstalk.	3	39	2.1	0.0460	9606.ENSP00000231061,9606.ENSP00000451040,9606.ENSP00000478570	SPARC,PGF,VEGFA
PMID:26078592	(2015) Characterization of Serum Cytokine Profile in Predominantly Colonic Inflammatory Bowel Disease to Delineate Ulcerative and Crohns Colitides.	3	39	2.1	0.0460	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:24959816	(2014) Biological roles of uterine glands in pregnancy.	3	39	2.1	0.0460	9606.ENSP00000220166,9606.ENSP00000276571,9606.ENSP00000478570	CTSH,CRH,VEGFA
PMID:25332783	(....) blood vessel repair and regeneration in the ischaemic heart.	3	39	2.1	0.0460	9606.ENSP00000363827,9606.ENSP00000451040,9606.ENSP00000478570	HSPG2,PGF,VEGFA
PMID:32619204	(2022) Optimized Curcumin, Pomegranate Extract, and Methylsulfonylmethane Reduce Acute, Systemic Inflammatory Response to a Half-marathon Race.	2	8	2.61	0.0461	9606.ENSP00000006053,9606.ENSP00000231061	CX3CL1,SPARC
PMID:32980358	(2022) Eclampsia in the 21st century.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32986992	(2022) Complement activation and regulation in preeclampsia and hemolysis, elevated liver enzymes, and low platelet count syndrome.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33096092	(2022) Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33910378	(2022) Assessment of Biomarker Heterogeneity in Sinus Versus Inferior Turbinate Tissue in Patients Without Chronic Rhinosinusitis.	2	7	2.67	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:33950200	(2022) Renal dysfunction and podocyturia in pre-eclampsia may be explained by increased urinary VEGF.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34159524	(2022) MiR-590-3p and its targets VEGF, PIGF, and MMP9 in early, middle, and late pregnancy: their longitudinal changes and correlations with risk of fetal growth restriction.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34260829	(2022) Monitoring intraocular proangiogenic and profibrotic cytokines within 7 days after adjunctive anti-vascular endothelial growth factor therapy for proliferative diabetic retinopathy.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34432111	(2022) Course of the sFlt-1PlGF ratio in fetal growth restriction and correlation with biometric measurements, feto-maternal Doppler parameters and time to delivery.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34494211	(2022) Acute Intracranial Hypertension During Pregnancy: Special Considerations and Management Adjustments.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34558384	(2022) Predictive value of vascular endothelial growth factor and placenta growth factor for placenta accreta spectrum.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34606040	(2022) Expanding the horizon of research into the pathogenesis of the white matter diseases: Proceedings of the 2021 Annual Workshop of the Albert Research Institute for White Matter and Cognition.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34617432	(2022) Association of Pre-Transplant Angiopoietin-2 Index with the Risk of Acute Graft-Versus-Host Disease after Hematopoietic Stem Cell Transplantation	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34687769	(2022) Therapeutic antibodies - natural and pathological barriers and strategies to overcome them.	3	40	2.09	0.0461	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:34714383	(2022) Cytokine profiles of macular neovascularization in the elderly based on a classification from a pachychoroiddrusen perspective.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34731094	(2022) changes in systemic levels of vascular endothelial growth factor after intravitreal injection of aflibercept or brolucizumab for neovascular age-related macular degeneration.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34741684	(2022) Dietary supplementation with L-arginine between days 14 and 25 of gestation enhances NO and polyamine syntheses and the expression of angiogenic proteins in porcine placentae.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34743622	(2022) Physiological characterization of an arginine vasopressin rat model of preeclampsia.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34781187	(2022) Matrine inhibits synovial angiogenesis in collagen-induced arthritis rats by regulating HIF-VEGF-Ang and inhibiting the PI3KAkt signaling pathway.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34782555	(2022) All roads lead to Rome - a review of the potential mechanisms by which exerkines exhibit neuroprotective effects in Alzheimers disease.	3	80	1.79	0.0461	9606.ENSP00000363827,9606.ENSP00000451040,9606.ENSP00000478570	HSPG2,PGF,VEGFA
PMID:34815778	(2022) Current trends in gene therapy for retinal diseases (Review).	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34847843	(2022) In-silico Screening of Phytoconstituents on Wound Healing Targets - Approaches and Current Status.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34875452	(2022) Mesenchymal stem cell therapy attenuates complement C3 deposition and improves the delicate equilibrium between angiogenic and anti-angiogenic factors in abortion-prone mice.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34954204	(2022) Intravitreal administration of recombinant human opticin protects against hyperoxia-induced pre-retinal neovascularization.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34962228	(2022) MonolithHydrogel composites as triamcinolone acetonide carriers for curing corneal neovascularization in mice by inhibiting the fibrinolytic system.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34986714	(2022) Safety and efficacy review of aflibercept for the treatment of metastatic colorectal cancer.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34986859	(2022) Application of decellularized bone matrix as a bioscaffold in bone tissue engineering.	2	13	2.4	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:34991614	(2022) Preeclampsia at delivery is associated with lower serum vitamin D and higher antiangiogenic factors: a case control study.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34996371	(2022) D-dimer level significance for deep vein thrombosis screening in the third trimester: a retrospective study.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35008401	(2022) The Functional Role of Extracellular Matrix Proteins in Cancer.	3	60	1.91	0.0461	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:35009464	(2022) Osteogenic Potential of Magnesium (Mg)-Doped Multicomponent Bioactive Glass: In Vitro and In Vivo Animal Studies.	2	8	2.61	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:35027613	(2022) Diabetic macular edema and proliferative diabetic retinopathy treated with anti-vascular endothelial growth factor under the reimbursement policy in Taiwan.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35028761	(2022) Comparison of before versus after intravitreal bevacizumab injection, growth factor levels and fibrotic markers in vitreous samples from patients with proliferative diabetic retinopathy.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35030965	(2022) Paeoniflorin alleviates NG-nitro-L-arginine methyl ester (L-NAME)-induced gestational hypertension and upregulates silent information regulator 2 related enzyme 1 (SIRT1) to reduce H2O2-induced endothelial cell damage.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35035489	(2022) Umbilical Cord Mesenchymal Stromal Cells for Cartilage Regeneration Applications.	3	91	1.73	0.0461	9606.ENSP00000363827,9606.ENSP00000451040,9606.ENSP00000478570	HSPG2,PGF,VEGFA
PMID:35053329	(2022) Atypical Roles of the Chemokine Receptor ACKR3CXCR7 in Platelet Pathophysiology.	3	63	1.89	0.0461	9606.ENSP00000006053,9606.ENSP00000304767,9606.ENSP00000478570	CX3CL1,P2RY1,VEGFA
PMID:35053547	(2022) Targeting PELP1 Attenuates Angiogenesis and Enhances Chemotherapy Efficiency in Colorectal Cancer.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35054779	(2022) Multiple Faces of the Glioblastoma Microenvironment.	3	94	1.72	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:35056766	(2022) The Effects of Polyphenol, Tannic Acid, or Tannic Acid in Combination with Pamidronate on Human Osteoblast Cell Line Metabolism.	2	11	2.47	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:35071967	(2022) Differential effects of vascular endothelial growth factor on glycocalyx of endothelial and tumor cells and potential targets for tumor metastasis.	2	13	2.4	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:35102748	(2022) Pentosan Polysulfate, a Semisynthetic Heparinoid Disease-Modifying Osteoarthritic Drug with Roles in Intervertebral Disc Repair Biology Emulating the Stem Cell Instructive and Tissue Reparative Properties of Heparan Sulfate.	2	4	2.91	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:35103255	(2022) Potential role of neurofilament in COVID-19 and preeclampsia.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35110976	(2022) Puerarin Reduces Radiation-Induced Vascular Endothelial Cell Damage Via miR-34aPlacental Growth Factor.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35119039	(2022) Angiogenin and MMP-2 as potential biomarkers in the differential diagnosis of gestational trophoblastic diseases.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35127458	(2022) Placental growth factor testing for pre-eclampsia.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35130745	(2022) The involvement of long noncoding RNA APOA1-AS in the pathogenesis of preeclampsia.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35140561	(2022) Serum biomarkers for the prediction and diagnosis of preeclampsia: A meta-analysis.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35141350	(2022) Delivery of nVEGFi using AAV8 for the treatment of neovascular age-related macular degeneration.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35163664	(2022) Electrospun Fiber-Coated Human Amniotic Membrane: A Potential Angioinductive Scaffold for Ischemic Tissue Repair.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35171350	(2022) Cabozantinib with or without Panitumumab for RAS wild-type metastatic colorectal cancer: impact of MET amplification on clinical outcomes and circulating biomarkers.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35173715	(2022) Decidualization of Stromal Cells Promotes Involvement of Mast Cells in Successful Human Pregnancy by Increasing Stem Cell Factor Expression.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35177223	(2022) Progress in the understanding of the pathophysiology of immunologic maladaptation related to early-onset preeclampsia and metabolic syndrome related to late-onset preeclampsia.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35183207	(2022) Nomogram for predicting occurrence of synchronous liver metastasis in colorectal cancer: a single-center retrospective study based on pathological factors.	2	8	2.61	0.0461	9606.ENSP00000362524,9606.ENSP00000478570	ANGPTL2,VEGFA
PMID:35202416	(2022) sFlt-1PlGF ratio for prediction of preeclampsia in clinical routine: A pragmatic real-world analysis of healthcare resource utilisation.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35203414	(2022) VEGF-Trap Modulates Retinal Inflammation in the Murine Oxygen-Induced Retinopathy (OIR) Model.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35203431	(2022) Transcriptomic and Lipidomic Mapping of Macrophages in the Hub of Chronic Beta-Adrenergic-Stimulation Unravels Hypertrophy-, Proliferation-, and Lipid Metabolism-Related Genes as Novel Potential Markers of Early Hypertrophy or Heart Failure.	3	114	1.63	0.0461	9606.ENSP00000006053,9606.ENSP00000231061,9606.ENSP00000304767	CX3CL1,SPARC,P2RY1
PMID:35203674	(2022) Minimum Effective Dose of DPP-4 Inhibitors for Treating Early Stages of Diabetic Retinopathy in an Experimental Model.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35206485	(2022) The Effectiveness of Brolucizumab and Aflibercept in Patients with Neovascular Age-Related Macular Degeneration.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35211228	(2022) Difficulties in Differentiating Hypertensive Disorders of Pregnancy With Polyarteritis Nodosa.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35215044	(2022) Elevated Urinary Biomarkers of Oxidative Damage in Photocopier Operators following Acute and Chronic Exposures.	2	13	2.4	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:35241761	(2022) The cognitive and psychiatric subacute impairment in severe Covid-19.	2	9	2.56	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:35242191	(2022) Effect of an Autogenous Leukocyte Platelet-Rich Fibrin Tooth Graft Combination around Immediately Placed Implants in Periodontally Compromised Sites: A Randomized Clinical Trial.	2	6	2.74	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:35246569	(2022) Hematobiochemical variability and predictors of new-onset and persistent postpartum preeclampsia.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35247371	(2022) Isoflurane and Netrin-1 combination therapy enhances angiogenesis and neurological recovery by improving the expression of HIF-1alpha-Netrin-1-UNC5BVEGF cascade to attenuate cerebral ischemia injury.	2	7	2.67	0.0461	9606.ENSP00000334329,9606.ENSP00000478570	UNC5B,VEGFA
PMID:35249426	(2022) Cardiovascular and hemodynamic consequences of recombinant placental growth factor administration in Guinea pigs.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35251705	(2022) Intravitreal Conbercept with GridFocal Photocoagulation for the Treatment of Diabetic Macular Edema: A Systematic Review and Meta-Analysis.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35252131	(2022) Decellularized Tissues for Wound Healing: Towards Closing the Gap Between Scaffold Design and Effective Extracellular Matrix Remodeling.	3	60	1.91	0.0461	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:35252267	(2022) Short-Term Efficacy in Polypoidal Choroidal Vasculopathy Patients Treated With Intravitreal Aflibercept or Conbercept.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35256840	(2022) Real-World Data on Intravitreal Aflibercept for Macular Edema Secondary to Central Retinal Vein Occlusion: 24-Month Outcomes.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35268340	(2022) The Role of Extracellular Matrix Proteins in Breast Cancer.	3	86	1.75	0.0461	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:35273734	(2022) Pars plana vitrectomy assisted by intravitreal injection of conbercept enhances the therapeutic effect and quality of life in patients with severe proliferative diabetic retinopathy.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35275947	(2022) The feasibility of soluble Fms-Like Tyrosine kinase-1 (sFLT-1) and Placental Growth Factor (PlGF) ratio biomarker in predicting preeclampsia and adverse pregnancy outcomes among medium to high risk mothers in Kuala Lumpur, Malaysia.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35277107	(2022) Sorafenib-loaded nanostructured lipid carriers for topical ocular therapy of corneal neovascularization: development, in-vitro and in vivo study.	2	6	2.74	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:35296029	(2022) Strategy for improving cell-mediated vascularized soft tissue formation in a hydrogen peroxide-triggered chemically-crosslinked hydrogel.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35300623	(2022) Placental growth factor level is correlated with intrapartum fetal heart rate findings.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35304587	(2022) Serum markers of cardiac complications in a systemic sclerosis cohort.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35312727	(2022) Placental lesions and differential expression of pro-and anti-angiogenic growth mediators and oxidative DNA damage marker in placentae of Ghanaian suboptimal and optimal health status pregnant women who later developed preeclampsia.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35327520	(2022) First-Trimester Screening for Fetal Growth Restriction and Small-for-Gestational-Age Pregnancies without Preeclampsia Using Cardiovascular Disease-Associated MicroRNA Biomarkers.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35327757	(2022) Preeclampsia and Cerebral Palsy in Offspring.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35329377	(2022) Autogenous Tooth Bone Grafts for Repair and Regeneration of Maxillofacial Defects: A Narrative Review.	2	8	2.61	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:35335889	(2022) Effect of Thrombopoietin Receptor Agonist on Pregnant Mice.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35344068	(2022) Expression of glycosaminoglycans in cirrhotic liver and hepatocellular carcinoma-a pilot study including etiology.	2	14	2.37	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:35350049	(2022) relationship between choroidal findings and growth factors, cytokines, and other inflammatory mediators after intravitreal ranibizumab injection in patients with macular edema secondary to branch retinal vein occlusion.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35352255	(2022) The Role of Cytokines in Maintaining the Dynamics of Cell-Cell Interaction between Natural Killer Cells and Trophoblast Cells.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35360216	(2022) Microvascular Changes in Parkinsons Disease- Focus on the Neurovascular Unit.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35365223	(2022) Functional and structural characteristics in patients with diabetic macular oedema after switching from ranibizumab to aflibercept treatment. Three year results in real world settings.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35368240	(2022) Neovascular Age-Related Macular Degeneration (nAMD): A Review of Emerging Treatment Options.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35371322	(2022) Tranexamic acid reduces endometrial cancer effects through the production of angiostatin.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35371996	(2022) Flavonoids Inhibit Cancer by Regulating the Competing Endogenous RNA Network.	2	9	2.56	0.0461	9606.ENSP00000006053,9606.ENSP00000379256	CX3CL1,NCALD
PMID:35373690	(2022) Corneal neovascularization inhibition and wound healing impregnability of conbercept on rabbit cornea after penetrating keratoplasty.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35378955	(2022) Insight in Hypoxia-Mimetic Agents as Potential Tools for Mesenchymal Stem Cell Priming in Regenerative Medicine.	3	72	1.83	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:35388745	(2022) Enhanced anti-angiogenetic effect of transferrin receptor-mediated delivery of VEGF-trap in a glioblastoma mouse model.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35392083	(2022) Neuroinflammation Following Traumatic Brain Injury: Take It Seriously or Not.	3	58	1.93	0.0461	9606.ENSP00000006053,9606.ENSP00000304767,9606.ENSP00000478570	CX3CL1,P2RY1,VEGFA
PMID:35393492	(2022) The CMS19 disease model specifies a pivotal role for collagen XIII in bone homeostasis.	2	11	2.47	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:35399721	(2022) MiR-211-5p Inhibits the Biological Behaviors of Colorectal Cancer via SPARC-Related Growth Factor Pathways.	2	8	2.61	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:35402416	(2022) A Review of Nanotechnology for Treating Dysfunctional Placenta.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35405946	(2022) Omega-3Omega-6 Long-Chain Fatty Acid Imbalance in Phase I Retinopathy of Prematurity.	2	12	2.43	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:35415271	(2022) Consecutive chorioangiomas in the same pregnancy: A clinical case and review of literature.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35419175	(2022) Comparative effects of Er:YAG laser, and EDTA, MTAD, and QMix irrigants on adhesion of stem cells from the apical papilla to dentin: A scanning electron microscopic study.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35422768	(2022) Effectiveness of Panretinal Photocoagulation Plus Intravitreal Anti-VEGF Treatment Against PRP Alone for Diabetic Retinopathy: A Systematic Review With Meta-Analysis.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35432451	(2022) Small Non-Coding RNAs in the Human Placenta: Regulatory Roles and Clinical Utility.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35464849	(2022) Effects of Inflammatory Response Genes on the Immune Microenvironment in Colorectal Cancer.	2	9	2.56	0.0461	9606.ENSP00000006053,9606.ENSP00000276571	CX3CL1,CRH
PMID:35487327	(2022) Placental protein levels in maternal serum are associated with adverse pregnancy outcomes in nulliparous patients.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35490598	(2022) The endocannabinoids anandamide and 2-arachidonoylglycerol modulate the expression of angiogenic factors on HTR8SVneo placental cells.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35491659	(2022) Impact of obstructive sleep apnea on the expression of inflammatory mediators in diabetic macular edema.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35493107	(2022) The Role of Syncytin in Placental Angiogenesis and Fetal Growth.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35596772	(2022) Correlation of chemokines and growth factors with radiation-induced liver injury after interstitial high dose rate (HDR) brachytherapy of liver metastases.	2	4	2.91	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:35625687	(2022) Vascular Endothelial Growth Factor as a Potential Biomarker of Neuroinflammation and Frontal Cognitive Impairment in Patients with Alcohol Use Disorder.	2	6	2.74	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:35726123	(2022) Association between placenta accreta spectrum and third-trimester serum levels of vascular endothelial growth factor, placental growth factor, and soluble Fms-like tyrosine kinase-1: A meta-analysis.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35760012	(2022) Neuropilin-1 is uniquely expressed on small syncytiotrophoblast extracellular vesicles but not on mediumlarge vesicles from preeclampsia and normal placentae.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35770197	(2022) Aqueous Humor Analyses in Patients with Diabetic Retinopathy Who Had Undergone Panretinal Photocoagulation.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35771301	(2022) Phase I study of aflibercept in combination with docetaxel in Japanese patients with advanced solid malignancies.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35782511	(2022) Bone Marrow Derived Mesenchymal Stromal Cells Promote Vascularization and Ciliation in Airway Mucosa Tri-Culture Models in Vitro.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35792789	(2022) Effects of teriparatide on bone formation in rats with experimentally induced premaxillary expansion.	2	3	3.04	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:35846042	(2022) A nonrandomized phase I and biomarker trial of regorafenib in advanced myeloid malignancies.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35866241	(2022) An observational study of pro- and anti-angiogenic factors in hypertensive disorders of pregnancy in women of African ancestry.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35878392	(2022) Characterization of the Expression of Angiogenic Factors in Cutaneous Squamous Cell Carcinoma of Domestic Cats.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35923506	(2022) Model for Early Prediction of Preeclampsia: A Nested Case Controlled Study in Indian Women.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35954937	(2022) Seawater Hydration Modulates IL-6 and Apelin Production during Triathlon Events: A Crossover Randomized Study.	2	11	2.47	0.0461	9606.ENSP00000006053,9606.ENSP00000231061	CX3CL1,SPARC
PMID:35970387	(2022) Placental growth factor stabilizes VEGF receptor-2 protein in retinal pigment epithelial cells by downregulating glycogen synthase kinase 3 activity.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:36012558	(2022) Dentin Particulate for Bone Regeneration: An In Vitro Study.	2	7	2.67	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:36032250	(2022) Peripheral inflammation levels associated with degree of advanced brain aging in schizophrenia.	2	13	2.4	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:36049461	(2022) Artificial microvesicles: new perspective on healing tendon wounds.	2	2	3.21	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:36063615	(2022) 2, 2, 4, 4-tetrabromodiphenyl ether induces placental toxicity via activation of p38 MAPK signaling pathway in vivo and in vitro.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:36075122	(2022) Maternal cadmium exposure impairs placental angiogenesis in preeclampsia through disturbing thyroid hormone receptor signaling.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:36077527	(2022) Evaluation of the Effect of the Fibroblast Growth Factor Type 2 (FGF-2) Administration on Placental Gene Expression in a Murine Model of Preeclampsia Induced by L-NAME.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:36081818	(2022) Cognitive changes mediated by adenosine receptor blockade in a resveratrol-treated atherosclerosis-prone lupus mouse model.	2	5	2.81	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:36110982	(2022) Expression and Relationship of Netrin-1, DCC, UNC5B, and VEGF in Villous Tissues of Patients with Delayed Abortion.	2	3	3.04	0.0461	9606.ENSP00000334329,9606.ENSP00000478570	UNC5B,VEGFA
PMID:36114375	(2022) Design, construction and in vivo functional assessment of a hinge truncated sFLT01.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:36120723	(2022) Serum levels of angiogenesis-related factors in patients with psoriasis.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:36135186	(2022) Circulating Angiogenic Markers in Gastroenteropancreatic Neuroendocrine Neoplasms: A Systematic Review.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:36157115	(2022) Prognostic role of expression of angiogenesis markers in hepatocellular carcinoma: A bioinformatics analysis.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:36181981	(2022) Adipocyte coculture induces a pro-inflammatory, fibrotic, angiogenic, and proliferative microenvironment in uterine leiomyoma cells.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:36228770	(2022) Attenuated effect of zinc gluconate on oxidative stress, inflammation, and angiogenic imbalance in pre-eclampsia rats.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31307255	(2021) Maternal and neonatal serum expression of the vascular growth factors in hyperglycemia in pregnancy.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31421056	(2021) Neurobiology of resilience in depression: immune and vascular insights from human and animal studies.	3	41	2.08	0.0461	9606.ENSP00000006053,9606.ENSP00000276571,9606.ENSP00000478570	CX3CL1,CRH,VEGFA
PMID:31581866	(2021) DNA methylation profiles of genes associated with angiogenesis in the samples of placenta in pregnancies complicated by intrauterine growth restriction.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31608721	(2021) Syndecan 4, galectin 2, and death receptor 3 (DR3) as novel proteins in pathophysiology of preeclampsia.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31690095	(2021) Change of cytokines after intravitreal ranibizumab in patients with recurrent branch retinal vein occlusion and macular edema.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32131668	(2021) Halogen gas exposure: toxic effects on the parturient.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32253702	(2021) Perlecan Domain-V Enhances Neurogenic Brain Repair After Stroke in Mice.	2	11	2.47	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:32269060	(2021) Gene therapy for neovascular age-related macular degeneration: rationale, clinical trials and future directions.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32347034	(2021) A Moderate Increase in Ambient Temperature Influences The Structure and Hormonal Secretion of Adrenal Glands in Rats.	2	5	2.81	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:32583963	(2021) Soluble Flt-1, Placental Growth Factor, and Vascular Endothelial Growth Factor Serum Levels to Differentiate Between Active Lupus Nephritis During Pregnancy and Preeclampsia.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32617576	(2021) Role of A Novel Angiogenesis FKBPL-CD44 Pathway in Preeclampsia Risk Stratification and Mesenchymal Stem Cell Treatment.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32804349	(2021) Circulating endothelial progenitor cells during pregnancy in multiple sclerosis.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32813109	(2021) Vitreous levels of vascular endothelial growth factor, stromal cell-derived factor-1alpha, and angiopoietin-like protein 2 in patients with active proliferative diabetic retinopathy.	2	2	3.21	0.0461	9606.ENSP00000362524,9606.ENSP00000478570	ANGPTL2,VEGFA
PMID:32920752	(2021) COVID-19 and its Therapeutics: Special Emphasis on Mesenchymal Stem Cells Based Therapy.	3	69	1.85	0.0461	9606.ENSP00000231061,9606.ENSP00000451040,9606.ENSP00000478570	SPARC,PGF,VEGFA
PMID:33137710	(2021) MZe786, a hydrogen sulfide-releasing aspirin prevents preeclampsia in heme oxygenase-1 haplodeficient pregnancy under high soluble flt-1 environment.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33157413	(2021) The binding of kaempferol-3-O-rutinoside to vascular endothelial growth factor potentiates anti-inflammatory efficiencies in lipopolysaccharide-treated mouse macrophage RAW264.7 cells.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33176035	(2021) Vascular endothelial growth factor and poor prognosis after ischaemic stroke.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33188643	(2021) Investigating apoptotic, inflammatory, and growth markers in poor responders undergoing natural in vitro fertilization cycles: a pilot study.	2	5	2.81	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:33199490	(2021) Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33211274	(2021) Fetal Growth Restriction: Does an Integrated Maternal Hemodynamic-Placental Model Fit Better?	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33216690	(2021) Summary and Conclusion: Framing a New Research Agenda on Maternal Morbidities and Mortality in the United States.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33227710	(2021) Capilliposide B blocks VEGF-induced angiogenesis in vitro in primary human retinal microvascular endothelial cells.	2	5	2.81	0.0461	9606.ENSP00000220166,9606.ENSP00000478570	CTSH,VEGFA
PMID:33229723	(2021) Bioinformatic analysis of cytokine expression in the proximal and distal nerve stumps after peripheral nerve injury.	3	52	1.97	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:33289019	(2021) Acute, Exercise-Induced Alterations in Cytokines and Chemokines in the Blood Distinguish Physically Active and Sedentary Aging.	2	12	2.43	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:33301375	(2021) First-in-Human Phase I Study of MP0250, a First-in-Class DARPin Drug Candidate Targeting VEGF and HGF, in Patients With Advanced Solid Tumors.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33307629	(2021) One-year Results of Aflibercept Treatment for Polypoidal Choroidal Vasculopathy with Good Visual Acuity.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33335277	(2021) Tackling AKI: prevention, timing of dialysis and follow-up.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33388468	(2021) A Case-Control Study of Peripartum Cardiomyopathy Using the Rochester Epidemiology Project.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33391442	(2021) Prognostic Factors of Survival with Aflibercept and FOLFIRI (fluorouracil, leucovorin, irinotecan) as Second-line Therapy for Patients with Metastatic Colorectal Cancer.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33404981	(2021) Impact of COVID-19 in the Mental Health in Elderly: Psychological and Biological Updates.	2	14	2.37	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:33407494	(2021) PlGF knockdown attenuates hypoxia-induced stimulation of cell proliferation and glycolysis of lung adenocarcinoma through inhibiting Wntbeta-catenin pathway.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33410627	(2021) Pandemic of the aging society - sporadic cerebral small vessel disease.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33412121	(2021) Macular Microvascular Changes and Their Correlation With Peripheral Nonperfusion in Branch Retinal Vein Occlusion.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33413598	(2021) Preclinical efficacy of stem cell therapy for skin flap: a systematic review and meta-analysis.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33415353	(2021) Switching anti-VEGF agent for wet AMD: evaluation of impact on visual acuity, treatment frequency and retinal morphology in a real-world clinical setting.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33419165	(2021) Pravastatin Promotes Endothelial Colony-Forming Cell Function, Angiogenic Signaling and Protein Expression In Vitro.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33420256	(2021) Hypoxia-induced amniotic fluid stem cell secretome augments cardiomyocyte proliferation and enhances cardioprotective effects under hypoxic-ischemic conditions.	3	42	2.07	0.0461	9606.ENSP00000362524,9606.ENSP00000451040,9606.ENSP00000478570	ANGPTL2,PGF,VEGFA
PMID:33430201	(2021) Endothelial Cells as Tools to Model Tissue Microenvironment in Hypoxia-Dependent Pathologies.	3	75	1.81	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:33432033	(2021) Relationship between distribution and severity of non-perfusion and cytokine levels and macular thickness in branch retinal vein occlusion.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33441810	(2021) A pilot study investigating anterior segment optical coherence tomography angiography as a non-invasive tool in evaluating corneal vascularisation.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33445804	(2021) Purinergic Receptor Blockade with Suramin Increases Survival of Postnatal Neural Progenitor Cells In Vitro.	2	10	2.51	0.0461	9606.ENSP00000304767,9606.ENSP00000478570	P2RY1,VEGFA
PMID:33451290	(2021) Asymmetric response to ranibizumab in mixed choroidal neovascularization in a neovascular age-related macular degeneration diagnosed on OCT angiography - case report.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33463594	(2021) Commentary: Switching of anti-vascular endothelial growth factor agents in refractory diabetic macular edema.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33463910	(2021) Physical activity differentially regulates VEGF, PlGF, and their receptors in the human placenta.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33469129	(2021) Intrastromal versus subconjunctival anti-VEGF agents for treatment of corneal neovascularization: a rabbit study.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33498916	(2021) Hypertensive Disorders of Pregnancy in Relation to Coffee and Tea Consumption: The Japan Environment and Childrens Study.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33503177	(2021) Previous preeclampsia and its association with the future development of cardiovascular diseases: a systematic review and meta-analysis.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33504861	(2021) Placental and maternal sFlt1PlGF expression in gestational diabetes mellitus.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33507997	(2021) Choroidal congestion mouse model: Could it serve as a pachychoroid model?	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33511039	(2021) Central nervous system solitary fibrous tumourhemangiopericytoma presenting as nausea, vomiting and hepatic dysfunction after the first trimester of pregnancy: A case report.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33511299	(2021) Protocol for a feasibility and early efficacy study of the Comprehensive Lifestyle Improvement Program for Prostate Cancer-2 (CLIPP2).	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33511599	(2021) Effect of Caffeic Acid Phenethyl Ester Provision on Fibroblast Growth Factor-2, Matrix Metalloproteinase-9 Expression, Osteoclast and Osteoblast Numbers during Experimental Tooth Movement in Wistar Rats (Rattus norvegicus).	2	12	2.43	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:33518533	(2021) Myristoleic Acid Promotes Anagen Signaling by Autophagy through Activating Wntbeta-Catenin and ERK Pathways in Dermal Papilla Cells.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33520013	(2021) Myokines and Heart Failure: Challenging Role in Adverse Cardiac Remodeling, Myopathy, and Clinical Outcomes.	3	53	1.97	0.0461	9606.ENSP00000006053,9606.ENSP00000231061,9606.ENSP00000478570	CX3CL1,SPARC,VEGFA
PMID:33521368	(2021) Type of culture medium determines properties of cultivated retinal endothelial cells: induction of substantial phenotypic conversion by standard DMEM.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33521587	(2021) Modelling preeclampsia: a comparative analysis of the common human trophoblast cell lines.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33540895	(2021) Silk Fibroin as a Functional Biomaterial for Tissue Engineering.	2	11	2.47	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:33546596	(2021) Eosinophil-to-monocyte ratio is a potential biomarker in the prediction of functional outcome among patients with acute ischemic stroke.	2	7	2.67	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:33553594	(2021) Least squares and maximum likelihood estimation of sufficient reductions in regressions with matrix-valued predictors.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33553932	(2021) A Three-Dimensional Microfluidic Device for Monitoring Cancer and Chemotherapy-Associated Platelet Activation.	2	8	2.61	0.0461	9606.ENSP00000304767,9606.ENSP00000478570	P2RY1,VEGFA
PMID:33558654	(2021) Berberine alleviates visceral hypersensitivity in rats by altering gut microbiome and suppressing spinal microglial activation.	2	3	3.04	0.0461	9606.ENSP00000006053,9606.ENSP00000276571	CX3CL1,CRH
PMID:33562840	(2021) Multicellular 3D Models to Study Tumour-Stroma Interactions.	2	12	2.43	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:33571295	(2021) Aflibercept for treatment-naive diabetic macula oedema in a multi-ethnic population: Real-world outcomes from North West London.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33572320	(2021) Overview of MMP-13 as a Promising Target for the Treatment of Osteoarthritis.	3	76	1.81	0.0461	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:33578584	(2021) Higher levels of circulating ANGPTL2 are associated with macular edema in patients with type 2 diabetes.	2	5	2.81	0.0461	9606.ENSP00000362524,9606.ENSP00000478570	ANGPTL2,VEGFA
PMID:33589713	(2021) Relapse of pathological angiogenesis: functional role of the basement membrane and potential treatment strategies.	3	52	1.97	0.0461	9606.ENSP00000363827,9606.ENSP00000451040,9606.ENSP00000478570	HSPG2,PGF,VEGFA
PMID:33593720	(2021) Rediscovery of a forgotten disease: Hereditary Angioedema.	2	13	2.4	0.0461	9606.ENSP00000450482,9606.ENSP00000478570	BDKRB2,VEGFA
PMID:33614783	(2021) Imaging Hyperreflective Foci as an Inflammatory Biomarker after Anti-VEGF Treatment in Neovascular Age-Related Macular Degeneration Patients with Optical Coherence Tomography Angiography.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33627152	(2021) Au-siRNA@ aptamer nanocages as a high-efficiency drug and gene delivery system for targeted lung cancer therapy.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33628483	(2021) Clinical Observation of Phacoemulsification Combined with Intravitreal Injection of Conbercept in Cataract Patients with Diabetic Macular Edema.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33628552	(2021) Intravitreal Aflibercept as a Rescue Therapy for Retinal Neovascularization and Macular Edema due to Eales Disease.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33630242	(2021) Patient profiles as an aim to optimize selection in the second line setting: the role of aflibercept.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33630870	(2021) A ligand-targeting peptide-drug conjugate: Targeted intracellular drug delivery by VEGF-binding helix-loop-helix peptides via receptor-mediated endocytosis.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33646290	(2021) Tear Fluid Angiogenic Factors: Potential Noninvasive Biomarkers for Retinopathy of Prematurity Screening in Preterm Infants.	2	11	2.47	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:33652530	(2021) Hypoxia during incubation and its effects on broilers embryonic development.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33652665	(2021) Combined Effects of Methyldopa and Flavonoids on the Expression of Selected Factors Related to Inflammatory Processes and Vascular Diseases in Human Placenta Cells-An In Vitro Study.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33658584	(2021) Effect of intravitreal ranibizumab and aflibercept injections on retinal nerve fiber layer thickness.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33662577	(2021) Selective deletion of connective tissue growth factor attenuates experimentally-induced pulmonary fibrosis and pulmonary arterial hypertension.	2	11	2.47	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:33663431	(2021) Intravitreal conbercept for choroidal neovascularisation secondary to pathological myopia in a real-world setting in China : Intravitreal conbercept was safe and effective in treating myopic choroidal neovascularization.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33671638	(2021) Disabling VEGF-Response of Purkinje Cells by Downregulation of KDR via miRNA-204-5p.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33674712	(2021) 80 Years of vision: preventing blindness from retinopathy of prematurity.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33679614	(2021) Clinical Heterogeneity of Acquired Idiopathic Isolated Adrenocorticotropic Hormone Deficiency.	2	13	2.4	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:33682756	(2021) Prediction of hypertensive disorders in pregnancy based on placental growth factor.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33688979	(2021) Cerebrovascular development: mechanisms and experimental approaches.	3	61	1.9	0.0461	9606.ENSP00000362524,9606.ENSP00000363827,9606.ENSP00000478570	ANGPTL2,HSPG2,VEGFA
PMID:33694304	(2021) Biological drug therapy for ocular angiogenesis: Anti-VEGF agents and novel strategies based on nanotechnology.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33710019	(2021) Plasma biomarker factors associated with neurodevelopmental outcomes in children with perinatal HIV infection and controlled viremia.	2	10	2.51	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:33718834	(2021) A robust platform for high-throughput screening of therapeutic strategies for acute and chronic spinal cord injury.	3	50	1.99	0.0461	9606.ENSP00000006053,9606.ENSP00000304767,9606.ENSP00000478570	CX3CL1,P2RY1,VEGFA
PMID:33720933	(2021) Human induced pluripotent stem cell-derived three-dimensional cardiomyocyte tissues ameliorate the rat ischemic myocardium by remodeling the extracellular matrix and cardiac protein phenotype.	2	10	2.51	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:33727707	(2021) Short-term prediction of preeclampsia using the sFlt-1PlGF ratio: a subanalysis of pregnant Japanese women from the PROGNOSIS Asia study.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33731008	(2021) The Bdkrb2 gene family provides a novel view of viviparity adaptation in Sebastes schlegelii.	2	10	2.51	0.0461	9606.ENSP00000450482,9606.ENSP00000478570	BDKRB2,VEGFA
PMID:33732305	(2021) Effect of intravitreal conbercept injection on VEGF-A and -B levels in the aqueous and vitreous humor of patients with proliferative diabetic retinopathy.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33738349	(2021) Endostatin and Vascular Endothelial Growth Factor-A165b May Contribute to Classification of Pulmonary Hypertension.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33740264	(2021) FIGO (international Federation of Gynecology and obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33747556	(2021) Aflibercept Intervention in Experimental Branch Retinal Vein Occlusion Results in Upregulation of DnaJ Homolog Subfamily C Member 17.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33752600	(2021) The migratory pathways of the cells that form the endocardium, dorsal aortae, and head vasculature in the mouse embryo.	2	10	2.51	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:33758662	(2021) Invasive procedures in patients undergoing treatment with lenvatinib for thyroid cancer.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33760176	(2021) Interaction of non-parenchymal hepatocytes in the process of hepatic fibrosis (Review).	3	47	2.02	0.0461	9606.ENSP00000363827,9606.ENSP00000451040,9606.ENSP00000478570	HSPG2,PGF,VEGFA
PMID:33761782	(2021) Human NK cells: From development to effector functions.	3	111	1.64	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:33766798	(2021) Sequestered cell-secreted extracellular matrix proteins improve murine folliculogenesis and oocyte maturation for fertility preservation.	2	4	2.91	0.0461	9606.ENSP00000363827,9606.ENSP00000451040	HSPG2,PGF
PMID:33772356	(2021) Effects of ranibizumab on growth factors and mediators of inflammation in the aqueous humor of patients with diabetic macular edema.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33774655	(2021) KisspeptinKiss1r system and angiogenic and immunological mediators at the maternal-fetal interface of domestic cats.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33776318	(2021) Standardization and characterization of adipose-derived stromal vascular fraction from New Zealand white rabbits for bone tissue engineering.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33779058	(2021) Revealing serum lipidomic characteristics and potential lipid biomarkers in patients with POEMS syndrome.	2	3	3.04	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:33783686	(2021) A bi-directional dialog between vascular cells and monocytesmacrophages regulates tumor progression.	3	111	1.64	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:33789617	(2021) Panretinal photocoagulation after or prior to intravitreal conbercept injection for diabetic macular edema: a retrospective study.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33790566	(2021) NeutrophilLymphocyte Ratio as an Inflammatory Predictor of Dry Eye Disease: A Case-Control Study.	2	11	2.47	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:33795022	(2021) Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33804681	(2021) Role of bFGF in Acquired Resistance upon Anti-VEGF Therapy in Cancer.	3	40	2.09	0.0461	9606.ENSP00000006053,9606.ENSP00000231061,9606.ENSP00000478570	CX3CL1,SPARC,VEGFA
PMID:33808559	(2021) Insight into the Key Points of Preeclampsia Pathophysiology: Uterine Artery Remodeling and the Role of MicroRNAs.	3	54	1.96	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:33810434	(2021) Involvement of Cytokines in the Pathogenesis of Diabetic Macular Edema.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33820497	(2021) Imbalance of growth factors mRNA expression associated with oxidative stress in the early pregnancy loss.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33825942	(2021) Therapeutic aspects of cell signaling and communication in Duchenne muscular dystrophy.	3	81	1.78	0.0461	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:33830623	(2021) Placental growth factor level in plasma predicts COVID-19 severity and in-hospital mortality.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33840170	(2021) Screening of novel alkaloid inhibitors for vascular endothelial growth factor in cancer cells: an integrated computational approach.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33841102	(2021) Phosphoinositides: Roles in the Development of Microglial-Mediated Neuroinflammation and Neurodegeneration.	3	65	1.88	0.0461	9606.ENSP00000006053,9606.ENSP00000304767,9606.ENSP00000478570	CX3CL1,P2RY1,VEGFA
PMID:33876907	(2021) Physiopathology of late-onset fetal growth restriction.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33889280	(2021) Clinical efficacy and safety of second line and salvage aflibercept for advanced colorectal cancer in Akita prefecture.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33899746	(2021) Metastatic medullary thyroid carcinoma presenting as ectopic Cushings syndrome.	2	10	2.51	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:33910626	(2021) Identification of a prognostic long noncoding RNA signature in lung squamous cell carcinoma: a population-based study with a mean follow-up of 3.5 years.	2	14	2.37	0.0461	9606.ENSP00000276571,9606.ENSP00000304767	CRH,P2RY1
PMID:33913859	(2021) Commentary: Systemic versus imaging biomarkers for diabetic macular oedema - Where do we stand?	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33918101	(2021) Biocompatibility of a HAbeta-TCPC Scaffold as a Pulp-Capping Agent for Vital Pulp Treatment: An In Vivo Study in Rat Molars.	2	7	2.67	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:33920299	(2021) Anti-Angiogenic Therapy: Albumin-Binding Proteins Could Mediate Mechanisms Underlying the Accumulation of Small Molecule Receptor Tyrosine Kinase Inhibitors in Normal Tissues with Potential Harmful Effects on Health.	2	6	2.74	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:33923095	(2021) Anti-Inflammatory Role of Netrin-4 in Diabetic Retinopathy.	2	12	2.43	0.0461	9606.ENSP00000334329,9606.ENSP00000478570	UNC5B,VEGFA
PMID:33924191	(2021) Astrocyte Activation in Neurovascular Damage and Repair Following Ischaemic Stroke.	3	95	1.71	0.0461	9606.ENSP00000231061,9606.ENSP00000451040,9606.ENSP00000478570	SPARC,PGF,VEGFA
PMID:33924614	(2021) Evaluating Oxygen Tensions Related to Bone Marrow and Matrix for MSC Differentiation in 2D and 3D Biomimetic Lamellar Scaffolds.	2	10	2.51	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:33926468	(2021) A heparin-rosuvastatin-loaded P(LLA-CL) nanofiber-covered stent inhibits inflammatory smooth-muscle cell viability to reduce in-stent stenosis and thrombosis.	2	13	2.4	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:33942489	(2021) Transforming growth factor-beta1 signalling triggers vascular endothelial growth factor resistance and monocyte dysfunction in type 2 diabetes mellitus.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33959027	(2021) Fibroblast Growth Factor Type 2 (FGF2) Administration Attenuated the Clinical Manifestations of Preeclampsia in a Murine Model Induced by L-NAME.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33959030	(2021) MAZ51 Blocks the Tumor Growth of Prostate Cancer by Inhibiting Vascular Endothelial Growth Factor Receptor 3.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33976663	(2021) Multimodal Imaging Findings and Treatment with Dexamethasone Implant in Three Cases of Idiopathic Macular Telangiectasia Type 1.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33987019	(2021) Identification of potential genes in upper tract urothelial carcinoma using next-generation sequencing with bioinformatics and in vitro analyses.	2	11	2.47	0.0461	9606.ENSP00000379256,9606.ENSP00000478570	NCALD,VEGFA
PMID:33988313	(2021) Involvement of chronic inflammation via monocyte chemoattractant protein-1 in uraemic cardiomyopathy: a human biopsy study.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33996679	(2021) Pre-eclampsia Complicated With Maternal Renal Dysfunction Is Associated With Poor Neurological Development at 3 Years Old in Children Born Before 34 Weeks of Gestation.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33997500	(2021) In situ bone regeneration with sequential delivery of aptamer and BMP2 from an ECM-based scaffold fabricated by cryogenic free-form extrusion.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33997524	(2021) Conduits Biology Regulates the Outcomes of Coronary Artery Bypass Grafting.	2	11	2.47	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:33998251	(2021) Sex, HIV Status, and Measures of Cardiac Stress and Fibrosis in Uganda.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34006633	(2021) Heparin-binding VEGFR1 variants as long-acting VEGF inhibitors for treatment of intraocular neovascular disorders.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34010297	(2021) Vitreous expression of cytokines and growth factors in patients with diabetic retinopathy-An investigation of their expression based on clinical diabetic retinopathy grade.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34010327	(2021) Circulating levels of angiogenic factors and their association with preeclampsia among pregnant women at Mulago National Referral Hospital in Uganda.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34010703	(2021) Development of strategies to modulate gene expression of angiogenesis-related molecules in the retina.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34011723	(2021) Significance of monitoring vascular endothelial growth factor, monocyte chemoattractant protein-1 and Interleukin-8 in diabetic macular edema towards early identification of nonresponders to ranibizumab therapy.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34013746	(2021) Effects of exercise training with weight loss on skeletal muscle expression of angiogenic factors in overweight and obese older men.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34015042	(2021) Relationship between proteinuria and optical coherence tomographic features of the chorioretina in patients with pre-eclampsia.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34017449	(2021) Celecoxib reduces inflammation and angiogenesis in mice with adenomyosis.	2	4	2.91	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:34024085	(2021) Transforming growth factor-beta and liver injury in an arginine vasopressin-induced pregnant rat model.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34025681	(2021) Skin Responses in Newly Diagnosed Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes (POEMS) Syndrome After Therapy With Low-Dose Lenalidomide Plus Dexamethasone.	2	7	2.67	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:34031126	(2021) Bartonella henselae Persistence within Mesenchymal Stromal Cells Enhances Endothelial Cell Activation and Infectibility That Amplifies the Angiogenic Process.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34040463	(2021) A Review of Research Progress of Pregnancy with Twins with Preeclampsia.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34042284	(2021) Maternal microbiome in preeclampsia pathophysiology and implications on offspring health.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34056992	(2021) Discovery of new VEGFR-2 inhibitors based on bis([1, 2, 4]triazolo)[4,3-a:3,4-c]quinoxaline derivatives as anticancer agents and apoptosis inducers.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34063169	(2021) A Narrative Review of Current Understanding of the Pathophysiology of Polycystic Ovary Syndrome: Focus on Plausible Relevance of Vitamin D.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34064101	(2021) Microvascular Tissue Engineering-A Review.	2	13	2.4	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:34066660	(2021) Acid Sensing Ion Channel 2a Is Reduced in the Reduced Uterine Perfusion Pressure Mouse Model and Increases Seizure Susceptibility in Pregnant Mice.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34072146	(2021) The Influence of Hyaluronic Acid Biofunctionalization of a Bovine Bone Substitute on Osteoblast Activity In Vitro.	2	5	2.81	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:34098522	(2021) Reduction of serum-induced endothelial STAT3(Y705) activation is associated with preeclampsia.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34137197	(2021) Long non-coding ribonucleic acid urothelial carcinoma-associated 1 promotes high glucose-induced human retinal endothelial cells angiogenesis through regulating micro-ribonucleic acid-624-3pvascular endothelial growth factor C.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34141797	(2021) Pancreatic neuroendocrine carcinoma in a pregnant woman: A case report and review of the literature.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34149611	(2021) FKBPL and SIRT-1 Are Downregulated by Diabetes in Pregnancy Impacting on Angiogenesis and Endothelial Function.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34162424	(2021) Surfing the clinical trials of mesenchymal stem cell therapy in ischemic cardiomyopathy.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34164606	(2021) Tolerating subretinal fluid in the treatment of neovascular age-related macular degeneration with intravitreal aflibercept.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34171101	(2021) The HIF1alpha-PFKFB3 Pathway: A Key Player in Diabetic Retinopathy.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34173157	(2021) Reduction of impulsivity in patients receiving deep transcranial magnetic stimulation treatment for obesity.	2	11	2.47	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:34174018	(2021) Prenatal intake of omega-3 promotes Wntbeta-catenin signaling pathway, and preserves integrity of the blood-brain barrier in preeclamptic rats.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34176292	(2021) Accurate Prediction of Total PlGF (Placental Growth Factor) From Free PlGF and sFlt-1 (Soluble Fms-Like Tyrosine Kinase-1): Evidence for Markedly Elevated PlGF Levels in Women With Acute Fatty Liver of Pregnancy.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34177798	(2021) Myokine Responses to Exercise in a Rat Model of LowHigh Adaptive Potential.	2	13	2.4	0.0461	9606.ENSP00000006053,9606.ENSP00000231061	CX3CL1,SPARC
PMID:34187151	(2021) Aflibercept Treatment Results and Association with Baseline Characteristics in Cases of Newly Diagnosed Neovascular Age-Related Macular Degeneration	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34192895	(2021) Aflibercept, a VEGF (Vascular Endothelial Growth Factor)-Trap, Reduces Vascular Permeability and Stroke-Induced Brain Swelling in Obese Mice.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34198488	(2021) Paracrine Signaling from a Three-Dimensional Model of Bladder Carcinoma and from Normal Bladder Switch the Phenotype of Stromal Fibroblasts.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34199150	(2021) New Heparanase-Inhibiting Triazolo-Thiadiazoles Attenuate Primary Tumor Growth and Metastasis.	2	5	2.81	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:34204372	(2021) Current Perspectives on the Role of Matrix Metalloproteinases in the Pathogenesis of Basal Cell Carcinoma.	3	53	1.97	0.0461	9606.ENSP00000006053,9606.ENSP00000363827,9606.ENSP00000478570	CX3CL1,HSPG2,VEGFA
PMID:34207031	(2021) Methylation Status of Corticotropin-Releasing Factor (CRF) Receptor Genes in Colorectal Cancer.	2	13	2.4	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:34207884	(2021) Chimeric Antigen Receptor (CAR) T Cell Therapy for Metastatic Melanoma: Challenges and Road Ahead.	3	108	1.66	0.0461	9606.ENSP00000231061,9606.ENSP00000451040,9606.ENSP00000478570	SPARC,PGF,VEGFA
PMID:34208449	(2021) Effects of Macro-Micro-Channels on Vascularization and Immune Response of Tissue Engineering Scaffolds.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34209508	(2021) Angiogenic Properties of NK Cells in Cancer and Other Angiogenesis-Dependent Diseases.	3	112	1.64	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:34209832	(2021) sFlt-1, Not PlGF, Is Related to Twin Gestation Choronicity in the First and Third Trimesters of Pregnancy.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34211264	(2021) Real-World Anti-Vascular Endothelial Growth Factor Therapy Outcomes in Myopic Choroidal Neovascularization.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34221026	(2021) Progress in Mesenchymal Stem Cell Therapy for Ischemic Stroke.	3	57	1.93	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:34249735	(2021) Role of NRP1 in Bladder Cancer Pathogenesis and Progression.	3	67	1.86	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:34260629	(2021) Vascular endothelial growth factor-A promoter polymorphisms, circulating VEGF-A and survival in acute coronary syndromes.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34272419	(2021) Long-term outcomes of ranibizumab vs. aflibercept for neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34276434	(2021) The Prenatal Hormone Milieu in Autism Spectrum Disorder.	2	12	2.43	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:34278740	(2021) Chemokine-Capturing Wound Contact Layer Rescues Dermal Healing.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34285463	(2021) Aflibercept versus Ranibizumab as a Second Line Therapy After Bevacizumab for Diabetic Macular Edema.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34290391	(2021) Fluid shear stress regulates placental growth factor expression via heme oxygenase 1 and iron.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34291186	(2021) KSI-301: antibody biopolymer conjugate in retinal disorders.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34293588	(2021) Serum levels of TGF-beta1, cytokines, angiogenic, and anti-angiogenic factors in pregnant women who smoke.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34294146	(2021) Antiangiogenic therapy reverses the immunosuppressive breast cancer microenvironment.	3	55	1.95	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:34298666	(2021) Albumin Nanostructures for Nucleic Acid Delivery in Cancer: Current Trend, Emerging Issues, and Possible Solutions.	2	11	2.47	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:34298680	(2021) Extracellular Matrices and Cancer-Associated Fibroblasts: Targets for Cancer Diagnosis and Therapy?	3	106	1.66	0.0461	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:34299190	(2021) Early Microvascular Dysfunction: Is the Vasa Vasorum a Missing Link in Insulin Resistance and Atherosclerosis.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34299636	(2021) The HDACHSP90 Inhibitor G570 Attenuated Blue Light-Induced Cell Migration in RPE Cells and Neovascularization in Mice through Decreased VEGF Production.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34302038	(2021) Neutralization of the induced VEGF-A potentiates the therapeutic effect of an anti-VEGFR2 antibody on gastric cancer in vivo.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34320947	(2021) Circulating angiogenic factors and HIV among pregnant women in Zambia: a nested case-control study.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34321574	(2021) Role of ICAM-1 in impaired retinal circulation in rhegmatogenous retinal detachment.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34326776	(2021) Elevated Levels of Soluble Axl (sAxl) Regulates Key Angiogenic Molecules to Induce Placental Endothelial Dysfunction and a Preeclampsia-Like Phenotype.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34326842	(2021) Predictive Value of High ICAM-1 Level for Poor Treatment Response to Low-Dose Decitabine in Adult Corticosteroid Resistant ITP Patients.	2	10	2.51	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:34336027	(2021) The role of vitamin D in perinatology. An up-to-date review.	2	13	2.4	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:34336494	(2021) Bench to Bedside: Proteomic Biomarker Analysis of Cerebrospinal Fluid in Patients With Spondylomyelopathy.	2	13	2.4	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:34341712	(2021) Promising Intervention Approaches to Potentially Resolve Neuroinflammation And Steroid Hormones Alterations in Alzheimers Disease and Its Neuropsychiatric Symptoms.	3	62	1.9	0.0461	9606.ENSP00000006053,9606.ENSP00000276571,9606.ENSP00000478570	CX3CL1,CRH,VEGFA
PMID:34354341	(2021) Guidelines for the Management of Center-Involving Diabetic Macular Edema: Treatment Options and Patient Monitorization.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34356821	(2021) Collagen-Containing Fish Sidestream-Derived Protein Hydrolysates Support Skin Repair via Chemokine Induction.	2	9	2.56	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:34356828	(2021) Comparing Patient Characteristics, Clinical Outcomes, and Biomarkers of Severe Asthma Patients in Taiwan.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34359588	(2021) Recent Advances in Glioma Therapy: Combining Vascular Normalization and Immune Checkpoint Blockade.	3	75	1.81	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:34359764	(2021) Aflibercept Plus FOLFIRI as Second-Line Treatment for Metastatic Colorectal Cancer: A Single-Institution Real-Life Experience.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34360613	(2021) Cytokine-Laden Extracellular Vesicles Predict Patient Prognosis after Cerebrovascular Accident.	3	49	2.0	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:34360849	(2021) Immunoendocrine Dysregulation during Gestational Diabetes Mellitus: The Central Role of the Placenta.	3	107	1.66	0.0461	9606.ENSP00000276571,9606.ENSP00000451040,9606.ENSP00000478570	CRH,PGF,VEGFA
PMID:34361013	(2021) Netrin-1 in Glioblastoma Neovascularization: The New Partner in Crime?	3	62	1.9	0.0461	9606.ENSP00000334329,9606.ENSP00000451040,9606.ENSP00000478570	UNC5B,PGF,VEGFA
PMID:34371934	(2021) A Systematic Review of Bisphenol A from Dietary and Non-Dietary Sources during Pregnancy and Its Possible Connection with Fetal Growth Restriction: Investigating Its Potential Effects and the Window of Fetal Vulnerability.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34373728	(2021) Aminophylline modulates the permeability of endothelial cells via the Slit2-Robo4 pathway in lipopolysaccharide-induced inflammation.	2	12	2.43	0.0461	9606.ENSP00000334329,9606.ENSP00000478570	UNC5B,VEGFA
PMID:34375370	(2021) Induced endothelial cells from peripheral arterial disease patients and neonatal fibroblasts have comparable angiogenic properties.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34386323	(2021) Targeted inhibition of GRK2 kinase domain by CP-25 to reverse fibroblast-like synoviocytes dysfunction and improve collagen-induced arthritis in rats.	3	44	2.05	0.0461	9606.ENSP00000220166,9606.ENSP00000231061,9606.ENSP00000478570	CTSH,SPARC,VEGFA
PMID:34387398	(2021) Soluble vascular endothelial growth factor receptor 2 and prognosis in patients with chronic heart failure.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34389547	(2021) Placental growth factor in assessment of women with suspected pre-eclampsia to reduce maternal morbidity: a stepped wedge cluster randomised control trial (PARROT Ireland).	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34408591	(2021) Serum concentration of matrix metalloproteinases and angiogenic factors in patients with venous leg ulcers.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34408721	(2021) A Paradigm for Post-Covid-19 Fatigue Syndrome Analogous to MECFS.	2	10	2.51	0.0461	9606.ENSP00000006053,9606.ENSP00000276571	CX3CL1,CRH
PMID:34409045	(2021) Angiocrine Regulation of Epithelial Barrier Integrity in Inflammatory Bowel Disease.	3	40	2.09	0.0461	9606.ENSP00000363827,9606.ENSP00000451040,9606.ENSP00000478570	HSPG2,PGF,VEGFA
PMID:34425102	(2021) Hypoxic and osmotic expression of Kir2.1 potassium channels in retinal pigment epithelial cells: Contribution to vascular endothelial growth factor expression.	2	7	2.67	0.0461	9606.ENSP00000304767,9606.ENSP00000478570	P2RY1,VEGFA
PMID:34425780	(2021) A case report: pseudoxanthoma elasticum diagnosed based on ocular angioid streaks and the curative effect of Conbercept treatment.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34426415	(2021) Intraindividual Long-term Immune Marker Stability in Plasma Samples Collected in Median 9.4 Years Apart in 304 Adult Cancer-free Individuals.	2	12	2.43	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:34429387	(2021) Is Biochemical Follow Up Possible in Peripheral Arterial Disease Treatment: Hypoxia Inducible Factor-1 Alpha?	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34433812	(2021) Nivolumab in combination with cabozantinib for metastatic triple-negative breast cancer: a phase II and biomarker study.	3	42	2.07	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:34439743	(2021) A Runners High for New Neurons? Potential Role for Endorphins in Exercise Effects on Adult Neurogenesis.	2	7	2.67	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:34441264	(2021) A Narrative Review of the Complex Relationship between Pregnancy and Eye Changes.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34445248	(2021) Repair Mechanisms of the Neurovascular Unit after Ischemic Stroke with a Focus on VEGF.	3	58	1.93	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:34449509	(2021) Peripartum cardiomyopathy and acute heart failure associated with prolonged tocolytic therapy in pregnancy: A case report.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34452097	(2021) Intravitreal Anti-Vascular Endothelial Growth Factor Agents for the Treatment of Diabetic Retinopathy: A Review of the Literature.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34454473	(2021) Long-term effects of intravitreal bevacizumab and aflibercept on intraocular pressure in wet age-related macular degeneration.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34459248	(2021) Decision Threshold for Kryptor sFlt-1PlGF Ratio in Women With Suspected Preeclampsia: Retrospective Study in a Routine Clinical Setting.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34470469	(2021) The Protective Benefit of Heme Oxygenase-1 Gene-Modified Human Placenta-Derived Mesenchymal Stem Cells in a N-Nitro-L-Arginine Methyl Ester-Induced Preeclampsia-Like Rat Model: Possible Implications for Placental Angiogenesis.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34470571	(2021) MiR-212-3p promotes proliferation and migration of trophoblast in fetal growth restriction by targeting placental growth factor.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34485251	(2021) Improved Posterolateral Lumbar Spinal Fusion Using a Biomimetic, Nanocomposite Scaffold Augmented by Autologous Platelet-Rich Plasma.	2	6	2.74	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:34488669	(2021) Activation of quiescent polypoidal choroidal vasculopathy after membrane peeling vitrectomy for epiretinal membrane: a case report.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34489701	(2021) Short-and Long-Term Expression of Vegf: A Temporal Regulation of a Key Factor in Diabetic Retinopathy.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34502429	(2021) Growth Factors, Reactive Oxygen Species, and Metformin-Promoters of the Wound Healing Process in Burns?	3	43	2.06	0.0461	9606.ENSP00000363827,9606.ENSP00000451040,9606.ENSP00000478570	HSPG2,PGF,VEGFA
PMID:34502440	(2021) Conditional Mutation of Hand1 in the Mouse Placenta Disrupts Placental Vascular Development Resulting in Fetal Loss in Both Early and Late Pregnancy.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34504981	(2021) Off-label intravitreal brolucizumab for recalcitrant diabetic macular edema: A real-world case series.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34512888	(2021) Place of intravitreal dexamethasone implant in the treatment armamentarium of diabetic macular edema.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34512895	(2021) Polymorphisms in HIF-1a gene are not associated with diabetic retinopathy in China.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34513835	(2021) Autophagy-Related Genes and Long Noncoding RNAs Signatures as Predictive Biomarkers for Osteosarcoma Survival.	2	12	2.43	0.0461	9606.ENSP00000334329,9606.ENSP00000478570	UNC5B,VEGFA
PMID:34516333	(2021) Long non-coding RNA ARAP1-AS1 contributes to cell proliferation and migration in clear cell renal cell carcinoma via the miR-361-3pplacental growth factor axis.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34522081	(2021) Brolucizumab in Neovascular Age-Related Macular Degeneration - Indian Real-World Experience: The BRAILLE Study.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34552150	(2021) Early postoperative urinary MCP-1 as a potential biomarker predicting acute rejection in living donor kidney transplantation: a prospective cohort study.	2	11	2.47	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:34575413	(2021) Peptide Inhibitors of Vascular Endothelial Growth Factor A: Current Situation and Perspectives.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34584816	(2021) Postpartum Respiratory Distress Due to Hypertension-Related Pulmonary Edema.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34600566	(2021) SCO-spondin, a giant matricellular protein that regulates cerebrospinal fluid activity.	3	71	1.84	0.0461	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:34620181	(2021) TGF-beta gene polimorphisms as risk factors for asthma control among clinic patients.	2	12	2.43	0.0461	9606.ENSP00000231061,9606.ENSP00000363827	SPARC,HSPG2
PMID:34620968	(2021) sFlt-1 and CA 15.3 are indicators of endothelial damage and pulmonary fibrosis in SARS-CoV-2 infection.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34638388	(2021) Remodeling the Tumor Myeloid Landscape to Enhance Antitumor Antibody Immunotherapies.	3	103	1.68	0.0461	9606.ENSP00000006053,9606.ENSP00000362524,9606.ENSP00000478570	CX3CL1,ANGPTL2,VEGFA
PMID:34638571	(2021) Current Biomaterial-Based Bone Tissue Engineering and Translational Medicine.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34638935	(2021) Ocular Therapeutics and Molecular Delivery Strategies for Neovascular Age-Related Macular Degeneration (nAMD).	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34650995	(2021) Correlations Between Different Angiogenic and Inflammatory Factors in Vitreous Fluid of Eyes With Proliferative Diabetic Retinopathy.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34654463	(2021) Multiomic study of skin, peripheral blood, and serum: is serum proteome a reflection of disease process at the end-organ level in systemic sclerosis?	3	43	2.06	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:34659227	(2021) PlGF Reduction Compromises Angiogenesis in Diabetic Foot Disease Through Macrophages.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34663835	(2021) A simple detection method for the serum sFLT1 protein in preeclampsia.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34665260	(2021) Hypoxia-inducible factor-1beta is essential for upregulation of the hypoxia-induced FLT1 gene in placental trophoblasts.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34670301	(2021) Association between Adverse Maternal Clinical Outcomes and Imbalance of Cytokines and Angiogenic Factors in Preterm Preeclampsia.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34675650	(2021) Insights into the Mechanisms of Fetal Growth Restriction-Induced Programming of Hypertension.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34677569	(2021) Targeting Plasma Kallikrein With a Novel Bicyclic Peptide Inhibitor (THR-149) Reduces Retinal Thickening in a Diabetic Rat Model.	2	13	2.4	0.0461	9606.ENSP00000450482,9606.ENSP00000478570	BDKRB2,VEGFA
PMID:34680450	(2021) Profiles of Cytokines Secreted by ARPE-19 Cells Exposed to Light and Incubated with Anti-VEGF Antibody.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34681920	(2021) Placental Ischemia Says NO to Proper NOS-Mediated Control of Vascular Tone and Blood Pressure in Preeclampsia.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34683963	(2021) Functionalized Nanoparticles Targeting Tumor-Associated Macrophages as Cancer Therapy.	3	86	1.75	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:34684166	(2021) Stimulation of Healing of Non-Infected Stagnated Diabetic Wounds by Copper Oxide-Impregnated Wound Dressings.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34685572	(2021) Lymphatic Clearance of Immune Cells in Cardiovascular Disease.	3	58	1.93	0.0461	9606.ENSP00000006053,9606.ENSP00000363827,9606.ENSP00000478570	CX3CL1,HSPG2,VEGFA
PMID:34693076	(2021) Exacerbation of pigment epithelial detachment following aflibercept: A case of bevacizumab rescue.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34697354	(2021) Aqueous humor analyses of diabetic macular edema patients with subretinal fluid.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34703740	(2021) Combined intravitreal ranibizumab and posterior subtenon triamcinolone acetonide injections for patients with diabetic macular edema refractory to intravitreal ranibizumab monotherapy.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34703742	(2021) One-year results of switching to aflibercept for persistent diabetic macular edema resistant to bevacizumab.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34712132	(2021) Conbercept for Treatment of Neovascular Age-Related Macular Degeneration and Visual Impairment due to Diabetic Macular Edema or Pathologic Myopia Choroidal Neovascularization: A Systematic Review and Meta-Analysis.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34735690	(2021) The relationship between vascular endothelial growth factor (VEGF) and amnestic mild cognitive impairment among older adults living with HIV.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34746171	(2021) Efficacy of Conbercept in the Treatment of Choroidal Neovascularization Secondary to Pathologic Myopia.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34746835	(2021) Effect of heat pre-conditioning on recovery following exercise-induced muscle damage.	2	5	2.81	0.0461	9606.ENSP00000450482,9606.ENSP00000478570	BDKRB2,VEGFA
PMID:34751741	(2021) Effect of Lecithin-Bound Iodine Treatment on Inherited Retinal Degeneration in Mice.	2	7	2.67	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:34752817	(2021) Shikonin alleviates choroidal neovascularization by inhibiting proangiogenic factor production from infiltrating macrophages.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34760146	(2021) Correlation between 25-Hydroxyvitamin D, sFlt-1, PLGF, and Hypertension in Pregnancy.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34768025	(2021) Maternal vitamin D deficiency reduces docosahexaenoic acid, placental growth factor and peroxisome proliferator activated receptor gamma levels in the pup brain in a rat model of preeclampsia.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34796270	(2021) Association between serum soluble fms-like tyrosine kinase-1 and the central choroidal thickness during pregnancy: a prospective study.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34797313	(2021) Cross-sectional study of the association of 5 single nucleotide polymorphisms with enalapril treatment response among South African adults with hypertension.	2	7	2.67	0.0461	9606.ENSP00000450482,9606.ENSP00000478570	BDKRB2,VEGFA
PMID:34799548	(2021) Efficient protein incorporation and release by a jigsaw-shaped self-assembling peptide hydrogel for injured brain regeneration.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34805227	(2021) Phosphatidylserine Exposing Extracellular Vesicles in Pre-eclamptic Patients.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34819824	(2021) Circulating microRNA-126 as an Independent Risk Predictor of Coronary Artery Disease: A Case-Control Study.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34827172	(2021) The BPH5 Mouse Model of Superimposed Preeclampsia Is Not a Model of HELLP Syndrome.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34827623	(2021) Long-Term Consequences of Placental Vascular Pathology on the Maternal and Offspring Cardiovascular Systems.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34827628	(2021) Preface for the Special Issue on the Exploration of the Multifaceted Roles of Glycosaminoglycans: GAGs.	2	9	2.56	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:34830826	(2021) Molecular Targets and Emerging Therapies for Advanced Gallbladder Cancer.	3	41	2.08	0.0461	9606.ENSP00000231061,9606.ENSP00000451040,9606.ENSP00000478570	SPARC,PGF,VEGFA
PMID:34830872	(2021) Blood Cytokine Analysis Suggests That SARS-CoV-2 Infection Results in a Sustained Tumour Promoting Environment in Cancer Patients.	3	43	2.06	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:34837033	(2021) Progress in preeclampsia: the contribution of animal models.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34847607	(2021) [Interstitial cystitis: the latest findings on its aetiopathogenesis].	2	2	3.21	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:34852012	(2021) Hypertensive disorders in pregnancy and child development at 36 months in the All Our Families prospective cohort study.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34869275	(2021) A Fluorescent Aptasensor Based on Assembled G-Quadruplex and Thioflavin T for the Detection of Biomarker VEGF165.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34871241	(2021) Soluble fms-like tyrosine kinase 1, placental growth factor and procalcitonin as biomarkers of gram-negative sepsis: Analysis through a derivation and a validation cohort.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34879854	(2021) Cardiac dysfunction and remodeling regulated by anti-angiogenic environment in patients with preeclampsia: the ANGIOCOR prospective cohort study protocol.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34882742	(2021) Relationship between the sFlt-1PlGF ratio and the optical coherence tomographic features of chorioretina in patients with preeclampsia.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34884495	(2021) The ECM: To Scaffold, or Not to Scaffold, That Is the Question.	2	12	2.43	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:34884923	(2021) Designing Cardiovascular Implants Taking in View the Endothelial Basement Membrane.	3	63	1.89	0.0461	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:34900335	(2021) Syndecan-4 functionalization of tissue regeneration scaffolds improves interaction with endothelial progenitor cells.	2	10	2.51	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:34904074	(2021) Dysregulated Serum Lipid Metabolism Promotes the Occurrence and Development of Diabetic Retinopathy Associated With Upregulated Circulating Levels of VEGF-A, VEGF-D, and PlGF.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34925835	(2021) Association between proteinuria and placental pathology in preeclampsia: A retrospective study.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34927512	(2021) Clinical value of serum VEGF and sFlt-1 in pernicious placenta previa.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34934529	(2021) Consequences of maternal heat stress at different stages of embryonic and fetal development on dairy cows progeny.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34934987	(2021) Nonhormonal therapy for endometriosis: a randomized, placebo-controlled, pilot study of cabergoline versus norethindrone acetate.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34941834	(2021) Immunophenotyping of an Unusual Mixed-Type Extraskeletal Osteosarcoma in a Dog.	2	13	2.4	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:34943786	(2021) Mesenchymal StemStromal Cells Derived from Human and Animal Perinatal Tissues-Origins, Characteristics, Signaling Pathways, and Clinical Trials.	3	100	1.69	0.0461	9606.ENSP00000231061,9606.ENSP00000451040,9606.ENSP00000478570	SPARC,PGF,VEGFA
PMID:34944440	(2021) New Insights into the Role of Cysteine Cathepsins in Neuroinflammation.	3	51	1.98	0.0461	9606.ENSP00000006053,9606.ENSP00000220166,9606.ENSP00000363827	CX3CL1,CTSH,HSPG2
PMID:34944571	(2021) Endothelial Dysfunction in Pregnancy Complications.	3	53	1.97	0.0461	9606.ENSP00000334329,9606.ENSP00000451040,9606.ENSP00000478570	UNC5B,PGF,VEGFA
PMID:34944710	(2021) Therapy of Pseudoxanthoma Elasticum: Current Knowledge and Future Perspectives.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34945034	(2021) Short-Term Outcomes of Switching to Ranibizumab in Polypoidal Choroidal Vasculopathy Resistant to Aflibercept Therapy.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34945035	(2021) The Impact of Interval between Recurrence and Reinjection in Anti-VEGF Therapy for Diabetic Macular Edema in Pro Re Nata Regimen.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34946296	(2021) Increased Vascular Endothelial Growth Factor Serum Level and the Role of +936CT Gene Polymorphism in Chronic Obstructive Pulmonary Disease.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34956424	(2021) Early gestational profiling of oxidative stress and angiogenic growth mediators as predictive, preventive and personalised (3P) medical approach to identify suboptimal health pregnant mothers likely to develop preeclampsia.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34956615	(2021) Venom of the desert black snake Walterinnesia aegyptia enhances anti-tumor immunity via its beneficial modulatory effects on pro- and anti-tumorigenic inflammatory mediators in cultured colon cancer cells.	2	7	2.67	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:34956899	(2021) Osteosarcoma and Metastasis.	3	81	1.78	0.0461	9606.ENSP00000231061,9606.ENSP00000362524,9606.ENSP00000478570	SPARC,ANGPTL2,VEGFA
PMID:34959804	(2021) Developmental Vitamin D Deficiency in Pregnant Rats Does Not Induce Preeclampsia.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35002773	(2021) Hyperreflective Foci and Subretinal Fluid Are Potential Imaging Biomarkers to Evaluate Anti-VEGF Effect in Diabetic Macular Edema.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35008355	(2021) Macrophage and Neutrophil Interactions in the Pancreatic Tumor Microenvironment Drive the Pathogenesis of Pancreatic Cancer.	3	104	1.67	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:35009311	(2021) Electrical Stimulation and Cellular Behaviors in Electric Field in Biomedical Research.	2	13	2.4	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:35010703	(2021) Neurovascular Impairment and Therapeutic Strategies in Diabetic Retinopathy.	3	59	1.92	0.0461	9606.ENSP00000006053,9606.ENSP00000363827,9606.ENSP00000478570	CX3CL1,HSPG2,VEGFA
PMID:35011851	(2021) Beyond Bronchiolitis Obliterans: In-Depth Histopathologic Characterization of Bronchiolitis Obliterans Syndrome after Lung Transplantation.	2	4	2.91	0.0461	9606.ENSP00000450482,9606.ENSP00000478570	BDKRB2,VEGFA
PMID:35011961	(2021) Updates in Clinical and Translational Glaucoma Research.	2	2	3.21	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:35047495	(2021) Perfused Platforms to Mimic Bone Microenvironment at the MacroMilliMicroscale: Pros and Cons.	2	13	2.4	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:35056350	(2021) Three-Year Outcomes of Wet Age-Related Macular Degeneration Treatment in Polish Therapeutic Programs.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35070664	(2021) Retinopathy of prematurity in Saudi Arabia: Exploring maternal risk factors.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35083234	(2021) The Optimization of an Anti-VEGF Therapeutic Regimen for Neovascular Glaucoma.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35095555	(2021) Assessing the Role of Uric Acid as a Predictor of Preeclampsia.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35095876	(2021) When a Friend Becomes Your Enemy: Natural Killer Cells in Atherosclerosis and Atherosclerosis-Associated Risk Factors.	3	56	1.94	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:35097005	(2021) Diosmin Alleviates Venous Injury and Muscle Damage in a Mouse Model of Iliac Vein Stenosis.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35174182	(2021) Publication Trends of Research on Polypoidal Choroidal Vasculopathy During 2001-2020: A 20-Year Bibliometric Study.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35186968	(2021) The Value of Prenatal First Systolic Blood Pressure Can Predict Severe Preeclampsia and Birth Weight in Patients With Preeclampsia.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35223882	(2021) Efficacy of Initial vs. Delayed Photodynamic Therapy in Combination With Conbercept for Polypoidal Choroidal Vasculopathy.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35391816	(2021) Regression in polypoidal choroidal vasculopathy treated with ziv-aflibercept monotherapy - short term study.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35423075	(2021) Identification of key lipid metabolites during metabolic dysregulation in the diabetic retinopathy disease mouse model and efficacy of Keluoxin capsule using an UHPLC-MS-based non-targeted lipidomics approach.	2	11	2.47	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:29666970	(2020) Histopathological and molecular predictors of growth patterns and recurrence in craniopharyngiomas: a systematic review.	2	8	2.61	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:29726284	(2020) Evolution of intravitreal therapy for retinal and macular disorders.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30736075	(2020) [Comparative Clinical and Ultrastructural Analysis of the Results from Ranibizumab and Aflibercept in Patients with PDR].	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30816576	(2020) Endothelial cell-cardiomyocyte crosstalk in heart development and disease.	3	64	1.88	0.0461	9606.ENSP00000362524,9606.ENSP00000451040,9606.ENSP00000478570	ANGPTL2,PGF,VEGFA
PMID:30868678	(2020) Impact of extracardiac pathology on head growth in fetuses with congenital heart defect.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31087311	(2020) Findings in Stillbirths Associated with Placental Disease.	2	4	2.91	0.0461	9606.ENSP00000276571,9606.ENSP00000451040	CRH,PGF
PMID:31420920	(2020) Aspirin for the prevention and treatment of pre-eclampsia: A matter of COX-1 andor COX-2 inhibition?	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31541381	(2020) A phase II study of cabozantinib alone or in combination with trastuzumab in breast cancer patients with brain metastases.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31545526	(2020) Genetic interaction between placental growth factor and vascular endothelial growth factor A in psoriasis.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31551479	(2020) Respiratory outcomes of late preterm infants of mothers with early and late onset preeclampsia.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31608707	(2020) The role of PIGF blockade in the treatment of colorectal cancer: overcoming the pitfalls.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31707538	(2020) Reconciling the distinct roles of angiogenicanti-angiogenic factors in the placenta and maternal circulation of normal and pathological pregnancies.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31715077	(2020) Pravastatin for early-onset pre-eclampsia: a randomised, blinded, placebo-controlled trial.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31715306	(2020) Follistatin and Soluble Endoglin Predict 1-Year Nonrelapse Mortality after Allogeneic Hematopoietic Cell Transplantation.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31719675	(2020) Longitudinal neovascular changes on optical coherence tomography angiography in proliferative diabetic retinopathy treated with panretinal photocoagulation alone versus with intravitreal conbercept plus panretinal photocoagulation: a pilot ...	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31726490	(2020) A randomized clinical study to compare intrapleural infusion with intravenous infusion of bevacizumab in the management of malignant pleural effusion in patients with non-small-cell lung cancer.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31727675	(2020) Impact of Prior Bevacizumab Treatment on VEGF-A and PlGF Levels and Outcome Following Second-Line Aflibercept Treatment: Biomarker Post Hoc Analysis of the VELOUR Trial.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31733305	(2020) The novel axis of YAP1, transcription enhancer factor 3 and Down Syndrome Candidate Region 1 isoform 1L is a common signaling pathway downstream of several angiogenic factors.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31744386	(2020) Can Extracorporeal Shockwave Promote Osteogenesis of Equine Bone Marrow-Derived Mesenchymal Stem Cells In Vitro?	2	6	2.74	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:31746472	(2020) Natural Killer Cells Contribute to Pathogenesis of Severe Alcoholic Hepatitis by Inducing Lysis of Endothelial Progenitor Cells.	2	9	2.56	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:31863654	(2020) Short Pretreatment with Calcitriol Is Far Superior to Continuous Treatment in Stimulating Proliferation and Osteogenic Differentiation of Human Adipose Stem Cells.	2	11	2.47	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:31883129	(2020) Advances in the repair of segmental nerve injuries and trends in reconstruction.	2	10	2.51	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:31884526	(2020) Netrin-1 works with UNC5B to regulate angiogenesis in diabetic kidney disease.	2	4	2.91	0.0461	9606.ENSP00000334329,9606.ENSP00000478570	UNC5B,VEGFA
PMID:31907738	(2020) Phase I dose-escalation study of the safety, tolerability, and pharmacokinetics of aflibercept in combination with S-1 in Japanese patients with advanced solid malignancies.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31924819	(2020) In vivo evidence of significant placental growth factor release by normal pregnancy placentas.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31928443	(2020) Cytokine and Chemokine Concentration in the Tear of Patients with Age-Related Cataract.	3	44	2.05	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:31936463	(2020) Oral Delivery of a Tetrameric Tripeptide Inhibitor of VEGFR1 Suppresses Pathological Choroid Neovascularization.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31936590	(2020) Recent Advances in Natural Gum-Based Biomaterials for Tissue Engineering and Regenerative Medicine: A Review.	2	12	2.43	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:31936659	(2020) Maternal Serum Placental Growth Factor, Soluble Fms-Like Tyrosine Kinase-1, and Soluble Endoglin in Twin Gestations and the Risk of Preeclampsia-A Systematic Review.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31948540	(2020) [Intervention of Vascular Dysplasia Caused by Different Mechanisms - Anlotinib for Right Lung Squamous Cell Carcinoma Combined with Thromboangiitis Obliterans: A Case Report and Literature Review].	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31950133	(2020) The antithrombin binding regions of heparin mediate fetal growth and reduced placental damage in the RUPP model of preeclampsia+.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31952188	(2020) Vascular Endothelial Growth Factor A and VEGFR-1 Change during Preimplantation in Heifers.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31956170	(2020) Early Transplantation of Human Cranial Bone-derived Mesenchymal Stem Cells Enhances Functional Recovery in Ischemic Stroke Model Rats.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31969665	(2020) Ursodeoxycholic Acid Attenuates the Retinal Vascular Abnormalities in Anti-PDGFR-beta Antibody-Induced Pericyte Depletion Mouse Models.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31972145	(2020) Communication, Cross Talk, and Signal Integration in the Adult Hippocampal Neurogenic Niche.	3	55	1.95	0.0461	9606.ENSP00000006053,9606.ENSP00000231061,9606.ENSP00000478570	CX3CL1,SPARC,VEGFA
PMID:31979233	(2020) The Incorporation of Marine Coral Microparticles into Collagen-Based Scaffolds Promotes Osteogenesis of Human Mesenchymal Stromal Cells via Calcium Ion Signalling.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31985300	(2020) Investigational plasma kallikrein inhibitors for the treatment of diabetic macular edema: an expert assessment.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31994602	(2020) Anti-placental growth factor antibody ameliorates hyperoxia-mediated impairment of lung development in neonatal rats.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31999703	(2020) Changes in gene expression in human skeletal stem cells transduced with constitutively active Gsalpha correlates with hallmark histopathological changes seen in fibrous dysplastic bone.	3	55	1.95	0.0461	9606.ENSP00000362524,9606.ENSP00000451040,9606.ENSP00000478570	ANGPTL2,PGF,VEGFA
PMID:32009522	(2020) Angiogenesis-Related Genes in Endothelial Progenitor Cells May Be Involved in Sickle Cell Stroke.	3	45	2.04	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:32009528	(2020) Vascular Endothelial Growth Factor-121 Administration Mitigates Halogen Inhalation-Induced Pulmonary Injury and Fetal Growth Restriction in Pregnant Mice.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32010988	(2020) The impact of tobacco chemicals and nicotine on placental development.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32013135	(2020) Trabecular Bone Deficit and Enhanced Anabolic Response to Re-Ambulation after Disuse in Perlecan-Deficient Skeleton.	2	12	2.43	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:32013913	(2020) The effect of adjunctive intravitreal conbercept at the end of diabetic vitrectomy for the prevention of post-vitrectomy hemorrhage in patients with severe proliferative diabetic retinopathy: a prospective, randomized pilot study.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32016802	(2020) Effect of Placental Growth Factor on Trophoblast-Endothelial Cell Interactions In Vitro.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32017014	(2020) Diagnostic accuracy of repeat placental growth factor measurements in women with suspected preeclampsia: A case series study.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32027702	(2020) Pregnancy complications recur independently of maternal vascular malperfusion lesions.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32030795	(2020) NCALD affects drug resistance and prognosis by acting as a ceRNA of CX3CL1 in ovarian cancer.	2	2	3.21	0.0461	9606.ENSP00000006053,9606.ENSP00000379256	CX3CL1,NCALD
PMID:32033594	(2020) Diagnostic accuracy of sFlt1PlGF ratio as a marker for preeclampsia.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32039444	(2020) Differential regulation of sFlt-1 splicing by U2AF65 and JMJD6 in placental-derived and endothelial cells.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32041578	(2020) Production of an anti-angiogenic factor sFLT1 is suppressed via promoter hypermethylation of FLT1 gene in choriocarcinoma cells.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32051729	(2020) Role of Erythromycin-Regulated Histone Deacetylase-2 in Benign Tracheal Stenosis.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32052203	(2020) Novel Interventions for the Prevention of Preeclampsia.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32054088	(2020) Dynamics of Early Signalling Events during Fracture Healing and Potential Serum Biomarkers of Fracture Non-Union in Humans.	3	62	1.9	0.0461	9606.ENSP00000231061,9606.ENSP00000451040,9606.ENSP00000478570	SPARC,PGF,VEGFA
PMID:32057945	(2020) Secreted protein acidic and rich in cysteine (SPARC) regulates thermogenesis in white and brown adipocytes.	2	2	3.21	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:32057965	(2020) Comparison of aqueous humor levels of PlGF and VEGF in proliferative diabetic retinopathy before and after intravitreal conbercept injection.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32060315	(2020) Comprehensive biophysical and functional study of ziv-aflibercept: characterization and forced degradation.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32061839	(2020) MDA-9Syntenin (SDCBP): Novel gene and therapeutic target for cancer metastasis.	3	55	1.95	0.0461	9606.ENSP00000231061,9606.ENSP00000304767,9606.ENSP00000478570	SPARC,P2RY1,VEGFA
PMID:32063058	(2020) Combining Biomarkers to Predict Pregnancy Complications and Redefine Preeclampsia: The Angiogenic-Placental Syndrome.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32065066	(2020) Monitoring Dual VEGF Inhibition in Human Pancreatic Tumor Xenografts With Dynamic Contrast-Enhanced Ultrasound.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32084272	(2020) Correlation of Aqueous, Vitreous, and Plasma Cytokine Levels in Patients With Proliferative Diabetic Retinopathy.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32085768	(2020) Detecting gastrointestinal manifestations in patients with systemic sclerosis using anti-gAChR antibodies.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32092052	(2020) A spontaneous complex structural variant in rcan-1 increases exploratory behavior and laboratory fitness of Caenorhabditis elegans.	2	8	2.61	0.0461	9606.ENSP00000276571,9606.ENSP00000363827	CRH,HSPG2
PMID:32092864	(2020) Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: An Immunological Perspective.	3	43	2.06	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:32092919	(2020) Bisphenol S in Food Causes Hormonal and Obesogenic Effects Comparable to or Worse than Bisphenol A: A Literature Review.	2	8	2.61	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:32093623	(2020) Maternal serum glycosylated fibronectin as a short-term predictor of preeclampsia: a prospective cohort study.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32095777	(2020) Effect of intravitreal injection of aflibercept on blood coagulation parameters in patients with age-related macular degeneration.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32102234	(2020) Discovery of Small-Molecule Activators for Glucose-6-Phosphate Dehydrogenase (G6PD) Using Machine Learning Approaches.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32112634	(2020) Different Polymorphisms of Vascular Endothelial Growth Factor Gene in Patients with Pre-Eclampsia among The Iranian Women Population.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32116527	(2020) Hierarchical Clustering Analyses of Plasma Proteins in Subjects With Cardiovascular Risk Factors Identify Informative Subsets Based on Differential Levels of Angiogenic and Inflammatory Biomarkers.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32117942	(2020) Trophoblast-Targeted Nanomedicine Modulates Placental sFLT1 for Preeclampsia Treatment.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32123494	(2020) Evaluation of recombinant human vascular endothelial growth factor VEGF121-loaded poly-l-lactide microparticles as a controlled release delivery system.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32125783	(2020) Complex formation of anti-VEGF-C with VEGF-C released during blood coagulation resulted in an artifact in its serum pharmacokinetics.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32140065	(2020) Innate Lymphoid Cells at the Maternal-Fetal Interface in Human Pregnancy.	3	90	1.74	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:32144129	(2020) Placental growth factor in beta cells plays an essential role in gestational beta-cell growth.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32149117	(2020) Human Uterine Decidual NK Cells in Women with a History of Early Pregnancy Enhance Angiogenesis and Trophoblast Invasion.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32150760	(2020) Tuning cytokines enriches dendritic cells and regulatory T cells in the periodontium.	2	12	2.43	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:32152939	(2020) Effect of Novel Design Modifications on Fibrotic Encapsulation: An In Vivo Glaucoma Drainage Device Study in a Rabbit Model.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32157692	(2020) The role of integrins in melanoma: a review.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32157802	(2020) The role of ultrasound in enhancing mesenchymal stromal cell-based therapies.	3	62	1.9	0.0461	9606.ENSP00000304767,9606.ENSP00000451040,9606.ENSP00000478570	P2RY1,PGF,VEGFA
PMID:32161438	(2020) Two Year Visual Acuity and Structural Outcomes in Patients with Diabetic Macular Oedema Treated with Intravitreal Aflibercept - A Retrospective Cohort Study.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32164758	(2020) Association of vascular endothelial growth factor polymorphisms with polycystic ovarian syndrome risk: a meta-analysis.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32169861	(2020) Real-world management of treatment-naive diabetic macular oedema: 2-year visual outcome focusing on the starting year of intervention from STREAT-DMO study.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32173975	(2020) Micro-RNAs in the aqueous humour of patients with diabetic macular oedema.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32179066	(2020) Pivotal Involvement of the CX3CL1-CX3CR1 Axis for the Recruitment of M2 Tumor-Associated Macrophages in Skin Carcinogenesis.	2	5	2.81	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:32179765	(2020) Common variants of fetal and maternal complement genes in preeclampsia: pregnancy specific complotype.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32183142	(2020) Does Cysteine Rule (CysR) Complete the CendR Principle? Increase in Affinity of Peptide Ligands for NRP-1 Through the Presence of N-Terminal Cysteine.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32185233	(2020) Glucose-Regulated Protein 78 in the Aqueous Humor of Patients with Diabetic Macular Edema.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32195931	(2020) The effect of icariin for infertile women with thin endometrium: A protocol for systematic review.	2	10	2.51	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:32196388	(2020) Real-World Evidence: Multicenter Efficacy and Toxicity Analysis of Nintedanib With Docetaxel as Second-Line Treatment in Mexican Patients With Advanced Lung Adenocarcinoma.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32214330	(2020) Creation of different bioluminescence resonance energy transfer based biosensors with high affinity to VEGF.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32215825	(2020) The role and mechanism of asymmetric dimethylarginine in fetal growth restriction via interference with endothelial function and angiogenesis.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32218218	(2020) Thymosin beta4 Identified by Transcriptomic Analysis from HF Anagen to Telogen Promotes Proliferation of SHF-DPCs in Albas Cashmere Goat.	2	13	2.4	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:32221404	(2020) The Association of Pregnancy-induced Hypertension with Bronchopulmonary Dysplasia - A Retrospective Study Based on the Korean Neonatal Network database.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32225060	(2020) Autophagy Modulators Profoundly Alter the Astrocyte Cellular Proteome.	3	71	1.84	0.0461	9606.ENSP00000006053,9606.ENSP00000220166,9606.ENSP00000478570	CX3CL1,CTSH,VEGFA
PMID:32230892	(2020) Release of the Non-Steroidal Anti-Inflammatory Drug Flufenamic Acid by Multiparticulate Delivery Systems Promotes Adipogenic Differentiation of Adipose-Derived Stem Cells.	2	9	2.56	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:32236812	(2020) One-Year Effectiveness Study of Intravitreously Administered Conbercept((R)) Monotherapy in Diabetic Macular Degeneration: A Systematic Review and Meta-Analysis.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32244546	(2020) Safety of Aflibercept in Metastatic Colorectal Cancer: A Literature Review and Expert Perspective on Clinical and Real-World Data.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32245416	(2020) A risk factor-based predictive model for new-onset hypertension during pregnancy in Chinese Han women.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32255175	(2020) A meta-analysis of the vascular endothelial growth factor polymorphisms associated with the risk of pre-eclampsia.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32259534	(2020) Dysregulation of trophic factors contributes to diabetic retinopathy in the Ins2(Akita) mouse.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32260158	(2020) Increased Angiogenesis and Lymphangiogenesis in the Placental Villi of Women with Chronic Venous Disease during Pregnancy.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32266227	(2020) Angiogenesis in Tissue Engineering: As Nature Intended?	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32276449	(2020) A G-Protein Coupled Receptor and Macular Degeneration.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32280526	(2020) Comparison of the Efficacy and Safety of Intravitreal Conbercept with Intravitreal Ranibizumab for Treatment of Diabetic Macular Edema: A Meta-Analysis.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32285152	(2020) Role of Fibronectin-1 polymorphism genes with the pathogenesis of intraventricular hemorrhage in preterm infants.	2	7	2.67	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:32308578	(2020) A Case of Isolated Adrenocorticotropic Hormone Deficiency Caused by Pembrolizumab.	2	10	2.51	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:32315307	(2020) Systematic review of prediction models for gestational hypertension and preeclampsia.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32317791	(2020) Brolucizumab-another anti-VEGF or beyond.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32318284	(2020) Four-Year Outcome of Aflibercept Treatment-Naive Patients for Neovascular Age-Related Macular Degeneration: Evidence from a Clinical Setting.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32319336	(2020) Distinct Characteristics of VEGF-D and VEGF-C to Predict Mortality in Patients With Suspected or Known Coronary Artery Disease.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32325956	(2020) The Ionophoric Activity of a Pro-Apoptotic VEGF165 Fragment on HUVEC Cells.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32336238	(2020) Multiplex Analysis of Circulating Maternal Cardiovascular Biomarkers Comparing Preeclampsia Subtypes.	2	4	2.91	0.0461	9606.ENSP00000006053,9606.ENSP00000451040	CX3CL1,PGF
PMID:32346415	(2020) Intravitreal injection of conbercept combined with retinal photocoagulation on macular edema secondary to branch retinal vein occlusion.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32349586	(2020) Prenatal and Postnatal Cardiac Development in Offspring of Hypertensive Pregnancies.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32354384	(2020) Basic Biology of Extracellular Matrix in the Cardiovascular System, Part 14: JACC Focus Seminar.	3	82	1.78	0.0461	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:32356367	(2020) Intravitreal aflibercept for treatment of macular oedema associated with immune recovery uveitis.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32357516	(2020) Enhanced Serum Levels of sFlt1: Impact on Materno-Fetal CMV Transmission.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32361393	(2020) Down-regulation of B2R contributes to preeclampsia by inhibiting human trophoblast cell invasion and angiogenesis.	2	3	3.04	0.0461	9606.ENSP00000450482,9606.ENSP00000451040	BDKRB2,PGF
PMID:32364167	(2020) Significance of vascular endothelium growth factor testing in exhaled breath condensate of patients with acute respiratory distress syndrome.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32368159	(2020) Platelet Indices and CXCL12 Levels in Patients with Intrauterine Growth Restriction.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32373503	(2020) Expression of Diverse Angiogenesis Factor in Different Stages of the 4T1 Tumor as a Mouse Model of Triple-Negative Breast Cancer.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32374047	(2020) Binding of the placental growth factor to VEGF receptor type 1 modulates human T cell functions.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32375082	(2020) Risk of Dyslipidemia Associated with VEGFVEGFR Inhibitors: A Meta-Analysis.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32380699	(2020) Strategies to Improve Nanofibrous Scaffolds for Vascular Tissue Engineering.	2	14	2.37	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:32382226	(2020) Pulmonary manifestations of chronic liver disease: a comprehensive review.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32382537	(2020) Comparison of the Efficacy of Three Loading Doses of Intravitreal Injection of Conbercept with Injection Combined with PDT for the Treatment of PCV.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32399582	(2020) Beneficial switch from aflibercept to ranibizumab for the treatment of refractory neovascular age-related macular degeneration.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32407290	(2020) Ovulation and ovarian wound healing are impaired with advanced reproductive age.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32408394	(2020) Acute cytotoxicity and increased vascular endothelial growth factor after in vitro nitrogen mustard vapor exposure.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32410995	(2020) Kaempferol, a Major Flavonoid in Ginkgo Folium, Potentiates Angiogenic Functions in Cultured Endothelial Cells by Binding to Vascular Endothelial Growth Factor.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32418891	(2020) Real life polycyclic aromatic hydrocarbon (PAH) mixtures modulate hCG, hPL and hPLGF levels and disrupt the physiological ratio of MMP-2 to MMP-9 and VEGF expression in human placenta cell lines.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32429087	(2020) The Neuropeptide System and Colorectal Cancer Liver Metastases: Mechanisms and Management.	3	112	1.64	0.0461	9606.ENSP00000006053,9606.ENSP00000276571,9606.ENSP00000478570	CX3CL1,CRH,VEGFA
PMID:32429380	(2020) Evaluation of Second-line Anti-VEGF after First-line Anti-EGFR Based Therapy in RAS Wild-Type Metastatic Colorectal Cancer: The Multicenter SLAVE Study.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32439930	(2020) Ranibizumab non-response in pachychoroid neovasculopathy: Effects of switching to aflibercept.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32440321	(2020) Cardiovascular responses produced by resistin injected into paraventricular nucleus mediated by the glutamatergic and CRFergic transmissions within rostral ventrolateral medulla.	2	6	2.74	0.0461	9606.ENSP00000231061,9606.ENSP00000276571	SPARC,CRH
PMID:32446247	(2020) Inflammatory and Angiogenic Mediators in Amniotic Fluid Are Associated With the Development of Retinopathy of Prematurity in Preterm Infants.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32452405	(2020) Combining metformin and sulfasalazine additively reduces the secretion of antiangiogenic factors from the placenta: Implications for the treatment of preeclampsia.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32454401	(2020) CD24-targeted fluorescence imaging in patient-derived xenograft models of high-grade serous ovarian carcinoma.	2	12	2.43	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:32454402	(2020) CD24-targeted intraoperative fluorescence image-guided surgery leads to improved cytoreduction of ovarian cancer in a preclinical orthotopic surgical model.	2	8	2.61	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:32455670	(2020) Single-Cell Transcriptomic Analysis of Tumor-Derived Fibroblasts and Normal Tissue-Resident Fibroblasts Reveals Fibroblast Heterogeneity in Breast Cancer.	3	106	1.66	0.0461	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000451040	SPARC,HSPG2,PGF
PMID:32456015	(2020) Prepregnancy Endocrine, Autoimmune Disorders and the Risks of Gestational Hypertension-Preeclampsia in Primiparas: A Nationwide Population-Based Study in Taiwan.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32456248	(2020) Role of Extracellular Matrix in Gastrointestinal Cancer-Associated Angiogenesis.	3	78	1.8	0.0461	9606.ENSP00000231061,9606.ENSP00000334329,9606.ENSP00000363827	SPARC,UNC5B,HSPG2
PMID:32457610	(2020) Traditional Chinese Medicine in Depression Treatment: From Molecules to Systems.	2	10	2.51	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:32457655	(2020) The Effect of Exercise Training During Pregnancy to Improve Maternal Vascular Health: Focus on Gestational Hypertensive Disorders.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32461558	(2020) Angiogenic cytokines can reflect the synovitis severity and treatment response to biologics in rheumatoid arthritis.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32462405	(2020) Heparanase, cell signaling, and viral infections.	3	74	1.82	0.0461	9606.ENSP00000363827,9606.ENSP00000451040,9606.ENSP00000478570	HSPG2,PGF,VEGFA
PMID:32470876	(2020) Increased NDRG1 expression suppresses angiogenesis via PI3KAKT pathway in human placental cells.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32471123	(2020) Vav1 is Essential for HIF-1alpha Activation via a Lysosomal VEGFR1-Mediated Degradation Mechanism in Endothelial Cells.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32473644	(2020) Safety and efficacy of direct Cardiac Shockwave Therapy in patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting (the CAST-HF trial): study protocol for a randomized controlled trial.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32477592	(2020) New Frontiers in Retina: highlights of the 2020 angiogenesis, exudation and degeneration symposium.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32481293	(2020) A systematic review and meta-analysis to compare the efficacy of conbercept with ranibizumab in patients with macular edema secondary to retinal vein occlusion.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32482148	(2020) The limited knowledge of placental damage due to neglected infections: ongoing problems in Latin America.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32487395	(2020) Polymeric nanofibrous scaffolds laden with cell-derived extracellular matrix for bone regeneration.	2	5	2.81	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:32487450	(2020) Lymphangiogenesis induced by vascular endothelial growth factor receptor 1 signaling contributes to the progression of endometriosis in mice.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32494207	(2020) Case Series on Initial Responses to Intravitreal Brolucizumab in Patients with Recalcitrant Chronic Wet Age-Related Macular Degeneration.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32503534	(2020) Relationship between retinal blood flow and cytokines in central retinal vein occlusion.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32513597	(2020) Prevention of preeclampsia.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32518833	(2020) Impact of intravitreal aflibercept dosing regimens in treatment-naive patients with neovascular age-related macular degeneration in routine clinical practice in France: results from the RAINBOW study.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32522165	(2020) The local hypothalamic-pituitary-adrenal axis in cultured human dermal papilla cells.	2	11	2.47	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:32529705	(2020) Inhibition of the Notch1 pathway induces peripartum cardiomyopathy.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32541890	(2020) Building on the success of anti-vascular endothelial growth factor therapy: a vision for the next decade.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32548078	(2020) Three-dimensional bio-printing and bone tissue engineering: technical innovations and potential applications in maxillofacial reconstructive surgery.	2	4	2.91	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:32581764	(2020) Excessive Production of Transforming Growth Factor beta1 Causes Mural Cell Depletion From Cerebral Small Vessels.	2	8	2.61	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:32589498	(2020) Changes in Aqueous Cytokine Levels Following Intravitreal Aflibercept in Treatment-Naive Patients with Diabetic Macular Edema.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32599742	(2020) Differential Expression of Kinin Receptors in Human Wet and Dry Age-Related Macular Degeneration Retinae.	2	10	2.51	0.0461	9606.ENSP00000450482,9606.ENSP00000478570	BDKRB2,VEGFA
PMID:32600286	(2020) Nephrotic syndrome due to preeclampsia before 20 weeks of gestation: a case report.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32603330	(2020) Cardiac, renal and uterine hemodynamics changes throughout pregnancy in rats with a prolonged high fat diet from an early age.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32618892	(2020) Administration of recombinant human placental growth factor decreases blood pressure in obese hypertensive pregnant rats.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32623922	(2020) Affinity-Enhanced Multimeric VEGF (Vascular Endothelial Growth Factor) and PlGF (Placental Growth Factor) Variants for Specific Adsorption of sFlt-1 to Restore Angiogenic Balance in Preeclampsia.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32625064	(2020) Reduced Fractalkine Levels Lead to Striatal Synaptic Plasticity Deficits in Huntingtons Disease.	2	13	2.4	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:32626540	(2020) Adverse Cardiac Remodelling after Acute Myocardial Infarction: Old and New Biomarkers.	3	68	1.86	0.0461	9606.ENSP00000231061,9606.ENSP00000362524,9606.ENSP00000478570	SPARC,ANGPTL2,VEGFA
PMID:32629855	(2020) Bis(maltolato)oxovanadium(IV) Induces Angiogenesis via Phosphorylation of VEGFR2.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32637296	(2020) Targeted Molecular Iron Oxide Contrast Agents for Imaging Atherosclerotic Plaque.	2	8	2.61	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:32637755	(2020) Studies of nanoparticle delivery with in vitro bio-engineered microtissues.	2	10	2.51	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:32642428	(2020) Vascular endothelial growth factor for in vivo bone formation: A systematic review.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32665552	(2020) Angiogenesis Analyzer for ImageJ - A comparative morphometric analysis of Endothelial Tube Formation Assay and Fibrin Bead Assay.	2	14	2.37	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:32674264	(2020) Towards Clinical Implementation of Adeno-Associated Virus (AAV) Vectors for Cancer Gene Therapy: Current Status and Future Perspectives.	3	64	1.88	0.0461	9606.ENSP00000231061,9606.ENSP00000451040,9606.ENSP00000478570	SPARC,PGF,VEGFA
PMID:32678284	(2020) Maternal total cell-free DNA in preeclampsia with and without intrauterine growth restriction.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32685542	(2020) Evaluation of Microvascular Structure Changes after Conbercept Treatment on Macular Edema Secondary to Retinal Vein Occlusion.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32695299	(2020) Triiodothyronine potentiates angiogenesis-related factor expression through PI3KAKT signaling pathway in human osteoarthritic osteoblasts.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32707641	(2020) Polymeric Nanoparticles for Drug Delivery: Recent Developments and Future Prospects.	2	11	2.47	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:32714608	(2020) Safety of Intravitreal Injection of Biosimilar of Aflibercept in Rabbit Eyes.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32737299	(2020) A protein-independent fluorescent RNA aptamer reporter system for plant genetic engineering.	2	14	2.37	0.0461	9606.ENSP00000006053,9606.ENSP00000231061	CX3CL1,SPARC
PMID:32740838	(2020) The impact of particulate matter 2.5 on the risk of preeclampsia: an updated systematic review and meta-analysis.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32741971	(2020) First-in-human, dose-escalation, phase 1 study of anti-angiopoietin-2 LY3127804 as monotherapy and in combination with ramucirumab in patients with advanced solid tumours.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32742760	(2020) Safety and Biocompatibility of Aflibercept-Loaded Microsphere Thermo-Responsive Hydrogel Drug Delivery System in a Nonhuman Primate Model.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32752005	(2020) Expression of Stress-Mediating Genes is Increased in Term Placentas of Women with Chronic Self-Perceived Anxiety and Depression.	2	10	2.51	0.0461	9606.ENSP00000276571,9606.ENSP00000451040	CRH,PGF
PMID:32752023	(2020) Title: Pachydrusen in Fellow Eyes Predict Response to Aflibercept Monotherapy in Patients with Polypoidal Choroidal Vasculopathy.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32755413	(2020) Preconception Blood Pressure and Its Change Into Early Pregnancy: Early Risk Factors for Preeclampsia and Gestational Hypertension.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32758718	(2020) Heme oxygenase-1 gene modified human placental mesenchymal stem cells promote placental angiogenesis and spiral artery remodeling by improving the balance of angiogenic factors in vitro.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32758764	(2020) Chronic elevation of plasma vascular endothelial growth factor-A (VEGF-A) is associated with a history of blast exposure.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32764303	(2020) Transcriptomic Analysis of Four Cerianthid (Cnidaria, Ceriantharia) Venoms.	2	10	2.51	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:32765123	(2020) Inhibitors of the Autotaxin-Lysophosphatidic Acid Axis and Their Potential in the Treatment of Interstitial Lung Disease: Current Perspectives.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32782280	(2020) CD146, from a melanoma cell adhesion molecule to a signaling receptor.	3	45	2.04	0.0461	9606.ENSP00000334329,9606.ENSP00000451040,9606.ENSP00000478570	UNC5B,PGF,VEGFA
PMID:32783421	(2020) Prospective Clinical Trial of Intravitreal Aflibercept Treat-and-extend Regimen for Diabetic Macular Edema: 1-Year Outcomes.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32796694	(2020) Use of Oral Anticoagulation and Diabetes Do Not Inhibit the Angiogenic Potential of Hypoxia Preconditioned Blood-Derived Secretomes.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32801629	(2020) Effects of VEGF Inhibitor Conbercept on Corneal Neovascularization Following Penetrating Keratoplasty in Rabbit Model.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32818603	(2020) Heparan sulfate deficiency leads to hypertrophic chondrocytes by increasing bone morphogenetic protein signaling.	2	11	2.47	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:32823391	(2020) Interleukins and cytokine biomarkers in uveitis.	3	68	1.86	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:32823863	(2020) Prognostic and Clinicopathological Significance of MiR-155 in Breast Cancer: A Systematic Review.	2	10	2.51	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:32839716	(2020) Calcium silicate-based root canal sealers: a literature review.	2	6	2.74	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:32844801	(2020) Comparison of Placental Growth Factor Levels in Maternal Serum at Early Pregnancy between Normotensive Pregnant Women and Patients with Hypertensive Disorders in Pregnancy.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32848728	(2020) Stabilization of HIF-1alpha in Human Retinal Endothelial Cells Modulates Expression of miRNAs and Proangiogenic Growth Factors.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32848875	(2020) Structural and Functional Remodeling of the Brain Vasculature Following Stroke.	3	105	1.67	0.0461	9606.ENSP00000363827,9606.ENSP00000451040,9606.ENSP00000478570	HSPG2,PGF,VEGFA
PMID:32849870	(2020) Morphological Characteristics and Clinical Significance of Different Types of Tumor Vessels in Patients with Stages I-IIA of Squamous Cervical Cancer.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32850867	(2020) Angiogenesis Inhibition by a Short 13 Amino Acid Peptide Sequence of Tetrastatin, the alpha4(IV) NC1 Domain of Collagen IV.	2	11	2.47	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:32855818	(2020) The Efficacy of Conbercept in Polypoidal Choroidal Vasculopathy: A Systematic Review.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32855852	(2020) Microporous Drug Delivery System for Sustained Anti-VEGF Delivery to the Eye.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32863837	(2020) Extra Virgin Olive Oil Modulates Vasodilator Enzyme Level by Repairing Angiogenesis Function in Rat Model of Preeclampsia.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32864064	(2020) Long-term Outcomes of Treat and Extend Regimen of Anti-vascular Endothelial Growth Factor in Neovascular Age-related Macular Degeneration.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32864460	(2020) The Diagnostic and Prognostic Role of Vascular Endothelial Growth Factor C in Sepsis and Septic Shock.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32864636	(2020) Discovery and Verification of Extracellular miRNA Biomarkers for Non-invasive Prediction of Pre-eclampsia in Asymptomatic Women.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32871950	(2020) Evaluation of the efficacy of Conbercept in the treatment of diabetic macular edema based on OCTA.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32879419	(2020) VEGF-A splice variants bind VEGFRs with differential affinities.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32879883	(2020) Vascular Endothelial Growth Factor Inhibits Phagocytosis of Apoptotic Cells by Airway Epithelial Cells.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32884948	(2020) Comparative Analysis of the Occurrence and Role of CX3CL1 (Fractalkine) and Its Receptor CX3CR1 in Hemophilic Arthropathy and Osteoarthritis.	2	12	2.43	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:32922549	(2020) Role of the erythropoietin receptor in Lung Cancer cells: erythropoietin exhibits angiogenic potential.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32922730	(2020) Melanoma in pregnancy: certainties unborn.	2	9	2.56	0.0461	9606.ENSP00000276571,9606.ENSP00000451040	CRH,PGF
PMID:32929074	(2020) Chitinase-3 like-protein-1 function and its role in diseases.	3	52	1.97	0.0461	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:32932150	(2020) Equivalence of human and bovine dentin matrix molecules for dental pulp regeneration: proteomic analysis and biological function.	2	12	2.43	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:32937768	(2020) The Effect of Swimming on Anxiety-Like Behaviors and Corticosterone in Stressed and Unstressed Rats.	2	10	2.51	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:32937952	(2020) Heparan Sulfate Proteoglycans Biosynthesis and Post Synthesis Mechanisms Combine Few Enzymes and Few Core Proteins to Generate Extensive Structural and Functional Diversity.	3	70	1.84	0.0461	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:32962278	(2020) Association between Polygenic Risk Score and One-Year Outcomes Following As-Needed Aflibercept Therapy for Exudative Age-Related Macular Degeneration.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32971873	(2020) Complement in Reproductive White Adipose Tissue Characterizes the Obese Preeclamptic-Like BPH5 Mouse Prior to and During Pregnancy.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32975735	(2020) Development of a Recombinant Monospecific Anti-PLGF Bivalent Nanobody and Evaluation of it in Angiogenesis Modulation.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32977633	(2020) Advances on Bone Substitutes through 3D Bioprinting.	2	6	2.74	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:32977791	(2020) Clinical effect of conbercept on improving diabetic macular ischemia by OCT angiography.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32982684	(2020) P2X7 Receptor-Dependent microRNA Expression Profile in the Brain Following Status Epilepticus in Mice.	2	14	2.37	0.0461	9606.ENSP00000304767,9606.ENSP00000478570	P2RY1,VEGFA
PMID:32983771	(2020) Physical, Biochemical, and Biologic Properties of Fat Graft Processed via Different Methods.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32984231	(2020) The Endocrine Disruption of Prenatal Phthalate Exposure in Mother and Offspring.	2	9	2.56	0.0461	9606.ENSP00000276571,9606.ENSP00000451040	CRH,PGF
PMID:32993787	(2020) The role of microenvironment in tumor angiogenesis.	3	113	1.64	0.0461	9606.ENSP00000231061,9606.ENSP00000451040,9606.ENSP00000478570	SPARC,PGF,VEGFA
PMID:32994736	(2020) APOE2 promotes the development and progression of subretinal neovascularization in age-related macular degeneration via MAPKs signaling pathway.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33005448	(2020) Short-Term Results of Switch from Conbercept to Bevacizumab or Ranibizumab in Eyes with Persistent Neovascular Age-Related Macular Degeneration.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33013445	(2020) Stromal Cells Promote Neovascular Invasion Across Tissue Interfaces.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33014856	(2020) Combination of Cordycepin and Apatinib Synergistically Inhibits NSCLC Cells by Down-Regulating VEGFPI3KAkt Signaling Pathway.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33026915	(2020) Primary Cilia in Trophoblastic Cells: Potential Involvement in Preeclampsia.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33041582	(2020) Periosteum eversion technique versus subpedicle connective tissue graft technique for root coverage of gingival recessions: A randomized split-mouth study.	2	7	2.67	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:33042222	(2020) Low Ethanol Concentrations Promote Endothelial Progenitor Cell Capacity and Reparative Function.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33046787	(2020) Assessment of conbercept therapy for high myopia macular neovascularization by optical coherence tomography angiography.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33050237	(2020) Emergence of Cancer-Associated Fibroblasts as an Indispensable Cellular Player in Bone Metastasis Process.	3	88	1.74	0.0461	9606.ENSP00000334329,9606.ENSP00000363827,9606.ENSP00000478570	UNC5B,HSPG2,VEGFA
PMID:33050335	(2020) Eicosanoid Profiles in the Vitreous Humor of Patients with Proliferative Diabetic Retinopathy.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33059692	(2020) Clinical features of genetically characterized types of hereditary angioedema with normal C1 inhibitor: a systematic review of qualitative evidence.	2	14	2.37	0.0461	9606.ENSP00000450482,9606.ENSP00000478570	BDKRB2,VEGFA
PMID:33062591	(2020) Pulmonary Complications in Patients with Liver Cirrhosis.	2	6	2.74	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:33068876	(2020) Differential regulation of a placental SAM68 and sFLT1 gene pathway and the relevance to maternal vitamin D sufficiency.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33072861	(2020) 3D Immunocompetent Organ-on-a-Chip Models.	3	87	1.75	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:33077473	(2020) Aflibercept ameliorates retinal pericyte loss and restores perfusion in streptozotocin-induced diabetic mice.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33080700	(2020) Everolimus-related unilateral abdominal lymphedema in a renal cancer patient: A case report.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33086609	(2020) Are Titania Photocatalysts and Titanium Implants Safe? Review on the Toxicity of Titanium Compounds.	2	11	2.47	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:33088937	(2020) Isthmin 2 is decreased in preeclampsia and highly expressed in choriocarcinoma.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33094011	(2020) Use of Placental Growth Factor for Trisomy 21 Screening in Pregnancy: A Systematic Review.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33094098	(2020) Tumor Immune Microenvironments (TIMEs): Responsive Nanoplatforms for Antitumor Immunotherapy.	2	13	2.4	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:33097752	(2020) Increasing thermal stability and improving biodistribution of VEGFR2-binding affibody molecules by a combination of in silico and directed evolution approaches.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33101055	(2020) Comparative Serum Analyses Identify Cytokines and Hormones Commonly Dysregulated as Well as Implicated in Promoting Osteolysis in MMP-2-Deficient Mice and Children.	3	65	1.88	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:33101619	(2020) Correlation between smoking and neovascularization in biceps tendinopathy: a functional preoperative and immunohistochemical study.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33109108	(2020) Genetic polymorphisms of PGF and TNFAIP2 genes related to cervical cancer risk among Uygur females from China.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33112826	(2020) Association of n-6 PUFAs with the risk of diabetic retinopathy in diabetic patients.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33117488	(2020) Clinical characteristics and treatment outcomes of angioid streak associated choroidal neovascular membrane (AS-CNV): a Zambian case series.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33117607	(2020) VEGF TrapR1R2 Suspended in the Semifluorinated Alkane F6H8 Inhibits Inflammatory Corneal Hem- and Lymphangiogenesis.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33121005	(2020) Factors Affecting the Formation and Treatment of Thrombosis by Natural and Synthetic Compounds.	3	92	1.73	0.0461	9606.ENSP00000006053,9606.ENSP00000304767,9606.ENSP00000478570	CX3CL1,P2RY1,VEGFA
PMID:33130176	(2020) Synergistic interactions of PlGF and VEGF contribute to blood-retinal barrier breakdown through canonical NFkappaB activation.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33133822	(2020) Three-Year Results of Management of Adult-Onset Coats Disease by Possibly Targeting Placental Growth Factor.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33143661	(2020) Involvement of Hdac3-mediated inhibition of microRNA cluster 17-92 in bronchopulmonary dysplasia development.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33144174	(2020) Exposure to perfluorobutane sulfonate and perfluorooctanesulfonic acid disrupts the production of angiogenesis factors and stress responses in human placental syncytiotrophoblast.	2	4	2.91	0.0461	9606.ENSP00000276571,9606.ENSP00000451040	CRH,PGF
PMID:33147235	(2020) Heterotopic autotransplantation of ovarian tissue in a large animal model: Effects of cooling and VEGF.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33149867	(2020) In vitro combination therapy of pathologic angiogenesis using anti-vascular endothelial growth factor and anti-neuropilin-1 nanobodies.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33150941	(2020) The role of extracellular matrix in tumour angiogenesis: the throne has NOx servants.	3	43	2.06	0.0461	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:33171691	(2020) HOX Genes Family and Cancer: A Novel Role for Homeobox B9 in the Resistance to Anti-Angiogenic Therapies.	3	63	1.89	0.0461	9606.ENSP00000362524,9606.ENSP00000451040,9606.ENSP00000478570	ANGPTL2,PGF,VEGFA
PMID:33172503	(2020) Biodegradable materials for bone defect repair.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33178814	(2020) Pulmonary hypertension: Proteins in the blood.	3	46	2.03	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:33184413	(2020) Identifying potential biomarkers related to pre-term delivery by proteomic analysis of amniotic fluid.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33187209	(2020) Cancer Extracellular Matrix Proteins Regulate Tumour Immunity.	3	54	1.96	0.0461	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:33192326	(2020) Phenotyping CCL2 Containing Central Amygdala Neurons Controlling Alcohol Withdrawal-Induced Anxiety.	2	13	2.4	0.0461	9606.ENSP00000006053,9606.ENSP00000276571	CX3CL1,CRH
PMID:33192853	(2020) Exercise Intervention in Treatment of Neuropsychological Diseases: A Review.	2	8	2.61	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:33193075	(2020) Endocrine Evaluation in POEMS Syndrome: A Cohort Study.	2	4	2.91	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:33193856	(2020) Early palliative care of non-small cell lung cancer in the context of immunotherapy.	2	8	2.61	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:33195137	(2020) Red Carrot Cells Cultured in vitro Are Effective, Stable, and Safe Ingredients for Skin Care, Nutraceutical, and Food Applications.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33195474	(2020) Engineering Myocardium for Heart Regeneration-Advancements, Considerations, and Future Directions.	2	14	2.37	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:33196778	(2020) Preclinical Efficacy and Safety of VEGF-Grab, a Novel Anti-VEGF Drug, and Its Comparison to Aflibercept.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33198179	(2020) Purinergic Signaling in Endometriosis-Associated Pain.	3	51	1.98	0.0461	9606.ENSP00000006053,9606.ENSP00000304767,9606.ENSP00000478570	CX3CL1,P2RY1,VEGFA
PMID:33203393	(2020) Protocol of the EFFORT study: a prospective study of FOLFIRI plus aflibercept as second-line treatment after progression on FOLFOXIRI plus bevacizumab or during maintenance treatment in patients with unresectablemetastatic colorectal cancer.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33204258	(2020) Clinical Characteristics and Management of Functional Pancreatic Neuroendocrine Neoplasms: A Single Institution 20-Year Experience with 286 Patients.	2	14	2.37	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:33209740	(2020) Placental Genetic Variants in the Upstream Region of the FLT1 Gene in Pre-eclampsia.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33224336	(2020) Utility of biochemical tests in prediction, diagnostics and clinical management of preeclampsia: a review.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33230438	(2020) Dual-Acting Antiangiogenic Gene Therapy Reduces Inflammation and Regresses Neovascularization in Diabetic Mouse Retina.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33237074	(2020) Prenatal vitamin D supplementation reduces blood pressure and improves placental angiogenesis in an animal model of preeclampsia.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33239034	(2020) Neurotransmitter and neuropeptide regulation of mast cell function: a systematic review.	3	52	1.97	0.0461	9606.ENSP00000006053,9606.ENSP00000276571,9606.ENSP00000478570	CX3CL1,CRH,VEGFA
PMID:33239875	(2020) Bidirectional Enhancement of Cell Proliferation Between Iron Oxide Nanoparticle-Labeled Mesenchymal Stem Cells and Choroid Plexus in a Cell-Based Therapy Model of Ischemic Stroke.	3	42	2.07	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:33247781	(2020) Endothelial progenitorstem cells in engineered vessels for vascular transplantation.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33251275	(2020) A Modern View of the Interstitial Space in Health and Disease.	2	13	2.4	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:33255666	(2020) Semen Modulates Inflammation and Angiogenesis in the Reproductive Tract of Female Rabbits.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33256685	(2020) Angiopoietin-like 2 is a potential biomarker for diabetic foot patients.	2	6	2.74	0.0461	9606.ENSP00000362524,9606.ENSP00000478570	ANGPTL2,VEGFA
PMID:33281342	(2020) The distribution pattern and growth factor level in platelet-rich fibrin incorporated skin-derived mesenchymal stem cells: An in vitro study.	2	10	2.51	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:33287124	(2020) Differential Diagnosis of Preeclampsia Based on Urine Peptidome Features Revealed by High Resolution Mass Spectrometry.	3	41	2.08	0.0461	9606.ENSP00000363827,9606.ENSP00000451040,9606.ENSP00000478570	HSPG2,PGF,VEGFA
PMID:33292249	(2020) A comparison of the efficacy of antiangiogenic agents combined with chemotherapy for the treatment of non-small cell lung cancer: a network meta-analysis.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33292364	(2020) Novel biomarkers with promising benefits for diagnosis of cervical neoplasia: a systematic review.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33303870	(2020) Intravitreal ranibizumab reduced ocular blood flow and aqueous cytokine levels and improved retinal morphology in patients with diabetic macular edema.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33321819	(2020) Regulators at Every Step-How microRNAs Drive Tumor Cell Invasiveness and Metastasis.	3	100	1.69	0.0461	9606.ENSP00000231061,9606.ENSP00000451040,9606.ENSP00000478570	SPARC,PGF,VEGFA
PMID:33322258	(2020) Expression of Extracellular Matrix-Related Genes and Their Regulatory microRNAs in Problematic Colorectal Polyps.	2	13	2.4	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:33330082	(2020) Anti-Angiogenic Agents in Management of Sarcoma Patients: Overview of Published Trials.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33334029	(2020) TGF-beta Serum Levels in Diabetic Retinopathy Patients and the Role of Anti-VEGF Therapy.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33335385	(2020) Diagnostic and Management Strategies in Patients with Persistent Fetal Vasculature: Current Insights.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33336062	(2020) Circular RNA hsa_circ_0007121 regulates proliferation, migration, invasion, and epithelial-mesenchymal transition of trophoblast cells by miR-182-5pPGF axis in preeclampsia.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33343968	(2020) Endometrial CD56+ natural killer cells in women with recurrent implantation failure: An immunohistochemical study.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33344666	(2020) VEGFA Promoter Polymorphisms rs699947 and rs35569394 Are Associated With the Risk of Anterior Cruciate Ligament Ruptures Among Indian Athletes: A Cross-sectional Study.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33361764	(2020) Endothelial activation and dysfunction in COVID-19: from basic mechanisms to potential therapeutic approaches.	3	64	1.88	0.0461	9606.ENSP00000006053,9606.ENSP00000450482,9606.ENSP00000478570	CX3CL1,BDKRB2,VEGFA
PMID:33363367	(2020) Simultaneous Detection of VEGF and CEA by Time-Resolved Chemiluminescence Enzyme-Linked Aptamer Assay.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33371267	(2020) TMEFF2: A Transmembrane Proteoglycan with Multifaceted Actions in Cancer and Disease.	3	44	2.05	0.0461	9606.ENSP00000231061,9606.ENSP00000276571,9606.ENSP00000478570	SPARC,CRH,VEGFA
PMID:33375281	(2020) Retinal Microcirculation and Cytokines as Predictors for Recurrence of Macular Edema after Intravitreal Ranibizumab Injection in Branch Retinal Vein Occlusion.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33378412	(2020) Potency of Tokishakuyakusan in treating preeclampsia: Drug repositioning method by in vitro screening of the Kampo library.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33379399	(2020) Sex Differences in Placental Protein Expression and Efficiency in a Rat Model of Fetal Programming Induced by Maternal Undernutrition.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33392191	(2020) Nerves in the Tumor Microenvironment: Origin and Effects.	3	87	1.75	0.0461	9606.ENSP00000006053,9606.ENSP00000276571,9606.ENSP00000478570	CX3CL1,CRH,VEGFA
PMID:33392506	(2020) Vascular dysfunction promotes regional hypoxia after bevacizumab therapy in recurrent glioblastoma patients.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33417661	(2020) The Impact of Kinase Insert Domain (KDR) Gene Polymorphism rs2305948 on Clopidogrel Resistance in Iraqi Patients Undergoing Elective Percutaneous Coronary Intervention (PCI).	2	11	2.47	0.0461	9606.ENSP00000304767,9606.ENSP00000478570	P2RY1,VEGFA
PMID:33456431	(2020) Functionally graded biomaterials for use as model systems and replacement tissues.	2	11	2.47	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:33456605	(2020) Melatonin Levels Decrease in the Umbilical Cord in Case of Intrauterine Growth Restriction.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33469537	(2020) The Role of Anti-angiogenesis in the Treatment Landscape of Non-small Cell Lung Cancer - New Combinational Approaches and Strategies of Neovessel Inhibition.	3	44	2.05	0.0461	9606.ENSP00000450482,9606.ENSP00000451040,9606.ENSP00000478570	BDKRB2,PGF,VEGFA
PMID:33473260	(2020) Alphastatin-C a new inhibitor of endothelial cell activation is a pro-arteriogenic agent in vivo and retards B16-F10 melanoma growth in a preclinical model.	2	14	2.37	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:33510596	(2020) Advanced Materials to Enhance Central Nervous System Tissue Modeling and Cell Therapy.	2	14	2.37	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:33511108	(2020) Bioinspired Modifications of PEEK Implants for Bone Tissue Engineering.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33511134	(2020) Bearing My Heart: The Role of Extracellular Matrix on Cardiac Development, Homeostasis, and Injury Response.	3	65	1.88	0.0461	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:33519380	(2020) Structural and Functional Features of Developing Brain Capillaries, and Their Alteration in Schizophrenia.	2	13	2.4	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:33542603	(2020) Intravitreal aflibercept treatment for choroidal neovascularization secondary to laser pointer.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33551572	(2020) Materials for blood brain barrier modeling in vitro.	2	10	2.51	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:33552057	(2020) Evaluation of Proteoforms of the Transmembrane Chemokines CXCL16 and CX3CL1, Their Receptors, and Their Processing Metalloproteinases ADAM10 and ADAM17 in Proliferative Diabetic Retinopathy.	2	13	2.4	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:33796275	(2020) Combined vitrectomy, near-confluent panretinal endolaser, bevacizumab and cyclophotocoagulation for neovascular glaucoma - a retrospective interventional case series.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33854919	(2020) Frequency of monocyte subsets is linked to the severity of atherosclerosis in patients with ischemic heart disease: A case-control study.	3	56	1.94	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:34056022	(2020) Structural Studies on an Anti-Angiogenic Peptide Using Molecular Modeling.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34396233	(2020) The TICONC (Ticagrelor-Oncology) Study: Implications of P2Y12 Inhibition for Metastasis and Cancer-Associated Thrombosis.	2	6	2.74	0.0461	9606.ENSP00000304767,9606.ENSP00000478570	P2RY1,VEGFA
PMID:34713223	(2020) CRISPR Technology for Ocular Angiogenesis.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35117410	(2020) Prolactin (PRL), placenta growth factor (PIGF) and nerve growth factor receptor (NGFR) as biomarkers for early diagnosis and prognosis in patients with esophageal squamous cell carcinoma (ESCC).	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28358746	(2019) solitary retinal capillary hemangioma in a patient with bilateral chorioretinal coloboma.	2	5	2.81	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:29027018	(2019) Accelerated growth of hemangioblastoma in pregnancy: the role of proangiogenic factors and upregulation of hypoxia-inducible factor (HIF) in a non-oxygen-dependent pathway.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29370571	(2019) An Intraocular Inflammatory Profile of Rubella Associated Uveitis.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29439617	(2019) Low-Density Lipoprotein Receptor-Related Protein 6 Is Essential for Trophoblast Survival and Invasion.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29455633	(2019) Placental growth factor, vascular endothelial growth factor, and hypoxia-inducible factor-1alpha in the placentas of women with pre-eclampsia.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29470308	(2019) efficacy and safety outcomes of intravitreal aflibercept focusing on patients with diabetic macular edema from japan.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29656148	(2019) Basement membrane mechanics shape development: Lessons from the fly.	2	8	2.61	0.0461	9606.ENSP00000231061,9606.ENSP00000363827	SPARC,HSPG2
PMID:29685073	(2019) The association of second trimester biomarkers in amniotic fluid and fetal outcome.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30003436	(2019) Angiogenic capacity in pre-eclampsia and uncomplicated pregnancy estimated by assay of angiogenic proteins and an in vitro vasculogenesisangiogenesis test.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30048978	(2019) Aqueous Humor Levels of Cytokines in Patients with Age-Related Macular Degeneration.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30073769	(2019) Different effects of various anti-angiogenic treatments in an experimental mouse model of retinopathy of prematurity.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30122546	(2019) Renal Disorders in Pregnancy: Core Curriculum 2019.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30136881	(2019) Adeno-associated virus 2 mediated gene transfer of vascular endothelial growth factor Trap: a new treatment option for glioma.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30149103	(2019) Extracellular matrix roles in cardiorenal fibrosis: Potential therapeutic targets for CVD and CKD in the elderly.	3	88	1.74	0.0461	9606.ENSP00000006053,9606.ENSP00000231061,9606.ENSP00000478570	CX3CL1,SPARC,VEGFA
PMID:30160658	(2019) Sympathetic nervous system control of vascular function and blood pressure during pregnancy and preeclampsia.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30254189	(2019) A Phase II Trial of Pazopanib in Patients with Metastatic Alveolar Soft Part Sarcoma.	2	9	2.56	0.0461	9606.ENSP00000362524,9606.ENSP00000478570	ANGPTL2,VEGFA
PMID:30291853	(2019) A Mesenchymal stem cell line (B10) increases angiogenesis in a rat MCAO model.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30292477	(2019) Characterization of receptor binding kinetics for vascular endothelial growth factor-A using SPR.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30298670	(2019) Intraocular cytokine profile and autoimmune reactions in retinitis pigmentosa, age-related macular degeneration, glaucoma and cataract.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30325071	(2019) Tie-ing Up Angiogenesis to Treat Nonalcoholic Steatohepatitis.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30339194	(2019) Biomarker analysis beyond angiogenesis: RASRAF mutation status, tumour sidedness, and second-line ramucirumab efficacy in patients with metastatic colorectal carcinoma from RAISE-a global phase III study.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30343358	(2019) Contribution of the plasma and lymph Degradome and Peptidome to the MHC Ligandome.	3	66	1.87	0.0461	9606.ENSP00000006053,9606.ENSP00000363827,9606.ENSP00000478570	CX3CL1,HSPG2,VEGFA
PMID:30352305	(2019) Immune regulation in the aging retina.	3	60	1.91	0.0461	9606.ENSP00000006053,9606.ENSP00000231061,9606.ENSP00000478570	CX3CL1,SPARC,VEGFA
PMID:30376696	(2019) Present and future of tissue engineering scaffolds for dentin-pulp complex regeneration.	2	12	2.43	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:30385175	(2019) The role of placental growth factor (PlGF) and its receptor system in retinal vascular diseases.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30403537	(2019) 3D human bone marrow stromal and endothelial cell spheres promote bone healing in an osteogenic niche.	2	10	2.51	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:30445173	(2019) Early Changes in Cardiovascular Biomarkers with Contemporary Thoracic Radiation Therapy for Breast Cancer, Lung Cancer, and Lymphoma.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30461195	(2019) VEGF-A regulates angiogenesis during osseointegration of Ti implants via paracrineautocrine regulation of osteoblast response to hierarchical microstructure of the surface.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30532012	(2019) The lung microenvironment: an important regulator of tumour growth and metastasis.	3	82	1.78	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:30536359	(2019) Effects of formaldehyde on vascular endothelial growth factor, matrix metallopeptidase 2 and osteonectin levels in periodontal membrane and alveolar bone in rats.	2	3	3.04	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:30553875	(2019) Skim milk powder with high content of Maillard reaction products affect weight gain, organ development and intestinal inflammation in early life in rats.	2	8	2.61	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:30571561	(2019) Melanocortin-4 Receptor Deficiency Attenuates Placental Ischemia-Induced Hypertension in Pregnant Rats.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30572193	(2019) Involvement of stromal cell-derived factor-1alpha (SDF-1alpha), stem cell factor (SCF), fractalkine (FKN) and VEGF in TSG protection against intimal hyperplasia in rat balloon injury.	2	7	2.67	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:30574927	(2019) Treatment of corneal neovascularization with topical aflibercept in a case of exposure keratopathy following cerebellar astrocytoma surgery.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30586702	(2019) Antiangiogenic VEGF165b Regulates Macrophage Polarization via S100A8S100A9 in Peripheral Artery Disease.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30587700	(2019) Value of Placental Growth Factor as a Predictor of Adverse Events During the Acute Phase of Acute Decompensated Heart Failure.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30587915	(2019) Anatomical and functional response after conversion to aflibercept using the treat-and-extend regimen protocol in bevacizumab treatment-resistant wet age-related macular degeneration.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30594551	(2019) Decidual natural killer cells: A critical pregnancy mediator altered in preeclampsia.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30597763	(2019) miR-20b, miR-296, and Let-7f Expression in Human Adipose Tissue is Related to Obesity and Type 2 Diabetes.	2	5	2.81	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:30611902	(2019) Urinary Cysteine-Rich Protein 61 and Trefoil Factor 3 as Diagnostic Biomarkers for Colorectal Cancer.	2	14	2.37	0.0461	9606.ENSP00000231061,9606.ENSP00000362524	SPARC,ANGPTL2
PMID:30620888	(2019) Increased circulating levels of Epidermal Growth Factor-like Domain 7 in pregnant women affected by preeclampsia.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30626412	(2019) CSF inflammatory markers differ in gram-positive versus gram-negative shunt infections.	2	13	2.4	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:30628094	(2019) Excessive inflammation portends complications: Wound cytokines and head and neck surgery outcomes.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30630515	(2019) Significant association between joint ultrasonographic parameters and synovial inflammatory factors in rheumatoid arthritis.	2	10	2.51	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:30635789	(2019) Fibroblast polarization over the myocardial infarction time continuum shifts roles from inflammation to angiogenesis.	3	53	1.97	0.0461	9606.ENSP00000006053,9606.ENSP00000231061,9606.ENSP00000478570	CX3CL1,SPARC,VEGFA
PMID:30646868	(2019) Intravitreal ranibizumab or conbercept for retinal arterial macroaneurysm: a case series.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30652389	(2019) Short PlGF-derived peptides bind VEGFR-1 and VEGFR-2 in vitro and on the surface of endothelial cells.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30657223	(2019) Phase II trial of aflibercept with FOLFIRI as a second-line treatment for Japanese patients with metastatic colorectal cancer.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30660179	(2019) Combining hydrophilic chemotherapy and hydrophobic phytotherapy via tumor-targeted albumin-QDs nano-hybrids: covalent coupling and phospholipid complexation approaches.	2	8	2.61	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:30661944	(2019) The impact of implant abutment surface treatment with TiO2 on peri-implant levels of angiogenesis and bone-related markers: a randomized clinical trial.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30662355	(2019) Sulforaphane Attenuates Angiotensin II-Induced Vascular Smooth Muscle Cell Migration via Suppression of NOX4ROSNrf2 Signaling.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30673862	(2019) Review of Biomarkers in Ocular Matrices: Challenges and Opportunities.	3	114	1.63	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:30682331	(2019) Role of aldose reductase in diabetes-induced retinal microglia activation.	2	7	2.67	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:30685337	(2019) Estrogen metabolism pathways in preeclampsia and normal pregnancy.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30686838	(2019) Follicular Fluid Levels of Adrenomedullin 2, Vascular Endothelial Growth Factor and its Soluble Receptors Are Associated with Ovarian Response During ART Cycles.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30689065	(2019) Fibroblast Growth Factor-2 Binding to Heparan Sulfate Proteoglycans Varies with Shear Stress in Flow-Adapted Cells.	2	8	2.61	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:30690930	(2019) Efficacy and safety of FOLFIRIaflibercept in second-line treatment of metastatic colorectal cancer in a real-world population: Prognostic and predictive markers.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30696472	(2019) Novel stereotactic body radiation therapy (SBRT)-based partial tumor irradiation targeting hypoxic segment of bulky tumors (SBRT-PATHY): improvement of the radiotherapy outcome by exploiting the bystander and abscopal effects.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30700844	(2019) What is the best first-line treatment for POEMS syndrome: autologous transplantation, melphalan and dexamethasone, or lenalidomide and dexamethasone?	2	3	3.04	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:30702616	(2019) Low dose of apatinib in treating chemotherapy and EGFR-TKI refractory non-small cell lung cancer: A case report.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30712068	(2019) Promoting Brain Repair and Regeneration After Stroke: a Plea for Cell-Based Therapies.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30712667	(2019) The Angiotensin II type 1 receptor mediates the effects of low oxygen on early placental angiogenesis.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30720441	(2019) Comprehensive Lifestyle Improvement Program for Prostate Cancer (CLIPP): Protocol for a Feasibility and Exploratory Efficacy Study in Men on Androgen Deprivation Therapy.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30721786	(2019) Placental morphology, apoptosis, angiogenesis and epithelial mechanisms in early-onset preeclampsia.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30728380	(2019) Intravitreal aflibercept for active polypoidal choroidal vasculopathy without active polyps.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30732627	(2019) Co-inhibition of PGF and VEGF blocks their expression in mononuclear phagocytes and limits neovascularization and leakage in the murine retina.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30737365	(2019) CYFRA 21-1 and Placental Growth Factor as Screening Markers for Endometriosis.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30738311	(2019) High glutathionylation of placental endothelial nitric oxide synthase in preeclampsia.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30742781	(2019) Regulation of Blood and Lymphatic Vessels by Immune Cells in Tumors and Metastasis.	3	94	1.72	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:30742782	(2019) Normalizing Function of Tumor Vessels: Progress, Opportunities, and Challenges.	3	44	2.05	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:30771259	(2019) Placental growth factor blunts uterine artery responses to angiotensin II.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30775250	(2019) Regulatory signaling network in the tumor microenvironment of prostate cancer bone and visceral organ metastases and the development of novel therapeutics.	3	63	1.89	0.0461	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:30784518	(2019) Erratum to: Park I, Yang H, Park JS et al. VEGF-Grab Enhances the Efficacy of Radiation Therapy by Blocking VEGF-A and Treatment-Induced PlGF. Int J Radiat Oncol Biol Phys 2018;102:609-618.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30815371	(2019) Existing anti-angiogenic therapeutic strategies for patients with metastatic colorectal cancer progressing following first-line bevacizumab-based therapy.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30816637	(2019) Sorafenib in Hepatopulmonary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.	2	9	2.56	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:30824385	(2019) Sulfasalazine reduces placental secretion of antiangiogenic factors, up-regulates the secretion of placental growth factor and rescues endothelial dysfunction.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30824681	(2019) Effect of Autologous Platelet-Rich Plasma Gel on Skin Flap Survival.	2	5	2.81	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:30826791	(2019) PARROT Ireland: Placental growth factor in Assessment of women with suspected pre-eclampsia to reduce maternal morbidity: a Stepped Wedge Cluster Randomised Control Trial Research Study Protocol.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30834627	(2019) Human chorionic gonadotropin and risk of pre-eclampsia: prospective population-based cohort study.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30838548	(2019) The Association Between Trimester-Specific Weight Gain and Severe PreeclampsiaAdverse Perinatal Outcome in Gestational Diabetes Mellitus Complicated by Preeclampsia: A Retrospective Case Study.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30854497	(2019) Randomized Phase 2 Study of Trebananib (AMG 386) with or without Continued Anti-Vascular Endothelial Growth Factor Therapy in Patients with Renal Cell Carcinoma Who Have Progressed on Bevacizumab, Pazopanib, Sorafenib, or Sunitinib - Results ...	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30858526	(2019) Behavioral, electrophysiological and neuropathological characteristics of the occurrence of hypertension in pregnant rats.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30867699	(2019) VEGF and sFLT-1 in serum of PIH patients and effects on the foetus.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30882594	(2019) Ultra-high sensitive C-reactive protein during normal pregnancy and in preeclampsia: a pilot study.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30882632	(2019) The association between vascular endothelial growth factor gene polymorphisms and stroke: A PRISMA-compliant meta-analysis.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30895188	(2019) Highlights from the ERS International Congress 2018: Assembly 13 - Pulmonary Vascular Diseases.	2	13	2.4	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:30914800	(2019) Targeting AU-rich element-mediated mRNA decay with a truncated active form of the zinc-finger protein TIS11bBRF1 impairs major hallmarks of mammary tumorigenesis.	2	10	2.51	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:30914894	(2019) SEMA3B but Not CUL1 as Marker for Pre-Eclampsia Progression.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30916896	(2019) Short-term effect on the ocular circulation induced by unilateral intravitreal injection of aflibercept in age-related maculopathy.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30921436	(2019) Long-term effect of pregnancy-related factors on the development of endometrial neoplasia: A nationwide retrospective cohort study.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30925782	(2019) Effects of Caffeine Treatment on Hepatopulmonary Syndrome in Biliary Cirrhotic Rats.	2	13	2.4	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:30931481	(2019) Emerging concepts of shear stress in placental development and function.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30934765	(2019) Interaction of Nerve Growth Factor beta with Adiponectin and SPARC Oppositely Modulates its Biological Activity.	2	14	2.37	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:30935786	(2019) [Potential value of placental angiogenic factors as biomarkers in preeclampsia for clinical physicians].	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30936038	(2019) Response profiles to a controlled adverse desiccating environment based on clinical and tear molecule changes.	2	7	2.67	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:30937838	(2019) Formononetin Antagonizes the Interleukin-1beta-Induced Catabolic Effects Through Suppressing Inflammation in Primary Rat Chondrocytes.	2	7	2.67	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:30937928	(2019) Tetramethylpyrazine reduces the consequences of nitric oxide inhibition in pregnant rats.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30939820	(2019) Natural Killer Cells as Key Players of Tumor Progression and Angiogenesis: Old and Novel Tools to Divert Their Pro-Tumor Activities into Potent Anti-Tumor Effects.	3	104	1.67	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:30941347	(2019) Engineering Organoid Vascularization.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30948485	(2019) Immune marker changes and risk of multiple myeloma: a nested case-control study using repeated pre-diagnostic blood samples.	2	14	2.37	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:30948500	(2019) Long non-coding RNA H19 promotes corneal neovascularization by targeting microRNA-29c.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30953637	(2019) Chemotherapeutic and antiangiogenic drugs beyond tumor progression in colon cancer: Evaluation of the effects of switched schedules and related pharmacodynamics.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30955944	(2019) The Association of Angiogenesis Markers With Acute Kidney Injury and Mortality After Cardiac Surgery.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30959004	(2019) Aqueous Humor Cytokines and Long-Term Response to Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30964071	(2019) Diabetic retinopathy and age-related macular degeneration: a survey of pharmacoutilization and cost in Calabria, Italy.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30980286	(2019) Upregulated VEGF and Robo4 correlate with the reduction of miR-15a in the development of diabetic retinopathy.	2	9	2.56	0.0461	9606.ENSP00000334329,9606.ENSP00000478570	UNC5B,VEGFA
PMID:30982664	(2019) Oncogenic Notch Triggers Neoplastic Tumorigenesis in a Transition-Zone-like Tissue Microenvironment.	2	11	2.47	0.0461	9606.ENSP00000231061,9606.ENSP00000363827	SPARC,HSPG2
PMID:30983803	(2019) Correlation of vascular endothelial growth factor and vascular endothelial growth factor receptor-1 levels in serum and thyroid nodules with histopathological and radiological variables.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30983997	(2019) Bradykinin Type 1 Receptor - Inducible Nitric Oxide Synthase: A New Axis Implicated in Diabetic Retinopathy.	2	13	2.4	0.0461	9606.ENSP00000450482,9606.ENSP00000478570	BDKRB2,VEGFA
PMID:30984741	(2019) Rational Design of Antiangiogenic Helical Oligopeptides Targeting the Vascular Endothelial Growth Factor Receptors.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31002746	(2019) Intermittent hypoxia impairs uterine artery function in pregnant mice.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31007914	(2019) Hypertension in pregnancy: Pathophysiology and treatment.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31022243	(2019) The performance of pre-delivery serum concentrations of angiogenic factors in predicting postpartum antihypertensive drug therapy following abdominal delivery in severe preeclampsia and normotensive pregnancy.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31029586	(2019) FAM3A - A mitochondrial route to the stimulation of angiogenesis?	2	9	2.56	0.0461	9606.ENSP00000304767,9606.ENSP00000478570	P2RY1,VEGFA
PMID:31042676	(2019) Arg-Leu-Tyr-Glu Suppresses Retinal Endothelial Permeability and Choroidal Neovascularization by Inhibiting the VEGF Receptor 2 Signaling Pathway.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31043645	(2019) Optimizing Measurement of Vascular Endothelial Growth Factor in Small Blood Samples of Premature Infants.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31043958	(2019) Two-Year Outcome of Aflibercept for the Treatment of Choroidal Neovascularization in Punctate Inner Choroidopathy.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31045763	(2019) Rheumatoid arthritis-like active synovitis with T-cell activation in a case of idiopathic multicentric Castleman disease: A case report.	2	10	2.51	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:31046716	(2019) A case of cancer-associated retinopathy with chorioretinitis and optic neuritis associated with occult small cell lung cancer.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31048752	(2019) Computational prediction and in vitro validation of VEGFR1 as a novel protein target for 2,3,7,8-tetrachlorodibenzo-p-dioxin.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31049099	(2019) The Role of Placental Growth Factor, Soluble Endoglin, and Uterine Artery Diastolic Notch to Predict the Early Onset of Preeclampsia.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31055948	(2019) The Placental Growth Factor Pathway and Its Potential Role in Macular Degenerative Disease.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31055951	(2019) Preeclampsia and Cerebrovascular Disease.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31063258	(2019) Using serum placenta growth factor could improve the sensitivity of colorectal cancer screening in fecal occult blood negative population: A multicenter with independent cohort validation study.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31063756	(2019) Metastasis Organotropism: Redefining the Congenial Soil.	3	100	1.69	0.0461	9606.ENSP00000006053,9606.ENSP00000231061,9606.ENSP00000478570	CX3CL1,SPARC,VEGFA
PMID:31065021	(2019) VEGF Receptor 1-Expressing Macrophages Recruited from Bone Marrow Enhances Angiogenesis in Endometrial Tissues.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31076229	(2019) Association of Circulating Proinflammatory and Anti-inflammatory Protein Biomarkers in Extremely Preterm Born Children with Subsequent Brain Magnetic Resonance Imaging Volumes and Cognitive Function at Age 10 Years.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31079531	(2019) VEGF (Vascular Endothelial Growth Factor) Functionalized Magnetic Beads in a Microfluidic Device to Improve the Angiogenic Balance in Preeclampsia.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31088543	(2019) One-year outcome of combination therapy with intravitreal aflibercept and photodynamic therapy for polypoidal choroidal vasculopathy.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31090176	(2019) Sequential cetuximabbevacizumab therapy is associated with improved outcomes in patients with wild-type KRAS exon 2 metastatic colorectal cancer.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31100966	(2019) Molecular Mechanisms Responsible for Therapeutic Potential of Mesenchymal Stem Cell-Derived Secretome.	3	86	1.75	0.0461	9606.ENSP00000276571,9606.ENSP00000451040,9606.ENSP00000478570	CRH,PGF,VEGFA
PMID:31102206	(2019) How Successful is Switching from Bevacizumab or Ranibizumab to Aflibercept in Age-Related Macular Degeneration? A Systematic Overview.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31106153	(2019) Neoadjuvant Chemotherapy Alters Neuropilin-1, PlGF, and SNAI1 Expression Levels and Predicts Breast Cancer Patients Response.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31111484	(2019) The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31113191	(2019) Peribiliary gland damage due to liver transplantation involves peribiliary vascular plexus and vascular endothelial growth factor.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31114380	(2019) Antitumor effects of Endostar(rh-endostatin) combined with gemcitabine in different administration sequences to treat Lewis lung carcinoma.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31124509	(2019) Intravitreal aflibercept injection in Indian eyes with retinopathy of prematurity.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31129598	(2019) Longitudinal circulating placental growth factor (PlGF) and soluble FMS-like tyrosine kinase-1 (sFlt-1) concentrations during pregnancy in Asian women: a prospective cohort study.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31130046	(2019) Study on the Effect of Severity of Maternal Iron Deficiency Anemia on Regulators of Angiogenesis in Placenta.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31139023	(2019) Anti-vascular endothelial growth factor agent reduces inflammation in macular edema with central retinal vein occlusion.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31139684	(2019) CSF placental growth factor - a novel candidate biomarker of frontotemporal dementia.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31151389	(2019) Correlation of retinal layer changes with vision gain in diabetic macular edema during conbercept treatment.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31164986	(2019) Long-term cardiovascular effects of vandetanib and pazopanib in normotensive rats.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31174285	(2019) Synergistic Anti-Angiogenic Effects Using Peptide-Based Combinatorial Delivery of siRNAs Targeting VEGFA, VEGFR1, and Endoglin Genes.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31174552	(2019) Leucine-rich repeat kinase-2 (LRRK2) modulates paraquat-induced inflammatory sickness and stress phenotype.	2	11	2.47	0.0461	9606.ENSP00000006053,9606.ENSP00000276571	CX3CL1,CRH
PMID:31178840	(2019) Maternal-Fetal Conflict During Infection: Lessons From a Mouse Model of Placental Malaria.	2	14	2.37	0.0461	9606.ENSP00000450482,9606.ENSP00000478570	BDKRB2,VEGFA
PMID:31179386	(2019) Effectiveness and safety of intravitreal aflibercept in patients with wet age-related macular degeneration treated in routine clinical practices across France: 12-month outcomes of the RAINBOW study.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31183436	(2019) Narrowing abdominal aorta and vein is a simple and useful method for preparing a mice model of gestational hypertension.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31185956	(2019) What is the impact of intravitreal injection of conbercept on neovascular glaucoma patients: a prospective, interventional case series study.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31190866	(2019) Long-term progression-free survival of apatinib monotherapy for relapsed ovarian cancer: a case report and literature review.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31190952	(2019) Tivozanib for the treatment of renal cell carcinoma: patient selection and perspectives.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31191997	(2019) Cytokines and the Pathogenesis of Macular Edema in Branch Retinal Vein Occlusion.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31195628	(2019) The Role of Nitric Oxide, ADMA, and Homocysteine in The Etiopathogenesis of Preeclampsia-Review.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31198600	(2019) Early Onset Pre-Eclampsia with Nephrotic Range Proteinuria as the Initial Manifestation of Lupus Nephritis: Report of three cases.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31200683	(2019) Expression profiles of VEGF-A, VEGF-D and VEGFR1 are higher in distant metastases than in matched primary high grade epithelial ovarian cancer.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31204276	(2019) Placental effects and transfer of sildenafil in healthy and preeclamptic conditions.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31206561	(2019) Preeclampsia and intrauterine growth restriction: Role of human umbilical cord mesenchymal stem cells-trophoblast cross-talk.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31210419	(2019) Molecular biomarker-guided anti-angiogenic targeted therapy for malignant glioma.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31210429	(2019) Preliminary Findings of Platelet-Rich Plasma-Induced Ameliorative Effect on Polycystic Ovarian Syndrome.	2	13	2.4	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:31227283	(2019) Damaging Variants in Proangiogenic Genes Impair Growth in Fetuses with Cardiac Defects.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31238076	(2019) Some aspects of the hypothalamic and pituitary development, metamorphosis, and reproductive behavior as studied in amphibians.	2	5	2.81	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:31238423	(2019) Comparison of intravitreal ziv-aflibercept and bevacizumab monotherapy in treatment-naive polypoidal choroidal vasculopathy.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31238424	(2019) Commentary: Ziv-aflibercept: An alternative antivascular endothelial growth factor agent for polypoidal choroidal vasculopathy.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31243296	(2019) Adult Pgf(--) mice behaviour and neuroanatomy are altered by neonatal treatment with recombinant placental growth factor.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31249451	(2019) Plasma Nogo-A and placental growth factor levels are associated with portal hypertension in patients with liver cirrhosis.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31252589	(2019) Acceleration of Osteogenesis via Stimulation of Angiogenesis by Combination with Scaffold and Connective Tissue Growth Factor.	2	10	2.51	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:31258669	(2019) Evaluation of fibroblast growth factor-2 on the proliferation of osteogenic potential and protein expression of stem cell spheroids composed of stem cells derived from bone marrow.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31263371	(2019) Mammaglobin-A, VEGFR3, and Ki67 in Human Breast Cancer Pathology and Five Year Survival.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31265210	(2019) Effects of VEGF inhibitors on human retinal pigment epithelium under high glucose and hypoxia.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31272714	(2019) Endothelin-1 profiles in advanced maternal age complicated with hypertensive disorders of pregnancy.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31275984	(2019) Influence of Insertion Torque on Clinical and Biological Outcomes before and after Loading of Mandibular Implant-Retained Overdentures in Atrophic Edentulous Mandibles.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31276595	(2019) Insights into the G-rich VEGF-binding aptamer V7t1: when two G-quadruplexes are better than one!	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31278348	(2019) Retinal myeloid cells regulate tip cell selection and vascular branching morphogenesis via Notch ligand Delta-like 1.	2	13	2.4	0.0461	9606.ENSP00000334329,9606.ENSP00000478570	UNC5B,VEGFA
PMID:31284523	(2019) 3-UTR Polymorphisms in the Vascular Endothelial Growth Factor Gene (VEGF) Contribute to Susceptibility to Recurrent Pregnancy Loss (RPL).	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31291799	(2019) Placental sFLT1 is associated with complement activation and syncytiotrophoblast damage in preeclampsia.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31297012	(2019) Increased expression of vascular endothelial growth factor-C and vascular endothelial growth factor receptor-3 after pilocarpine-induced status epilepticus in mice.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31297348	(2019) The correlation between serum vascular endothelial growth factor (VEGF) and tumor VEGF receptor 3 in colorectal cancer.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31298475	(2019) Born this way: Hippocampal neurogenesis across the lifespan.	2	12	2.43	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:31300030	(2019) Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications.	3	70	1.84	0.0461	9606.ENSP00000231061,9606.ENSP00000451040,9606.ENSP00000478570	SPARC,PGF,VEGFA
PMID:31300062	(2019) Urinary trace metals, maternal circulating angiogenic biomarkers, and preeclampsia: a single-contaminant and mixture-based approach.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31303747	(2019) Two-year analysis of changes in the optic nerve and retina following anti-VEGF treatments in diabetic macular edema patients.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31306826	(2019) Hierarchically designed bone scaffolds: From internal cues to external stimuli.	2	8	2.61	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:31308631	(2019) Activation of the P38CREBMMP13 axis is associated with osteoarthritis.	2	12	2.43	0.0461	9606.ENSP00000231061,9606.ENSP00000363827	SPARC,HSPG2
PMID:31316752	(2019) Uterine natural killer cells: Time for a re-appraisal?	3	62	1.9	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:31320911	(2019) Effects of Curcumin on Vessel Formation Insight into the Pro- and Antiangiogenesis of Curcumin.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31322059	(2019) Plasma Placental Growth Factor Concentrations Are Elevated Well in Advance of Type 2 Diabetes Mellitus Onset: Prospective Data From the WHS.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31322247	(2019) Sustained effect of continuous treatment with bevacizumab following bevacizumab in combination with chemotherapy in a human ovarian clear cell carcinoma xenograft model.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31328391	(2019) Procyanidin B2 inhibits the activation of hepatic stellate cells and angiogenesis via the Hedgehog pathway during liver fibrosis.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31328447	(2019) Functional Outcomes Following Microfragmented Adipose Tissue Versus Bone Marrow Aspirate Concentrate Injections for Symptomatic Knee Osteoarthritis.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31334227	(2019) SemNet: Using Local Features to Navigate the Biomedical Concept Graph.	2	9	2.56	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:31334871	(2019) CCN5 Reduces Ligamentum Flavum Hypertrophy by Modulating the TGF-beta Pathway.	2	6	2.74	0.0461	9606.ENSP00000362524,9606.ENSP00000478570	ANGPTL2,VEGFA
PMID:31342170	(2019) A Review of Angiogenic Imbalance in HIV-Infected Hypertensive Disorders of Pregnancy.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31344805	(2019) Mast Cells, Stress, Fear and Autism Spectrum Disorder.	2	11	2.47	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:31345176	(2019) A cross sectional study to assess the sFlt-1:PlGF ratio in pregnant women with and without preeclampsia.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31346151	(2019) Evaluating the recent developments in palliative chemotherapy for metastatic colorectal cancer.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31350249	(2019) Pharmacological interventions for the prevention of fetal growth restriction: protocol for a systematic review and network meta-analysis.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31351870	(2019) Aflibercept regulates retinal inflammation elicited by high glucose via the PlGFERK pathway.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31354296	(2019) Association between potentially functional polymorphisms of chemokine family members and the survival of esophageal cancer patients in a Chinese population.	2	12	2.43	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:31357391	(2019) Innate Immune Cells and Toll-like Receptor-Dependent Responses at the Maternal-Fetal Interface.	3	100	1.69	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:31360266	(2019) Expression of B2 Receptor on Circulating CD34-Positive Cells and Outcomes of Myocardial Infarction.	2	11	2.47	0.0461	9606.ENSP00000450482,9606.ENSP00000478570	BDKRB2,VEGFA
PMID:31367468	(2019) Diabetic macular edema treated with intravitreal aflibercept injection after treatment with other anti-VEGF agents (SWAP-TWO study): 6-month interim analysis.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31369203	(2019) Anti-angiogenic effect of quercetin and its 8-methyl pentamethyl ether derivative in human microvascular endothelial cells.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31370204	(2019) Hydrophobic Interactions Drive Binding between Vascular Endothelial Growth Factor-A (VEGFA) and Polyphenolic Inhibitors.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31373873	(2019) Role of Cytokines in Ranibizumab Therapy for Macular Edema in Patients with Central Retinal Vein Occlusion.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31374938	(2019) Neuroprotective Peptides in Retinal Disease.	3	64	1.88	0.0461	9606.ENSP00000276571,9606.ENSP00000450482,9606.ENSP00000478570	CRH,BDKRB2,VEGFA
PMID:31378907	(2019) CX3CR1 participates in pulmonary angiogenesis in experimental hepatopulmonary syndrome mice through inhibiting AKTERK signaling pathway and regulating NONOS release.	2	6	2.74	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:31384312	(2019) Pilot study of bevacizumab in combination with docetaxel and cyclophosphamide as adjuvant treatment for patients with early stage HER-2 negative breast cancer, including analysis of candidate circulating markers of cardiac toxicity: ICORG ...	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31394786	(2019) Efficacy of a Bispecific Antibody Co-Targeting VEGFA and Ang-2 in Combination with Chemotherapy in a Chemoresistant Colorectal Carcinoma Xenograft Model.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31394787	(2019) Choline: Exploring the Growing Science on Its Benefits for Moms and Babies.	2	14	2.37	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:31397166	(2019) Placental growth factor levels in quadriceps muscle are reduced by a Western diet in association with advanced glycation end products.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31399137	(2019) Effect of curcumin supplementation on serum expression of select cytokines and chemokines in a female rat model of nonalcoholic steatohepatitis.	2	13	2.4	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:31406382	(2019) Placental growth factor regulates the generation of TH17 cells to link angiogenesis with autoimmunity.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31408378	(2019) Potential influence of the corpus luteum on circulating reproductive and volume regulatory hormones, angiogenic and immunoregulatory factors in pregnant women.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31409963	(2019) Results of switchback from ranibizumab to aflibercept in patients with exudative age-related macular degeneration.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31428646	(2019) Histological Analysis of Bone Repair in Mandibular Body Osteotomy Using Internal Fixation System in Three Different Gaps without Bone Graft in an Animal Model.	2	5	2.81	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:31435580	(2019) Angiogenic factors and the risk of preeclampsia: A systematic review and meta-analysis.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31438565	(2019) The Postprandial Appearance of Features of Cardiometabolic Risk: Acute Induction and Prevention by Nutrients and Other Dietary Substances.	2	14	2.37	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:31440056	(2019) Glioma-associated radiation retinopathy treated successfully with aflibercept.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31448051	(2019) Role of the P2X7 receptor in in vitro and in vivo glioma tumor growth.	2	9	2.56	0.0461	9606.ENSP00000304767,9606.ENSP00000478570	P2RY1,VEGFA
PMID:31451777	(2019) Expression of vascular infarction-related molecules after anti-vascular endothelium growth factor treatment for diabetic macular edema.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31456948	(2019) Folfiri-Aflibercept vs. Folfiri-Bevacizumab as Second Line Treatment of RAS Mutated Metastatic Colorectal Cancer in Real Practice.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31464958	(2019) Effects of Urinary Kallidinogenase on NIHSS score, mRS score, and fasting glucose levels in acute ischemic stroke patients with abnormal glucose metabolism: A prospective cohort study.	2	14	2.37	0.0461	9606.ENSP00000450482,9606.ENSP00000478570	BDKRB2,VEGFA
PMID:31471309	(2019) Angiogenic Factor and Cytokine Analysis among Patients Treated with Adjuvant VEGFR TKIs in Resected Renal Cell Carcinoma.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31480243	(2019) Preeclampsia: Maternal Systemic Vascular Disorder Caused by Generalized Endothelial Dysfunction Due to Placental Antiangiogenic Factors.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31481983	(2019) Assessment of the SFlt-1 and sFlt-125(OH)D Ratio as a Diagnostic Tool in Gestational Hypertension (GH), Preeclampsia (PE), and Gestational Diabetes Mellitus (GDM).	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31486114	(2019) Vitexin ameliorates preeclampsia phenotypes by inhibiting TFPI-2 and HIF-1alphaVEGF in a l-NAME induced rat model.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31487645	(2019) Is ELABELA a reliable biomarker for hypertensive disorders of pregnancy?	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31487961	(2019) Cerebral Blood Flow Regulation in Pregnancy, Hypertension, and Hypertensive Disorders of Pregnancy.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31490378	(2019) Apatinib is effective as third-line and more treatment of advanced metastatic non-small-cell lung cancer: A retrospective analysis in a real-world setting.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31496691	(2019) Poly(lactic-co-glycolic acid) nanoparticle-mediated interleukin-12 delivery for the treatment of diabetic retinopathy.	2	13	2.4	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:31507551	(2019) The Impact of Infection in Pregnancy on Placental Vascular Development and Adverse Birth Outcomes.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31510056	(2019) Effect of Low-Dose Aspirin on Soluble FMS-Like Tyrosine Kinase 1Placental Growth Factor (sFlt-1PlGF Ratio) in Pregnancies at High Risk for the Development of Preeclampsia.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31510832	(2019) Abnormal expression and clinical significance of 25-hydroxyvitamin D and sFlt-1 in patients with preeclampsia.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31513661	(2019) Characteristics of diabetic macular edema patients refractory to anti-VEGF treatments and a dexamethasone implant.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31518171	(2019) Endothelial Cell Development and Its Application to Regenerative Medicine.	3	76	1.81	0.0461	9606.ENSP00000006053,9606.ENSP00000362524,9606.ENSP00000478570	CX3CL1,ANGPTL2,VEGFA
PMID:31519996	(2019) Association of Maternal Preeclampsia with Neonatal Respiratory Distress Syndrome in Very-Low-Birth-Weight Infants.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31522187	(2019) Serum Levels of Angiogenic Factors Distinguish Between Women with Preeclampsia and Normotensive Pregnant Women But Not Severity of Preeclampsia in an Obstetric Center in Turkey.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31528507	(2019) Mapping research trends of retinal vein occlusion from 2009 to 2018: a bibliometric analysis.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31530999	(2019) Fetal Growth Restriction Prediction: How to Move beyond.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31531329	(2019) A patient misdiagnosed with central serous chorioretinopathy: A case report.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31534832	(2019) Peripartum Cardiomyopathy: A Review.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31540472	(2019) Pituitary Adenylate Cyclase-Activating Polypeptide: 30 Years in Research Spotlight and 600 Million Years in Service.	3	44	2.05	0.0461	9606.ENSP00000006053,9606.ENSP00000276571,9606.ENSP00000478570	CX3CL1,CRH,VEGFA
PMID:31546494	(2019) Commentary: Understanding angiogenic factors in pathogenesis of persistent fetal vasculature.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31546818	(2019) NK Cell Plasticity in Cancer.	3	57	1.93	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:31550452	(2019) A potential role for microglia in stress- and drug-induced plasticity in the nucleus accumbens: A mechanism for stress-induced vulnerability to substance use disorder.	2	11	2.47	0.0461	9606.ENSP00000006053,9606.ENSP00000276571	CX3CL1,CRH
PMID:31550776	(2019) [Different effects of pravastatin on sFlt-1, PlGF and VEGF in different preeclampsia-like mouse models].	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31552274	(2019) Editorial: Cardiac Microvascular Endothelium Contribution to Cardiac Myocyte Growth, Structure, and Contractile Function.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31554264	(2019) Type XVIII Collagen Modulates Keratohyalin Granule Formation and Keratinization in Oral Mucosa.	2	11	2.47	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:31555213	(2019) Identification of a Novel Functional Corticotropin-Releasing Hormone (CRH2) in Chickens and Its Roles in Stimulating Pituitary TSHbeta Expression and ACTH Secretion.	2	13	2.4	0.0461	9606.ENSP00000220166,9606.ENSP00000276571	CTSH,CRH
PMID:31565186	(2019) Anti-VEGFR2 therapy delays growth of preclinical pediatric tumor models and enhances anti-tumor activity of chemotherapy.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31572387	(2019) Tumors vs. Chronic Wounds: An Immune Cells Perspective.	3	54	1.96	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:31572524	(2019) Recent progress regarding kaempferol for the treatment of various diseases.	3	95	1.71	0.0461	9606.ENSP00000362524,9606.ENSP00000451040,9606.ENSP00000478570	ANGPTL2,PGF,VEGFA
PMID:31574232	(2019) Broad-spectrum chemokine inhibition blocks inflammation-induced angiogenesis, but preserves ischemia-driven angiogenesis.	2	11	2.47	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:31578584	(2019) High levels of Notch intracellular cleaved domain are associated with stemness and reduced bevacizumab efficacy in patients with advanced colon cancer.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31582998	(2019) Prostate Cancer with Intraluminal Inclusions: the Association of the Immunophenotype with Grade Score.	2	8	2.61	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:31582999	(2019) The Difference of Expression of 18 Genes in Axillary Invasion and Vascular Invasion Compared to Control Samples in Breast Cancer.	2	11	2.47	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:31583245	(2019) Receptor-Mediated Endocytosis of VEGF-A in Rat Liver Sinusoidal Endothelial Cells.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31585507	(2019) Placental growth factor negatively regulates retinal endothelial cell barrier function through suppression of glucose-6-phosphate dehydrogenase and antioxidant defense systems.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31590294	(2019) Preeclampsia: Risk Factors, Diagnosis, Management, and the Cardiovascular Impact on the Offspring.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31600597	(2019) The brain-placental axis: Therapeutic and pharmacological relevancy to pregnancy.	3	51	1.98	0.0461	9606.ENSP00000276571,9606.ENSP00000451040,9606.ENSP00000478570	CRH,PGF,VEGFA
PMID:31619195	(2019) Real-world data in retinal diseases treated with anti-vascular endothelial growth factor (anti-VEGF) therapy - a systematic approach to identify and characterize data sources.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31626572	(2019) Multicenter, Prospective, Phase II and Biomarker Study of High-Dose Bevacizumab as Induction Therapy in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannoma.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31647034	(2019) Differential placental ceramide levels during gestational diabetes mellitus (GDM).	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31647843	(2019) Safety of intravitreal ziv-aflibercept in choroido-retinal vascular diseases: A randomised double-blind intervention study.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31656464	(2019) Circulating soluble fms-like tyrosine kinase-1, soluble endoglin and placental growth factor during pregnancy in normotensive women in KwaZulu-Natal, South Africa.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31659187	(2019) Characterisation of the inflammatory cytokine and growth factor profile in a rabbit model of proliferative vitreoretinopathy.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31660113	(2019) Intravitreal Medications for Retinal Vein Occlusion: Systematic Review and Meta-analysis.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31663032	(2019) Molecular characterization of the netrin-1 UNC-5 receptor in Lucilia sericata larvae.	2	8	2.61	0.0461	9606.ENSP00000334329,9606.ENSP00000478570	UNC5B,VEGFA
PMID:31665139	(2019) Investigating the potential of the secretome of mesenchymal stem cells derived from sickle cell disease patients.	3	49	2.0	0.0461	9606.ENSP00000231061,9606.ENSP00000451040,9606.ENSP00000478570	SPARC,PGF,VEGFA
PMID:31666542	(2019) AST-120, an Oral Carbon Absorbent, Protects against the Progression of Atherosclerosis in a Mouse Chronic Renal Failure Model by Preserving sFlt-1 Expression Levels.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31669926	(2019) The Reduced Uterine Perfusion Pressure (RUPP) rat model of preeclampsia exhibits impaired systolic function and global longitudinal strain during pregnancy.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31675952	(2019) A phase Ib study of capecitabine and ziv-aflibercept followed by a phase II single-arm expansion cohort in chemotherapy refractory metastatic colorectal cancer.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31684007	(2019) Usefulness of Liquid Biopsy Biomarkers from Aqueous Humor in Predicting Anti-VEGF Response in Diabetic Macular Edema: Results of a Pilot Study.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31690271	(2019) Impact of parturition on maternal cardiovascular and neuronal integrity in a high risk cohort - a prospective cohort study.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31692775	(2019) Epidural cavernous haemangioma during pregnancy: a case report and a literature review.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31692815	(2019) VEGF-C Gene Polymorphisms Increase Susceptibility to Rheumatoid Arthritis.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31693715	(2019) Evidence to date: ranibizumab and its potential in the treatment of retinopathy of prematurity.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31709311	(2019) Recent advances in biomaterials for 3D scaffolds: A review.	2	12	2.43	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:31717527	(2019) VEGFR-1 Regulates EGF-R to Promote Proliferation in Colon Cancer Cells.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31731752	(2019) Preeclampsia with Intrauterine Growth Restriction Generates Morphological Changes in Endothelial Cells Associated with Mitochondrial Swelling-An In Vitro Study.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31737362	(2019) Adipokines and Endothelium Dysfunction Markers in Pregnant Women with Gestational Hypertension.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31737629	(2019) Long Non-coding RNA H19 Suppression Protects the Endothelium Against Hyperglycemic-Induced Inflammation via Inhibiting Expression of miR-29b Target Gene Vascular Endothelial Growth Factor a Through Activation of the Protein Kinase BEndothelial ...	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31744542	(2019) Genetic variants of VEGFR-1 gene promoter in acute myocardial infarction.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31747921	(2019) Pravastatin induces NO synthesis by enhancing microsomal arginine uptake in healthy and preeclamptic placentas.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31752122	(2019) VEGF-A and ICAM-1 Gene Polymorphisms as Predictors of Clinical Outcome to First-Line Bevacizumab-Based Treatment in Metastatic Colorectal Cancer.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31752157	(2019) Natural Histogel-Based Bio-Scaffolds for Sustaining Angiogenesis in Beige Adipose Tissue.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31757048	(2019) Synergy of Ginkgetin and Resveratrol in Suppressing VEGF-Induced Angiogenesis: A Therapy in Treating Colorectal Cancer.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31766690	(2019) Targeting Angiogenesis by Blocking the ATM-SerRS-VEGFA Pathway for UV-Induced Skin Photodamage and Melanoma Growth.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31774816	(2019) Mesenchymal Stem Stromal Cells metabolomic and bioactive factors profiles: A comparative analysis on the umbilical cord and dental pulp derived Stem Stromal Cells secretome.	3	68	1.86	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:31788051	(2019) A nomogram to predict vascular invasion before resection of colorectal cancer.	2	14	2.37	0.0461	9606.ENSP00000362524,9606.ENSP00000478570	ANGPTL2,VEGFA
PMID:31791965	(2019) Angiogenic factors during pregnancy in Asian women with elevated blood pressure in early pregnancy and the risk of preeclampsia: a longitudinal cohort study.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31796036	(2019) Maternal and perinatal outcomes of hypertensive disorders of pregnancy in Ethiopia: systematic review and meta-analysis.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31803759	(2019) A Systematic Review of Vascular Structure and Function in Pre-eclampsia: Non-invasive Assessment and Mechanistic Links.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31807298	(2019) Responses of the renin-angiotensin-aldosterone system in pregnant chronic kidney disease patients with and without superimposed pre-eclampsia.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31844086	(2019) Dysregulation of bladder corticotropin-releasing hormone receptor in the pathogenesis of human interstitial cystitisbladder pain syndrome.	2	10	2.51	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:31850390	(2019) Application of platelet-rich plasma and platelet lysate in the treatment of experimental lymphocutaneous sporotrichosi.	2	12	2.43	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:31861373	(2019) Multikinase Inhibitor Treatment in Thyroid Cancer.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31862943	(2019) Factors associated with the duration of action of dexamethasone intravitreal implants in diabetic macular edema patients.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31878889	(2019) Evaluation of long-term intravitreal anti-vascular endothelial growth factor injections on renal function in patients with and without diabetic kidney disease.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31921634	(2019) Role of Matrix Metalloproteinases in Angiogenesis and Cancer.	3	78	1.8	0.0461	9606.ENSP00000231061,9606.ENSP00000451040,9606.ENSP00000478570	SPARC,PGF,VEGFA
PMID:31921870	(2019) Inflammation and Progression of Cholangiocarcinoma: Role of Angiogenic and Lymphangiogenic Mechanisms.	3	68	1.86	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:31929700	(2019) Serum soluble FMS-like tyrosine kinase-1 in ectopic pregnancy.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31934591	(2019) Aqueous Humor Cytokine Levels in Diabetic Macular Edema Patients with Cotton-Wool Spots.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31988641	(2019) Evaluation of Serum Biomarkers and Other Diagnostic Modalities for Early Diagnosis of Preeclampsia.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32010611	(2019) Cancer Metastasis: The Role of the Extracellular Matrix and the Heparan Sulfate Proteoglycan Perlecan.	3	46	2.03	0.0461	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:32039177	(2019) Growth Factor Engineering Strategies for Regenerative Medicine Applications.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32082619	(2019) Comparison of Intravitreal Aflibercept and Ranibizumab for Treatment of Myopic Choroidal Neovascularization: One-Year Results-A Retrospective, Comparative Study.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32099563	(2019) Accumulation of CD4 and CD8 T Cells in Placenta of Malaria Infected Mice Induces the Expression of Hypoxia Inducible Factor-1alpha (HIF-1alpha) and Low Birth Weight (LBW) of the Fetus.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32157052	(2019) [Experience of Using Aflibercept Beta and FOLFIRI Chemotherapy for Metastatic Colorectal Cancer].	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32159148	(2019) Biomaterial-based endochondral bone regeneration: a shift from traditional tissue engineering paradigms to developmentally inspired strategies.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32923949	(2019) Ex vivo engineering of blood and lymphatic microvascular networks.	2	6	2.74	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:28299499	(2018) Evaluation of vitreous levels of advanced glycation end products and angiogenic factors as biomarkers for severity of diabetic retinopathy.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28301988	(2018) The Influence of Lipid and Proinflammatory Status on Maternal Uterine Blood Flow in Women With Late Onset Gestational Diabetes.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28320252	(2018) The impact of laser surgery on angiogenic and anti-angiogenic factors in twin-twin transfusion syndrome: a prospective study.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28486747	(2018) A simple rocker-induced mechanical stimulus upregulates mineralization by human osteoprogenitor cells in fibrous scaffolds.	2	9	2.56	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:28568605	(2018) Vascular beds maintain pancreatic tumour explants for ex vivo drug screening.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28741407	(2018) Pericytes secrete pro-regenerative molecules in response to platelet-derived growth factor-BB.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28834088	(2018) VEGF synthesis is induced by prostacyclin and TGF-beta in distal lung fibroblasts from COPD patients and control subjects: Implications for pulmonary vascular remodelling.	2	6	2.74	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:28861767	(2018) Placental growth factor signaling regulates isoform splicing of vascular endothelial growth factor A in the control of lung cancer cell metastasis.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28903888	(2018) Serum Angiogenic and Anti-angiogenic Markers in Pregnant Women with Placenta Percreta.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28937147	(2018) Comparison of effectiveness and safety between conbercept and ranibizumab for treatment of neovascular age-related macular degeneration. A retrospective case-controlled non-inferiority multiple center study.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28940252	(2018) Tobacco exposure and wound healing in head and neck surgical wounds.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28949775	(2018) Evaluation of sFLT1 protein levels in human eyes with the FLT1 rs9943922 polymorphism.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28967076	(2018) Aflibercept in the management of acute retinal necrosis syndrome-related macular edema.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28972822	(2018) Inhibition of TGF-beta Signaling in SHED Enhances Endothelial Differentiation.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28978662	(2018) Fractalkine induces angiogenic potential in CX3CR1-expressing monocytes.	2	5	2.81	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:29024419	(2018) A multicentre randomised controlled trial evaluating the efficacy of dehydrated human amnionchorion membrane (EpiFix((R)) ) allograft for the treatment of venous leg ulcers.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29025978	(2018) The Anti-Vascular Endothelial Growth Factor Receptor-1 Monoclonal Antibody D16F7 Inhibits Glioma Growth and Angiogenesis In Vivo.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29054986	(2018) Phase I Study of Enavatuzumab, a First-in-Class Humanized Monoclonal Antibody Targeting the TWEAK Receptor, in Patients with Advanced Solid Tumors.	2	14	2.37	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:29095972	(2018) Placental Growth Factor Is Required for Ovulation, Luteinization, and Angiogenesis in Primate Ovulatory Follicles.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29111087	(2018) Angiogenic factor screening in women with mild preeclampsia - New and significant proteins in plasma.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29138037	(2018) Genetic predisposition to preeclampsia is conferred by fetal DNA variants near FLT1, a gene involved in the regulation of angiogenesis.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29173997	(2018) The impact of different torques for the insertion of immediately loaded implants on the peri-implant levels of angiogenesis- and bone-related markers.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29174227	(2018) Angiogenic and antiangiogenic factors in preeclampsia.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29177891	(2018) Plasma levels of hypoxia-regulated factors in patients with age-related macular degeneration.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29193681	(2018) Angiogenic factors: potential to change clinical practice in pre-eclampsia?	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29196991	(2018) Biomarker Immunoassays in the Diagnosis of Preeclampsia: Calculating the sFlt1PlGF Ratio Using the Cobas((R))e 411 Analyser.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29196992	(2018) Assessing the Circulating Placental-Specific Anti-angiogenic Protein sFLT-1 e15a in Preeclampsia.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29207010	(2018) The potential inhibitory effects of miR-19b on vulnerable plaque formation via the suppression of STAT3 transcriptional activity.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29214752	(2018) Evaluation of sFlt-1PlGF Ratio for Predicting and Improving Clinical Management of Pre-eclampsia: Experience in a Specialized Perinatal Care Center.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29229785	(2018) The chemokine receptor CX3CR1 coordinates monocyte recruitment and endothelial regeneration after arterial injury.	2	11	2.47	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:29263797	(2018) VEGFR1 promotes cell migration and proliferation through PLCgamma and PI3K pathways.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29266846	(2018) High circulating miR-18a, miR-20a, and miR-92a expression correlates with poor prognosis in patients with non-small cell lung cancer.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29280310	(2018) Osteogenic Stimulation of Human Adipose-Derived Mesenchymal Stem Cells Using a Fungal Metabolite That Suppresses the Polycomb Group Protein EZH2.	3	61	1.9	0.0461	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:29284120	(2018) Colorimetric immunoassays for the screening and specificity evaluation of molecules disturbing VEGFsVEGFRs interactions.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29290570	(2018) Fractalkine and placental growth factor: A duet of inflammation and angiogenesis in cardiovascular disorders.	2	2	3.21	0.0461	9606.ENSP00000006053,9606.ENSP00000451040	CX3CL1,PGF
PMID:29293036	(2018) Radiation and hypoxia-induced non-targeted effects in normoxic and hypoxic conditions in human lung cancer cells.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29302021	(2018) Long Non-Coding RNAs Serve as Diagnostic Biomarkers of Preeclampsia and Modulate Migration and Invasiveness of Trophoblast Cells.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29310800	(2018) Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease.	3	102	1.68	0.0461	9606.ENSP00000363827,9606.ENSP00000451040,9606.ENSP00000478570	HSPG2,PGF,VEGFA
PMID:29327758	(2018) A computational analysis of pro-angiogenic therapies for peripheral artery disease.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29341453	(2018) Mechanism underlying the negative effect of prostate volume on the outcome of extensive transperineal ultrasound-guided template prostate biopsy.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29343949	(2018) Clinical observations on the use of new anti-VEGF drug, conbercept, in age-related macular degeneration therapy: a meta-analysis.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29355711	(2018) Implication of the Kallikrein-Kinin system in neurological disorders: Quest for potential biomarkers and mechanisms.	3	79	1.79	0.0461	9606.ENSP00000006053,9606.ENSP00000450482,9606.ENSP00000478570	CX3CL1,BDKRB2,VEGFA
PMID:29360776	(2018) Involvement of Bradykinin B2 Receptor in Pathological Vascularization in Oxygen-Induced Retinopathy in Mice and Rabbit Cornea.	2	12	2.43	0.0461	9606.ENSP00000450482,9606.ENSP00000478570	BDKRB2,VEGFA
PMID:29363738	(2018) Aeroallergen sensitization predicts acute chest syndrome in children with sickle cell anaemia.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29367581	(2018) Pre-Eclampsia and Eclampsia: An Update on the Pharmacological Treatment Applied in Portugal.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29375756	(2018) The use of human dental pulp stem cells for in vivo bone tissue engineering: A systematic review.	2	12	2.43	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:29380954	(2018) Mechanical ventilation strategies alter cardiovascular biomarkers in an infant rat model.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29385909	(2018) Wu-Tou Decoction Inhibits Angiogenesis in Experimental Arthritis by Targeting VEGFR2 Signaling Pathway.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29386883	(2018) Aflibercept for clinically significant diabetic macular edema: 12-month results in daily clinical practice.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29392826	(2018) Reduced angiogenic factor expression in intrauterine fetal growth restriction using semiquantitative immunohistochemistry and digital image analysis.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29395656	(2018) Serum protein marker panel for predicting preeclampsia.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29397867	(2018) Structure and function of vascular endothelial growth factor and its receptor system.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29403260	(2018) Evaluation of contrast sensitivity and other visual function outcomes in diabetic macular edema patients following treatment switch to aflibercept from ranibizumab.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29431212	(2018) Mast cells as sources of cytokines, chemokines, and growth factors.	3	60	1.91	0.0461	9606.ENSP00000276571,9606.ENSP00000451040,9606.ENSP00000478570	CRH,PGF,VEGFA
PMID:29434073	(2018) Placental growth factor (PlGF) is linked to inflammation and metabolic disorders in mice with diet-induced obesity.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29440946	(2018) Optimizing the use of anti VEGF targeted therapies in patients with metastatic colorectal cancer: review of literature.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29466360	(2018) Combining metformin and esomeprazole is additive in reducing sFlt-1 secretion and decreasing endothelial dysfunction - implications for treating preeclampsia.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29482567	(2018) Oxidative stress and endothelial function in normal pregnancy versus pre-eclampsia, a combined longitudinal and case control study.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29483617	(2018) Dysregulation of RNF213 promotes cerebral hypoperfusion.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29483825	(2018) Angiotensin 1-7 Overexpression Mediated by a Capsid-optimized AAV8 Vector Leads to Significant Growth Inhibition of Hepatocellular Carcinoma In vivo.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29487720	(2018) Efficacy and safety of targeting VEGFR drugs in treatment for advanced or metastatic gastric cancer: a systemic review and meta-analysis.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29495527	(2018) Glycosaminoglycans and Proteoglycans.	2	13	2.4	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:29497280	(2018) Short-term efficacy of intravitreal conbercept in treatment-naive patients with polypoidal choroidal vasculopathy.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29507304	(2018) Observation of optic disc neovascularization using OCT angiography in proliferative diabetic retinopathy after intravitreal conbercept injections.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29514999	(2018) Malaria in pregnancy alters l-arginine bioavailability and placental vascular development.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29522144	(2018) Aqueous Humor Cytokine Levels and Anatomic Response to Intravitreal Ranibizumab in Diabetic Macular Edema.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29525771	(2018) Impact of particulate matter on mothers and babies in Antwerp (IPANEMA): a prospective cohort study on the impact of pollutants and particulate matter in pregnancy.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29528272	(2018) Angiogenic and inflammatory biomarkers for screening and follow-up in patients with pulmonary arterial hypertension.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29532881	(2018) VEGF pathway-targeting drugs induce evasive adaptation by activation of neuropilin-1cMet in colon cancer cells.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29536116	(2018) Muscle StemProgenitor Cells and Mesenchymal Stem Cells of Bone Marrow Origin for Skeletal Muscle Regeneration in Muscular Dystrophies.	3	66	1.87	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:29538540	(2018) Is suicidal ideation associated with allergic asthma and allergic rhinitis?	2	10	2.51	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:29540166	(2018) HRG C633T polymorphism and risk of gestational hypertensive disorders: a pilot study.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29554973	(2018) Bushenhuoxue formula attenuates cartilage degeneration in an osteoarthritic mouse model through TGF-betaMMP13 signaling.	2	11	2.47	0.0461	9606.ENSP00000231061,9606.ENSP00000363827	SPARC,HSPG2
PMID:29558393	(2018) hCG and Its Disruption by Environmental Contaminants during Human Pregnancy.	2	14	2.37	0.0461	9606.ENSP00000276571,9606.ENSP00000451040	CRH,PGF
PMID:29562916	(2018) Integration of induced pluripotent stem cell-derived endothelial cells with polycaprolactonegelatin-based electrospun scaffolds for enhanced therapeutic angiogenesis.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29563992	(2018) Expression and clinical significance of serum MMP-7 and PTEN levels in patients with acute myeloid leukemia.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29575299	(2018) The PLGFc-MYCmiR-19a axis promotes metastasis and stemness in gallbladder cancer.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29579090	(2018) Cytotoxic effects of four different root canal sealers on human osteoblasts.	2	5	2.81	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:29584689	(2018) Extracellular Matrix as a Regulator of Epidermal Stem Cell Fate.	3	57	1.93	0.0461	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:29587383	(2018) Protein Expression in Tonsillar and Base of Tongue Cancer and in Relation to Human Papillomavirus (HPV) and Clinical Outcome.	3	86	1.75	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:29599604	(2018) Review article: Update on current and emergent data on hepatopulmonary syndrome.	2	11	2.47	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:29614308	(2018) Relationship between plasma angiogenic growth factors and diabetic foot ulcers.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29614637	(2018) Inflammation in sickle cell disease.	3	71	1.84	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:29618787	(2018) Prognostic value of serum vascular endothelial growth factor and hematological responses in patients with newly-diagnosed POEMS syndrome.	2	4	2.91	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:29631168	(2018) Decellularized materials derived from TSP2-KO mice promote enhanced neovascularization and integration in diabetic wounds.	2	8	2.61	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:29634432	(2018) Differential Gene Expression and Pathway Analysis in Juvenile Nasopharyngeal Angiofibroma Using RNA Sequencing.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29637419	(2018) The Endothelin System: A Critical Player in the Pathophysiology of Preeclampsia.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29643276	(2018) Expression of Placenta Growth Factor Is Associated with Unfavorable Prognosis of Advanced-Stage Serous Ovarian Cancer.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29649034	(2018) Obstructive Sleep Apnea in Pregnant Women: A Review of Pregnancy Outcomes and an Approach to Management.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29651134	(2018) Endothelial Cell Phenotypes are Maintained During Angiogenesis in Cultured Microvascular Networks.	2	9	2.56	0.0461	9606.ENSP00000334329,9606.ENSP00000478570	UNC5B,VEGFA
PMID:29652061	(2018) Bevacizumab and near infrared probe conjugated iron oxide nanoparticles for vascular endothelial growth factor targeted MR and optical imaging.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29652651	(2018) Prediction of organ involvement in systemic sclerosis by serum biomarkers and peripheral endothelial function.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29654043	(2018) Pregnancy outcomes among Chinese women with and without systemic lupus erythematosus: a retrospective cohort study.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29670046	(2018) Resistance to Anti-Angiogenic Therapy in Cancer-Alterations to Anti-VEGF Pathway.	3	56	1.94	0.0461	9606.ENSP00000362524,9606.ENSP00000451040,9606.ENSP00000478570	ANGPTL2,PGF,VEGFA
PMID:29670333	(2018) Upregulation of vascular endothelial growth factor receptor-1 contributes to sevoflurane preconditioning-mediated cardioprotection.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29675495	(2018) Maternal history and uterine artery wave form in the prediction of early-onset and late-onset preeclampsia: A cohort study.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29681832	(2018) One-Year Outcome of Aflibercept and Photodynamic Therapy in a Caucasian Patient with Polypoidal Choroidal Vasculopathy Refractory to Ranibizumab and Photodynamic Therapy.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29692666	(2018) Recanalization and remodeling of the great saphenous vein caused by the large melanomas cutaneous metastasis.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29695053	(2018) VEGF (Vascular Endothelial Growth Factor) and Fibrotic Lung Disease.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29700323	(2018) HIV antiretroviral exposure in pregnancy induces detrimental placenta vascular changes that are rescued by progesterone supplementation.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29706656	(2018) The constitutive activity of the virally encoded chemokine receptor US28 accelerates glioblastoma growth.	2	14	2.37	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:29726618	(2018) Metformins antitumour and anti-angiogenic activities are mediated by skewing macrophage polarization.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29730154	(2018) Histidine-rich glycoprotein-induced vascular normalization improves EPR-mediated drug targeting to and into tumors.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29732570	(2018) CD206-positive myeloid cells bind galectin-9 and promote a tumor-supportive microenvironment.	3	53	1.97	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:29744040	(2018) Recent advances in understanding and managing retinal vein occlusions.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29744450	(2018) The development of collagen based composite scaffolds for bone regeneration.	2	14	2.37	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:29744466	(2018) Chitosan based metallic nanocomposite scaffolds as antimicrobial wound dressings.	2	11	2.47	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:29752724	(2018) Pregnancy complications and subsequent breast cancer risk in the mother: a Nordic population-based case-control study.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29765019	(2018) Relationship between circulating vascular endothelial growth factor and its soluble receptor in patients with hemorrhagic fever with renal syndrome.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29768965	(2018) The therapeutic potential of the mesenchymal stem cell secretome in ischaemic stroke.	3	46	2.03	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:29769799	(2018) Placental growth factor promotes epithelial-mesenchymal transition-like changes in ARPE-19 cells under hypoxia.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29778695	(2018) Corticosteroids and perinatal hypoxic-ischemic brain injury.	3	54	1.96	0.0461	9606.ENSP00000006053,9606.ENSP00000276571,9606.ENSP00000478570	CX3CL1,CRH,VEGFA
PMID:29782634	(2018) Long term follow up of biomarkers of podocyte damage and renal function in patients with and without preeclampsia.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29804112	(2018) Comparing Cytokine Kinetics between Ranibizumab and Aflibercept in Central Retinal Vein Occlusion with Macular Edema.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29813117	(2018) Competition and niche construction in a model of cancer metastasis.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29845247	(2018) Long non-coding RNA SENCR alleviates the inhibitory effects of rapamycin on human umbilical vein endothelial cells.	2	10	2.51	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:29850202	(2018) Comparison of Intravitreal Aflibercept and Ranibizumab following Initial Treatment with Ranibizumab in Persistent Diabetic Macular Edema.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29850212	(2018) Difference in the Vitreal Protein Profiles of Patients with Proliferative Diabetic Retinopathy with and without Intravitreal Conbercept Injection.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29853657	(2018) A Phase I Study of Ganetespib and Ziv-Aflibercept in Patients with Advanced Carcinomas and Sarcomas.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29862317	(2018) Engineered Coatings for Titanium Implants To Present Ultralow Doses of BMP-7.	2	9	2.56	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:29867053	(2018) Cancer Metastases to Bone: Concepts, Mechanisms, and Interactions with Bone Osteoblasts.	3	70	1.84	0.0461	9606.ENSP00000006053,9606.ENSP00000231061,9606.ENSP00000478570	CX3CL1,SPARC,VEGFA
PMID:29879032	(2018) Inhibition of NF-kappaB signaling pathway induces apoptosis and suppresses proliferation and angiogenesis of human fibroblast-like synovial cells in rheumatoid arthritis.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29884282	(2018) Interoception and Inflammation in Psychiatric Disorders.	2	9	2.56	0.0461	9606.ENSP00000006053,9606.ENSP00000276571	CX3CL1,CRH
PMID:29884912	(2018) Sex-Specific Contributions of Endothelin to Hypertension.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29890683	(2018) Platelet-Rich Plasma May Offer a New Hope in Suppressed Wound Healing When Compared to Mesenchymal Stem Cells.	2	7	2.67	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:29895936	(2018) Int6eIF3e Silencing Promotes Placenta Angiogenesis in a Rat Model of Pre-eclampsia.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29902977	(2018) Conbercept for patients with age-related macular degeneration: a systematic review.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29908372	(2018) Association of fibrotic remodeling and cytokineschemokines content in epicardial adipose tissue with atrial myocardial fibrosis in patients with atrial fibrillation.	2	7	2.67	0.0461	9606.ENSP00000362524,9606.ENSP00000478570	ANGPTL2,VEGFA
PMID:29910669	(2018) New Trends in the Therapeutic Approach to Metastatic Colorectal Cancer.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29922131	(2018) Adult Hippocampal Neurogenesis: Regulation and Possible Functional and Clinical Correlates.	2	14	2.37	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:29922227	(2018) Maternal Circulating Placental Growth Factor and Neonatal Metabolic Health Biomarkers in Small for Gestational Age Infants.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29922445	(2018) High-fathigh-sucrose diet-induced obesity results in joint-specific development of osteoarthritis-like degeneration in a rat model.	2	10	2.51	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:29924910	(2018) Differentiating Antiproliferative and Chemopreventive Modes of Activity for Electron-Deficient Aryl Isothiocyanates against Human MCF-7 Cells.	2	10	2.51	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:29925004	(2018) Full Functional Knockout of Placental Growth Factor by Knockin with an Inactive Variant Able to Heterodimerize with VEGF-A.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29928383	(2018) Research progress on common adverse events caused by targeted therapy for colorectal cancer.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29928643	(2018) Circulating Protein Biomarkers in Systemic Sclerosis Related Pulmonary Arterial Hypertension: A Review of Published Data.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29929478	(2018) Clinical response of pigment epithelial detachment associated with neovascular age-related macular degeneration in switching treatment from Ranibizumab to Aflibercept.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29935312	(2018) The reciprocal function and regulation of tumor vessels and immune cells offers new therapeutic opportunities in cancer.	3	80	1.79	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:29941486	(2018) Phase I and Biomarker Study of Plerixafor and Bevacizumab in Recurrent High-Grade Glioma.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29941728	(2018) Polypoidal choroidal vasculopathy: Pearls in diagnosis and management.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29942527	(2018) Elevation of maternal serum sFlt-1 in pregnancy with mirror syndrome caused by fetal cardiac failure.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29942826	(2018) Targeting Heparan Sulfate Proteoglycans as a Novel Therapeutic Strategy for Mucopolysaccharidoses.	2	9	2.56	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:29944851	(2018) Potential effect on molecular pathways in different targeted genes in the VEGF family in retina - From the genomic point of view.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29949013	(2018) A best-practice position statement on pregnancy after kidney transplantation: focusing on the unsolved questions. The Kidney and Pregnancy Study Group of the Italian Society of Nephrology.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29971632	(2018) Preeclampsia and Related Cardiovascular Risk: Common Genetic Background.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29973139	(2018) Association of genetic polymorphisms in vascular endothelial growth factor with susceptibility to coronary artery disease: a meta-analysis.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29973254	(2018) Prevascularization promotes endogenous cell-mediated angiogenesis by upregulating the expression of fibrinogen and connective tissue growth factor in tissue-engineered bone grafts.	2	9	2.56	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:29973578	(2018) Apoptosis: Activation and Inhibition in Health and Disease.	3	100	1.69	0.0461	9606.ENSP00000006053,9606.ENSP00000334329,9606.ENSP00000478570	CX3CL1,UNC5B,VEGFA
PMID:29988841	(2018) A review on pregnancy complicated by ovarian epithelial and non-epithelial malignant tumors: Diagnostic and therapeutic perspectives.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29997150	(2018) Modulation of Circulating Protein Biomarkers in Cancer Patients Receiving Bevacizumab and the Anti-Endoglin Antibody, TRC105.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30017791	(2018) VEGF-Grab Enhances the Efficacy of Radiation Therapy by Blocking VEGF-A and Treatment-Induced PlGF.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30018198	(2018) The Air Sac Primordium of Drosophila: A Model for Invasive Development.	2	7	2.67	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:30022855	(2018) Neuropilin-1 expression is associated with lymph node metastasis in breast cancer tissues.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30028320	(2018) Vascular endothelial growth factor: an essential neurotrophic factor for motoneurons?	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30029536	(2018) In Vivo Performance of Decellularized Vascular Grafts: A Review Article.	2	11	2.47	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:30039754	(2018) Nutraceutical Targeting of Placental Synthesis of Soluble Fms-Like Tyrosine Kinase- 1 (sFlt-1) as Strategy for Preventing and Controlling Pre-eclampsia.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30044384	(2018) Level-Specific Differences in Systemic Expression of Pro- and Anti-Inflammatory Cytokines and Chemokines after Spinal Cord Injury.	2	14	2.37	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:30046459	(2018) Efficacy and Safety of Intravitreal Conbercept, Ranibizumab, and Triamcinolone on 23-Gauge Vitrectomy for Patients with Proliferative Diabetic Retinopathy.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30054439	(2018) CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30059715	(2018) Altered Angiogenic Growth Factors in Urine of Prostate Cancer Survivors With Radiation History and Radiation Cystitis.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30071898	(2018) ADAM-17 is expressed on rheumatoid arthritis fibroblast-like synoviocytes and regulates proinflammatory mediator expression and monocyte adhesion.	2	12	2.43	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:30074161	(2018) Conditioned Medium from Human Umbilical Vein Endothelial Cells Promotes Proliferation, Migration, Invasion and Angiogenesis of Adipose Derived Stem Cells.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30078142	(2018) Vasa vasorum inside outoutside in communication: a potential role in the patency of saphenous vein coronary artery bypass grafts.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30087567	(2018) Overexpression of Romo1 is an unfavorable prognostic biomarker and a predictor of lymphatic metastasis in non-small cell lung cancer patients.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30087698	(2018) Association between the expression of vascular endothelial growth factors and metabolic syndrome or its components: a systematic review and meta-analysis.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30104317	(2018) Predicting intrapartum fetal compromise at term using the cerebroplacental ratio and placental growth factor levels (PROMISE) study: randomised controlled trial protocol.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30106112	(2018) Therapeutic potential of hyaluronic acidchitosan nanoparticles for the delivery of curcuminoid in knee osteoarthritis and an in vitro evaluation in chondrocytes.	2	12	2.43	0.0461	9606.ENSP00000231061,9606.ENSP00000363827	SPARC,HSPG2
PMID:30110968	(2018) A Review on Properties of Natural and Synthetic Based Electrospun Fibrous Materials for Bone Tissue Engineering.	2	12	2.43	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:30116635	(2018) Extended Injection Intervals after Switching from Ranibizumab to Aflibercept in Macular Edema due to Central Retinal Vein Occlusion.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30122890	(2018) Relationship between vascular endothelial growth factor and macular edema in retinal vein branch obstruction.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30123059	(2018) Influence Of Angiogenic Mediators And Bone Remodelling In Pagets Disease Of Bone.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30127978	(2018) Decreased CRHBP expression is predictive of poor prognosis in patients with hepatocellular carcinoma.	2	6	2.74	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:30140083	(2018) Upregulation of Angiogenic Factors via Protein Kinase C and Hypoxia-induced Factor-1alpha Pathways under High-glucose Conditions in the Placenta.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30142763	(2018) STROBE: The correlation of Cyr61, CTGF, and VEGF with polymyositisdermatomyositis.	2	7	2.67	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:30144822	(2018) Pro-angiogenic therapeutics for preeclampsia.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30150144	(2018) Intravitreal aflibercept protects photoreceptors of mice against excessive light exposure.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30150545	(2018) Three-Dimensional In Vitro Hydro- and Cryogel-Based Cell-Culture Models for the Study of Breast-Cancer Metastasis to Bone.	2	12	2.43	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:30166586	(2018) Real-time in vivo two-photon imaging study reveals decreased cerebro-vascular volume and increased blood-brain barrier permeability in chronically stressed mice.	2	12	2.43	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:30173249	(2018) Vascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30174608	(2018) The Role of Placental Hormones in Mediating Maternal Adaptations to Support Pregnancy and Lactation.	3	54	1.96	0.0461	9606.ENSP00000276571,9606.ENSP00000451040,9606.ENSP00000478570	CRH,PGF,VEGFA
PMID:30178505	(2018) Induction of microvascular network growth in the mouse mesentery.	2	7	2.67	0.0461	9606.ENSP00000334329,9606.ENSP00000478570	UNC5B,VEGFA
PMID:30179860	(2018) Loss of placental growth factor ameliorates maternal hypertension and preeclampsia in mice.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30181760	(2018) The role of anti-vascular endothelial growth factor (anti-VEGF) in the management of proliferative diabetic retinopathy.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30188942	(2018) Linking systemic angiogenic markers to synovial vascularization in rheumatoid arthritis.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30190686	(2018) Growth Factor Proteins and Treatment-Resistant Depression: A Place on the Path to Precision.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30195213	(2018) Assessment of potential biomarkers of pre-receptive and receptive endometrium in uterine fluid and a functional evaluation of the potential role of CSF3 in fertility.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30200242	(2018) The Interplay between Circulating Tumor Cells and the Immune System: From Immune Escape to Cancer Immunotherapy.	3	93	1.72	0.0461	9606.ENSP00000006053,9606.ENSP00000231061,9606.ENSP00000478570	CX3CL1,SPARC,VEGFA
PMID:30202615	(2018) The Effects of Anti-Vascular Endothelial Growth Factor Drugs on Retinal Pigment Epithelial Cell Culture.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30202824	(2018) Serum Autotaxin Concentrations Reflect Changes in Liver Stiffness and Fibrosis After Antiviral Therapy in Patients with Chronic Hepatitis C.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30204781	(2018) Aqueous humor cytokine levels in patients with diabetic macular edema refractory to anti-VEGF treatment.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30214613	(2018) Expression of Livin and PlGF in human osteosarcoma is associated with tumor progression and clinical outcome.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30214754	(2018) Conventional and conservative management of placenta accreta is two ends of a single continuum: A report of three cases and literature review.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30216991	(2018) Synthetic and Marine-Derived Porous Scaffolds for Bone Tissue Engineering.	2	11	2.47	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:30223824	(2018) Microglia enhanced the angiogenesis, migration and proliferation of co-cultured RMECs.	2	14	2.37	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:30229567	(2018) Adrenergic receptor blockade attenuates placental ischemia-induced hypertension.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30232642	(2018) Concentration of soluble urokinase plasminogen activator receptor (suPAR) in the pre-ovulatory follicular fluid is associated with development of ovarian hyperstimulation syndrome during ovarian stimulation.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30241030	(2018) Combination antitumor immunotherapy with VEGF and PIGF siRNA via systemic delivery of multi-functionalized nanoparticles to tumor-associated macrophages and breast cancer cells.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30245717	(2018) Selected Metabolic Markers in Girls with Turner Syndrome: A Pilot Study.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30250793	(2018) Oscillatory Strain Promotes Vessel Stabilization and Alignment through Fibroblast YAP-Mediated Mechanosensitivity.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30258077	(2018) Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30259245	(2018) Association of SPARC gene polymorphisms rs3210714 and rs7719521 with VEGF expression and utility of Nottingham Prognostic Index scoring in breast cancer in a sample of Egyptian women.	2	2	3.21	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:30271222	(2018) Intravitreal aflibercept for choroidal neovascularization secondary to angioid streaks in a non-responder to intravitreal ranibizumab.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30276340	(2018) The role of vascular endothelial growth factor in angiogenesis and brain circulation after stroke.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30279491	(2018) Hyperglycaemia-induced methylglyoxal accumulation potentiates VEGF resistance of diabetic monocytes through the aberrant activation of tyrosine phosphatase SHP-2SRC kinase signalling axis.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30280757	(2018) p38-MAPK pathway is activated in retinopathy of microvascular disease of STZ-induced diabetic rat model.	2	2	3.21	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:30294635	(2018) Data sets of eQTL loci, correlation analysis, and overlapped genes among gene sets that their expression levels are closely related to genes of Vegf family.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30298138	(2018) Inflammatory-Driven Angiogenesis in Bone Augmentation with Bovine Hydroxyapatite, B-Tricalcium Phosphate, and Bioglasses: A Comparative Study.	2	7	2.67	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:30305054	(2018) Prognostic and predictive factors for angiosarcoma patients receiving paclitaxel once weekly plus or minus bevacizumab: an ancillary study derived from a randomized clinical trial.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30310263	(2018) Activator protein-1 contributes to the NaCl-induced expression of VEGF and PlGF in RPE cells.	3	40	2.09	0.0461	9606.ENSP00000304767,9606.ENSP00000451040,9606.ENSP00000478570	P2RY1,PGF,VEGFA
PMID:30323627	(2018) The efficacy and safety of apatinib for refractory malignancies: a review and meta-analysis.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30353107	(2018) Retinal vascular changes and aqueous humor cytokines changes after aflibercept intravitreal injection in treatment-naive myopic choroidal neovascularization.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30353684	(2018) Effects of maternal western-style diet on amniotic fluid volume and amnion VEGF profiles in a nonhuman primate model.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30355166	(2018) Basic Cardiovascular Sciences Scientific Sessions 2018.	2	10	2.51	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:30355790	(2018) Study protocol for a randomised controlled trial: treatment of early intrauterine growth restriction with low molecular weight heparin (TRACIP).	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30355978	(2018) Inflammatory Markers in Anorexia Nervosa: An Exploratory Study.	3	41	2.08	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:30356007	(2018) The Low Molecular Weight Heparin Tinzaparin Attenuates Platelet Activation in Terms of Metastatic Niche Formation by Coagulation-Dependent and Independent Pathways.	2	10	2.51	0.0461	9606.ENSP00000304767,9606.ENSP00000478570	P2RY1,VEGFA
PMID:30361676	(2018) Hyperhomocysteinemia Causes Chorioretinal Angiogenesis with Placental Growth Factor Upregulation.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30363976	(2018) Circulating Heme Oxygenase-1: Not a Predictor of Preeclampsia but Highly Expressed in Pregnant Women Who Subsequently Develop Severe Preeclampsia.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30370266	(2018) Funds Reimbursement of High-Cost Drugs in Gastrointestinal Oncology: An Italian Real Practice 1 Year Experience at the National Cancer Institute of Naples.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30372756	(2018) Mechanistic Evaluation of Panretinal Photocoagulation Versus Aflibercept in Proliferative Diabetic Retinopathy: CLARITY Substudy.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30377995	(2018) Concentrations of VEGF and PlGF Decrease in Eyes After Intravitreal Conbercept Injection.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30397583	(2018) Comparative in vitrotheoretical studies on the anti-angiogenic activity of date pollen hydro-alcoholic extract: Highlighting the important roles of its hot polyphenols.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30402314	(2018) A Case of Lenvatinib-Induced Focal Segmental Glomerulosclerosis (FSGS) in Metastatic Medullary Thyroid Cancer.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30405783	(2018) Lectin histochemical analysis of uterine natural killer cells in normal, hydatidiform molar and invasive molar pregnancy.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30419802	(2018) The relationship between chemokines CCL2, CCL3, and CCL4 with the tumor microenvironment and tumor-associated macrophage markers in colorectal cancer.	2	8	2.61	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:30419922	(2018) GAP43, a novel metastasis promoter in non-small cell lung cancer.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30423986	(2018) The Prognostic Value of the Combination of Low VEGFR-1 and High VEGFR-2 Expression in Endothelial Cells of Colorectal Cancer.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30425214	(2018) Pancreatic ductal adenocarcinoma: Role of chemotherapy & future perspectives.	2	11	2.47	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:30451173	(2018) Current management strategy of polypoidal choroidal vasculopathy.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30451174	(2018) Diabetic macular edema: Evidence-based management.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30451990	(2018) RNAi modulation of placental sFLT1 for the treatment of preeclampsia.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30459364	(2018) Probing tumor microenvironment in patients with newly diagnosed glioblastoma during chemoradiation and adjuvant temozolomide with functional MRI.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30464394	(2018) Clinical effectiveness of ranibizumab and conbercept for neovascular age-related macular degeneration: a meta-analysis.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30464931	(2018) Potential of ramucirumab in treating hepatocellular carcinoma patients with elevated baseline alpha-fetoprotein.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30478339	(2018) HIF-2alpha, but not HIF-1alpha, mediates hypoxia-induced up-regulation of Flt-1 gene expression in placental trophoblasts.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30486258	(2018) Vascular Endothelial Growth Factor, from Basic Research to Clinical Applications.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30487752	(2018) Are the Cognitive Alterations Present in Children Born From Preeclamptic Pregnancies the Result of Impaired Angiogenesis? Focus on the Potential Role of the VEGF Family.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30505176	(2018) Biomolecular phases in transverse palatal distraction: A review.	2	12	2.43	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:30514962	(2018) PDGF enhances the protective effect of adipose stem cell-derived extracellular vesicles in a model of acute hindlimb ischemia.	3	51	1.98	0.0461	9606.ENSP00000362524,9606.ENSP00000451040,9606.ENSP00000478570	ANGPTL2,PGF,VEGFA
PMID:30519022	(2018) Nanoparticle-modified chitosan-agarose-gelatin scaffold for sustained release of SDF-1 and BMP-2.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30524502	(2018) Cell surface engineering and application in cell delivery to heart diseases.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30534004	(2018) Dynamics of soluble vascular endothelial growth factor receptors and their ligands in aqueous humour during ranibizumab for age-related macular degeneration.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30544486	(2018) Microbiome-The Missing Link in the Gut-Brain Axis: Focus on Its Role in Gastrointestinal and Mental Health.	2	12	2.43	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:30554564	(2018) VEGF-C and Mortality in Patients With Suspected or Known Coronary Artery Disease.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30555478	(2018) Extracellular Vesicle-Mediated Immune Regulation of Tissue Remodeling and Angiogenesis After Myocardial Infarction.	3	70	1.84	0.0461	9606.ENSP00000362524,9606.ENSP00000451040,9606.ENSP00000478570	ANGPTL2,PGF,VEGFA
PMID:30567594	(2018) Does osteogenic potential of clonal human bone marrow mesenchymal stemstromal cells correlate with their vascular supportive ability?	3	73	1.83	0.0461	9606.ENSP00000231061,9606.ENSP00000334329,9606.ENSP00000478570	SPARC,UNC5B,VEGFA
PMID:30568515	(2018) The umbilical cord, preeclampsia and the VEGF family.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30572565	(2018) Hyaluronic AcidBone Substitute Complex Implanted on Chick Embryo Chorioallantoic Membrane Induces Osteoblastic Differentiation and Angiogenesis, but not Inflammation.	2	5	2.81	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:30581528	(2018) Hydrogen Sulfide Ameliorates Developmental Impairments of Rat Offspring with Prenatal Hyperhomocysteinemia.	2	8	2.61	0.0461	9606.ENSP00000276571,9606.ENSP00000451040	CRH,PGF
PMID:30596096	(2018) Change of Circulating and Tissue-Based miR-20a in Human Cancers and Associated Prognostic Implication: A Systematic Review and Meta-Analysis.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30619185	(2018) Bradykinin Sequestration by Plasmodium berghei Infected Erythrocytes Conditions B2R Signaling and Parasite Uptake by Fetal Trophoblasts.	2	10	2.51	0.0461	9606.ENSP00000450482,9606.ENSP00000478570	BDKRB2,VEGFA
PMID:30619286	(2018) Cancer Stem Cells and Immunosuppressive Microenvironment in Glioma.	3	93	1.72	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:30622442	(2018) Preeclampsia in 2018: Revisiting Concepts, Physiopathology, and Prediction.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30632730	(2018) The Use of Soluble FMS-like Tyrosine Kinase 1Placental Growth Factor Ratio in the Clinical Management of Pre-eclampsia.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30638632	(2018) Maternal exercise and growth restriction in rats alters placental angiogenic factors and blood space area in a sex-specific manner.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30674839	(2018) Photocrosslinked Dextran-Based Hydrogels as Carrier System for the Cells and Cytokines Induce Bone Regeneration in Critical Size Defects in Mice.	2	10	2.51	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:30873504	(2018) Blockade of Vascular Endothelial Growth Factor Receptor-1 (Flt-1), Reveals a Novel Analgesic For Osteoarthritis-Induced Joint Pain.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32175444	(2018) Association of single-nucleotide polymorphisms in NAT9 and MAP3K3 genes with litter size traits in Berkshire pigs.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32714582	(2018) Cross-talk between blood vessels and neural progenitors in the developing brain.	3	47	2.02	0.0461	9606.ENSP00000334329,9606.ENSP00000451040,9606.ENSP00000478570	UNC5B,PGF,VEGFA
PMID:26661237	(2017) Mice deficient in endothelial alpha5 integrin are profoundly resistant to experimental ischemic stroke.	2	7	2.67	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:27076257	(2017) Maternal hemoglobin concentration and hematocrit values may affect fetus development by influencing placental angiogenesis.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27079786	(2017) Help-me signaling: Non-cell autonomous mechanisms of neuroprotection and neurorecovery.	3	65	1.88	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:27256927	(2017) Association between angiogenic factors and signs of arterial aging in women with pre-eclampsia.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27471825	(2017) aqueous humor cytokine levels as biomarkers of disease severity in diabetic macular edema.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27572288	(2017) Endothelial epsins as regulators and potential therapeutic targets of tumor angiogenesis.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27628062	(2017) Efficacy of fixed-dosing aflibercept for treating polypoidal choroidal vasculopathy: 1-year results of the VAULT study.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27650263	(2017) Current and Upcoming Therapies for Ocular Surface Chemical Injuries.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27671308	(2017) 2-(&#969;-Carboxyethyl)pyrrole Antibody as a New Inhibitor of Tumor Angiogenesis and Growth.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27678201	(2017) Aqueous humour concentrations of TGF-beta, PLGF and FGF-1 and total retinal blood flow in patients with early non-proliferative diabetic retinopathy.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27735991	(2017) PlGF Knockdown Decreases Tumorigenicity and Stemness Properties of Spheroid Body Cells Derived from Gastric Cancer Cells.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27750398	(2017) Vascular endothelial growth factor control mechanisms in skeletal growth and repair.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27789775	(2017) Phase II and Biomarker Study of Cabozantinib in Metastatic Triple-Negative Breast Cancer Patients.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27798520	(2017) clinical and electrophysiological evaluation after intravitreal ziv-aflibercept for exudative age-related macular degeneration.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27853960	(2017) Phase II study of tivozanib, an oral VEGFR inhibitor, in patients with recurrent glioblastoma.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27864335	(2017) Effects of maternal obesity on placental function and fetal development.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27868196	(2017) Differential regulation of blood flow-induced neovascularization and mural cell recruitment by vascular endothelial growth factor and angiopoietin signalling.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27886182	(2017) Vitreous levels of placental growth factor correlate with activity of proliferative diabetic retinopathy and are not influenced by bevacizumab treatment.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27888621	(2017) Intraperitoneal ziv-aflibercept effectively manages refractory ascites in colorectal cancer patients.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27893623	(2017) efficacy and safety of intravitreal conbercept injections in macular edema secondary to retinal vein occlusion.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27906745	(2017) Should We Add Pravastatin to Aspirin for Preeclampsia Prevention in High-risk Women?	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27913120	(2017) Gene delivery nanoparticles to modulate angiogenesis.	3	59	1.92	0.0461	9606.ENSP00000363827,9606.ENSP00000451040,9606.ENSP00000478570	HSPG2,PGF,VEGFA
PMID:27927026	(2017) Modulation of Local and Systemic Heterocellular Communication by Mechanical Forces: A Role of Endothelial Nitric Oxide Synthase.	3	50	1.99	0.0461	9606.ENSP00000450482,9606.ENSP00000451040,9606.ENSP00000478570	BDKRB2,PGF,VEGFA
PMID:27927766	(2017) Phase 1 dose-finding study of rebastinib (DCC-2036) in patients with relapsed chronic myeloid leukemia and acute myeloid leukemia.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27928742	(2017) Implementation of infrared and Raman modalities for glycosaminoglycan characterization in complex systems.	2	11	2.47	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:27942839	(2017) Immune modulation associated with vascular endothelial growth factor (VEGF) blockade in patients with glioblastoma.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27943386	(2017) Early-onset Preeclampsia in Lupus Pregnancy.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27959632	(2017) The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer.	3	91	1.73	0.0461	9606.ENSP00000363827,9606.ENSP00000451040,9606.ENSP00000478570	HSPG2,PGF,VEGFA
PMID:27986932	(2017) Placental-specific sFLT-1: role in pre-eclamptic pathophysiology and its translational possibilities for clinical prediction and diagnosis.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27995418	(2017) The effects of sildenafil citrate on urinary podocin and nephrin mRNA expression in an L-NAME model of pre-eclampsia.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27996292	(2017) Activation of dengue virus-specific T cells modulates vascular endothelial growth factor receptor 2 expression.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27996960	(2017) Recombinant vascular endothelial growth factor 121 injection for the prevention of fetal growth restriction in a preeclampsia mouse model.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28002269	(2017) efficacy of intravitreal aflibercept in macular telangiectasia type 1 is linked to the ocular angiogenic profile.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28053541	(2017) Nasopharyngeal carcinoma treated with bevacizumab combined with paclitaxel liposome plus cisplatin: a case report and literature review.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28068394	(2017) Prediction of Small for Gestational Age Infants in Healthy Nulliparous Women Using Clinical and Ultrasound Risk Factors Combined with Early Pregnancy Biomarkers.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28081548	(2017) Serum LDH predicts benefit from bevacizumab beyond progression in metastatic colorectal cancer.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28081641	(2017) Vessel pruning or healing: endothelial metabolism as a novel target?	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28091415	(2017) Advances of Coagulation Factor XIII.	2	13	2.4	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:28096716	(2017) Molecular Targeted Therapy in Modern Oncology: Imaging Assessment of Treatment Response and Toxicities.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28098245	(2017) Natural cytotoxicity receptor 1 in mouse uNK cell maturation and function.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28106709	(2017) systemic pharmacokinetics and pharmacodynamics of intravitreal aflibercept, bevacizumab, and ranibizumab.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28114884	(2017) EVERREST prospective study: a 6-year prospective study to define the clinical and biological characteristics of pregnancies affected by severe early onset fetal growth restriction.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28116649	(2017) Phase I trial of aflibercept (VEGF trap) with radiation therapy and concomitant and adjuvant temozolomide in patients with high-grade gliomas.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28117425	(2017) The Role of Vascular Endothelial Growth Factor in Small-airway Remodelling in a Rat Model of Chronic Obstructive Pulmonary Disease.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28119994	(2017) Placental Growth Factor and Vascular Endothelial Growth Factor Together Regulate Tumour Progression via Increased Vasculature in Cutaneous T-cell Lymphoma.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28122882	(2017) Effects of miRNA-200b on the development of diabetic retinopathy by targeting VEGFA gene.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28123525	(2017) Correlation between liver cancer pain and the HIF-1 and VEGF expression levels.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28126966	(2017) Obstetric antiphospholipid syndrome: early variations of angiogenic factors are associated with adverse outcomes.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28138259	(2017) Advances in antiangiogenic treatment of small-cell lung cancer.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28148450	(2017) Is an episode of suspected preterm labor that subsequently leads to a term delivery benign?	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28160128	(2017) Blockade of the kinin B1 receptor affects the cytokinechemokine profile in rat brain subjected to autoimmune encephalomyelitis.	2	10	2.51	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:28162769	(2017) Cord Blood Biomarkers of Placental Maternal Vascular Underperfusion Predict Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28167976	(2017) Chondroprotective Effects and Multitarget Mechanisms of Fu Yuan Capsule in a Rat Osteoarthritis Model.	2	14	2.37	0.0461	9606.ENSP00000231061,9606.ENSP00000363827	SPARC,HSPG2
PMID:28178662	(2017) Association between single nucleotide variants of vascular endothelial growth factor A and the risk of thyroid carcinoma and nodular goiter in a Han Chinese population.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28180980	(2017) Myofibroblast in the ligamentum flavum hypertrophic activity.	2	5	2.81	0.0461	9606.ENSP00000362524,9606.ENSP00000478570	ANGPTL2,VEGFA
PMID:28189628	(2017) Perlecan and vascular endothelial growth factor-encoding DNA-loaded chitosan scaffolds promote angiogenesis and wound healing.	2	2	3.21	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:28191928	(2017) Self-Assembling Multidomain Peptide Nanofibers for Delivery of Bioactive Molecules and Tissue Regeneration.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28194443	(2017) Sustained inflammation after pericyte depletion induces irreversible blood-retina barrier breakdown.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28199380	(2017) The effects of pravastatin on the normal human placenta: Lessons from ex-vivo models.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28207826	(2017) Changes of plasma cytokines and chemokines expression level in nasopharyngeal carcinoma patients after treatment with definitive intensity-modulated radiotherapy (IMRT).	2	14	2.37	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:28209068	(2017) Urinary cytokineschemokines after magnetic resonance-guided high intensity focused ultrasound for palliative treatment of painful bone metastases.	2	13	2.4	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:28209985	(2017) Ig-like domain 6 of VCAM-1 is a potential therapeutic target in TNFalpha-induced angiogenesis.	2	9	2.56	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:28212521	(2017) Angiogenesis in the atherosclerotic plaque.	3	85	1.76	0.0461	9606.ENSP00000362524,9606.ENSP00000451040,9606.ENSP00000478570	ANGPTL2,PGF,VEGFA
PMID:28216083	(2017) Maternal vitamin D sufficiency and reduced placental gene expression in angiogenic biomarkers related to comorbidities of pregnancy.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28220848	(2017) Elevated expression of placental growth factor is associated with airway-wall vascular remodelling and thickening in smokers with asthma.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28241310	(2017) Editing VEGFR2 Blocks VEGF-Induced Activation of Akt and Tube Formation.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28243027	(2017) Effects of Histone Deacetylase Inhibitor (Valproic Acid) on the Expression of Hypoxia-inducible Factor-1 Alpha in Human Retinal Muller Cells.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28243252	(2017) Neurobiological Mechanism of Acupuncture for Relieving Visceral Pain of Gastrointestinal Origin.	2	14	2.37	0.0461	9606.ENSP00000276571,9606.ENSP00000304767	CRH,P2RY1
PMID:28246700	(2017) Integrin signaling in atherosclerosis.	3	87	1.75	0.0461	9606.ENSP00000006053,9606.ENSP00000363827,9606.ENSP00000478570	CX3CL1,HSPG2,VEGFA
PMID:28249037	(2017) Effects of a skin-massaging device on the ex-vivo expression of human dermis proteins and in-vivo facial wrinkles.	2	8	2.61	0.0461	9606.ENSP00000276571,9606.ENSP00000363827	CRH,HSPG2
PMID:28253223	(2017) Observation and Clinical Pattern in Patients with White Dot Syndromes: The Role of Color Photography in Monitoring Ocular Changes in Long-Term Observation.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28264495	(2017) The Endothelin Type A Receptor as a Potential Therapeutic Target in Preeclampsia.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28267633	(2017) Sclerostin stimulates angiogenesis in human endothelial cells.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28272300	(2017) A Human Antibody That Binds to the Sixth Ig-Like Domain of VCAM-1 Blocks Lung Cancer Cell Migration In Vitro.	2	11	2.47	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:28273207	(2017) Kaempferol inhibited VEGF and PGF expression and in vitro angiogenesis of HRECs under diabetic-like environment.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28278173	(2017) Circulating progenitor and angiogenic cell frequencies are abnormally static over pregnancy in women with preconception diabetes: A pilot study.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28279224	(2017) Urethral reconstruction with autologous urine-derived stem cells seeded in three-dimensional porous small intestinal submucosa in a rabbit model.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28284376	(2017) The Tubulointerstitial Pathophysiology of Progressive Kidney Disease.	2	10	2.51	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:28292023	(2017) Green tea and its anti-angiogenesis effects.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28293063	(2017) Evaluation of Prognostic and Predictive Significance of Circulating MicroRNAs in Ovarian Cancer Patients.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28298545	(2017) Homeobox B9 Mediates Resistance to Anti-VEGF Therapy in Colorectal Cancer Patients.	2	12	2.43	0.0461	9606.ENSP00000362524,9606.ENSP00000478570	ANGPTL2,VEGFA
PMID:28301910	(2017) Soluble fms-Like Tyrosine Kinase 1 as a Link Between Angiogenesis and Endothelial Dysfunction in Pediatric Patients With beta-Thalassemia Intermedia.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28303237	(2017) The effect of biomechanical stimulation on osteoblast differentiation of human jaw periosteum-derived stem cells.	2	10	2.51	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:28323906	(2017) FLT-1 gene polymorphisms and protein expression profile in rheumatoid arthritis.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28344956	(2017) Maternal serum placental growth factor and pregnancy-associated plasma protein A measured in the first trimester as parameters of subsequent pre-eclampsia and small-for-gestational-age infants: A prospective observational study.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28345626	(2017) Elevated angiopoietin 2 in aqueous of patients with neovascular age related macular degeneration correlates with disease severity at presentation.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28348418	(2017) Expression of CGRP, vasculogenesis and osteogenesis associated mRNAs in the developing mouse mandible and tibia.	2	10	2.51	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:28350328	(2017) Vitamin D Decreases Serum VEGF Correlating with Clinical Improvement in Vitamin D-Deficient Women with PCOS: A Randomized Placebo-Controlled Trial.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28350837	(2017) Semaphorin 3F expression is reduced in pregnancy complicated by preeclampsia. An observational clinical study.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28356711	(2017) Intravitreal aflibercept versus intravitreal ranibizumab for the treatment of diabetic macular edema.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28363815	(2017) Proteomic profiling of isogenic primary and metastatic medulloblastoma cell lines reveals differential expression of key metastatic factors.	2	5	2.81	0.0461	9606.ENSP00000231061,9606.ENSP00000451040	SPARC,PGF
PMID:28368336	(2017) Serum Concentrations of Angiopoietin-2 and Soluble fms-Like Tyrosine Kinase 1 (sFlt-1) Are Associated with Coagulopathy among Patients with Acute Pancreatitis.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28373914	(2017) Effect of intravitreal aflibercept on recalcitrant diabetic macular edema.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28377069	(2017) Inflammatory cytokines and angiogenic factors as potential biomarkers in South African pancreatic ductal adenocarcinoma patients: A preliminary report.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28377452	(2017) Differential Expression of VEGFA Isoforms Regulates Metastasis and Response to Anti-VEGFA Therapy in Sarcoma.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28377591	(2017) A safety study of high concentration and high frequency intravitreal injection of conbercept in rabbits.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28387019	(2017) Plasma N-Terminal Probrain Natriuretic Peptide, Vascular Endothelial Growth Factor, and Cardiac Troponin I as Novel Biomarkers of Hypertensive Disease and Target Organ Damage in Cats.	2	4	2.91	0.0461	9606.ENSP00000220166,9606.ENSP00000478570	CTSH,VEGFA
PMID:28388642	(2017) Association of maternal hypertensive disorders with retinopathy of prematurity: A systematic review and meta-analysis.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28391576	(2017) Phase I trial and pharmacokinetic study of tanibirumab, a fully human monoclonal antibody to vascular endothelial growth factor receptor 2, in patients with refractory solid tumors.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28395175	(2017) Oxygen and oxidative stress in the perinatal period.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28395330	(2017) Contributions to the dynamics of cervix remodeling prior to term and preterm birth.	2	11	2.47	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:28396239	(2017) Microvascular anomaly conditions in psychiatric disease. Schizophrenia - angiogenesis connection.	3	47	2.02	0.0461	9606.ENSP00000231061,9606.ENSP00000451040,9606.ENSP00000478570	SPARC,PGF,VEGFA
PMID:28406476	(2017) WISP-1 positively regulates angiogenesis by controlling VEGF-A expression in human osteosarcoma.	2	12	2.43	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:28418447	(2017) Association of Oral Cavity and Oropharyngeal Cancer Biomarkers in Surgical Drain Fluid With Patient Outcomes.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28420611	(2017) Characterization of the conbercept gene localization in DHFR- amplified CHO cells using fluorescence in situ hybridization.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28423052	(2017) Inflammation-induced fetal growth restriction in rats is associated with increased placental HIF-1alpha accumulation.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28423594	(2017) The hypoxia-activated prodrug evofosfamide in combination with multiple regimens of radiotherapy.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28424632	(2017) Pro-angiogenic Role of Insulin: From Physiology to Pathology.	3	67	1.86	0.0461	9606.ENSP00000362524,9606.ENSP00000451040,9606.ENSP00000478570	ANGPTL2,PGF,VEGFA
PMID:28426731	(2017) Effect of genetic variation in microRNA binding site in WNT1-inducible signaling pathway protein 1 gene on oral squamous cell carcinoma susceptibility.	2	11	2.47	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:28427198	(2017) Hypoxia activates placental growth factor expression in lymphatic endothelial cells.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28428965	(2017) Natural Killer Cells in the Orchestration of Chronic Inflammatory Diseases.	3	47	2.02	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:28429366	(2017) Analysis of transcriptional activities of angiogenic biomarkers during intrauterine complications leading to preterm birth.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28430629	(2017) Vascular endothelial growth factor A polymorphisms are associated with increased risk of coronary heart disease: a meta-analysis.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28433660	(2017) Redox regulation of gasotransmission in the vascular system: A focus on angiogenesis.	3	57	1.93	0.0461	9606.ENSP00000304767,9606.ENSP00000451040,9606.ENSP00000478570	P2RY1,PGF,VEGFA
PMID:28438505	(2017) Turning down the volume: Astrocyte volume change in the generation and termination of epileptic seizures.	2	14	2.37	0.0461	9606.ENSP00000304767,9606.ENSP00000450482	P2RY1,BDKRB2
PMID:28439237	(2017) Biomarkers of Osteosarcoma, Chondrosarcoma, and Ewing Sarcoma.	3	95	1.71	0.0461	9606.ENSP00000231061,9606.ENSP00000451040,9606.ENSP00000478570	SPARC,PGF,VEGFA
PMID:28444128	(2017) Low-dose ionizing radiation induces therapeutic neovascularization in a pre-clinical model of hindlimb ischemia.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28447504	(2017) Placental growth factor (PlGF) as an angiogenicinflammatory switcher: lesson from early pregnancy losses.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28451952	(2017) A Systematic Review of the Treat and Extend Treatment Regimen with Anti-VEGF Agents for Neovascular Age-Related Macular Degeneration.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28454692	(2017) Maternal vascular malperfusion of the placental bed associated with hypertensive disorders in the Boston Birth Cohort.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28455450	(2017) Microvascular function in pre-eclampsia is influenced by insulin resistance and an imbalance of angiogenic mediators.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28465443	(2017) Phase I and Preliminary Phase II Study of TRC105 in Combination with Sorafenib in Hepatocellular Carcinoma.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28467355	(2017) Atg7 Regulates Brain Angiogenesis via NF-kappaB-Dependent IL-6 Production.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28467427	(2017) Comparison between 1-year outcomes of aflibercept with and without photodynamic therapy for polypoidal choroidal vasculopathy: Retrospective observation study.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28475144	(2017) Undariopsis peterseniana Promotes Hair Growth by the Activation of Wntbeta-Catenin and ERK Pathways.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28483697	(2017) Preparation and evaluation of human choroid extracellular matrix scaffolds for the study of cell replacement strategies.	2	11	2.47	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:28483805	(2017) Treating the dysfunctional placenta.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28484955	(2017) Ranibizumab in the Treatment of Diabetic Macular Edema: A Review of the Current Status, Unmet Needs, and Emerging Challenges.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28487022	(2017) Maternal choline supplementation during murine pregnancy modulates placental markers of inflammation, apoptosis and vascularization in a fetal sex-dependent manner.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28494174	(2017) Human endometrial stromal cell plasticity: Reversible sFlt1 expression negatively coincides with decidualization.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28496299	(2017) Response of eyes with age-related macular degeneration to anti-VEGF drugs and implications for therapy planning.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28502557	(2017) Antecedents and early correlates of high and low concentrations of angiogenic proteins in extremely preterm newborns.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28527040	(2017) Fundamental principles of an anti-VEGF treatment regimen: optimal application of intravitreal anti-vascular endothelial growth factor therapy of macular diseases.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28529486	(2017) The Role of Statins in Prevention of Preeclampsia: A Promise for the Future?	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28538392	(2017) Maculopapular rash after intravitreal injection of an antivascular endothelial growth factor, aflibercept, for treating age-related macular degeneration: A case report.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28549467	(2017) The prediction, diagnosis and management of complications in monochorionic twin pregnancies: the OMMIT (Optimal Management of Monochorionic Twins) study.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28559722	(2017) Topical versus subconjunctival anti-vascular endothelial growth factor therapy (Bevacizumab, Ranibizumab and Aflibercept) for treatment of corneal neovascularization.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28561757	(2017) Implications of Extracellular Matrix Production by Adipose Tissue-Derived Stem Cells for Development of Wound Healing Therapies.	2	12	2.43	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:28564655	(2017) Aqueous Humor Levels of Soluble Vascular Endothelial Growth Factor Receptor and Inflammatory Factors in Diabetic Macular Edema.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28565757	(2017) An exploratory study into the role of miR-204-5p in pregnancy-induced hypertension.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28566469	(2017) Visceral adipose tissue activated macrophage content and inflammatory adipokine secretion is higher in pre-eclampsia than in healthy pregnancys.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28570613	(2017) Clinical, ultrasound and molecular biomarkers for early prediction of large for gestational age infants in nulliparous women: An international prospective cohort study.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28580450	(2017) Expression of placental growth factor mRNA in preeclampsia.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28587659	(2017) Glutaminyl cyclase activity correlates with levels of Abeta peptides and mediators of angiogenesis in cerebrospinal fluid of Alzheimers disease patients.	3	43	2.06	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:28591698	(2017) Bevacizumab for ramucirumab refractory malignant pleural effusion in non-small cell lung cancer: a case report and review of the literature.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28598396	(2017) Embryotoxicity Caused by DON-Induced Oxidative Stress Mediated by Nrf2HO-1 Pathway.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28603410	(2017) Full-thickness macular hole formation following anti-VEGF injections for neovascular age-related macular degeneration.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28634380	(2017) Late-onset Circulatory Collapse and Continuous Positive Airway Pressure are Useful Predictors of Treatment-requiring Retinopathy of Prematurity: A 9-year Retrospective Analysis.	2	3	3.04	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:28640960	(2017) Ferulic acid alleviates symptoms of preeclampsia in rats by upregulating vascular endothelial growth factor.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28652462	(2017) Protective Low-Frequency Variants for Preeclampsia in the Fms Related Tyrosine Kinase 1 Gene in the Finnish Population.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28653131	(2017) Novel Risk Stratification Assays for Acute Coronary Syndrome.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28667900	(2017) Improving in vivo outcomes of decellularized vascular grafts via incorporation of a novel extracellular matrix.	2	11	2.47	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:28670885	(2017) Anti-Vascular Endothelial Growth Factor Effects of Sorafenib and Arsenic Trioxide in Acute Myeloid Leukemia Cell Lines	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28671725	(2017) Trisomy 13-confined placental mosaicism: is there an increased risk of gestational hypertensive disorders?	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28677792	(2017) Peroxisome proliferator-activated receptor gamma mediates porcine placental angiogenesis through hypoxia inducible factor-, vascular endothelial growth factor- and angiopoietin-mediated signaling.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28679123	(2017) Advanced alveolar soft part sarcoma responds to apatinib.	2	12	2.43	0.0461	9606.ENSP00000362524,9606.ENSP00000478570	ANGPTL2,VEGFA
PMID:28680263	(2017) Cedilanid inhibits retinal neovascularization in a mouse model of oxygen-induced retinopathy.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28683315	(2017) Laminin Levels Regulate Tissue Migration and Anterior-Posterior Polarity during Egg Morphogenesis in Drosophila.	2	6	2.74	0.0461	9606.ENSP00000231061,9606.ENSP00000363827	SPARC,HSPG2
PMID:28686443	(2017) Identification of Peptidic Antagonists of Vascular Endothelial Growth Factor Receptor 1 by Scanning the Binding Epitopes of Its Ligands.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28691930	(2017) Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy.	2	6	2.74	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:28707058	(2017) Is there any relationship between adipocytokines and angiogenesis factors to address endothelial dysfunction and platelet aggregation in untreated patients with preeclampsia?	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28709403	(2017) The role of vitamin D in pre-eclampsia: a systematic review.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28709426	(2017) Xue-fu-Zhu-Yu decoction protects rats against retinal ischemia by downregulation of HIF-1alpha and VEGF via inhibition of RBP2 and PKM2.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28714356	(2017) Complexity of macrophage migration inhibitory factor (MIF) and other angiogenic biomarkers profiling in pulmonary arterial hypertension.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28744168	(2017) Spotlight on ramucirumab in the treatment of nonsmall cell lung cancer: design, development, and clinical activity.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28751444	(2017) Pediatric Phase I Trial and Pharmacokinetic Study of Trebananib in Relapsed Solid Tumors, Including Primary Tumors of the Central Nervous System ADVL1115: A Childrens Oncology Group Phase I Consortium Report.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28757591	(2017) Notch Signaling in Endothelial Cells: Is It the Therapeutic Target for Vascular Neointimal Hyperplasia?	3	47	2.02	0.0461	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:28761750	(2017) European Medicines Agency approval summary: Zaltrap for the treatment of patients with oxaliplatin-resistant metastatic colorectal cancer.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28763502	(2017) Onset of microglial entry into developing quail retina coincides with increased expression of active caspase-3 and is mediated by extracellular ATP and UDP.	2	12	2.43	0.0461	9606.ENSP00000006053,9606.ENSP00000304767	CX3CL1,P2RY1
PMID:28765159	(2017) The power of the few.	2	14	2.37	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:28788063	(2017) Localization of VEGF to Vascular ECM Is an Important Aspect of Tumor Angiogenesis.	2	9	2.56	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:28790977	(2017) Micro- and Nano-vesicles from First Trimester Human Placentae Carry Flt-1 and Levels Are Increased in Severe Preeclampsia.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28797134	(2017) Looking beyond the intervertebral disc: the need for behavioral assays in models of discogenic pain.	2	9	2.56	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:28798419	(2017) DNA methylation of the RUNX2 P1 promoter mediates MMP13 transcription in chondrocytes.	2	8	2.61	0.0461	9606.ENSP00000231061,9606.ENSP00000363827	SPARC,HSPG2
PMID:28798939	(2017) Orphan Nuclear Receptor TR3Nur77 is a Specific Therapeutic Target for Hepatic Cancers.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28815088	(2017) Use of Anti-VEGF Agents in Glaucoma Surgery.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28820169	(2017) Aflibercept for recurrent or recalcitrant polypoidal choroidal vasculopathy in Indian eyes: Early experience.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28820409	(2017) [the role of angiogenic factors in the diagnostics of pregnancy complicated with preeclampsia].	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28824438	(2017) Sunitinib in Metastatic Renal Cell Carcinoma: The Pharmacological Basis of the Alternative 21 Schedule.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28835854	(2017) Retinal and choroidal angiogenesis: a review of new targets.	3	81	1.78	0.0461	9606.ENSP00000362524,9606.ENSP00000451040,9606.ENSP00000478570	ANGPTL2,PGF,VEGFA
PMID:28837651	(2017) Difference of polymorphism VEGF-gene rs699947 in Indonesian chronic liver disease population.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28841827	(2017) Comparison of 12-month therapeutic effect of conbercept and ranibizumab for diabetic macular edema: a real-life clinical practice study.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28848442	(2017) Biodegradable Carriers for Delivery of VEGF Plasmid DNA for the Treatment of Critical Limb Ischemia.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28850122	(2017) Distinct transcriptional responses of lymphatic endothelial cells to VEGFR-3 and VEGFR-2 stimulation.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28855067	(2017) What are the metabolic precursors which increase the risk of pre-eclampsia and how could these be investigated further.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28860570	(2017) CXCL12 overexpression promotes the angiogenesis potential of periodontal ligament stem cells.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28871010	(2017) Exploring the association between chorangioma and infantile haemangioma in singleton and multiple pregnancies: a case-control study in a Swedish tertiary centre.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28881730	(2017) Suppression of microRNA-205-5p in human mesenchymal stem cells improves their therapeutic potential in treating diabetic foot disease.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28900543	(2017) Switching to Aflibercept in Diabetic Macular Edema Not Responding to Ranibizumab andor Intravitreal Dexamethasone Implant.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28912068	(2017) Angiogenic imbalance and diminished matrix metalloproteinase-2 and -9 underlie regional decreases in uteroplacental vascularization and feto-placental growth in hypertensive pregnancy.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28932080	(2017) Comparison between tocotrienol and omeprazole on gastric growth factors in stress-exposed rats.	2	7	2.67	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:28939845	(2017) FLT1 and transcriptome-wide polyadenylation site (PAS) analysis in preeclampsia.	3	67	1.86	0.0461	9606.ENSP00000276571,9606.ENSP00000451040,9606.ENSP00000478570	CRH,PGF,VEGFA
PMID:28939873	(2017) Brain Inflammation, Blood Brain Barrier dysfunction and Neuronal Synaptophysin Decrease after Inhalation Exposure to Titanium Dioxide Nano-aerosol in Aging Rats.	2	14	2.37	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:28942512	(2017) Altered Endothelial Nitric Oxide Signaling as a Paradigm for Maternal Vascular Maladaptation in Preeclampsia.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28955180	(2017) Tumor Regulation of Lymph Node Lymphatic Sinus Growth and Lymph Flow in Mice and in Humans.	2	12	2.43	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:28955220	(2017) Alterations in the Interplay between Neurons, Astrocytes and Microglia in the Rat Dentate Gyrus in Experimental Models of Neurodegeneration.	2	9	2.56	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:28962701	(2017) DNA methylation-mediated silencing of FLT1 in parthenogenetic porcine placentas.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28963486	(2017) Enhanced HIF2alpha expression during human trophoblast differentiation into syncytiotrophoblast suppresses transcription of placental growth factor.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28965804	(2017) Neutralization of placental growth factor as a novel treatment option in diabetic retinopathy.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28978162	(2017) Effects of VEGF and VEGFR polymorphisms on the outcome of patients with metastatic renal cell carcinoma treated with sunitinib: a systematic review and meta-analysis.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29026131	(2017) Mechanical stress induces elastic fibre disruption and cartilage matrix increase in ligamentum flavum.	2	10	2.51	0.0461	9606.ENSP00000362524,9606.ENSP00000478570	ANGPTL2,VEGFA
PMID:29026849	(2017) Increased Levels of VEGF-A and HIF-1alpha in Turkish Children with Crimean-Congo Hemorrhagic Fever.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29031892	(2017) Altered angiogenesis as a common mechanism underlying preterm birth, small for gestational age, and stillbirth in women living with HIV.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29033483	(2017) The impact of antidepressant treatment on brain-derived neurotrophic factor level: An evidence-based approach through systematic review and meta-analysis.	2	6	2.74	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:29033580	(2017) The influence of vascular endothelial growth factor-A and matrix metalloproteinase-2 and -9 in angiogenesis, metastasis, and prognosis of endometrial cancer.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29034214	(2017) Pathogenic CD8(+) T Cells Cause Increased Levels of VEGF-A in Experimental Malaria-Associated Acute Respiratory Distress Syndrome, but Therapeutic VEGFR Inhibition Is Not Effective.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29037482	(2017) The prediction of fetal death with a simple maternal blood test at 20-24 weeks: a role for angiogenic index-1 (PlGFsVEGFR-1 ratio).	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29039130	(2017) Aspirin for Prevention of Preeclampsia.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29047245	(2017) 11beta-Hydroxysteroid Dehydrogenase Type 1 Inhibition Attenuates the Adverse Effects of Glucocorticoids on Dermal Papilla Cells.	2	9	2.56	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:29049209	(2017) Pravastatin for prevention of HELLP syndrome: A case report.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29050240	(2017) Total flavones of abelmoschus manihot enhances angiogenic ability both in vitro and in vivo.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29055792	(2017) The effect of acetyl salicylic acid (Aspirin) on trophoblast-endothelial interaction in vitro.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29063054	(2017) Revision of the concept of anti-angiogenesis and its applications in tumor treatment.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29069789	(2017) Postoperative course and prognostic value of circulating angiogenic cytokines after pancreatic cancer resection.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29075785	(2017) SPARC suppresses lymph node metastasis by regulating the expression of VEGFs in ovarian carcinoma.	2	5	2.81	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:29077165	(2017) Role of secreted protein acidic in hematogenous metastasis of gastric cancer.	2	2	3.21	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:29077188	(2017) Aflibercept in the Treatment of Diabetic Macular Edema: A Review and Consensus Paper.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29084878	(2017) Placental Growth Factor as a Prognostic Tool in Women With Hypertensive Disorders of Pregnancy: A Systematic Review.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29088755	(2017) Suppression of hypoxia-induced excessive angiogenesis by metformin via elevating tumor blood perfusion.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29093970	(2017) Two-Year Outcome of Aflibercept in Patients with Pigment Epithelial Detachment due to Neovascular Age-Related Macular Degeneration (nAMD) Refractory to Ranibizumab.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29094167	(2017) Effects of Aflibercept for Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis of Observational Comparative Studies.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29099033	(2017) VEGF-B Levels in the Vitreous of Diabetic and Non-Diabetic Patients with Ocular Diseases and Its Correlation with Structural Parameters.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29104816	(2017) Versatile synthetic alternatives to Matrigel for vascular toxicity screening and stem cell expansion.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29110608	(2017) The Profile of Angiogenic Factors in Vitreous Humor of the Patients with Proliferative Diabetic Retinopathy.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29113221	(2017) SPARC inhibits breast cancer bone metastasis and may be a clinical therapeutic target.	2	10	2.51	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:29115294	(2017) Placental growth factor and pre-eclampsia.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29129537	(2017) A Moving Source of Matrix Components Is Essential for De Novo Basement Membrane Formation.	2	4	2.91	0.0461	9606.ENSP00000231061,9606.ENSP00000363827	SPARC,HSPG2
PMID:29133637	(2017) The inhibitory effect of different concentrations of KH902 eye drops on corneal neovascularization induced by alkali burn.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29133850	(2017) Astrocyte elevated gene-1 promotes tumour growth and invasion by inducing EMT in oral squamous cell carcinoma.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29143774	(2017) Disrupting VEGF-VEGFR1 Interaction: De Novo Designed Linear Helical Peptides to Mimic the VEGF13-25 Fragment.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29153696	(2017) Dysregulation of circulating autoantibodies against VEGF-A, VEGFR-1 and PlGF in preeclampsia - A role in placental and vascular health?	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29180757	(2017) Discovery of High-Affinity PDGF-VEGFR Interactions: Redefining RTK Dynamics.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29194374	(2017) Subcellular Interactions during Vascular Morphogenesis in 3D Cocultures between Endothelial Cells and Fibroblasts.	2	8	2.61	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:29201161	(2017) Identification of key genes influenced by fixation stability in early fracture hematoma and elucidation of their roles in fracture healing.	2	11	2.47	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:29201458	(2017) Switch to Aflibercept in the Treatment of Neovascular AMD: Long-Term Results.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29202760	(2017) Injections frequency and health care costs in patients treated with aflibercept compared to ranibizumab: new real-life evidence from Switzerland.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29204832	(2017) Plasticity of the Muscle Stem Cell Microenvironment.	3	63	1.89	0.0461	9606.ENSP00000006053,9606.ENSP00000363827,9606.ENSP00000478570	CX3CL1,HSPG2,VEGFA
PMID:29232698	(2017) Low-energy extracorporeal shockwave therapy (ESWT) improves metaphyseal fracture healing in an osteoporotic rat model.	2	10	2.51	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:29238626	(2017) c-kit Positive Cardiac Outgrowth Cells Demonstrate Better Ability for Cardiac Recovery Against Ischemic Myopathy.	2	13	2.4	0.0461	9606.ENSP00000362524,9606.ENSP00000478570	ANGPTL2,VEGFA
PMID:29244779	(2017) Omega-3 Long-Chain Polyunsaturated Fatty Acids and Preeclampsia: Trials Say No, but Is It the Final Word?	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29259701	(2017) Quantitative assessment of angiogenesis and pericyte coverage in human cell-derived vascular sprouts.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29260119	(2017) One-year outcomes of ziv-aflibercept for macular edema in central retinal vein occlusion.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29267273	(2017) Mechanistic modeling quantifies the influence of tumor growth kinetics on the response to anti-angiogenic treatment.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29270405	(2017) Therapy for Cancer: Strategy of Combining Anti-Angiogenic and Target Therapies.	3	54	1.96	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:29276655	(2017) Polypoidal Choroidal Vasculopathy.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29285182	(2017) Effects of CASZI on bronchopulmonary development of neonatal rats.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29290937	(2017) Non-classical monocytes in tissue injury and cancer.	2	8	2.61	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:29317864	(2017) Cost-Effectiveness and Budget Impact Analysis of Apatinib for Advanced Metastatic Gastric Cancer from the Perspective of Health Insurance System.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29348786	(2017) DNA Methylation and the Potential Role of Methyl-Containing Nutrients in Cardiovascular Diseases.	2	10	2.51	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:29354304	(2017) Calcium phosphate cements for bone engineering and their biological properties.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29375562	(2017) Simultaneous Ablation of Uterine Natural Killer Cells and Uterine Mast Cells in Mice Leads to Poor Vascularization and Abnormal Doppler Measurements That Compromise Fetal Well-being.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29381963	(2017) Apatinib concurrent gemcitabine for controlling malignant ascites in advanced pancreatic cancer patient: A case report.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29629873	(2017) A Maternally Sequestered, Biopolymer-Stabilized Vascular Endothelial Growth Factor (VEGF) Chimera for Treatment of Preeclampsia.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29662801	(2017) Advances of stem cell based-therapeutic approaches for tendon repair.	2	14	2.37	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:29760757	(2017) Inhibitory Activities of Platelet-Rich and Platelet-Poor Plasma on the Growth of Pathogenic Bacteria.	2	12	2.43	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:29765853	(2017) The Effects of Acute Exercise on Mood, Cognition, Neurophysiology, and Neurochemical Pathways: A Review.	2	13	2.4	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:30087783	(2017) Rehmanniae Radix, an Effective Treatment for Patients with Various Inflammatory and Metabolic Diseases: Results from a Review of Korean Publications.	2	13	2.4	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:31740637	(2017) Targeting the P2X7 Receptor in Age-Related Macular Degeneration.	2	14	2.37	0.0461	9606.ENSP00000304767,9606.ENSP00000478570	P2RY1,VEGFA
PMID:25893545	(2016) Pravastatin to prevent recurrent fetal death in massive perivillous fibrin deposition of the placenta (MPFD).	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25955799	(2016) Targeting hypoxia-inducible factor 1 to stimulate tissue vascularization.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26205065	(2016) Assessment of angiogenesis modulators in pregnant women with pre-eclampsia: a case-control study.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26228018	(2016) Placental hypoxia, endoplasmic reticulum stress and maternal endothelial sensitisation by sFLT1 in pre-eclampsia.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26333278	(2016) Serum VEGF and PGF may be significant markers in prediction of severity of preeclampsia.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26431933	(2016) Elevated levels of neuropeptide Y in preeclampsia: A pilot study implicating a role for stress in pathogenesis of the disease.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26432463	(2016) Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26475217	(2016) Apelin as a marker for monitoring the tumor vessel normalization window during antiangiogenic therapy.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26514244	(2016) Aflibercept as primary treatment for myopic choroidal neovascularisation: a retrospective study.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26529476	(2016) Vascular Endothelial Growth FactorPlacental Growth Factor Heterodimer Levels in Preterm Infants with Bronchopulmonary Dysplasia.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26545374	(2016) Malignant Peritoneal Mesothelioma: Characterization of the Inflammatory Response in the Tumor Microenvironment.	2	11	2.47	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:26546397	(2016) IL-1alpha induces angiogenesis in brain endothelial cells in vitro: implications for brain angiogenesis after acute injury.	2	9	2.56	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:26573919	(2016) Ginkgo biloba Extract Prevents Female Mice from Ischemic Brain Damage and the Mechanism Is Independent of the HO1Wnt Pathway.	2	9	2.56	0.0461	9606.ENSP00000334329,9606.ENSP00000478570	UNC5B,VEGFA
PMID:26581401	(2016) Phase I trial of FOLFIRI in combination with sorafenib and bevacizumab in patients with advanced gastrointestinal malignancies.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26612342	(2016) Abnormal uterine artery remodelling in the stroke prone spontaneously hypertensive rat.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26646502	(2016) Placental growth factor deficiency is associated with impaired cerebral vascular development in mice.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26663584	(2016) MicroRNA-31 is a positive modulator of endothelial-mesenchymal transition and associated secretory phenotype induced by TGF-beta.	2	10	2.51	0.0461	9606.ENSP00000006053,9606.ENSP00000362524	CX3CL1,ANGPTL2
PMID:26667393	(2016) Circulating multimarker profile of patients with symptomatic heart failure supports enhanced fibrotic degradation and decreased angiogenesis.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26671566	(2016) Angiotensin-(1-7) Decreases Cell Growth and Angiogenesis of Human Nasopharyngeal Carcinoma Xenografts.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26696276	(2016) Predisposing Factors to Abnormal First Trimester Placentation and the Impact on Fetal Outcomes.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26702929	(2016) Placental growth factor and vascular endothelial growth factor serum levels in Tunisian Arab women with suspected preeclampsia.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26715573	(2016) Phase I trial of vandetanib in combination with gemcitabine and capecitabine in patients with advanced solid tumors with an expanded cohort in pancreatic and biliary cancers.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26728464	(2016) Novel Interaction Mechanism of a Domain Antibody-based Inhibitor of Human Vascular Endothelial Growth Factor with Greater Potency than Ranibizumab and Bevacizumab and Improved Capacity over Aflibercept.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26735326	(2016) Angiopoietin-2 May Be Involved in the Resistance to Bevacizumab in Recurrent Glioblastoma.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26745613	(2016) Combination of Controlled Release Platelet-Rich Plasma Alginate Beads and Bone Morphogenetic Protein-2 Genetically Modified Mesenchymal Stem Cells for Bone Regeneration.	2	8	2.61	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:26767411	(2016) Reducing the risk of fetal distress with sildenafil study (RIDSTRESS): a double-blind randomised control trial.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26771090	(2016) Response to anti-VEGF-A treatment of endothelial cells in vitro.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26773192	(2016) Vascular endothelial growth factor pathway in endometriosis: genetic variants and plasma biomarkers.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26785251	(2016) Placenta Growth Factor in Eyes with Neovascular Glaucoma Is Decreased after Intravitreal Ranibizumab Injection.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26801060	(2016) Gene Therapy in Cardiac Surgery: Clinical Trials, Challenges, and Perspectives.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26807786	(2016) Lung Infection by Human Bocavirus Induces the Release of Profibrotic Mediator Cytokines In Vivo and In Vitro.	3	68	1.86	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:26808525	(2016) ECM-Regulator timp Is Required for Stem Cell Niche Organization and Cyst Production in the Drosophila Ovary.	2	14	2.37	0.0461	9606.ENSP00000231061,9606.ENSP00000363827	SPARC,HSPG2
PMID:26831193	(2016) Placental Growth Factor Administration Abolishes Placental Ischemia-Induced Hypertension.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26833080	(2016) Perspectives on the design and methodology of periconceptional nutrient supplementation trials.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26846845	(2016) Placenta growth factor and neuropilin-1 collaborate in promoting melanoma aggressiveness.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26850575	(2016) Understanding the FOLFOXIRI-regimen to optimize treatment for metastatic colorectal cancer.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26853091	(2016) Neurologic cues modulate immune-mediated liver injury and regeneration.	2	8	2.61	0.0461	9606.ENSP00000334329,9606.ENSP00000478570	UNC5B,VEGFA
PMID:26857947	(2016) Aflibercept for neovascular age-related macular degeneration.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26861297	(2016) Generation of Potent Anti-Vascular Endothelial Growth Factor Neutralizing Antibodies from Mouse Phage Display Library for Cancer Therapy.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26861512	(2016) Morphological Changes of Cortical and Hippocampal Neurons after Treatment with VEGF and Bevacizumab.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26861699	(2016) Recombinant pharmaceuticals from microbial cells: a 2015 update.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26863111	(2016) Serum angiogenic profile in abnormal placentation.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26866529	(2016) possible molecular basis of bevacizumab therapy for macular edema in branch retinal vein occlusion.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26883761	(2016) Enhanced in vitro angiogenic behaviour of human umbilical vein endothelial cells on thermally oxidized TiO2 nanofibrous surfaces.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26891117	(2016) The Oxygen Environment at Birth Specifies the Population of Alveolar Epithelial Stem Cells in the Adult Lung.	2	14	2.37	0.0461	9606.ENSP00000220166,9606.ENSP00000478570	CTSH,VEGFA
PMID:26893100	(2016) Vasohibin-1 expression inhibits advancement of ovarian cancer producing various angiogenic factors.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26893739	(2016) Heparanase regulates in vitro VEGF-C expression and its clinical significance to pancreatic ductal cell adenocarcinoma.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26903689	(2016) Increased Umbilical Cord PAI-1 Levels in Placental Insufficiency Are Associated with Fetal Hypoxia and Angiogenesis.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26907516	(2016) Aflibercept for the treatment of diabetic macular edema.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26909159	(2016) Circulating angiogenic factors in a pregnant woman on intensive hemodialysis: a case report.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26912965	(2016) Overview of Ocular Anti-Vascular Endothelial Growth Factor Therapy in the Management of Diabetic Eye Complications.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26925444	(2016) Elevated levels of vascular endothelial growth factor in adults with severe dengue infection.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26926673	(2016) SPARC Promotes Cell Invasion In Vivo by Decreasing Type IV Collagen Levels in the Basement Membrane.	2	12	2.43	0.0461	9606.ENSP00000231061,9606.ENSP00000363827	SPARC,HSPG2
PMID:26929869	(2016) Neonatal Thrombocytopenia as a Consequence of Maternal Preeclampsia.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26930265	(2016) Attenuation of hyperglycemia-induced apoptotic signaling and anti-angiogenic milieu in cultured cytotrophoblast cells.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26930634	(2016) Impact of Obstructive Sleep Apnea on the Levels of Placental Growth Factor (PlGF) and Their Value for Predicting Short-Term Adverse Outcomes in Patients with Acute Coronary Syndrome.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26961182	(2016) The differential effects of metronomic gemcitabine and antiangiogenic treatment in patient-derived xenografts of pancreatic cancer: treatment effects on metabolism, vascular function, cell proliferation, and tumor growth.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26965914	(2016) Differential immunohistochemical expression profiles of perlecan-binding growth factors in epithelial dysplasia, carcinoma in situ, and squamous cell carcinoma of the oral mucosa.	2	6	2.74	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:26968576	(2016) PlGF knockdown inhibited tumor survival and migration in gastric cancer cell via PI3KAkt and p38MAPK pathways.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26974965	(2016) The mitogen-activated protein kinase pathway plays a critical role in regulating immunological properties of BRAF mutant cutaneous melanoma cells.	2	9	2.56	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:26976425	(2016) Efficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2-Associated Vestibular Schwannomas.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26985335	(2016) Performance of Circulating Placental Growth Factor as A Screening Marker for Diagnosis of Ovarian Endometriosis: A Pilot Study.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26985798	(2016) Evaluating Efficacy of Aflibercept in Refractory Exudative Age-Related Macular Degeneration With OCT Segmentation Volumetric Analysis.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26987390	(2016) Dynamic Contrast-Enhanced Magnetic Resonance Imaging as a Surrogate Biomarker for Bevacizumab in Colorectal Cancer Liver Metastasis: A Single-Arm, Exploratory Trial.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26988973	(2016) A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26988990	(2016) Intracrine VEGF Signaling Mediates the Activity of Prosurvival Pathways in Human Colorectal Cancer Cells.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26989294	(2016) Soluble TNF-Like Weak Inducer of Apoptosis as a New Marker in Preeclampsia: A Pilot Clinical Study.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26992682	(2016) MiR 20a,-20b and -200c are involved in hydrogen sulfide stimulation of VEGF production in human placental trophoblasts.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26994110	(2016) Effects of switching from ranibizumab to aflibercept in eyes with exudative age-related macular degeneration.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27007885	(2016) Glucocorticoid effects on angiogenesis are associated with mTOR pathway activity.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27009216	(2016) Dll4 Inhibition plus Aflibercept Markedly Reduces Ovarian Tumor Growth.	2	11	2.47	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:27009237	(2016) Autocrine VEGFR1 and VEGFR2 signaling promotes survival in human glioblastoma models in vitro and in vivo.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27013828	(2016) The effect of intravitreal bevacizumab and ranibizumab on macular edema of the contralateral eye: A comparative study of two anti-VEGFs.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27014389	(2016) Current and Future Techniques in Wound Healing Modulation after Glaucoma Filtering Surgeries.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27020496	(2016) Tumour-associated macrophages are recruited and differentiated in the neoplastic stroma of oral squamous cell carcinoma.	2	11	2.47	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:27023608	(2016) Hemorrhage Caused by Snake Venom Metalloproteinases: A Journey of Discovery and Understanding.	2	9	2.56	0.0461	9606.ENSP00000231061,9606.ENSP00000363827	SPARC,HSPG2
PMID:27028698	(2016) A comparison of the diagnostic utility of the sFlt-1PlGF ratio versus PlGF alone for the detection of preeclampsiaHELLP syndrome.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27029414	(2016) Role of splenic reservoir monocytes in pulmonary vascular monocyte accumulation in experimental hepatopulmonary syndrome.	2	8	2.61	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:27032981	(2016) Micronutrient deficiencies in pregnancy worldwide: health effects and prevention.	2	11	2.47	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:27034822	(2016) A Randomized Controlled Trial of Conbercept Pretreatment before Vitrectomy in Proliferative Diabetic Retinopathy.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27035677	(2016) Hormone signaling pathways as treatment targets in renal cell cancer (Review).	2	11	2.47	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:27038329	(2016) Modifying the tumor microenvironment using nanoparticle therapeutics.	3	43	2.06	0.0461	9606.ENSP00000231061,9606.ENSP00000451040,9606.ENSP00000478570	SPARC,PGF,VEGFA
PMID:27038485	(2016) VEGF receptor-2-specific signaling mediated by VEGF-E induces hemangioma-like lesions in normal and in malignant tissue.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27038933	(2016) Impaired Purinergic Regulation of the Glial (Muller) Cell Volume in the Retina of Transgenic Rats Expressing Defective Polycystin-2.	2	5	2.81	0.0461	9606.ENSP00000304767,9606.ENSP00000478570	P2RY1,VEGFA
PMID:27039845	(2016) Randomized Phase 2 Trial of the Oncolytic Virus Pelareorep (Reolysin) in Upfront Treatment of Metastatic Pancreatic Adenocarcinoma.	2	5	2.81	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:27042064	(2016) Sustained dual release of placental growth factor-2 and bone morphogenic protein-2 from heparin-based nanocomplexes for direct osteogenesis.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27047962	(2016) Human Umbilical Cord Mesenchymal Stem Cells Therapy in Cyclophosphamide-Induced Premature Ovarian Failure Rat Model.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27051317	(2016) Profile of bevacizumab in the treatment of platinum-resistant ovarian cancer: current perspectives.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27055905	(2016) Inhibition of the Nuclear Receptor RORgamma and Interleukin-17A Suppresses Neovascular Retinopathy: Involvement of Immunocompetent Microglia.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27070577	(2016) Placental Expression Patterns of Galectin-1, Galectin-2, Galectin-3 and Galectin-13 in Cases of Intrauterine Growth Restriction (IUGR).	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27075560	(2016) A phase I study of the human anti-activin receptor-like kinase 1 antibody PF-03446962 in Asian patients with advanced solid tumors.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27084089	(2016) Mesenchymal stem cells (MSCs) as skeletal therapeutics - an update.	3	42	2.07	0.0461	9606.ENSP00000006053,9606.ENSP00000231061,9606.ENSP00000478570	CX3CL1,SPARC,VEGFA
PMID:27085138	(2016) Vascular Endothelial Growth Factor Receptor Type 1 Signaling Prevents Delayed Wound Healing in Diabetes by Attenuating the Production of IL-1beta by Recruited Macrophages.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27085264	(2016) Alterations in intraocular cytokine levels following intravitreal ranibizumab.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27091894	(2016) Placental Growth Factor Reduces Blood Pressure in a Uteroplacental Ischemia Model of Preeclampsia in Nonhuman Primates.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27094197	(2016) SPARCling Study of a Drosophila Cardiomyopathy.	2	6	2.74	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:27103202	(2016) Soluble VEGF receptor 1 (sFLT1) induces non-apoptotic death in ovarian and colorectal cancer cells.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27111418	(2016) Topical Use of Angiopoietin-like Protein 2 RNAi-loaded Lipid Nanoparticles Suppresses Corneal Neovascularization.	2	7	2.67	0.0461	9606.ENSP00000362524,9606.ENSP00000478570	ANGPTL2,VEGFA
PMID:27119078	(2016) Ocular Complications of Diabetes and Therapeutic Approaches.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27121738	(2016) Urinary cytokineschemokines pattern in patients with painful bone metastases undergoing external beam radiotherapy experiencing pain flare.	2	10	2.51	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:27130072	(2016) Angiogenic balance (sFlt-1PlGF) and preeclampsia.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27130844	(2016) Integrative biomarker analyses indicate etiological variations in hepatocellular carcinoma.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27148504	(2016) Oxygen Supplementation to Stabilize Preterm Infants in the Fetal to Neonatal Transition: No Satisfactory Answer.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27156946	(2016) Expression of Chemokine XCL2 and CX3CL1 in Lung Cancer.	2	7	2.67	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:27159542	(2016) Decidual Cox2 inhibition improves fetal and maternal outcomes in a preeclampsia-like mouse model.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27160159	(2016) Cytokine Kinetics after Monthly Intravitreal Bevacizumab for Retinal Vein Occlusion Associated with Macular Oedema.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27166252	(2016) Novel 1, 3-N, O-Spiroheterocyclic compounds inhibit heparanase activity and enhance nedaplatin-induced cytotoxicity in cervical cancer cells.	2	13	2.4	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:27175642	(2016) Association of Genetic Polymorphisms on VEGFA and VEGFR2 With Risk of Coronary Heart Disease.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27182813	(2016) Treatment of hind limb ischemia using angiogenic peptide nanofibers.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27186496	(2016) Maternal diabetes impairs oxidative and inflammatory response in murine placenta.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27187738	(2016) Reduced Uterine Perfusion Pressure (RUPP) Model of Preeclampsia in Mice.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27195296	(2016) The Possible Roles of Biological Bone Constructed with Peripheral Blood Derived EPCs and BMSCs in Osteogenesis and Angiogenesis.	2	12	2.43	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:27212611	(2016) [Predictive and prognostic factors of preeclampsia: Interest of PlGF and sFLT-1].	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27213036	(2016) Administration of cells with thermosensitive hydrogel enhances the functional recovery in ischemic rat heart.	2	13	2.4	0.0461	9606.ENSP00000362524,9606.ENSP00000478570	ANGPTL2,VEGFA
PMID:27213858	(2016) Hypertensive disorders of pregnancy: what the physician needs to know.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27220225	(2016) Wet age related macular degeneration management and follow-up.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27230578	(2016) Osmotic induction of placental growth factor in retinal pigment epithelial cells in vitro: contribution of NFAT5 activity.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27239344	(2016) Human Decidual Stromal Cells as a Component of the Implantation Niche and a Modulator of Maternal Immunity.	3	77	1.8	0.0461	9606.ENSP00000006053,9606.ENSP00000276571,9606.ENSP00000478570	CX3CL1,CRH,VEGFA
PMID:27250635	(2016) Stem Cells in Bone Regeneration.	2	13	2.4	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:27253272	(2016) The early developments of preeclampsia drugs.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27255568	(2016) Differential hypoxic response of human choroidal and retinal endothelial cells proposes tissue heterogeneity of ocular angiogenesis.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27271610	(2016) Hypoxia Inducible Factor 1 (HIF-1) Recruits Macrophage to Activate Pancreatic Stellate Cells in Pancreatic Ductal Adenocarcinoma.	2	14	2.37	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:27275161	(2016) Angiogenic Factors and Risks of Technique Failure and Cardiovascular Events in Patients Receiving Peritoneal Dialysis.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27287066	(2016) The decidua-the maternal bed embracing the embryo-maintains the pregnancy.	3	85	1.76	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:27299886	(2016) Low Soluble Syndecan-1 Precedes Preeclampsia.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27307700	(2016) One-year outcome of intravitreal aflibercept injection for age-related macular degeneration resistant to ranibizumab: rapid morphologic recovery and subsequent visual improvement.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27315098	(2016) Association between Placental Lesions, Cytokines and Angiogenic Factors in Pregnant Women with Preeclampsia.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27322195	(2016) Heparanase Activates Antithrombin through the Binding to Its Heparin Binding Site.	2	11	2.47	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:27328421	(2016) Blood vessel crosstalk during organogenesis-focus on pancreas and endothelial cells.	3	62	1.9	0.0461	9606.ENSP00000334329,9606.ENSP00000451040,9606.ENSP00000478570	UNC5B,PGF,VEGFA
PMID:27330279	(2016) Resistance to anti-VEGF therapy in neovascular age-related macular degeneration: a comprehensive review.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27330805	(2016) Effects of definitive chemoradiation on circulating immunologic angiogenic cytokines in head and neck cancer patients.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27338342	(2016) miR-126 Regulation of Angiogenesis in Age-Related Macular Degeneration in CNV Mouse Model.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27340254	(2016) Bevacizumab in the treatment of nonsquamous non-small cell lung cancer: clinical trial evidence and experience.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27350037	(2016) Continuous administration of bevacizumab plus capecitabine, even after acquired resistance to bevacizumab, restored anti-angiogenic and antitumor effect in a human colorectal cancer xenograft model.	3	71	1.84	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:27351218	(2016) Systematic analysis of circulating soluble angiogenesis-associated proteins in ICON7 identifies Tie2 as a biomarker of vascular progression on bevacizumab.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27355331	(2016) Therapeutic effects of a novel PIGF-1 derived peptide, ZY-1, on corneal neovascularization in vitro and in vivo.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27357606	(2016) Loss of membranous VEGFR1 expression is associated with an adverse phenotype and shortened survival in breast cancer.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27357800	(2016) Heat therapy promotes the expression of angiogenic regulators in human skeletal muscle.	2	9	2.56	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:27357932	(2016) A prospective study of angiogenic markers and postmenopausal breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27358589	(2016) Acupuncture: could it become everyday practice in oncology?	2	8	2.61	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:27385360	(2016) G-Protein-coupled receptors as potential drug candidates in preeclampsia: targeting the relaxininsulin-like family peptide receptor 1 for treatment and prevention.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27391437	(2016) Cell surgery and growth factors in dry age-related macular degeneration: visual prognosis and morphological study.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27393180	(2016) Decreased expression of connective tissue growth factor in non-small cell lung cancer is associated with clinicopathological variables and can be restored by epigenetic modifiers.	2	10	2.51	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:27403807	(2016) Non-responsiveness to intravitreal aflibercept treatment in neovascular age-related macular degeneration: implications of serous pigment epithelial detachment.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27435924	(2016) Antiangiogenic and Antitumor Activities of Aflibercept, a Soluble VEGF Receptor-1 and -2, in a Mouse Model of Hepatocellular Carcinoma.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27456522	(2016) Association of Maternal Antiangiogenic Profile at Birth With Early Postnatal Loss of Microvascular Density in Offspring of Hypertensive Pregnancies.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27464822	(2016) Angiogenic cytokines and their influence on circulating tumour cells in sera of patients with the primary diagnosis of breast cancer before treatment.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27478833	(2016) Impact of Dental Implant Surface Modifications on Osseointegration.	2	10	2.51	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:27479949	(2016) Recurrence of Epithelioid Hemangioendothelioma during Pregnancy: Case Report and Systematic Review.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27480772	(2016) The Retinoid Agonist Tazarotene Promotes Angiogenesis and Wound Healing.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27480835	(2016) Suppressed Production of Soluble Fms-Like Tyrosine Kinase-1 Contributes to Myocardial Remodeling and Heart Failure.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27482235	(2016) Bone marrow mesenchymal stem cell therapy in ischemic stroke: mechanisms of action and treatment optimization strategies.	3	62	1.9	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:27499172	(2016) The molecular mechanisms of action of PPAR-gamma agonists in the treatment of corneal alkali burns (Review).	3	51	1.98	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:27512150	(2016) EPHB4 Regulates Human Trophoblast Cell Line HTR-8SVneo Function: Implications for the Role of EPHB4 in Preeclampsia.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27513332	(2016) Anti-Vascular Endothelial Growth Factor Antibody Suppresses ERK and NF-kappaB Activation in Ischemia-Reperfusion Lung Injury.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27527872	(2016) Towards a multi protein and mRNA expression of biological predictive and distinguish model for post stroke depression.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27537264	(2016) The Intraocular Cytokine Profile and Therapeutic Response in Persistent Neovascular Age-Related Macular Degeneration.	2	6	2.74	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:27545811	(2016) Collagen I hydrogel microstructure and composition conjointly regulate vascular network formation.	2	7	2.67	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:27547223	(2016) Enhanced Osteogenic and Vasculogenic Differentiation Potential of Human Adipose Stem Cells on Biphasic Calcium Phosphate Scaffolds in Fibrin Gels.	2	9	2.56	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:27549205	(2016) Hypoxia and its implications in rheumatoid arthritis.	3	56	1.94	0.0461	9606.ENSP00000362524,9606.ENSP00000451040,9606.ENSP00000478570	ANGPTL2,PGF,VEGFA
PMID:27559727	(2016) Plasma Level of Placenta-Derived Macrophage-Stimulating Protein -Chain in Preeclampsia before 20 Weeks of Pregnancy.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27559943	(2016) Increased risk of hemorrhage in metastatic colorectal cancer patients treated with bevacizumab: An updated meta-analysis of 12 randomized controlled trials.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27563165	(2016) Predictors of Impaired Postpartum Renal Function in Women after Preeclampsia: Results of a Prospective Single Center Study.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27563195	(2016) Effects of scaling and root planing on gingival crevicular fluid vascular endothelial growth factor level in chronic periodontitis patients with and without diabetes mellitus: A clinicobiochemical study.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27563629	(2016) Diagnostic and prognostic significance of serum soluble endoglin levels in preeclampsia and eclampsia.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27564266	(2016) Roles of SPARC in urothelial carcinogenesis, progression and metastasis.	2	9	2.56	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:27566180	(2016) Changes in PlGF and MET-HGF expressions in paired initial and recurrent glioblastoma.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27582594	(2016) Glaucoma Surgery in Pregnancy: A Case Series and Literature Review.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27590379	(2016) Detection of angiogenic factors in midtrimester amniotic fluid and the prediction of preterm birth.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27612948	(2016) Secreted trophic factors of mesenchymal stem cells support neurovascular and musculoskeletal therapies.	3	77	1.8	0.0461	9606.ENSP00000231061,9606.ENSP00000451040,9606.ENSP00000478570	SPARC,PGF,VEGFA
PMID:27625610	(2016) Impaired Neovascularization and Reduced Capillary Supply in the Malignant vs. Non-malignant Course of Experimental Renovascular Hypertension.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27626690	(2016) The antiangiogenic effects of polyisoprenylated cysteinyl amide inhibitors in HUVEC, chick embryo and zebrafish is dependent on the polyisoprenyl moiety.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27637083	(2016) Long non-coding RNA CRNDE promotes gallbladder carcinoma carcinogenesis and as a scaffold of DMBT1 and C-IAP1 complexes to activating PI3K-AKT pathway.	2	14	2.37	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:27648002	(2016) Regulatory SNPs Alter the Gene Expression of Diabetic Retinopathy Associated Secretary Factors.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27656206	(2016) Treatment with Antiangiogenic Drugs in Multiple Lines in Patients with Metastatic Colorectal Cancer: Meta-Analysis of Randomized Trials.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27669225	(2016) PlGF and VEGF-A Regulate Growth of High-Risk MYCN-Single Copy Neuroblastoma Xenografts via Different Mechanisms.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27672589	(2016) A novel model of retinopathy of prematurity in normobaric hyperoxic conditions.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27676657	(2016) A cholinergic-sympathetic pathway primes immunity in hypertension and mediates brain-to-spleen communication.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27678389	(2016) Volume regulatory hormones and plasma volume in pregnant women with sickle cell disorder.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27695045	(2016) Tumor Specific Epigenetic Silencing of Corticotropin Releasing Hormone -Binding Protein in Renal Cell Carcinoma: Association of Hypermethylation and Metastasis.	2	9	2.56	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:27695480	(2016) Meroxest improves the prognosis of immunocompetent C57BL6 mice with allografts of E0771 mouse breast tumor cells.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27697834	(2016) Tumor macrophages are pivotal constructors of tumor collagenous matrix.	3	46	2.03	0.0461	9606.ENSP00000006053,9606.ENSP00000231061,9606.ENSP00000363827	CX3CL1,SPARC,HSPG2
PMID:27698062	(2016) Agonistic Autoantibodies to the Angiotensin II Type 1 Receptor Enhance Angiotensin II-Induced Renal Vascular Sensitivity and Reduce Renal Function During Pregnancy.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27698752	(2016) Serum biomarkers combined with uterine artery Doppler in prediction of preeclampsia.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27703326	(2016) Intravitreal ziv-aflibercept for macular edema following retinal vein occlusion.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27711226	(2016) Placental Growth Factor Is Secreted by the Human Endometrium and Has Potential Important Functions during Embryo Development and Implantation.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27712015	(2016) Randomized study of FOLFIRI plus either panitumumab or bevacizumab for wild-type KRAS colorectal cancer-WJOG 6210G.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27729757	(2016) The Efficacy of Intravitreal Aflibercept in Submacular Hemorrhage Secondary to Wet Age-related Macular Degeneration.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27746630	(2016) Isolation and Quantification of Glycosaminoglycans from Human Hair Shaft.	2	9	2.56	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:27746673	(2016) Transthyretin represses neovascularization in diabetic retinopathy.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27766947	(2016) Vascular endothelial growth factor (VEGFA) gene variation in polycystic ovary syndrome in a Tunisian women population.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27777791	(2016) Intravitreal Conbercept Injection with and without Grid Laser Photocoagulation in the Treatment of Diffuse Diabetic Macular Edema in Real-Life Clinical Practice.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27779169	(2016) Comparison of the 1-year Outcomes of Conbercept Therapy between Two Different Angiographic Subtypes of Polypoidal Choroidal Vasculopathy.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27780936	(2016) Low dose angiostatic treatment counteracts radiotherapy-induced tumor perfusion and enhances the anti-tumor effect.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27787529	(2016) Self-assembly of vascularized tissue to support tumor explants in vitro.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27790618	(2016) Designer Leptin Receptor Antagonist Allo-aca Inhibits VEGF Effects in Ophthalmic Neoangiogenesis Models.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27795701	(2016) Targeted therapy in gastric cancer.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27806942	(2016) Placental Hypoxia During Early Pregnancy Causes Maternal Hypertension and Placental Insufficiency in the Hypoxic Guinea Pig Model.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27809279	(2016) Extracellular Matrix, a Hard Player in Angiogenesis.	3	70	1.84	0.0461	9606.ENSP00000363827,9606.ENSP00000451040,9606.ENSP00000478570	HSPG2,PGF,VEGFA
PMID:27812483	(2016) VEGF +936 CT Genetic Polymorphism in Patients with Cervical Dysplasia.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27822012	(2016) Cardioprotective activity of placental growth factor combined with oral supplementation of l-arginine in a rat model of acute myocardial infarction.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27841282	(2016) Aflibercept and Ang1 supplementation improve neoadjuvant or adjuvant chemotherapy in a preclinical model of resectable breast cancer.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27847620	(2016) Conversion back to bevacizumab or ranibizumab for recurrent neovascular activity with aflibercept in age-related macular degeneration: a case series.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27847621	(2016) Fusion proteins for treatment of retinal diseases: aflibercept, ziv-aflibercept, and conbercept.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27853189	(2016) A multiscale computational model predicts distribution of anti-angiogenic isoform VEGF165b in peripheral arterial disease in human and mouse.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27853350	(2016) Intravitreal aflibercept for the treatment of choroidal neovascularization associated with pathologic myopia: a pilot study.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27854328	(2016) Parenchymal and Stromal Cells Contribute to Pro-Inflammatory Myocardial Environment at Early Stages of Diabetes: Protective Role of Resveratrol.	2	8	2.61	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:27876856	(2016) The trend and the disease prediction of vascular endothelial growth factor and placenta growth factor in nontuberculous mycobacterial lung disease.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27877121	(2016) The Indispensable Roles of Microglia and Astrocytes during Brain Development.	3	57	1.93	0.0461	9606.ENSP00000006053,9606.ENSP00000231061,9606.ENSP00000478570	CX3CL1,SPARC,VEGFA
PMID:27887594	(2016) First trimester serum placental growth factor and hyperglycosylated human chorionic gonadotropin are associated with pre-eclampsia: a case control study.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27895527	(2016) Phase II Trial of Angiotensin-(1-7) for the Treatment of Patients with Metastatic Sarcoma.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27899972	(2016) Efficacy and safety of aflibercept in metastatic colorectal cancer pretreated with bevacizumab: A report of five cases.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27910940	(2016) Supportive angiogenic and osteogenic differentiation of mesenchymal stromal cells and endothelial cells in monolayer and co-cultures.	2	13	2.4	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:27929426	(2016) Serum Soluble Fms-Like Tyrosine Kinase 1 (sFlt-1) Predicts the Severity of Acute Pancreatitis.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27936130	(2016) Angiogenic proteins, placental weight and perinatal outcomes among pregnant women in Tanzania.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27958226	(2016) Correlation of Vascular Endothelial Growth Factor Production with Photochemical Reaction-induced Retinal Edema.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27974772	(2016) Mimicking biological functionality with polymers for biomedical applications.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27980400	(2016) Cigarette smoke extract induces placental growth factor release from human bronchial epithelial cells via ROSMAPK (ERK-12)Egr-1 axis.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27999450	(2016) Association between Vascular Endothelial Growth Factor Polymorphisms and Age-Related Macular Degeneration: An Updated Meta-Analysis.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28005980	(2016) The Prognosis of Anti-Angiogenesis Treatments Combined with Standard Therapy for Newly Diagnosed Glioblastoma: A Meta-Analysis of Randomized Controlled Trials.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28018113	(2016) Smoc2 potentiates proliferation of hepatocellular carcinoma cells via promotion of cell cycle progression.	2	12	2.43	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:28031961	(2016) Fetal origins of autism spectrum disorders: the non-associated maternal factors.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28066431	(2016) The Role of the Tumor Vasculature in the Host Immune Response: Implications for Therapeutic Strategies Targeting the Tumor Microenvironment.	3	65	1.88	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:28155728	(2016) Multi-scale mathematical modelling of tumour growth and microenvironments in anti-angiogenic therapy.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28164613	(2016) High Concentrations of the Angiogenic Peptide VEGF-A in Seminal Fluid and its Association to Prostasomes.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28190957	(2016) Spotlight on bevacizumab in metastatic colorectal cancer: patient selection and perspectives.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28208844	(2016) Spectrum of Factors Triggering Endothelial Dysfunction in PIH.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28217207	(2016) An Update into the Application of Nanotechnology in Bone Healing.	2	10	2.51	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:28348774	(2016) Latent infection of human bocavirus accompanied by flare of chronic cough, fatigue and episodes of viral replication in an immunocompetent adult patient, Cologne, Germany.	3	64	1.88	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:28653043	(2016) Bioactive polymeric scaffolds for tissue engineering.	2	12	2.43	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:28773392	(2016) Composite Hydrogels for Bone Regeneration.	2	13	2.4	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:28955559	(2016) Osteocalcin and osteonectin expression after double application of platelet-rich plasma in rabbits.	2	4	2.91	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:29313007	(2016) Microfluidics-based 3D cell culture models: Utility in novel drug discovery and delivery research.	2	11	2.47	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:29435365	(2016) Novel active agents in patients with advanced NSCLC without driver mutations who have progressed after first-line chemotherapy.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29509338	(2016) Effects of strontium ranelate on sutural bone formation: a histological and immunohistochemical study.	2	4	2.91	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:29900100	(2016) Developmental origins of metabolic disorders: The need for biomarker candidates and therapeutic targets from adequate preclinical models.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31557993	(2016) beta2GP1, Anti-beta2GP1 Antibodies and Platelets: Key Players in the Antiphospholipid Syndrome.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32309582	(2016) Discoveries Interview: Professor Harold F. Dvorak on the discovery of Vascular Endothelial Growth Factor (VEGF).	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24964971	(2015) The potential role of perlecan domain V as novel therapy in vascular dementia.	2	3	3.04	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:24968203	(2015) Evidence for proangiogenic cellular and humoral systemic response in patients with acute onset of spinal cord injury.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25181428	(2015) Concentrations of eNOS, VEGF, ACE and PlGF in maternal blood as predictors of impaired fetal growth in pregnancy complicated by gestational hypertensionpreeclampsia.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25200689	(2015) The relationship between the VEGFsVEGFR-1 ratio and threatened abortion.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25245499	(2015) Imaging of activated complement using ultrasmall superparamagnetic iron oxide particles (USPIO)--conjugated vectors: an in vivo in utero non-invasive method to predict placental insufficiency and abnormal fetal brain development.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25283599	(2015) SDF-1alpha is a novel autocrine activator of platelets operating through its receptor CXCR4.	2	13	2.4	0.0461	9606.ENSP00000006053,9606.ENSP00000304767	CX3CL1,P2RY1
PMID:25325976	(2015) Measuring sulfatase expression and invasion in glioblastoma.	2	11	2.47	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:25331161	(2015) Improvement of risk assessment in systemic light-chain amyloidosis using human placental growth factor.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25354293	(2015) Influence of maternal pre-eclampsia on VEGFPlGF heterodimer levels in preterm infants.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25359881	(2015) Investigating the role of angiogenesis in systemic lupus erythematosus.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25370707	(2015) Lack of evidence for PlGF mediating the tumor resistance after anti-angiogenic therapy in malignant gliomas.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25407442	(2015) A phase I study of TRC105 anti-endoglin (CD105) antibody in metastatic castration-resistant prostate cancer.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25426617	(2015) Perfusion computed tomography as functional biomarker in randomized run-in study of bevacizumab and everolimus in well-differentiated neuroendocrine tumors.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25434840	(2015) Maternal circulating angiogenic factors in twin and singleton pregnancies.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25437315	(2015) Controlled direct effects of preeclampsia on neonatal health after accounting for mediation by preterm birth.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25452470	(2015) Neurokinin 3 receptor and phosphocholine transferase: missing factors for pathogenesis of C-reactive protein in preeclampsia.	2	9	2.56	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:25459668	(2015) Angiogenic factors in chronic lymphocytic leukaemia (CLL): Where do we stand?	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25521546	(2015) Urinary excretion of C5b-9 is associated with the anti-angiogenic state in severe preeclampsia.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25527204	(2015) A Phase Ibiomarker study of bevacizumab in combination with CNTO 95 in patients with advanced solid tumors.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25528754	(2015) The glycosylation-dependent interaction of perlecan core protein with LDL: implications for atherosclerosis.	2	9	2.56	0.0461	9606.ENSP00000231061,9606.ENSP00000363827	SPARC,HSPG2
PMID:25529825	(2015) Health care response to CCHF in US soldier and nosocomial transmission to health care providers, Germany, 2009.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25530850	(2015) Cell-derived matrices for tissue engineering and regenerative medicine applications.	3	40	2.09	0.0461	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:25534360	(2015) Novel glycosylated VEGF decoy receptor fusion protein, VEGF-Grab, efficiently suppresses tumor angiogenesis and progression.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25555620	(2015) The beneficial effect of extracorporeal shockwave myocardial revascularization in patients with refractory angina.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25561062	(2015) Identification of novel vascular projections with cellular trafficking abilities on the microvasculature of pancreatic ductal adenocarcinoma.	2	8	2.61	0.0461	9606.ENSP00000334329,9606.ENSP00000478570	UNC5B,VEGFA
PMID:25563584	(2015) Early exercise after spinal cord injury (Switch-On): study protocol for a randomised controlled trial.	2	13	2.4	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:25572584	(2015) Patterns of ranibizumab and aflibercept treatment of central retinal vein occlusion in routine clinical practice in the USA.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25573181	(2015) Cardiac and inflammatory biomarkers do not correlate with volume of heart or lung receiving radiation.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25573346	(2015) Role of TGFbeta in regulation of the tumor microenvironment and drug delivery (review).	3	78	1.8	0.0461	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:25575808	(2015) The non glycanated endocan polypeptide slows tumor growth by inducing stromal inflammatory reaction.	2	8	2.61	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:25583406	(2015) Activation of villous trophoblastic p38 and ERK12 signaling pathways in preterm preeclampsia and HELLP syndrome.	2	12	2.43	0.0461	9606.ENSP00000276571,9606.ENSP00000451040	CRH,PGF
PMID:25593123	(2015) The search for exercise factors in humans.	2	5	2.81	0.0461	9606.ENSP00000006053,9606.ENSP00000231061	CX3CL1,SPARC
PMID:25593638	(2015) Keratinocytic vascular endothelial growth factor as a novel biomarker for pathological skin condition.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25594425	(2015) Effect of living cellular sheets on the angiogenic potential of human microvascular endothelial cells.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25603823	(2015) Interferon-alpha and angiogenic dysregulation in pregnant lupus patients who develop preeclampsia.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25605928	(2015) Improved tumor vascularization after anti-VEGF therapy with carboplatin and nab-paclitaxel associates with survival in lung cancer.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25622897	(2015) Recombinant interleukin-1 receptor antagonist conjugated to superparamagnetic iron oxide nanoparticles for theranostic targeting of experimental glioblastoma.	2	14	2.37	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:25629013	(2015) Midtrimester maternal plasma concentrations of angiopoietin 1, angiopoietin 2, and placental growth factor in pregnant women who subsequently develop preeclampsia.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25634982	(2015) Role of soluble vascular endothelial growth factor receptor signaling and other factors or cytokines in central retinal vein occlusion with macular edema.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25638730	(2015) Aspirin inhibits expression of sFLT1 from human cytotrophoblasts induced by hypoxia, via cyclo-oxygenase 1.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25644816	(2015) Preeclampsia and diabetes.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25648460	(2015) ERK12 and AKT are vital factors in regulation of the migration of rat Schwann cells.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25653880	(2015) The use of a dehydrated amnionchorion membrane allograft in patients who subsequently undergo reexploration after posterior lumbar instrumentation.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25656129	(2015) [Screening for predictive biomarkers of bevacizumab treatment in gastric cancer subcutaneous xenografts].	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25657624	(2015) VEGF111: new insights in tissue invasion.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25663437	(2015) Binding of VEGF-A is sufficient to abrogate the disturbing effects of VEGF-B together with VEGF-A on retinal endothelial cells.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25665055	(2015) Angiogenesis induced by prenatal ischemia predisposes to periventricular hemorrhage during postnatal mechanical ventilation.	2	9	2.56	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:25666410	(2015) Blood and interstitial flow in the hierarchical pore space architecture of bone tissue.	2	10	2.51	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:25680186	(2015) 18F-FET microPET and microMRI for anti-VEGF and anti-PlGF response assessment in an orthotopic murine model of human glioblastoma.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25700714	(2015) Comparative safety and tolerability of anti-VEGF therapy in age-related macular degeneration.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25709489	(2015) New approach to the understanding of keloid: psychoneuroimmune-endocrine aspects.	2	13	2.4	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:25716926	(2015) Regulation of soluble fms-like tyrosine kinase-1 production in response to placental ischemiahypoxia: role of angiotensin II.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25717174	(2015) Atherosclerosis.	3	41	2.08	0.0461	9606.ENSP00000006053,9606.ENSP00000334329,9606.ENSP00000362524	CX3CL1,UNC5B,ANGPTL2
PMID:25717429	(2015) Expression Patterns of VEGF and Flk-1 in Human Endometrium during the Menstrual Cycle.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25736847	(2015) Implementation of the sFlt-1PlGF ratio for prediction and diagnosis of pre-eclampsia in singleton pregnancy: implications for clinical practice.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25738355	(2015) Adrenergic regulation of monocyte chemotactic protein 1 leads to enhanced macrophage recruitment and ovarian carcinoma growth.	2	12	2.43	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:25741463	(2015) Expression of vascular endothelial growth factor in oral squamous cell carcinoma.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25748241	(2015) Successful combination of sunitinib and girentuximab in two renal cell carcinoma animal models: a rationale for combination treatment of patients with advanced RCC.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25748802	(2015) Ephrin-B2 mediates trophoblast-dependent maternal spiral artery remodeling in first trimester.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25750626	(2015) Systems pharmacology approaches for optimization of antiangiogenic therapies: challenges and opportunities.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25750742	(2015) Recent advances in the diagnosis and management of pre-eclampsia.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25752543	(2015) Structural basis for VEGF-C binding to neuropilin-2 and sequestration by a soluble splice form.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25753566	(2015) Angiogenic biomarkers in pregnancy: defining maternal and fetal health.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25753846	(2015) Formerly eclamptic women have lower nonpregnant blood pressure compared with formerly pre-eclamptic women: a retrospective cohort study.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25755096	(2015) The antifungal plant defensin AhPDF1.1b is a beneficial factor involved in adaptive response to zinc overload when it is expressed in yeast cells.	2	8	2.61	0.0461	9606.ENSP00000220166,9606.ENSP00000231061	CTSH,SPARC
PMID:25759146	(2015) Circulating angiogenic factors associated with response and survival in patients with acute graft-versus-host disease: results from Blood and Marrow Transplant Clinical Trials Network 0302 and 0802.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25767277	(2015) FKBPL is a critical antiangiogenic regulator of developmental and pathological angiogenesis.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25767397	(2015) Comparison between three oxaliplatin-based regimens with bevacizumab in patients with metastatic colorectal cancer.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25767405	(2015) Risk factors and effective management of preeclampsia.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25769545	(2015) Key endothelial cell angiogenic mechanisms are stimulated by the circulating milieu in sickle cell disease and attenuated by hydroxyurea.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25772179	(2015) VEGF-VEGFR System as a Target for Suppressing Inflammation and other Diseases.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25780392	(2015) Role of the angiopoietinTie system in pregnancy (Review).	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25783445	(2015) Levels of angiogenesis-related vascular endothelial growth factor family in neovascular glaucoma eyes.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25788991	(2015) Depression in cancer patients: Pathogenesis, implications and treatment (Review).	2	14	2.37	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:25789063	(2015) Insufficient radiofrequency ablation promotes human hepatoma SMMC7721 cell proliferation by stimulating vascular endothelial growth factor overexpression.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25799546	(2015) Placental expression of miR-517ab and miR-517c contributes to trophoblast dysfunction and preeclampsia.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25800869	(2015) Fluid shear stress promotes proprotein convertase-dependent activation of MT1-MMP.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25804872	(2015) Targeting of metastasis-promoting tumor-associated fibroblasts and modulation of pancreatic tumor-associated stroma with a carboxymethylcellulose-docetaxel nanoparticle.	2	4	2.91	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:25813196	(2015) Poststroke angiogenesis, pro: making the desert bloom.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25816765	(2015) Insulin use and risk of diabetic macular edema in diabetes mellitus: a systemic review and meta-analysis of observational studies.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25817288	(2015) Chronic exposure of VEGF inhibitors promotes the malignant phenotype of colorectal cancer cells.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25830984	(2015) Skin changes after bariatric surgery.	2	8	2.61	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:25833353	(2015) Stromal cell-derived factor-1 (SDF1)-dependent recruitment of bone marrow-derived renal endothelium-like cells in a mouse model of acute kidney injury.	2	7	2.67	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:25844177	(2015) Functionalized scaffolds to enhance tissue regeneration.	2	9	2.56	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:25853509	(2015) Therapeutic effects of topical netrin-4 inhibits corneal neovascularization in alkali-burn rats.	2	13	2.4	0.0461	9606.ENSP00000334329,9606.ENSP00000478570	UNC5B,VEGFA
PMID:25860260	(2015) Full-length human placental sFlt-1-e15a isoform induces distinct maternal phenotypes of preeclampsia in mice.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25861724	(2015) Biomaterial strategies for engineering implants for enhanced osseointegration and bone repair.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25867824	(2015) HeparinHeparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use.	3	65	1.88	0.0461	9606.ENSP00000363827,9606.ENSP00000451040,9606.ENSP00000478570	HSPG2,PGF,VEGFA
PMID:25869733	(2015) Utilizing cardiac biomarkers to detect and prevent chemotherapy-induced cardiomyopathy.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25874221	(2015) Recent advances in molecular magnetic resonance imaging of liver fibrosis.	2	9	2.56	0.0461	9606.ENSP00000231061,9606.ENSP00000363827	SPARC,HSPG2
PMID:25877699	(2015) Secreted protein acidic and rich in cysteine facilitates age-related cardiac inflammation and macrophage M1 polarization.	2	5	2.81	0.0461	9606.ENSP00000006053,9606.ENSP00000231061	CX3CL1,SPARC
PMID:25880726	(2015) Cell type- and tumor zone-specific expression of pVEGFR-1 and its ligands influence colon cancer metastasis.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25881012	(2015) A novel engineered VEGF blocker with an excellent pharmacokinetic profile and robust anti-tumor activity.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25882666	(2015) Human bone marrow stromal cell confluence: effects on cell characteristics and methods of assessment.	3	96	1.71	0.0461	9606.ENSP00000362524,9606.ENSP00000451040,9606.ENSP00000478570	ANGPTL2,PGF,VEGFA
PMID:25883982	(2015) Activating transcription factor 4 promotes angiogenesis of breast cancer through enhanced macrophage recruitment.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25886819	(2015) Albumin infusion for the critically ill--is it beneficial and, if so, why and how?	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25888914	(2015) Analgesia for neuropathic pain by dorsal root ganglion transplantation of genetically engineered mesenchymal stem cells: initial results.	2	14	2.37	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:25889119	(2015) Induction of tumor inhibitory anti-angiogenic response through immunization with interferon Gamma primed placental endothelial cells: ValloVax(TM).	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25890381	(2015) Albumin nanoparticles increase the anticancer efficacy of albendazole in ovarian cancer xenograft model.	2	5	2.81	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:25897612	(2015) Camel Heavy Chain Polyclonal Antibody Raised Against Recombinant Murine Placental Growth Factor Expressed in Escherichia coli.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25906026	(2015) First-Trimester Maternal Serum Levels of sFLT1, PGF and ADMA Predict Preeclampsia.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25910950	(2015) A Multicenter, Phase II, Randomized, Noncomparative Clinical Trial of Radiation and Temozolomide with or without Vandetanib in Newly Diagnosed Glioblastoma Patients.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25913709	(2015) Phthalate metabolites and bisphenol-A in association with circulating angiogenic biomarkers across pregnancy.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25918593	(2015) mRNA expression of VEGF and its receptors in fallopian tubes of women with ectopic pregnancies.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25919965	(2015) Nitric oxide mediates bleomycin-induced angiogenesis and pulmonary fibrosis via regulation of VEGF.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25920081	(2015) Evolution in the understanding of the pathophysiological basis of portal hypertension: How changes in paradigm are leading to successful new treatments.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25925044	(2015) [Role of VEGF in diseases of the retina].	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25925045	(2015) [Aflibercept. An approach to pharmacology].	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25925049	(2015) [Management of aflibercept in routine clinical practice].	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25926773	(2015) Detrimental role of prolonged sleep deprivation on adult neurogenesis.	2	12	2.43	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:25928356	(2015) Angiogenesis is induced and wound size is reduced by electrical stimulation in an acute wound healing model in human skin.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25932384	(2015) Sulfonylureas: Assets in the past, present and future.	2	6	2.74	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:25941990	(2015) Nanomedicine approaches for corneal diseases.	2	14	2.37	0.0461	9606.ENSP00000362524,9606.ENSP00000478570	ANGPTL2,VEGFA
PMID:25947099	(2015) The role of anti-angiogenesis in non-small-cell lung cancer: an update.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25949086	(2015) Idiopathic Peripapillary Subretinal Neovascular Membrane in a Young Woman with Recurrence of the Lesion during Pregnancy after Treatment with Intravitreal Bevacizumab.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25953926	(2015) Molecular controls of arterial morphogenesis.	3	56	1.94	0.0461	9606.ENSP00000334329,9606.ENSP00000451040,9606.ENSP00000478570	UNC5B,PGF,VEGFA
PMID:25954957	(2015) Increased expression of neuropilin 1 in melanoma progression and its prognostic significance in patients with melanoma.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25960634	(2015) Profile of conbercept in the treatment of neovascular age-related macular degeneration.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25960682	(2015) Anti-VEGF treatment patterns and associated health care costs in Switzerland: findings using real-world claims data.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25968146	(2015) Porcine placental immunoexpression of vascular endothelial growth factor, placenta growth factor, Flt-1 and Flk-1.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25975823	(2015) Systematic review and mixed treatment comparison of intravitreal aflibercept with other therapies for diabetic macular edema (DME).	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25980779	(2015) Angiogenesis in glaucoma filtration surgery and neovascular glaucoma: A review.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25982781	(2015) Is the imbalance between pro-angiogenic and anti-angiogenic factors associated with preeclampsia?	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25989873	(2015) Aflibercept versus ranibizumab for treating persistent diabetic macular oedema.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25997993	(2015) Angiogenic Factors in Cord Blood of Preterm Infants Predicts Subsequently Developing Bronchopulmonary Dysplasia.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26006236	(2015) Vasa vasorum in atherosclerosis and clinical significance.	3	40	2.09	0.0461	9606.ENSP00000363827,9606.ENSP00000451040,9606.ENSP00000478570	HSPG2,PGF,VEGFA
PMID:26008604	(2015) A phase I study of cediranib in combination with cilengitide in patients with recurrent glioblastoma.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26018511	(2015) Galectins: Double-edged Swords in the Cross-roads of Pregnancy Complications and Female Reproductive Tract Inflammation and Neoplasia.	3	47	2.02	0.0461	9606.ENSP00000276571,9606.ENSP00000451040,9606.ENSP00000478570	CRH,PGF,VEGFA
PMID:26024110	(2015) Systemic counterregulatory response of placental growth factor levels to intravitreal aflibercept therapy.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26033246	(2015) Phosphorylation of Ser-279282 and Tyr-265 positions on Cx43 as possible mediators of VEGF-165 inhibition of pregnancy-adapted Ca2+ burst function in ovine uterine artery endothelial cells.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26033606	(2015) Effect of Monocyte-Like THP-1 Cells on the Formation of Vascular Tubes by EA.Hy926s Endothelial Cells in the Presence of Cytokines.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26034985	(2015) The efficacy of combining antiangiogenic agents with chemotherapy for patients with advanced non-small cell lung cancer who failed first-line chemotherapy: a systematic review and meta-analysis.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26042465	(2015) Circulating Levels of sFlt1 Splice Variants as Predictive Markers for the Development of Preeclampsia.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26051097	(2015) Noninvasive detection of trophoblast protein signatures linked to early pregnancy loss using trophoblast retrieval and isolation from the cervix (TRIC).	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26062129	(2015) From Pre-Clinical Studies to Clinical Trials: Generation of Novel Therapies for Pregnancy Complications.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26065004	(2015) Serum Angiogenesis Markers and Their Correlation with Ultrasound-Detected Synovitis in Juvenile Idiopathic Arthritis.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26082773	(2015) First Trimester Pregnancy Loss and the Expression of Alternatively Spliced NKp30 Isoforms in Maternal Blood and Placental Tissue.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26084958	(2015) Assessment of Macular Peripapillary Nerve Fiber Layer and Choroidal Thickness Changes in Pregnant Women with Gestational Diabetes Mellitus, Healthy Pregnant Women, and Healthy Non-Pregnant Women.	2	7	2.67	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:26090874	(2015) Inhibition of pathological brain angiogenesis through systemic delivery of AAV vector expressing soluble FLT1.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26098965	(2015) Immunomodulatory role of vitamin D in the pathogenesis of preeclampsia.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26109847	(2015) Efficiency and safety of subconjunctival injection of anti-VEGF agent - bevacizumab - in treating dry eye.	2	14	2.37	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:26114826	(2015) Inhibitory Effect of Topical Aflibercept on Corneal Neovascularization in Rabbits.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26121675	(2015) Maternal Serum Meteorin Levels and the Risk of Preeclampsia.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26121939	(2015) BH3-mimetic small molecule inhibits the growth and recurrence of adenoid cystic carcinoma.	2	13	2.4	0.0461	9606.ENSP00000220166,9606.ENSP00000478570	CTSH,VEGFA
PMID:26125443	(2015) Vascular endothelial growth factor D  expression is a potential biomarker of  bevacizumab benefit in colorectal cancer.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26137497	(2015) Diabetic Retinopathy: Vascular and Inflammatory Disease.	3	43	2.06	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:26143364	(2015) Differential expression of vascular endothelial growth factor angiogenic factors in different endometrial compartments in women who have an elevated progesterone level before oocyte retrieval, during in vitro fertilization-embryo transfer ...	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26151457	(2015) A phase II and pharmacodynamic study of sunitinib in relapsedrefractory oesophageal and gastro-oesophageal cancers.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26155941	(2015) A first-in-human study of AMG 208, an oral MET inhibitor, in adult patients with advanced solid tumors.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26160630	(2015) Intracoronary Cytoprotective Gene Therapy: A Study of VEGF-B167 in a Pre-Clinical Animal Model of Dilated Cardiomyopathy.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26167115	(2015) Basal and apical regulation of VEGF-A and placenta growth factor in the RPEchoroid and primary RPE.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26171937	(2015) Impact of p16 status on pro- and anti-angiogenesis factors in head and neck cancers.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26177586	(2015) Role of vascular endothelial growth factor and placental growth factor expression on placenta structure in pre-eclamptic pregnancy.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26204137	(2015) Placental Angiogenic Factors Are Associated With Maternal Thyroid Function and Modify hCG-Mediated FT4 Stimulation.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26214510	(2015) Maternal Smoking History Enhances the Expression of Placental Growth Factor in Invasive Trophoblasts at Early Gestation Despite Cessation of Smoking.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26220066	(2015) Longitudinal Changes in Multiple Biomarkers Are Associated with Cardiotoxicity in Breast Cancer Patients Treated with Doxorubicin, Taxanes, and Trastuzumab.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26221124	(2015) The imbalance in expression of angiogenic and anti-angiogenic factors as candidate predictive biomarker in preeclampsia.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26223306	(2015) Decreased VEGF-A and sustained PEDF expression in a human retinal pigment epithelium cell line cultured under hypothermia.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26224565	(2015) Aflibercept a new target therapy in cancer treatment: a review.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26229424	(2015) Clinical experience with fixed bimonthly aflibercept dosing in treatment-experienced patients with neovascular age-related macular degeneration.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26235435	(2015) Nilotinib and bosutinib modulate pre-plaque alterations of blood immune markers and neuro-inflammation in Alzheimers disease models.	2	13	2.4	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:26240506	(2015) Aflibercept Treatment for Neovascular Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy Refractory to Anti-vascular Endothelial Growth Factor.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26245195	(2015) Biomarkers of pulmonary hypertension in patients with scleroderma: a case-control study.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26246786	(2015) Heading off depressive illness evolution and progression to treatment resistance.	2	3	3.04	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:26247020	(2015) Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells.	3	88	1.74	0.0461	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:26247969	(2015) Folate Deficiency Could Restrain Decidual Angiogenesis in Pregnant Mice.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26250494	(2015) New potential diagnostic biomarkers for pulmonary hypertension.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26251608	(2015) Critical evaluation of ramucirumab in the treatment of advanced gastric and gastroesophageal cancers.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26252298	(2015) Efficacy of Addition of Antiangiogenic Agents to Taxanes-Containing Chemotherapy in Advanced Nonsmall-Cell Lung Cancer: A Meta-Analysis and Systemic Review.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26262580	(2015) The vulnerable right ventricle.	2	8	2.61	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:26273192	(2015) The role of taxanes in triple-negative breast cancer: literature review.	2	11	2.47	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:26273198	(2015) The role of aflibercept in the management of diabetic macular edema.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26278057	(2015) Hypoplastic left heart syndrome is associated with structural and vascular placental abnormalities and leptin dysregulation.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26279749	(2015) Transplantation of bradykinin-preconditioned human endothelial progenitor cells improves cardiac function via enhanced AkteNOS phosphorylation and angiogenesis.	2	4	2.91	0.0461	9606.ENSP00000450482,9606.ENSP00000478570	BDKRB2,VEGFA
PMID:26285753	(2015) Vasculogenesis and Angiogenesis in VEGF Receptor-1 Deficient Mice.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26287164	(2015) Angiogenesis-Related Biomarkers (sFlt-1PLGF) in the Prediction and Diagnosis of Placental Dysfunction: An Approach for Clinical Integration.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26289356	(2015) Comparison of Eylea(R) with Lucentis(R) as first-line therapy in patients with treatment-naive neovascular age-related macular degeneration in real-life clinical practice: retrospective case-series analysis.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26315997	(2015) The impact of chronic blackberry intake on the neuroinflammatory status of rats fed a standard or high-fat diet.	2	7	2.67	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:26316721	(2015) Detection and correlation analysis of serum cytokines in non-small-cell lung cancer patients with bone and non-bone metastases.	2	13	2.4	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:26318034	(2015) Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial-to-mesenchymal transition in colon and breast cancers.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26325365	(2015) Anticancer activity of TTAC-0001, a fully human anti-vascular endothelial growth factor receptor 2 (VEGFR-2KDR) monoclonal antibody, is associated with inhibition of tumor angiogenesis.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26328006	(2015) Transplantation of bradykinin-preconditioned human endothelial progenitor cells improves cardiac function via enhanced AkteNOS phosphorylation and angiogenesis.	2	4	2.91	0.0461	9606.ENSP00000450482,9606.ENSP00000478570	BDKRB2,VEGFA
PMID:26335014	(2015) SPARC: A Potential Prognostic and Therapeutic Target in Pancreatic Cancer.	2	12	2.43	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:26337760	(2015) Functional Anatomy of the Outflow Facilities.	2	9	2.56	0.0461	9606.ENSP00000231061,9606.ENSP00000363827	SPARC,HSPG2
PMID:26350463	(2015) Corticotropin Releasing Hormone and Urocortin 3 Stimulate Vascular Endothelial Growth Factor Expression through the cAMPCREB Pathway.	2	5	2.81	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:26360379	(2015) A p38 mitogen-activated protein kinase inhibitor attenuates cardiotonic steroids-induced apoptotic and stress signaling in a Sw-71 cytotrophoblast cell line.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26365781	(2015) Enzymatically-responsive pro-angiogenic peptide-releasing poly(ethylene glycol) hydrogels promote vascularization in vivo.	2	4	2.91	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:26368550	(2015) Prognostic Impact of Placental Growth Factor on Mortality and Cardiovascular Events in Dialysis Patients.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26368672	(2015) Placental Growth Factor as a Novel Marker in Uremia-Related Cardiovascular Disease.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26369798	(2015) Clinical efficacy and mechanistic evaluation of aflibercept for proliferative diabetic retinopathy (acronym CLARITY): a multicentre phase IIb randomised active-controlled clinical trial.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26370787	(2015) Effect of ganglioside GT1b on the in vitro maturation of porcine oocytes and embryonic development.	2	11	2.47	0.0461	9606.ENSP00000450482,9606.ENSP00000478570	BDKRB2,VEGFA
PMID:26377659	(2015) Neuropilin-1 (NRP-1) and Magnetic Nanoparticles, a Potential Combination for Diagnosis and Therapy of Gliomas.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26382974	(2015) Klotho-related Molecules Upregulated by Smoking Habit in Apparently Healthy Men: A Cross-sectional Study.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26383984	(2015) [Current Status and Development of Traditional Chemotherapy in Non-small Cell Lung Cancer under the Background of Targeted Therapy].	2	13	2.4	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:26388563	(2015) Proliferative and Migration Activity of JEG-3 Trophoblast Cell Line in the Presence of Cytokines.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26392699	(2015) The periosteum eversion technique for coverage of denuded root surface.	2	7	2.67	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:26395178	(2015) Overexpression of MMP13 in human osteoarthritic cartilage is associated with the SMAD-independent TGF-beta signalling pathway.	2	12	2.43	0.0461	9606.ENSP00000231061,9606.ENSP00000363827	SPARC,HSPG2
PMID:26402225	(2015) Placental growth factor promotes metastases of ovarian cancer through MiR-543-regulated MMP7.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26404486	(2015) Distinct First Trimester Cytokine Profiles for Gestational Hypertension and Preeclampsia.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26409032	(2015) The extracellular matrix modulates H2O2 degradation and redox signaling in endothelial cells.	2	11	2.47	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:26413377	(2015) Ramucirumab: A New Therapy for Advanced Gastric Cancer.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26416897	(2015) Variations in genes regulating tumor-associated macrophages (TAMs) to predict outcomes of bevacizumab-based treatment in patients with metastatic colorectal cancer: results from TRIBE and FIRE3 trials.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26417453	(2015) Anti-VEGF Therapy and the Retina: An Update.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26425104	(2015) The clinical utility of aflibercept for diabetic macular edema.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26428491	(2015) Role of the fetoplacental endothelium in fetal growth restriction with abnormal umbilical artery Doppler velocimetry.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26434493	(2015) Difference of concentration of placental soluble fms-like tyrosine kinase-1(sFlt-1), placental growth factor (PlGF), and sFlt-1PlGF ratio in severe preeclampsia and normal pregnancy.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26442858	(2015) Treatment of Exudative Age-related Macular Degeneration: Focus on Aflibercept.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26445522	(2015) A single-arm, investigator-initiated study of the efficacy, safety, and tolerability of intravitreal aflibercept injection in subjects with exudative age-related macular degeneration previously treated with ranibizumab or bevacizumab (ASSESS ...	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26451078	(2015) The Role of Cytokines, Chemokines, and Growth Factors in the Pathogenesis of Pityriasis Rosea.	2	13	2.4	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:26453156	(2015) Adenosine-associated delivery systems.	2	10	2.51	0.0461	9606.ENSP00000304767,9606.ENSP00000478570	P2RY1,VEGFA
PMID:26453501	(2015) Skeletal muscle as an endocrine organ: PGC-1alpha, myokines and exercise.	3	50	1.99	0.0461	9606.ENSP00000006053,9606.ENSP00000231061,9606.ENSP00000478570	CX3CL1,SPARC,VEGFA
PMID:26457038	(2015) Sterile Inflammation after Intravitreal Injection of Aflibercept in a Korean Population.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26473356	(2015) Propionyl-L-Carnitine Enhances Wound Healing and Counteracts Microvascular Endothelial Cell Dysfunction.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26473833	(2015) Cardiovascular Complications of Pregnancy.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26490656	(2015) Fluorouracil, leucovorin and irinotecan associated with aflibercept can induce microscopic colitis in metastatic colorectal cancer patients.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26500886	(2015) Beyond Bevacizumab: An Outlook to New Anti-Angiogenics for the Treatment of Ovarian Cancer.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26503597	(2015) Three-Dimensional Blood-Brain Barrier Model for in vitro Studies of Neurovascular Pathology.	2	10	2.51	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:26504774	(2015) In Vitro Evaluation of Scaffolds for the Delivery of Mesenchymal Stem Cells to Wounds.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26510725	(2015) Double blind, randomised, placebo-controlled trial to evaluate the efficacy of esomeprazole to treat early onset pre-eclampsia (PIE Trial): a study protocol.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26511451	(2015) Increased CSF biomarkers of angiogenesis in Parkinson disease.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26516907	(2015) Real Time Monitoring of Inhibition of Adipogenesis and Angiogenesis by (-)-Epigallocatechin-3-Gallate in 3T3-L1 Adipocytes and Human Umbilical Vein Endothelial Cells.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26523562	(2015) Phenotypic and molecular characterization of intrauterine fetal growth restriction in interspecies sheep pregnancy.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26550186	(2015) Prognostic significance of placenta growth factor expression in patients with multiple cancers: a meta-analysis.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26559273	(2015) Identification of Poor-outcome Biliopancreatic Carcinoma Patients With Two-marker Signature Based on ATF6alpha and p-p38 STARD Compliant.	2	8	2.61	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:26576922	(2015) Systemic and coronary levels of CRP, MPO, sCD40L and PlGF in patients with coronary artery disease.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26578958	(2015) Molecular features of interaction between VEGFA and anti-angiogenic drugs used in retinal diseases: a computational approach.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26585689	(2015) Mesenchymal Stem Cells Induce Directional Migration of Invasive Breast Cancer Cells through TGF-beta.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26587316	(2015) Carving out its niche: A role for carbonic anhydrase IX in pre-metastatic niche development.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26588850	(2015) Preeclampsia and Retinopathy of Prematurity in Very-Low-Birth-Weight Infants: A Population-Based Study.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26591583	(2015) [t-lymphocytes and tissue growth factors].	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26601163	(2015) PlGF-induced VEGFR1-dependent vascular remodeling determines opposing antitumor effects and drug resistance to Dll4-Notch inhibitors.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26602442	(2015) Long range Trp-Trp interaction initiates the folding pathway of a pro-angiogenic beta-hairpin peptide.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26609252	(2015) VEGF involvement in psoriasis.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26610602	(2015) Pressuromodulation at the cell membrane as the basis for small molecule hormone and peptide regulation of cellular and nuclear function.	3	68	1.86	0.0461	9606.ENSP00000276571,9606.ENSP00000451040,9606.ENSP00000478570	CRH,PGF,VEGFA
PMID:26610918	(2015) Building from the Ground up: Basement Membranes in Drosophila Development.	2	14	2.37	0.0461	9606.ENSP00000231061,9606.ENSP00000363827	SPARC,HSPG2
PMID:26637913	(2015) Biomarker Analysis in a Phase II Study of Sunitinib in Patients with Advanced Melanoma.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26644877	(2015) Histological changes of kidney in diabetic nephropathy.	2	7	2.67	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:26648737	(2015) Cetuximab could be more effective without prior bevacizumab treatment in metastatic colorectal cancer patients.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26656750	(2015) Tracheal Aspirate Levels of the Matricellular Protein SPARC Predict Development of Bronchopulmonary Dysplasia.	2	12	2.43	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:26657013	(2015) The effects of high-fat feeding on physical function and skeletal muscle extracellular matrix.	2	11	2.47	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:26664137	(2015) Ultrasound-guided RNA interference targeting HIF-1 alpha improves the effects of transarterial chemoembolization in rat liver tumors.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26664823	(2015) Potential of Neural Stem Cell-Based Therapy for Parkinsons Disease.	2	14	2.37	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:26667262	(2015) Combination of Aflibercept and Bromfenac Therapy in Age-Related Macular Degeneration: A Pilot Study Aflibercept and Bromfenac in AMD.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26668569	(2015) Sustained Improvement in a Metastatic Colon Cancer Patient with FOLFIRI-Aflibercept after FOLFOX Failure.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26669334	(2015) Intravitreal aflibercept treatment in eyes with exudative age-related macular degeneration following prior treatment with intravitreal ranibizumab.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26674395	(2015) Effects of intravitreal injection of netrin-1 in retinal neovascularization of streptozotocin-induced diabetic rats.	2	6	2.74	0.0461	9606.ENSP00000334329,9606.ENSP00000478570	UNC5B,VEGFA
PMID:26676894	(2015) Exercise in Regulation of Inflammation-Immune Axis Function in Cancer Initiation and Progression.	3	44	2.05	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:26701102	(2015) Joint Effect of Urinary Total Arsenic Level and VEGF-A Genetic Polymorphisms on the Recurrence of Renal Cell Carcinoma.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26710495	(2015) VEGF Expression in Pancreatic Cancer and Other Malignancies: A Review of the Literature.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26720459	(2015) Bevacizumab and Aflibercept Activate Platelets via FcgammaRIIa.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26730316	(2015) Intravitreal Topotecan Inhibits Laser-induced Choroidal Neovascularization in a Rat Model.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26792996	(2015) Bioengineering Models for Breast Cancer Research.	2	5	2.81	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:26813805	(2015) Genitourinary mast cells and survival.	2	12	2.43	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:26816842	(2015) Prostate cancer metastasis: roles of recruitment and reprogramming, cell signal network and three-dimensional growth characteristics.	3	67	1.86	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:26834566	(2015) Depression as a Glial-Based Synaptic Dysfunction.	2	12	2.43	0.0461	9606.ENSP00000006053,9606.ENSP00000304767	CX3CL1,P2RY1
PMID:26839731	(2015) Angiogenesis in Inflammatory Bowel Disease.	3	67	1.86	0.0461	9606.ENSP00000276571,9606.ENSP00000451040,9606.ENSP00000478570	CRH,PGF,VEGFA
PMID:26843840	(2015) VEGF-C expression is not a prognostic factor in locally advanced colon adenocarcinoma.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26858849	(2015) Etiology of Ascites and Pleural Effusion Associated with Ovarian Tumors: Literature Review and Case Reports of Three Ovarian Tumors Presenting with Massive Ascites, but without Peritoneal Dissemination.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26925462	(2015) Controlled Angiogenesis in Peptide Nanofiber Composite Hydrogels.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27013452	(2015) Predictive value of circulating osteonectin in patients with ischemic symptomatic chronic heart failure.	2	7	2.67	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:28197244	(2015) Elusive Cardiac Angiosarcoma in a Young Pregnant Female: Rare Presentation With Fatal Outcome.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29018684	(2015) Rescue effects of intravitreal aflibercept in the treatment of neovascular age-related macular degeneration.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23749761	(2014) Effects of pravastatin on angiogenic and placental hypoxic imbalance in a mouse model of preeclampsia.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23820768	(2014) Biomaterials for tissue engineering.	2	8	2.61	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:23850058	(2014) In vivo electroporation of constitutively expressed HIF-1alpha plasmid DNA improves neovascularization in a mouse model of limb ischemia.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23979025	(2014) Perlecan domain V inhibits amyloid-beta induced brain endothelial cell toxicity and restores angiogenic function.	2	6	2.74	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:24042263	(2014) Osteocytes: master orchestrators of bone.	3	40	2.09	0.0461	9606.ENSP00000006053,9606.ENSP00000363827,9606.ENSP00000478570	CX3CL1,HSPG2,VEGFA
PMID:24048373	(2014) Suppressed soluble Fms-like tyrosine kinase-1 production aggravates atherosclerosis in chronic kidney disease.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24127643	(2014) Vascular endothelial growth factor receptor 1 expression in nasal polyp tissue.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24145997	(2014) A gene signature combining the tissue expression of three angiogenic factors is a prognostic marker in early-stage non-small cell lung cancer.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24154866	(2014) Heme oxygenase 1-mediated neurogenesis is enhanced by Ginkgo biloba (EGb 761(R)) after permanent ischemic stroke in mice.	2	11	2.47	0.0461	9606.ENSP00000334329,9606.ENSP00000478570	UNC5B,VEGFA
PMID:24159191	(2014) Maternal and foetal angiogenic imbalance in congenital heart defects.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24166749	(2014) Angiogenic factors in diagnosis, management, and research in preeclampsia.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24166754	(2014) Of risks and ratios: the usefulness of angiogenic balance for diagnosing preeclampsia at different gestational ages.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24182349	(2014) Circulating hematopoietic progenitor cells are decreased in COPD.	2	10	2.51	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:24189030	(2014) Picea mariana polyphenolic extract inhibits phlogogenic mediators produced by TNF-alpha-activated psoriatic keratinocytes: Impact on NF-kappaB pathway.	2	8	2.61	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:24206054	(2014) Heme oxygenase-1 is required for angiogenic function of bone marrow-derived progenitor cells: role in therapeutic revascularization.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24247824	(2014) Renal function in normal and disordered pregnancy.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24280453	(2014) Anti-angiogenic effect of the basement membrane protein nidogen-1 in a mouse model of choroidal neovascularization.	2	5	2.81	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:24292447	(2014) A phase II multicentre study of ziv-aflibercept in combination with cisplatin and pemetrexed in patients with previously untreated advancedmetastatic non-squamous non-small cell lung cancer.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24293397	(2014) Protective effects of placental growth factor on retinal neuronal cell damage.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24295154	(2014) Expression levels of seven candidate genes in human peripheral blood mononuclear cells and their association with preeclampsia.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24320751	(2014) Hyperbaric oxygen treatment of tissue-engineered mucosa enhances secretion of angiogenic factors in vitro.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24327581	(2014) Association of matrix metalloproteinase 2 plasma level with response and survival in patients treated with bevacizumab for recurrent high-grade glioma.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24353175	(2014) Adipose-derived mesenchymal stromal cells from aged patients with coronary artery disease keep mesenchymal stromal cell properties but exhibit characteristics of aging and have impaired angiogenic potential.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24365125	(2014) A phase I, open-label study of trebananib combined with sorafenib or sunitinib in patients with advanced renal cell carcinoma.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24365177	(2014) Polymorphisms in vascular endothelial growth factor receptor 2 are associated with better response rates to ranibizumab treatment in age-related macular degeneration.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24384238	(2014) Standards of care and novel approaches in the management of glioblastoma multiforme.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24388382	(2014) A microfluidic 3D in vitro model for specificity of breast cancer metastasis to bone.	2	12	2.43	0.0461	9606.ENSP00000006053,9606.ENSP00000231061	CX3CL1,SPARC
PMID:24389217	(2014) Endothelial dysfunction in the pathogenesis of pre-eclampsia.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24396477	(2014) Detection of circulating vascular endothelial growth factor and matrix metalloproteinase-9 in non-small cell lung cancer using Luminex multiplex technology.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24400024	(2014) A brief overview of preeclampsia.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24410720	(2014) Placenta growth factor and vascular endothelial growth factor a have differential, cell-type specific patterns of expression in vascular cells.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24412496	(2014) Design, structural and biological characterization of a VEGF inhibitor beta-hairpin-constrained peptide.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24419756	(2014) Bevacizumab efficacy in metastatic colorectal cancer is dependent on primary tumor resection.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24419917	(2014) Targeting VEGFR1 on endothelial progenitors modulates their differentiation potential.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24423299	(2014) Vascular pool of releasable soluble VEGF receptor-1 (sFLT1) in women with previous preeclampsia and uncomplicated pregnancy.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24427170	(2014) The anti-miR21 antagomir, a therapeutic tool for colorectal cancer, has a potential synergistic effect by perturbing an angiogenesis-associated miR30.	2	14	2.37	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:24444293	(2014) Screening models using multiple markers for early detection of late-onset preeclampsia in low-risk pregnancy.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24445500	(2014) Aflibercept--a decoy VEGF receptor.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24450440	(2014) Low-dose angiostatic tyrosine kinase inhibitors improve photodynamic therapy for cancer: lack of vascular normalization.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24452359	(2014) Insidious changes in stromal matrix fuel cancer progression.	3	57	1.93	0.0461	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:24455486	(2014) Serglycin: at the crossroad of inflammation and malignancy.	3	113	1.64	0.0461	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:24464955	(2014) Serum hyperglycosylated human chorionic gonadotrophin at 14-17 weeks of gestation does not predict preeclampsia.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24465515	(2014) Low-molecular weight heparin increases circulating sFlt-1 levels and enhances urinary elimination.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24468583	(2014) Enhanced trophic factor secretion by mesenchymal stemstromal cells with Glycine-Histidine-Lysine (GHK)-modified alginate hydrogels.	2	8	2.61	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:24475139	(2014) ITE and TCDD differentially regulate the vascular remodeling of rat placenta via the activation of AhR.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24477469	(2014) Expression patterning reveals retinal inflammation as a minor factor in experimental retinopathy of ZDF rats.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24483136	(2014) Pharmacokinetics, pharmacodynamics and pre-clinical characteristics of ophthalmic drugs that bind VEGF.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24484717	(2014) Metabolic syndrome and colorectal cancer: is hyperinsulinemiainsulin receptor-mediated angiogenesis a critical process?	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24485669	(2014) Biomarkers of endothelial dysfunction in preeclampsia and neonatal morbidity: a case-control study.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24487364	(2014) Soluble fms-like tyrosine kinase-1 and atherosclerosis in chronic kidney disease.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24487722	(2014) D-K6L 9 peptide combination with IL-12 inhibits the recurrence of tumors in mice.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24489717	(2014) A1Malpha1-microglobulin protects from heme-induced placental and renal damage in a pregnant sheep model of preeclampsia.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24493202	(2014) Fetuin-A influences vascular cell growth and production of proinflammatory and angiogenic proteins by human perivascular fat cells.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24498100	(2014) Trkb signaling in pericytes is required for cardiac microvessel stabilization.	2	14	2.37	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:24503248	(2014) Therapeutic potential of statins and the induction of heme oxygenase-1 in preeclampsia.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24504136	(2014) Epigenetic control of hypoxia inducible factor-1alpha-dependent expression of placental growth factor in hypoxic conditions.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24509440	(2014) The role of vascular-derived perlecan in modulating cell adhesion, proliferation and growth factor signaling.	2	14	2.37	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:24510852	(2014) Vascular normalization in cerebral angiogenesis: friend or foe?	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24510881	(2014) Assays to examine endothelial cell migration, tube formation, and gene expression profiles.	2	6	2.74	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:24511540	(2014) Serum levels of three angiogenic factors in systemic lupus erythematosus and their clinical significance.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24524446	(2014) Pathogenesis and prevention of intraventricular hemorrhage.	2	14	2.37	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:24525729	(2014) PlGF-MMP9-engineered iPS cells supported on a PEG-fibrinogen hydrogel scaffold possess an enhanced capacity to repair damaged myocardium.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24526122	(2014) CRH-R splicing in estrogen-sensitive breast cancer.	2	13	2.4	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:24550368	(2014) Vascular endothelial growth factor modulates the function of the retinal pigment epithelium in vivo.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24551591	(2014) Syndecans as modulators and potential pharmacological targets in cancer progression.	3	55	1.95	0.0461	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:24556040	(2014) Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: an open-label, randomised phase 3 trial.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24562175	(2014) The effects of infliximab or adalimumab on vascular endothelial growth factor and angiopoietin 1 angiogenic factor levels in inflammatory bowel disease: serial observations in 37 patients.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24572430	(2014) Antihypertensive drugs methyldopa, labetalol, hydralazine, and clonidine improve trophoblast interaction with endothelial cellular networks in vitro.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24583918	(2014) Increased serum level of soluble vascular endothelial growth factor receptor-1 is associated with poor coronary collateralization in patients with stable coronary artery disease.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24588321	(2014) Antioxidant and antiangiogenic activity of Astronium graveolens Jacq. leaves.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24592358	(2014) Role of the innate immunity in female reproductive tract.	3	53	1.97	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:24596498	(2014) Recombinant expression and purification of human placental growth factor 1 and specific camel heavy chain polyclonal antibody preparation.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24607753	(2014) First-trimester placental ultrasound and maternal serum markers as predictors of small-for-gestational-age infants.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24614949	(2014) Effect of aflibercept in insufficient responders to prior anti-VEGF therapy in neovascular AMD.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24618401	(2014) A prospective, randomised comparative study of weekly versus biweekly application of dehydrated human amnionchorion membrane allograft in the management of diabetic foot ulcers.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24631334	(2014) Capacity of aflibercept to counteract VEGF-stimulated abnormal behavior of retinal microvascular endothelial cells.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24633809	(2014) A Phase Ib study evaluating MNRP1685A, a fully human anti-NRP1 monoclonal antibody, in combination with bevacizumab and paclitaxel in patients with advanced solid tumors.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24633842	(2014) Direct role for smooth muscle cell mineralocorticoid receptors in vascular remodeling: novel mechanisms and clinical implications.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24643246	(2014) A small physiological electric field mediated responses of extravillous trophoblasts derived from HTR8SVneo cells: involvement of activation of focal adhesion kinase signaling.	2	13	2.4	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:24643426	(2014) Circulating angiogenic and inflammatory cytokine responses to acute aerobic exercise in trained and sedentary young men.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24647000	(2014) Endothelial Notch activity promotes angiogenesis and osteogenesis in bone.	3	66	1.87	0.0461	9606.ENSP00000334329,9606.ENSP00000451040,9606.ENSP00000478570	UNC5B,PGF,VEGFA
PMID:24664365	(2014) Persistent urinary podocyte loss following preeclampsia may reflect subclinical renal injury.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24669209	(2014) Redox Regulation and the Autistic Spectrum: Role of Tryptophan Catabolites, Immuno-inflammation, Autoimmunity and the Amygdala.	3	72	1.83	0.0461	9606.ENSP00000006053,9606.ENSP00000276571,9606.ENSP00000478570	CX3CL1,CRH,VEGFA
PMID:24670995	(2014) AAV-mediated expression of human PRELP inhibits complement activation, choroidal neovascularization and deposition of membrane attack complex in mice.	2	7	2.67	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:24672479	(2014) Transcriptomics of post-stroke angiogenesis in the aged brain.	3	102	1.68	0.0461	9606.ENSP00000231061,9606.ENSP00000362524,9606.ENSP00000478570	SPARC,ANGPTL2,VEGFA
PMID:24676680	(2014) SPARC expression is negatively correlated with clinicopathological factors of gastric cancer and inhibits malignancy of gastric cancer cells.	2	8	2.61	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:24679494	(2014) Pathophysiology of portal hypertension.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24688047	(2014) Differential antitumor activity of aflibercept and bevacizumab in patient-derived xenograft models of colorectal cancer.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24704473	(2014) Altered matrix metalloproteinase-2 and -9 expressionactivity links placental ischemia and anti-angiogenic sFlt-1 to uteroplacental and vascular remodeling and collagen deposition in hypertensive pregnancy.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24708917	(2014) Effect of selenium on markers of risk of pre-eclampsia in UK pregnant women: a randomised, controlled pilot trial.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24709687	(2014) Osteocyte apoptosis is required for production of osteoclastogenic signals following bone fatigue in vivo.	2	13	2.4	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:24711703	(2014) Retreatment with bevacizumab in patients with gynecologic malignancy is associated with clinical response and does not increase morbidity.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24712317	(2014) Influence of growth factors and cytokines on angiogenic function of endothelial progenitor cells: a review of in vitro human studies.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24714555	(2014) Added value of angiogenic factors for the prediction of early and late preeclampsia in the first trimester of pregnancy.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24718301	(2014) A longitudinal study of circulating angiogenic and antiangiogenic factors and AT1-AA levels in preeclampsia.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24730250	(2014) Scaffold design for bone regeneration.	3	43	2.06	0.0461	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:24739658	(2014) Protein synthesis and secretion in human mesenchymal cells derived from bone marrow, adipose tissue and Whartons jelly.	3	55	1.95	0.0461	9606.ENSP00000363827,9606.ENSP00000451040,9606.ENSP00000478570	HSPG2,PGF,VEGFA
PMID:24740170	(2014) Intravitreal aflibercept (Eylea((R))): a review of its use in patients with macular oedema secondary to central retinal vein occlusion.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24741461	(2014) Medullary thyroid carcinoma with ectopic adrenocorticotropic hormone syndrome.	2	11	2.47	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:24744930	(2014) Management of a patient with metastatic colorectal cancer and liver metastases.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24752433	(2014) Decreased endothelial progenitor cells in preeclampsia and consequences for developmental programming.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24758227	(2014) Severe hypoxia exerts parallel and cell-specific regulation of gene expression and alternative splicing in human mesenchymal stem cells.	3	76	1.81	0.0461	9606.ENSP00000231061,9606.ENSP00000451040,9606.ENSP00000478570	SPARC,PGF,VEGFA
PMID:24758329	(2014) Prognostic value of secreted phosphoprotein-1 in pleural effusion associated with non-small cell lung cancer.	2	9	2.56	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:24758593	(2014) Discovering up-regulated VEGF-C expression in swine umbilical vein endothelial cells by classical swine fever virus Shimen.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24775564	(2014) Epidithiodiketopiperazines (ETPs) exhibit in vitro antiangiogenic and in vivo antitumor activity by disrupting the HIF-1alphap300 complex in a preclinical model of prostate cancer.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24777200	(2014) MicroRNA-410 reduces the expression of vascular endothelial growth factor and inhibits oxygen-induced retinal neovascularization.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24778868	(2014) Aspirin for prevention of preeclampsia in lupus pregnancy.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24781648	(2014) Improvement and optimization of standards for a preclinical animal test model of laser induced choroidal neovascularization.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24783223	(2014) Age and SPARC change the extracellular matrix composition of the left ventricle.	2	7	2.67	0.0461	9606.ENSP00000231061,9606.ENSP00000363827	SPARC,HSPG2
PMID:24793974	(2014) Hyperglycemia impairs cytotrophoblast function via stress signaling.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24796548	(2014) Enhancement of the HIF-1alpha15-LO15-HETE axis promotes hypoxia-induced endothelial proliferation in preeclamptic pregnancy.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24800250	(2014) First trimester biomarkers in the prediction of later pregnancy complications.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24801162	(2014) Urinary biomarkers of acute kidney injury in deceased organ donors--kidney injury molecule-1 as an adjunct to predicting outcome.	2	6	2.74	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:24803508	(2014) Altered methylation and expression patterns of genes regulating placental angiogenesis in preterm pregnancy.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24803942	(2014) Hormones and hemodynamics in pregnancy.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24807156	(2014) A correlative biomarker analysis of the combination of bevacizumab and carboplatin-based chemotherapy for advanced nonsquamous non-small-cell lung cancer: results of the phase II randomized ABIGAIL study (BO21015).	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24819505	(2014) Regulation and novel action of thymidine phosphorylase in non-small cell lung cancer: crosstalk with Nrf2 and HO-1.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24836679	(2014) Angiogenic factors as potential drug target: efficacy and limitations of anti-angiogenic therapy.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24836825	(2014) Pathophysiology of ischemic placental disease.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24836864	(2014) Introduction. Treatment paradigms within the use of anti-VEGF agents.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24836865	(2014) Safety profiles of anti-VEGF drugs: bevacizumab, ranibizumab, aflibercept and ziv-aflibercept on human retinal pigment epithelium cells in culture.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24840734	(2014) Edaravone inhibits hypoxia-induced trophoblast-soluble Fms-like tyrosine kinase 1 expression: a possible therapeutic approach to preeclampsia.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24862165	(2014) Endothelin-1 increases the expression of VEGF-R1Flt-1 receptors in rat cultured astrocytes through ETB receptors.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24880953	(2014) Graft microvascular disease in solid organ transplantation.	3	64	1.88	0.0461	9606.ENSP00000363827,9606.ENSP00000451040,9606.ENSP00000478570	HSPG2,PGF,VEGFA
PMID:24885632	(2014) Soluble Flt1 and placental growth factor are novel determinants of newborn thyroid (dys)function: the generation R study.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24902850	(2014) Evaluation of the impact of transient interruption of antiangiogenic treatment using ultrasound-based techniques in a murine model of hepatocellular carcinoma.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24904662	(2014) Pancreatic head carcinoma and vascular endothelial growth factor (VEGF-A) concentration in portal blood: its association with cancer grade, tumor size and probably poor prognosis.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24910901	(2014) Exendin-4 alleviates retinal vascular leakage by protecting the blood-retinal barrier and reducing retinal vascular permeability in diabetic Goto-Kakizaki rats.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24914193	(2014) Downregulation of microvascular endothelial type B endothelin receptor is a central vascular mechanism in hypertensive pregnancy.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24928387	(2014) Secreted meningeal chemokines, but not VEGFA, modulate the migratory properties of medulloblastoma cells.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24929121	(2014) Biomarker predictors of cardiac hospitalization in chronic heart failure: a recurrent event analysis.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24940434	(2014) Transthyretin as a novel candidate biomarker for preeclampsia.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24947528	(2014) Transplanted perivascular adipose tissue accelerates injury-induced neointimal hyperplasia: role of monocyte chemoattractant protein-1.	2	13	2.4	0.0461	9606.ENSP00000362524,9606.ENSP00000478570	ANGPTL2,VEGFA
PMID:24947924	(2014) The combination of circulating Ang1 and Tie2 levels predicts progression-free survival advantage in bevacizumab-treated patients with ovarian cancer.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24955140	(2014) Image-guided pro-angiogenic therapy in diabetic stroke mouse models using a multi-modal nanoprobe.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24955357	(2014) The multiple roles of EG-VEGFPROK1 in normal and pathological placental angiogenesis.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24959436	(2014) Role of biomarkers in early detection of preeclampsia.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24968868	(2014) Acute resistance exercise increases the expression of chemotactic factors within skeletal muscle.	2	8	2.61	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:24970480	(2014) Live-cell imaging of invasion and intravasation in an artificial microvessel platform.	2	12	2.43	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:24971016	(2014) Bevacizumab in combination with chemotherapy in platinum-sensitive ovarian cancer.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24977735	(2014) Regulation of soluble neuropilin 1, an endogenous angiogenesis inhibitor, in liver development and regeneration.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24987458	(2014) Comparative in vitro study regarding the biocompatibility of titanium-base composites infiltrated with hydroxyapatite or silicatitanate.	2	14	2.37	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:24987805	(2014) Placental Nkx2-5 and target gene expression in early-onset and severe preeclampsia.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24987823	(2014) Therapeutic effects of artesunate in hepatocellular carcinoma: repurposing an ancient antimalarial agent.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24991539	(2014) Zirconium-89 labeled antibodies: a new tool for molecular imaging in cancer patients.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24994751	(2014) Decreased expression of cystathionine beta-synthase promotes glioma tumorigenesis.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25001273	(2014) Vasopressin in preeclampsia: a novel very early human pregnancy biomarker and clinically relevant mouse model.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25003612	(2014) Pre-eclampsia part 2: prediction, prevention and management.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25013382	(2014) Dimethyloxaloylglycine improves angiogenic activity of bone marrow stromal cells in the tissue-engineered bone.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25016027	(2014) Differential regulation of orphan nuclear receptor TR3 transcript variants by novel vascular growth factor signaling pathways.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25028532	(2014) Effect of intravitreal aflibercept injection for age-related macular degeneration with a retinal pigment epithelial tear refractory to intravitreal ranibizumab injection.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25035858	(2014) Fetal Vegf Genotype is More Important for Abortion Risk than Mother Genotype.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25042562	(2014) Suppression of angiogenic response in local vein wall is associated with reduced thrombus resolution.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25045279	(2014) Targeting metastatic colorectal cancer - present and emerging treatment options.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25045452	(2014) Clinical significance of assessment of thrombospondin and placenta growth factor levels in patients with sickle cell anemia: two centers egyptian studies.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25057087	(2014) [Relationship between fetal growth restriction and angiogenesis factors].	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25063757	(2014) Altered VEGF-stimulated Ca2+ signaling in part underlies pregnancy-adapted eNOS activity in UAEC.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25068098	(2014) Barriers to drug delivery in solid tumors.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25071762	(2014) Sinister self-sacrifice: the contribution of apoptosis to malignancy.	2	9	2.56	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:25077060	(2014) Cloning, expression and purification of functionally active human angiopoietin-like protein 2.	2	7	2.67	0.0461	9606.ENSP00000362524,9606.ENSP00000478570	ANGPTL2,VEGFA
PMID:25079024	(2014) Advances in the pathophysiology of preeclampsia and related podocyte injury.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25079461	(2014) Increased placental growth factor (PlGF) concentrations in children and adolescents with obesity and the metabolic syndrome.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25089267	(2014) Lymphangiogenesis and its correlation with the VEGF expression and the sentinel lymph node in cutaneous melanomas.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25093816	(2014) Low energy shock wave therapy induces angiogenesis in acute hind-limb ischemia via VEGF receptor 2 phosphorylation.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25100134	(2014) Investigation of novel circulating proteins, germ line single-nucleotide polymorphisms, and molecular tumor markers as potential efficacy biomarkers of first-line sunitinib therapy for advanced renal cell carcinoma.	3	82	1.78	0.0461	9606.ENSP00000231061,9606.ENSP00000451040,9606.ENSP00000478570	SPARC,PGF,VEGFA
PMID:25101167	(2014) VEGFR-1 blockade disrupts peri-implantation decidual angiogenesis and macrophage recruitment.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25115920	(2014) Mesenchymal stromal cell proliferation, gene expression and protein production in human platelet-rich plasma-supplemented media.	3	69	1.85	0.0461	9606.ENSP00000363827,9606.ENSP00000451040,9606.ENSP00000478570	HSPG2,PGF,VEGFA
PMID:25124978	(2014) Placental growth factor expression is reversed by antivascular endothelial growth factor therapy under hypoxic conditions.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25128406	(2014) The role of VEGF-A165b in trophoblast survival.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25128750	(2014) Engineering in vivo gradients of sphingosine-1-phosphate receptor ligands for localized microvascular remodeling and inflammatory cell positioning.	2	12	2.43	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:25132842	(2014) Repair and regeneration properties of Ginkgo biloba after ischemic brain injury.	2	9	2.56	0.0461	9606.ENSP00000334329,9606.ENSP00000478570	UNC5B,VEGFA
PMID:25136079	(2014) Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA).	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25136356	(2014) Targeting angiogenesis and tumor microenvironment in metastatic colorectal cancer: role of aflibercept.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25136369	(2014) Early prediction of preeclampsia.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25139628	(2014) Standard of care and future pharmacological treatment options for malignant glioma: an urgent need for screening and identification of novel tumor-specific antigens.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25141961	(2014) Follicular fluid placental growth factor is increased in polycystic ovarian syndrome: correlation with ovarian stimulation.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25143954	(2014) Cell microenvironment engineering and monitoring for tissue engineering and regenerative medicine: the recent advances.	2	13	2.4	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:25147341	(2014) Gestational loss and growth restriction by angiogenic defects in placental growth factor transgenic mice.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25149138	(2014) Expression of netrin-1 receptors in retina of oxygen-induced retinopathy in mice.	2	11	2.47	0.0461	9606.ENSP00000334329,9606.ENSP00000478570	UNC5B,VEGFA
PMID:25149386	(2014) Cardiotonic steroids induce anti-angiogenic and anti-proliferative profiles in first trimester extravillous cytotrophoblast cells.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25149706	(2014) Analysis of serum protein biomarkers, circulating tumor DNA, and dovitinib activity in patients with tyrosine kinase inhibitor-refractory gastrointestinal stromal tumors.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25152735	(2014) Platelets and their chemokines in atherosclerosis-clinical applications.	3	77	1.8	0.0461	9606.ENSP00000006053,9606.ENSP00000304767,9606.ENSP00000478570	CX3CL1,P2RY1,VEGFA
PMID:25162038	(2014) Autoimmune rheumatic diseases.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25178558	(2014) Development and in vitro assessment of enzymatically-responsive poly(ethylene glycol) hydrogels for the delivery of therapeutic peptides.	2	3	3.04	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:25178695	(2014) A think tank of TINKTANKs: tumor-infiltratingtumor-associated natural killer cells in tumor progression and angiogenesis.	3	66	1.87	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:25182455	(2014) Design of growth factor sequestering biomaterials.	3	42	2.07	0.0461	9606.ENSP00000363827,9606.ENSP00000451040,9606.ENSP00000478570	HSPG2,PGF,VEGFA
PMID:25186136	(2014) Concentrations of endothelial nitric oxide synthase, angiotensin-converting enzyme, vascular endothelial growth factor and placental growth factor in maternal blood and maternal metabolic status in pregnancy complicated by hypertensive ...	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25190312	(2014) [Review and expert opinion in age related macular degeneration. Focus on the pathophysiology, angiogenesis and pharmacological and clinical data].	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25202912	(2014) Carbon monoxide prevents hypertension and proteinuria in an adenovirus sFlt-1 preeclampsia-like mouse model.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25228732	(2014) The use of angiogenic and antiangiogenic factors in the differential diagnosis of pre-eclampsia, antiphospholipid syndrome nephropathy and lupus nephritis.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25230734	(2014) Multicenter prospective clinical study to evaluate the prediction of short-term outcome in pregnant women with suspected preeclampsia (PROGNOSIS): study protocol.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25231141	(2014) Expression of genes encoding extracellular matrix proteins: a macroarray study.	2	14	2.37	0.0461	9606.ENSP00000231061,9606.ENSP00000363827	SPARC,HSPG2
PMID:25233229	(2014) Specific matrix metalloproteinases play different roles in intraplaque angiogenesis and plaque instability in rabbits.	2	14	2.37	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:25240113	(2014) Evidence for altered inflammatory and repair responses in symptomatic carotid plaques from elderly patients.	2	10	2.51	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:25241658	(2014) Upregulation of stromal cell-derived factor 1alpha expression is associated with the resistance to neoadjuvant chemoradiotherapy of locally advanced rectal cancer: angiogenic markers of neoadjuvant chemoradiation.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25245329	(2014) Serum angiopoietin-2 and soluble VEGFR-2 levels predict malignancy of ovarian neoplasm and poor prognosis in epithelial ovarian cancer.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25249499	(2014) Perlecan heparan sulfate proteoglycan is a critical determinant of angiogenesis in response to mouse hind-limb ischemia.	2	6	2.74	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:25249506	(2014) The SK3 channel promotes placental vascularization by enhancing secretion of angiogenic factors.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25251016	(2014) In-vitro study of the effect of anti-hypertensive drugs on placental hormones and angiogenic proteins synthesis in pre-eclampsia.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25256831	(2014) Circulating biomarkers in advanced colorectal cancer patients randomly assigned to three bevacizumab-based regimens.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25275309	(2014) Synergy between sphingosine 1-phosphate and lipopolysaccharide signaling promotes an inflammatory, angiogenic and osteogenic response in human aortic valve interstitial cells.	3	77	1.8	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:25281695	(2014) Ramucirumab: successfully targeting angiogenesis in gastric cancer.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25285078	(2014) The Cerebrovascular Basement Membrane: Role in the Clearance of beta-amyloid and Cerebral Amyloid Angiopathy.	2	11	2.47	0.0461	9606.ENSP00000231061,9606.ENSP00000363827	SPARC,HSPG2
PMID:25298738	(2014) The impact of bevacizumab treatment on survival and quality of life in newly diagnosed glioblastoma patients.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25308335	(2014) Two-step self-assembly of liposome-multidomain peptide nanofiber hydrogel for time-controlled release.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25313509	(2014) Elevated serum neurotensin and CRH levels in children with autistic spectrum disorders and tail-chasing Bull Terriers with a phenotype similar to autism.	2	7	2.67	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:25314641	(2014) Challenges in developing a validated biomarker for angiogenesis inhibitors: the motesanib experience.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25340802	(2014) Activation of beta-catenin signalling leads to temporomandibular joint defects.	2	11	2.47	0.0461	9606.ENSP00000231061,9606.ENSP00000363827	SPARC,HSPG2
PMID:25341896	(2014) E2F1 suppresses cardiac neovascularization by down-regulating VEGF and PlGF expression.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25346691	(2014) Endothelial dysfunction and preeclampsia: role of oxidative stress.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25349575	(2014) Corticotropin-releasing Hormone and Its Biological Diversity toward Angiogenesis.	2	14	2.37	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:25364670	(2014) Advances in diabetic retinopathy.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25365378	(2014) Incidence and risk of proteinuria with aflibercept in cancer patients: a meta-analysis.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25368641	(2014) Extracellular matrices, artificial neural scaffolds and the promise of neural regeneration.	2	10	2.51	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:25371895	(2014) Sildenafil Inhibits Advanced Glycation End Products-induced sFlt-1 Release Through Upregulation of Heme Oxygenase-1.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25378873	(2014) Vascular endothelial growth factor trap-eye and trap technology: Aflibercept from bench to bedside.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25387128	(2014) N-terminal cleavage and release of the ectodomain of Flt1 is mediated via ADAM10 and ADAM 17 and regulated by VEGFR2 and the Flt1 intracellular domain.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25389282	(2014) Synergistic effect of gestational hypertension and postpartum incident hypertension on cardiovascular health: a nationwide population study.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25392994	(2014) Homozygosity mapping and whole exome sequencing reveal a novel homozygous COL18A1 mutation causing Knobloch syndrome.	2	8	2.61	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:25393290	(2014) In vivo experiments reveal the good, the bad and the ugly faces of sFlt-1 in pregnancy.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25393540	(2014) Dll4 blockade potentiates the anti-tumor effects of VEGF inhibition in renal cell carcinoma patient-derived xenografts.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25408721	(2014) Predictive factors for intrauterine growth restriction.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25422886	(2014) Evaluation of anti-HIF and anti-angiogenic properties of honokiol for the treatment of ocular neovascular diseases.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25426076	(2014) Changes in vitelline and utero-placental hemodynamics: implications for cardiovascular development.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25430444	(2014) Correlation between molecular biomarkers and risk factors for the clinical progression of benign prostatic hyperplasia using tissue microarray immunostaining.	2	8	2.61	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:25431020	(2014) The role of radiotherapy in the management of POEMS syndrome.	2	5	2.81	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:25450475	(2014) New approaches for managing preeclampsia: clues from clinical and basic research.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25463070	(2014) Vascular proteoglycans and atherosclerosis: not over yet.	2	7	2.67	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:25478272	(2014) Fatal gastrointestinal hemorrhage in a young boy with newly diagnosed metastatic medulloblastoma on high dose dexamethasone.	2	5	2.81	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:25479628	(2014) Effect of Danzhi decoction on expression of angiogenesis factors in patients with sequelae of pelvic inflammatory disease.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25503251	(2014) CX3CL1CX3CR1 and CCL2CCR2 chemokinechemokine receptor complex in patients with AMD.	2	13	2.4	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:25505929	(2014) The role of platelet gel in osteoarticular injuries of young and old patients.	2	12	2.43	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:25506919	(2014) Agrin and perlecan mediate tumorigenic processes in oral squamous cell carcinoma.	2	12	2.43	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:25515662	(2014) Simultaneous targeting of two ligand-binding sites on VEGFR2 using biparatopic Affibody molecules results in dramatically improved affinity.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25516351	(2014) Aberrant methylation of the SPARC gene promoter and its clinical implication in gastric cancer.	2	7	2.67	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:25520773	(2014) How can we manage resistance to antiangiogenic drugs?	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25525888	(2014) A phase 1b, open-label study of trebananib plus bevacizumab or motesanib in patients with solid tumours.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25526965	(2014) Gene expression and protein secretion during human mesenchymal cell differentiation into adipogenic cells.	3	61	1.9	0.0461	9606.ENSP00000363827,9606.ENSP00000451040,9606.ENSP00000478570	HSPG2,PGF,VEGFA
PMID:25531711	(2014) [Pro-angiogenic cytokines in systemic sclerosis].	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25538401	(2014) Anti-angiogenic therapies for advanced esophago-gastric cancer.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25541696	(2014) Vascular endothelial growth factor genotypes and haplotypes contribute to the susceptibility of obstructive sleep apnea syndrome.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25566266	(2014) The role of nucleotides and purinergic signaling in apoptotic cell clearance - implications for chronic inflammatory diseases.	3	44	2.05	0.0461	9606.ENSP00000006053,9606.ENSP00000304767,9606.ENSP00000478570	CX3CL1,P2RY1,VEGFA
PMID:25580262	(2014) Management of colorectal cancer.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25588083	(2014) Aflibercept: an update on recent milestones achieved.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25614736	(2014) Colorectal cancer and basement membranes: clinicopathological correlations.	2	8	2.61	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:25948970	(2014) Investigating the Association between Angiogenic Cytokines and Corneal Neovascularization in Sulfur Mustard Intoxicated Subjects 26 Years after Exposure.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26064856	(2014) VEGFR-1 Expression Relates to Fuhrman Nuclear Grade of Clear Cell Renal Cell Carcinoma.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26336417	(2014) Influence of proliferation signal inhibitors on vascular endothelial growth factor production in heart transplant recipients - preliminary report.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26361585	(2014) Using Copper to Improve the Well-Being of the Skin.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26997808	(2014) Wound Healing Modulation in Glaucoma Filtration Surgery- Conventional Practices and New Perspectives: Antivascular Endothelial Growth Factor and Novel Agents (Part II).	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22461185	(2013) Circulating angiopoietin and Tie-2 levels in systemic sclerosis.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22584294	(2013) The mRNA level of the transforming growth factor beta1 gene, but not the amount of the gene product, can be considered as a potential prognostic parameter in inflammatory bowel diseases in children.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22772900	(2013) Effect of semax and its C-terminal fragment Pro-Gly-Pro on the expression of VEGF family genes and their receptors in experimental focal ischemia of the rat brain.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22818386	(2013) Differential expression of vascular endothelial growth factor isoforms and receptor subtypes in the infarcted heart.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22941044	(2013) EG-VEGF controls placental growth and survival in normal and pathological pregnancies: case of fetal growth restriction (FGR).	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22950505	(2013) Novel pharmacologic approaches to the prevention and treatment of ulcerative colitis.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22957504	(2013) Circulating lymphangiogenic factors in preeclampsia.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22958404	(2013) KH902 suppresses high glucose-induced migration and sprouting of human retinal endothelial cells by blocking VEGF and PIGF.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22963269	(2013) Midtrimester amniotic fluid concentrations of angiogenic factors in relation to maternal, gestational and neonatal characteristics in normal pregnancies.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22982179	(2013) Role of the retinal vascular endothelial cell in ocular disease.	3	113	1.64	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:22991381	(2013) Effects of angiogenic factors, antagonists, and podocyte injury on development of proteinuria in preeclampsia.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23022376	(2013) Cytokine profile of conditioned medium from human tumor cell lines after acute and fractionated doses of gamma radiation and its effect on survival of bystander tumor cells.	2	8	2.61	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:23042533	(2013) Enhancement of placenta growth factor expression by oncostatin M in human rheumatoid arthritis synovial fibroblasts.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23046674	(2013) The placental growth factor as a target against hepatocellular carcinoma in a diethylnitrosamine-induced mouse model.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23053262	(2013) Assessing the in vivo efficacy of biologic antiangiogenic therapies.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23069656	(2013) Platelets govern pre-metastatic tumor communication to bone.	2	14	2.37	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:23102896	(2013) Targeted therapy for metastatic colorectal cancer: role of aflibercept.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23140147	(2013) PlGF and sVEGFR-1 in chronic subdural hematoma: implications for hematoma development.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23178506	(2013) Plasma cytokines and chemokines differentiate between active disease and non-active tuberculosis infection.	2	10	2.51	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:23179335	(2013) A phase I study of intravenous aflibercept with FOLFIRI in Japanese patients with previously treated metastatic colorectal cancer.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23199019	(2013) Aflibercept in lung cancer.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23211473	(2013) Role of corin and atrial natriuretic peptide in preeclampsia.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23232836	(2013) Increased expression of placental growth factor in high-grade endometrial             carcinoma.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23245384	(2013) Altered stress induced by partial transection of the infraspinatus tendon leads to perlecan (HSPG2) accumulation in an ovine model of tendinopathy.	2	6	2.74	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:23267058	(2013) Tumor cell-derived placental growth factor sensitizes antiangiogenic and antitumor effects of anti-VEGF drugs.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23268742	(2013) Bioassay-guided isolation of proanthocyanidins with antiangiogenic activities.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23279628	(2013) Endoglin in amniotic fluid as a risk factor for the subsequent development of bronchopulmonary dysplasia.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23298463	(2013) MMP13 is a critical target gene during the progression of osteoarthritis.	2	8	2.61	0.0461	9606.ENSP00000231061,9606.ENSP00000363827	SPARC,HSPG2
PMID:23299577	(2013) Role of vascular endothelial growth factor in the pathophysiology of nonalcoholic steatohepatitis in two rodent models.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23305078	(2013) Pharmacologically active microcarriers influence VEGF-A effects on mesenchymal stem cell survival.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23307955	(2013) Hyperoxia causes regression of vitreous neovascularization by downregulating VEGFVEGFR2 pathway.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23313168	(2013) Anti-angiogenic activity of rPAI-1(23) and vasa vasorum regression.	2	13	2.4	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:23317499	(2013) Aflibercept: a novel VEGF targeted agent to explore the future perspectives of anti-angiogenic therapy for the treatment of multiple tumors.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23326589	(2013) Gestation dependant changes in angiogenic factors and their associations with fetal growth measures in normotensive pregnancy.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23330778	(2013) Placental growth factor (PlGF): a key to optimizing fetal growth.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23333542	(2013) Maternal plasma concentrations of angiogenicantiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23333548	(2013) Evidence of an imbalance of angiogenicantiangiogenic factors in massive perivillous fibrin deposition (maternal floor infarction): a placental lesion associated with recurrent miscarriage and fetal death.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23334331	(2013) EMP2 regulates angiogenesis in endometrial cancer cells through induction of VEGF.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23339712	(2013) Utero-placental expression of angiotensin-(1-7) and ACE2 in the pregnant guinea-pig.	2	11	2.47	0.0461	9606.ENSP00000450482,9606.ENSP00000478570	BDKRB2,VEGFA
PMID:23339896	(2013) Synovial perlecan is required for osteophyte formation in knee osteoarthritis.	2	11	2.47	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:23343199	(2013) Characterization of adipose-derived mesenchymal stem cell combinations for vascularized bone engineering.	2	12	2.43	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:23344048	(2013) Role of the blood-brain barrier in the formation of  brain metastases.	3	82	1.78	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:23344286	(2013) Pravastatin for the prevention of preeclampsia in high-risk pregnant women.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23355903	(2013) Oxygen tension modulates differentiation and primary macrophage functions in the human monocytic THP-1 cell line.	2	11	2.47	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:23357180	(2013) STOX1: a new player in preeclampsia?	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23361051	(2013) A randomised, double-blind, placebo-controlled phase 2 study of trebananib (AMG 386) in combination with FOLFIRI in patients with previously treated metastatic colorectal carcinoma.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23364534	(2013) Alpha-CaMKII plays a critical role in determining the aggressive behavior of human osteosarcoma.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23364970	(2013) Blockade of VEGFR-1 and VEGFR-2 enhances paclitaxel sensitivity in gastric cancer cells.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23377373	(2013) A phase I study of hepatic arterial infusion of nab-paclitaxel in combination with intravenous gemcitabine and bevacizumab for patients with advanced cancers and predominant liver metastases.	2	10	2.51	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:23378460	(2013) Serum interleukin 6 is predictive of early functional decline and mortality in interstitial lung disease associated with systemic sclerosis.	2	8	2.61	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:23380766	(2013) Corticotropin-releasing hormone exerts direct effects on neuronal progenitor cells: implications for neuroprotection.	2	10	2.51	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:23394144	(2013) 1,2,3,4,6-Penta-O-galloyl-beta-D-glucopyranose inhibits angiogenesis via inhibition of capillary morphogenesis gene 2.	2	12	2.43	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:23394201	(2013) Osteogenic differentiation of adipose-derived stem cells is hypoxia-inducible factor-1 independent.	2	3	3.04	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:23395639	(2013) Sunitinib does not accelerate tumor growth in patients with metastatic renal cell carcinoma.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23399318	(2013) Neoproteoglycans in tissue engineering.	2	13	2.4	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:23407314	(2013) Development of sensory neuropathy in streptozotocin-induced diabetic mice.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23419196	(2013) The VEGF signaling pathway in cancer: the road ahead.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23429405	(2013) Maternal active and passive smoking and hypertensive disorders of pregnancy: risk with trimester-specific exposures.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23432698	(2013) The evolving role of VEGF-targeted therapies in the treatment of metastatic colorectal cancer.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23434935	(2013) Dual inhibition of classical protein kinase C-alpha and protein kinase C-beta isoforms protects against experimental murine diabetic nephropathy.	2	14	2.37	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:23437230	(2013) Characterisation of syncytiotrophoblast vesicles in normal pregnancy and pre-eclampsia: expression of Flt-1 and endoglin.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23437346	(2013) Role of CX3CR1 receptor in monocytemacrophage driven neovascularization.	2	7	2.67	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:23439671	(2013) Preeclampsia, gestational hypertension and subsequent hypothyroidism.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23440426	(2013) Vascular normalization as an emerging strategy to enhance cancer immunotherapy.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23441128	(2013) The proangiogenic phenotype of natural killer cells in patients with non-small cell lung cancer.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23444216	(2013) Aflibercept.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23444323	(2013) Expression of pro- and anti-angiogenic factors during the formation of the periocular vasculature and development of the avian cornea.	3	42	2.07	0.0461	9606.ENSP00000334329,9606.ENSP00000451040,9606.ENSP00000478570	UNC5B,PGF,VEGFA
PMID:23448345	(2013) Demystifying animal models of adverse pregnancy outcomes: touching bench and bedside.	2	11	2.47	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:23451163	(2013) Intravital immunofluorescence for visualizing the microcirculatory and immune microenvironments in the mouse ear dermis.	2	14	2.37	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:23457327	(2013) Current treatments in diabetic macular oedema: systematic review and meta-analysis.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23459241	(2013) Diabetic retinopathy and VEGF.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23460290	(2013) Pravastatin attenuates hypertension, oxidative stress, and angiogenic imbalance in rat model of placental ischemia-induced hypertension.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23463017	(2013) Placental growth factor supports neuroendocrine tumor growth and predicts disease prognosis in patients.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23464925	(2013) Targeted intraceptor nanoparticle therapy reduces angiogenesis and fibrosis in primate and murine macular degeneration.	2	5	2.81	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:23467190	(2013) Multiple pathologies in the kidney biopsy of a recently pregnant woman.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23469213	(2013) Structural characterization of a recombinant fusion protein by instrumental analysis and molecular modeling.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23471910	(2013) Promoting blood vessel growth in ischemic diseases: challenges in translating preclinical potential into clinical success.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23472116	(2013) Attenuation of hind-limb ischemia in mice with endothelial-like cells derived from different sources of human stem cells.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23473589	(2013) Aflibercept (VEGF Trap-Eye) for the treatment of exudative age-related macular degeneration.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23492946	(2013) Intraocular growth factors and cytokines in patients with dry and neovascular age-related macular degeneration.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23496762	(2013) Analysis of constant tissue remodeling in Syrian hamster Harderian gland: intra-tubular and inter-tubular syncytial masses.	2	5	2.81	0.0461	9606.ENSP00000220166,9606.ENSP00000478570	CTSH,VEGFA
PMID:23503202	(2013) Comparative effectiveness of aflibercept for the treatment of patients with neovascular age-related macular degeneration.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23507921	(2013) Immunotherapeutic organoids: a new approach to cancer treatment.	2	13	2.4	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:23509456	(2013) Comparative Analysis of Clinical, Hormonal and Morphological Studies in Patients with Neuroendocrine ACTH-Producing Tumours.	2	4	2.91	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:23511563	(2013) Antibody targeting of CD24 efficiently retards growth and influences cytokine milieu in experimental carcinomas.	3	94	1.72	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:23511629	(2013) VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23515621	(2013) The metastasis-promoting roles of tumor-associated immune cells.	3	92	1.73	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:23529165	(2013) Podocyturia predates proteinuria and clinical features of preeclampsia: longitudinal prospective study.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23549459	(2013) Maxillary sinus augmentation procedures through equine-derived biomaterial or calvaria autologous bone: immunohistochemical evaluation of OPGRANKL in humans.	2	5	2.81	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:23549899	(2013) Physical factors effecting cerebral aneurysm pathophysiology.	2	6	2.74	0.0461	9606.ENSP00000231061,9606.ENSP00000363827	SPARC,HSPG2
PMID:23554918	(2013) miR-141 contributes to fetal growth restriction by regulating PLAG1 expression.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23557166	(2013) First trimester PAPP-A levels correlate with sFlt-1 levels longitudinally in pregnant women with and without preeclampsia.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23558430	(2013) First-trimester serum soluble fms-like tyrosine kinase-1, free vascular endothelial growth factor, placental growth factor and uterine artery Doppler in preeclampsia.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23562587	(2013) Adverse events associated with antiangiogenic agents in combination with cytotoxic chemotherapy in metastatic colorectal cancer and their management.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23575433	(2013) Potential role of N-carbamoyl glutamate in biosynthesis of arginine and its significance in production of ruminant animals.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23601533	(2013) Vascular endothelial growth factor-B expression in postischemic rat brain.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23603666	(2013) Contrasting roles of E2F2 and E2F3 in endothelial cell growth and ischemic angiogenesis.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23604552	(2013) Fractalkine and its receptor mediate extracellular matrix accumulation in diabetic nephropathy in mice.	2	11	2.47	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:23607589	(2013) Reduced mRNA expression level of corticotropin-releasing hormone-binding protein is associated with aggressive human kidney cancer.	2	14	2.37	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:23612628	(2013) The course of angiogenic factors in early- vs. late-onset preeclampsia and HELLP syndrome.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23625582	(2013) Placental growth factor (PlGF)-specific uptake in tumor microenvironment of 89Zr-labeled PlGF antibody RO5323441.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23638089	(2013) Association between SPARC mRNA expression, prognosis and response to neoadjuvant chemotherapy in early breast cancer: a pooled in-silico analysis.	2	13	2.4	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:23639879	(2013) Osteopontin inhibits osmotic swelling of retinal glial (Muller) cells by inducing release of VEGF.	2	4	2.91	0.0461	9606.ENSP00000304767,9606.ENSP00000478570	P2RY1,VEGFA
PMID:23641361	(2013) Opportunities and challenges for successful use of bevacizumab in pediatrics.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23663420	(2013) Vasoactive agents for the prediction of early- and late-onset preeclampsia in a high-risk cohort.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23664153	(2013) Short-term outcomes of aflibercept for neovascular age-related macular degeneration in eyes previously treated with other vascular endothelial growth factor inhibitors.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23675495	(2013) HIF-1alpha transgenic bone marrow cells can promote tissue repair in cases of corticosteroid-induced osteonecrosis of the femoral head in rabbits.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23690796	(2013) Preeclampsia is a biomarker for vascular disease in both mother and child: the need for a medical alert system.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23695833	(2013) Response gene to complement 32 deficiency causes impaired placental angiogenesis in mice.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23704250	(2013) Sulfane sustains vascular health: insights into cystathionine gamma-lyase function.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23710641	(2013) Anti-vascular endothelial growth factor antibody attenuates inflammation and decreases mortality in an experimental model of severe sepsis.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23714001	(2013) Id1 enhances human ovarian cancer endothelial progenitor cell angiogenesis via PI3KAkt and NF-kappaBMMP-2 signaling pathways.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23719118	(2013) Expression of genes coding for proangiogenic factors and their receptors in human placenta complicated by preeclampsia and intrauterine growth restriction.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23719305	(2013) The biology of retinopathy of prematurity: how knowledge of pathogenesis guides treatment.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23719923	(2013) Mineralocorticoid receptors in vascular disease: connecting molecular pathways to clinical implications.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23720233	(2013) Loss of Pten promotes angiogenesis and enhanced vegfaa expression in zebrafish.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23723253	(2013) Effects of cell grafting on coronary remodeling after myocardial infarction.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23730520	(2013) Update on antiangiogenic therapy in colorectal cancer: aflibercept and regorafenib.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23741441	(2013) Expression of the growth factor progranulin in endothelial cells influences growth and development of blood vessels: a novel mouse model.	2	11	2.47	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:23742877	(2013) Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23761723	(2013) Vascular endothelial growth factor A polymorphisms and age-related macular degeneration: a systematic review and meta-analysis.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23766636	(2013) Long-term effectiveness of ranibizumab for age-related macular degeneration and diabetic macular edema.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23774818	(2013) The glomerular basement membrane as a barrier to albumin.	2	14	2.37	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:23794249	(2013) Reversible effects of oxygen partial pressure on genes associated with placental angiogenesis and differentiation in primary-term cytotrophoblast cell culture.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23799044	(2013) Contrasting roles of E2F2 and E2F3 in cardiac neovascularization.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23799140	(2013) VEGFR1 and VEGFR2 involvement in extracellular galectin-1- and galectin-3-induced angiogenesis.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23799579	(2013) Understanding vascular development.	3	75	1.81	0.0461	9606.ENSP00000334329,9606.ENSP00000451040,9606.ENSP00000478570	UNC5B,PGF,VEGFA
PMID:23799978	(2013) Flt-1 in colorectal cancer cells is required for the tumor invasive effect of placental growth factor through a p38-MMP9 pathway.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23803710	(2013) Comparison of vascular growth factors in the murine brain reveals placenta growth factor as prime candidate for CNS revascularization.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23806447	(2013) Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23807861	(2013) Anti-VEGF agents in metastatic colorectal cancer (mCRC): are they all alike?	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23818763	(2013) Profile of tivozanib and its potential for the treatment of advanced renal cell carcinoma.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23824055	(2013) Maternal Serum Macrophage Inhibitory Cytokine-1 as a Biomarker for Ectopic Pregnancy in Women with a Pregnancy of Unknown Location.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23825705	(2013) Placental growth factor inhibition for choroidal neovascularization.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23825706	(2013) Knockdown of the placental growth factor gene inhibits laser induced choroidal neovascularization in a murine model.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23825982	(2013) GnRH analogues in the prevention of ovarian hyperstimulation syndrome.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23833308	(2013) Phase II study of bevacizumab in combination with sorafenib in recurrent glioblastoma (N0776): a north central cancer treatment group trial.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23836955	(2013) Critical appraisal of ranibizumab in the treatment of diabetic macular edema.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23836958	(2013) Retinal pigment epithelium tear after intravitreal aflibercept injection.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23842041	(2013) Magnetic resonance imaging biomarkers in hepatocellular carcinoma: association with response and circulating biomarkers after sunitinib therapy.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23843722	(2013) Bevacizumab for the treatment of glioblastoma.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23844036	(2013) Genetic polymorphisms of the CASP8 gene promoter may not be associated with colorectal cancer in Han Chinese from southwest China.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23844967	(2013) Placental growth factor may predict increased left ventricular mass index in patients with mild to moderate chronic kidney disease--a prospective observational study.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23860016	(2013) Association of angiotensinogen gene polymorphisms and angiogenic factors with preeclampsia in Chinese women.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23861700	(2013) Therapeutic effects of saireito (chai-ling-tang), a traditional Japanese herbal medicine, on lymphedema caused by radiotherapy: a case series study.	2	5	2.81	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:23861747	(2013) Prospective validation of candidate SNPs of VEGFVEGFR pathway in metastatic colorectal cancer patients treated with first-line FOLFIRI plus bevacizumab.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23861940	(2013) Basic fibroblast growth factor contributes to a shift in the angioregulatory activity of retinal glial (Muller) cells.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23862123	(2013) Significance of secreted protein acidic and rich in cysteine expression in colorectal carcinoma.	2	9	2.56	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:23874680	(2013) Combination therapy of VEGF-trap and gemcitabine results in improved anti-tumor efficacy in a mouse lung cancer model.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23891065	(2013) Imbalance of expression of bFGF and PK1 is associated with defective maturation and antenatal placental insufficiency.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23891860	(2013) VEGF but not PlGF disturbs the barrier of retinal endothelial cells.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23899470	(2013) Advanced oxidation protein products enhances soluble Fms-like tyrosine kinase 1 expression in trophoblasts: a possible link between oxidative stress and preeclampsia.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23908970	(2013) Compartment model predicts VEGF secretion and investigates the effects of VEGF trap in tumor-bearing mice.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23911939	(2013) Protein kinase C regulates FLT1 abundance and stimulates its cleavage in vascular endothelial cells with the release of a soluble PlGFVEGF antagonist.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23918298	(2013) Pathobiology and management of prostate cancer-induced bone pain: recent insights and future treatments.	3	61	1.9	0.0461	9606.ENSP00000231061,9606.ENSP00000450482,9606.ENSP00000478570	SPARC,BDKRB2,VEGFA
PMID:23918367	(2013) Vascular endothelial growth factor-dependent spatiotemporal dual roles of placental growth factor in modulation of angiogenesis and tumor growth.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23918400	(2013) TNFSF15 inhibits vasculogenesis by regulating relative levels of membrane-bound and soluble isoforms of VEGF receptor 1.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23922657	(2013) Identification of a potent endothelium-derived angiogenic factor.	2	13	2.4	0.0461	9606.ENSP00000304767,9606.ENSP00000478570	P2RY1,VEGFA
PMID:23922700	(2013) Celecoxib ameliorates portal hypertension of the cirrhotic rats through the dual inhibitory effects on the intrahepatic fibrosis and angiogenesis.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23935036	(2013) Predicting response to bevacizumab in ovarian cancer: a panel of potential biomarkers informing treatment selection.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23936112	(2013) Differential gene expression at the maternal-fetal interface in preeclampsia is influenced by gestational age.	2	9	2.56	0.0461	9606.ENSP00000276571,9606.ENSP00000362524	CRH,ANGPTL2
PMID:23937721	(2013) Comparison of placental growth factor and fetal flow Doppler ultrasonography to identify fetal adverse outcomes in women with hypertensive disorders of pregnancy: an observational study.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23945248	(2013) [Advances of VEGR gene polymorphism and its clinical values in lung cancer].	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23950655	(2013) Platelet aggregation measurement for assessment of hemostasis failure mechanisms in patients with gastroduodenal ulcer bleeding.	2	12	2.43	0.0461	9606.ENSP00000304767,9606.ENSP00000478570	P2RY1,VEGFA
PMID:23950958	(2013) Novel VEGF decoy receptor fusion protein conbercept targeting multiple VEGF isoforms provide remarkable anti-angiogenesis effect in vivo.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23951338	(2013) Basement membrane-rich organoids with functional human blood vessels are permissive niches for human breast cancer metastasis.	2	13	2.4	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:23956832	(2013) Possible role of sonic hedgehog and epithelial-mesenchymal transition in renal cell cancer progression.	2	10	2.51	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:23957905	(2013) Pharmacological treatments in ARDS; a state-of-the-art update.	2	9	2.56	0.0461	9606.ENSP00000362524,9606.ENSP00000478570	ANGPTL2,VEGFA
PMID:23963139	(2013) Phase III trial of capecitabine and oxaliplatin in combination with bevacizumab and imatinib in patients with metastatic colorectal cancer: AIO KRK 0205.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23970848	(2013) Adult hippocampal neurogenesis inversely correlates with microglia in conditions of voluntary running and aging.	2	14	2.37	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:23984083	(2013) Investigating the Relationship between Serum Level of s-Met (Soluble Hepatic Growth Factor Receptor) and Preeclampsia in the First and Second Trimesters of Pregnancy.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23986744	(2013) Bone vascularization in normal and disease conditions.	3	40	2.09	0.0461	9606.ENSP00000006053,9606.ENSP00000231061,9606.ENSP00000478570	CX3CL1,SPARC,VEGFA
PMID:24004644	(2013) Mesenchymal stem cells protect podocytes from apoptosis induced by high glucose via secretion of epithelial growth factor.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24005035	(2013) VEGF-Trap decreases CD4+ T cells, Th17 cytokines improving psoriasis-like skin inflammation in KC-Tie2 mice.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24005860	(2013) Inhibition of stromal PlGF suppresses the growth of prostate cancer xenografts.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24008241	(2013) KH902, a recombinant human VEGF receptor fusion protein, reduced the level of placental growth factor in alkali burn induced-corneal neovascularization.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24009647	(2013) Dental Stem Cells and their Applications in Dental Tissue Engineering.	2	10	2.51	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:24015338	(2013) Circulating angiogenic modulatory factors predict survival and functional class in pulmonary arterial hypertension.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24025224	(2013) Bradykinin B2 receptor in the adrenal medulla of male rats and mice: glucocorticoid-dependent increase with immobilization stress.	2	3	3.04	0.0461	9606.ENSP00000276571,9606.ENSP00000450482	CRH,BDKRB2
PMID:24029057	(2013) Evaluation of a novel macromolecular cascade-polymer contrast medium for dynamic contrast-enhanced MRI monitoring of antiangiogenic bevacizumab therapy in a human melanoma model.	2	3	3.04	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:24033157	(2013) Neurotensin serum levels and skin gene expression are increased in atopic dermatitis.	2	4	2.91	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:24052001	(2013) Disruption of endogenous purinergic signaling inhibits vascular endothelial growth factor- and glutamate-induced osmotic volume regulation of Muller glial cells in knockout mice.	2	3	3.04	0.0461	9606.ENSP00000304767,9606.ENSP00000478570	P2RY1,VEGFA
PMID:24059699	(2013) Tumor cell response to bevacizumab single agent therapy in vitro.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24060899	(2013) Administration of interleukin-17 soluble receptor C suppresses TH17 cells, oxidative stress, and hypertension in response to placental ischemia during pregnancy.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24063386	(2013) Uteroplacental circulation and fetal vascular function and development.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24066611	(2013) Notch and VEGF pathways play distinct but complementary roles in tumor angiogenesis.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24070898	(2013) Progranulin directly binds to the CRD2 and CRD3 of TNFR extracellular domains.	2	13	2.4	0.0461	9606.ENSP00000231061,9606.ENSP00000363827	SPARC,HSPG2
PMID:24073247	(2013) Preeclampsia and the risk of bronchopulmonary dysplasia in VLBW infants: a population based study.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24074223	(2013) NK4 therapy: a new approach to target angiogenesis and inflammation in rheumatoid arthritis.	2	7	2.67	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:24076553	(2013) Angiogenic factors in preeclampsia: potential for diagnosis and treatment.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24079419	(2013) Nanotechnology in cancer therapy.	2	11	2.47	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:24088738	(2013) A phase II and biomarker study of ramucirumab, a human monoclonal antibody targeting the VEGF receptor-2, as first-line monotherapy in patients with advanced hepatocellular cancer.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24096014	(2013) Mind the gap: a survey of how cancer drug carriers are susceptible to the gap between research and practice.	2	7	2.67	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:24098382	(2013) Serotonin 5-HT2A receptor activation blocks TNF-alpha mediated inflammation in vivo.	2	11	2.47	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:24109193	(2013) Patient selection and targeted treatment in the management of platinum-resistant ovarian cancer.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24118824	(2013) Inhibition of placental growth factor improves surgical outcome of glaucoma surgery.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24138811	(2013) The relationship between lymphatic vascular density and vascular endothelial growth factor A (VEGF-A) expression with clinical-pathological features and survival in pancreatic adenocarcinomas.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24139944	(2013) Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24142467	(2013) Nitric oxide donors augment interleukin-1beta-induced vascular endothelial growth factor in airway smooth muscle cells.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24143074	(2013) Everolimus in the treatment of subependymal giant cell astrocytomas, angiomyolipomas, and pulmonary and skin lesions associated with tuberous sclerosis complex.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24143206	(2013) The association of alternate VEGF ligands with resistance to anti-VEGF therapy in metastatic colorectal cancer.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24144948	(2013) Advanced glycation end products as an upstream molecule triggers ROS-induced sFlt-1 production in extravillous trophoblasts: a novel bridge between oxidative stress and preeclampsia.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24147499	(2013) PET with 62Cu-ATSM and 62Cu-PTSM is a useful imaging tool for hypoxia and perfusion in pulmonary lesions.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24147919	(2013) Epidemiology of preeclampsia: impact of obesity.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24161217	(2013) Evidence for extraplacental sources of circulating angiogenic growth effectors in human pregnancy.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24163506	(2013) Inflammatory mediators of angiogenesis.	2	5	2.81	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:24179482	(2013) Aflibercept in the treatment of patients with metastatic colorectal cancer: latest findings and interpretations.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24190997	(2013) Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24192345	(2013) Healing effects of Musa sapientum var. paradisiaca in diabetic rats with co-occurring gastric ulcer: cytokines and growth factor by PCR amplification.	2	13	2.4	0.0461	9606.ENSP00000220166,9606.ENSP00000478570	CTSH,VEGFA
PMID:24194963	(2013) The hormone factory skin never sleeps or Methusalem drugs and other ancient friends, revisited!	2	10	2.51	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:24217170	(2013) Maternal imbalance between pro-angiogenic and anti-angiogenic factors in HIV-infected women with pre-eclampsia.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24222719	(2013) Effect of therapeutic inhibition of TNF on circulating endothelial progenitor cells in patients with rheumatoid arthritis.	2	6	2.74	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:24237985	(2013) HUS and TTP in Children.	2	14	2.37	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:24238698	(2013) Managing lupus patients during pregnancy.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24251094	(2013) Mechanisms of heparanase inhibition by the heparan sulfate mimetic PG545 and three structural analogues.	2	7	2.67	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:24260138	(2013) High glucose attenuates shear-induced changes in endothelial hydraulic conductivity by degrading the glycocalyx.	2	10	2.51	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:24260556	(2013) Attenuation of VEGFR-2 expression by sFlt-1 and low oxygen in human placenta.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24278397	(2013) Neuronal synapse formation induced by microglia and interleukin 10.	2	14	2.37	0.0461	9606.ENSP00000006053,9606.ENSP00000304767	CX3CL1,P2RY1
PMID:24282820	(2013) Tyrosine kinase inhibitors induced thyroid dysfunction: a review of its incidence, pathophysiology, clinical relevance, and treatment.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24284305	(2013) Tumor angiogenesis and anti-angiogenic therapies.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24288566	(2013) Subtoxic Levels of Apigenin Inhibit Expression and Secretion of VEGF by Uveal Melanoma Cells via Suppression of ERK12 and PI3KAkt Pathways.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24288569	(2013) Network-based biomarkers for cold coagulation blood stasis syndrome and the therapeutic effects of shaofu zhuyu decoction in rats.	2	8	2.61	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:24303054	(2013) Hevin plays a pivotal role in corneal wound healing.	2	8	2.61	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:24303126	(2013) Effects of prior acute exercise on circulating cytokine concentration responses to a high-fat meal.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24309662	(2013) Development, maintenance and disruption of the blood-brain barrier.	3	66	1.87	0.0461	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:24312300	(2013) LncRNAs expression in preeclampsia placenta reveals the potential role of LncRNAs contributing to preeclampsia pathogenesis.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24319688	(2013) Therapies for neovascular age-related macular degeneration: current approaches and pharmacologic agents in development.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24323378	(2013) Perlecan domain V is neuroprotective and affords functional improvement in a photothrombotic stroke model in young and aged mice.	2	9	2.56	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:24327864	(2013) Advances in systemic therapy for advanced pancreatobiliary malignancies.	2	5	2.81	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:24327973	(2013) Pathogenesis and promising non-invasive markers for preeclampsia.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24347979	(2013) Anti-vascular endothelial growth factor drugs safety and efficacy in ophthalmic diseases.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24349470	(2013) First-in-human phase I study of PRS-050 (Angiocal), an Anticalin targeting and antagonizing VEGF-A, in patients with advanced solid tumors.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24392302	(2013) Current and Novel Treatment Options for Metastatic Colorectal Cancer: Emphasis on Aflibercept.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24403715	(2013) Prognostic risk factors for early diagnosing of Preeclampsia in Nulliparas.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24501799	(2013) [The effect of tobacco smoking on serum concentration of selected angiogenic factors and somatomedin C in pregnant women and umbilical cord blood].	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24574654	(2013) VEGF and CD 34: A correlation between tumor angiogenesis and microvessel density-an immunohistochemical study.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24624293	(2013) Personalized Medicine in Ophthalmology: From Pharmacogenetic Biomarkers to Therapeutic and Dosage Optimization.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24843704	(2013) Vascular endothelial growth factor-B as a therapeutic target to prevent ectopic fat deposition.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25032013	(2013) Ziv-aflibercept use in metastatic colorectal cancer.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25206477	(2013) Changes of hypoxia-inducible factor-1 signaling and the effect of cilostazol in chronic cerebral ischemia.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25206642	(2013) Huoxue Rongluo Tablet reduces matrix metalloproteinase-9 expression in infarcted brain tissue.	2	6	2.74	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:25505656	(2013) Inhibition of VEGF: a novel mechanism to control angiogenesis by Withania somniferas key metabolite Withaferin A.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25984326	(2013) Rejuvenation: an integrated approach to regenerative medicine.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26012208	(2013) [Snake venom proteins related to vascular endothelial growth factor: new tools for therapeutic angiogenesis].	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26105841	(2013) Developing potential biomarkers for preeclampsia: Why is the current strategy failing?	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26816732	(2013) VEGF is associated with the poor survival of patients with prostate cancer: a meta-analysis.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26877912	(2013) Is VEGF a new therapeutic target for hypertension in chronic kidney disease?	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26877915	(2013) Decreased serum level and increased urinary excretion of vascular endothelial growth factor-C in patients with chronic kidney disease.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26933402	(2013) Resveratrol inhibits proteinase-activated receptor-2-induced release of soluble vascular endothelial growth factor receptor-1 from human endothelial cells.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30613209	(2013) Emergence of dual VEGF and PDGF antagonists in the treatment of exudative age-related macular degeneration.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21384270	(2012) Hypocellularity and insufficient expression of angiogenic factors in implanted autologous bone marrow in patients with chronic critical limb ischemia.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21604271	(2012) Occurrence, biochemical profile of vascular endothelial growth factor (VEGF) isoforms and their functions in endochondral ossification.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21827822	(2012) The paracrinology of tubal ectopic pregnancy.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21867402	(2012) Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21882255	(2012) Ras inhibition in hepatocarcinoma by S-trans-trans-farnesylthiosalicyclic acid: association of its tumor preventive effect with cell proliferation, cell cycle events, and angiogenesis.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21902814	(2012) Physiological remodelling of the maternal uterine circulation during pregnancy.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21904550	(2012) The Role of PTEN in Tumor Angiogenesis.	3	44	2.05	0.0461	9606.ENSP00000363827,9606.ENSP00000451040,9606.ENSP00000478570	HSPG2,PGF,VEGFA
PMID:21911594	(2012) The adaptation of the blood-brain barrier to vascular endothelial growth factor and placental growth factor during pregnancy.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21941547	(2012) Integrin-mediated cell-matrix interaction in physiological and pathological blood vessel formation.	3	99	1.69	0.0461	9606.ENSP00000363827,9606.ENSP00000451040,9606.ENSP00000478570	HSPG2,PGF,VEGFA
PMID:21954923	(2012) Exogenous thrombin delivery promotes collateral capillary arterialization and tissue reperfusion in the murine spinotrapezius muscle ischemia model.	2	13	2.4	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:21988672	(2012) Evaluation of placental growth factor and soluble Fms-like tyrosine kinase 1 as predictors of all-cause and cardiovascular mortality in patients with Type 1 diabetes with and without diabetic nephropathy.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22032637	(2012) The effects of sorafenib on the portal hypertensive syndrome in patients with liver cirrhosis and hepatocellular carcinoma--a pilot study.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22057655	(2012) Intracranial transplantation of monocyte-derived multipotential cells enhances recovery after ischemic stroke in rats.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22075622	(2012) Human choriocarcinomas: placental growth factor-dependent preclinical tumor models.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22077987	(2012) Global protein synthesis in human trophoblast is resistant to inhibition by hypoxia.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22085793	(2012) Angiogenic biomarkers predict the occurrence of digital ulcers in systemic sclerosis.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22097923	(2012) Circulating anti-angiogenic factors during hypertensive pregnancy and increased risk of respiratory distress syndrome in preterm neonates.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22100059	(2012) Effect of clopidogrel on circulating biomarkers of angiogenesis and endothelial activation.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22112608	(2012) A phase II study of aflibercept in patients with advanced epithelial ovarian cancer and symptomatic malignant ascites.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22113066	(2012) Body mass index is directly associated with biomarkers of angiogenesis and inflammation in children and adolescents.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22120277	(2012) Novel animal glioma models that separately exhibit two different invasive and angiogenic phenotypes of human glioblastomas.	2	5	2.81	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:22126916	(2012) PlGF knockout delays brain vessel growth and maturation upon systemic hypoxic challenge.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22130514	(2012) Regulator of G-protein signaling 5 (RGS5) protein: a novel marker of cancer vasculature elicited and sustained by the tumors proangiogenic microenvironment.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22142700	(2012) DLK1, delta-like 1 homolog (Drosophila), regulates tumor cell differentiation in vivo.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22160787	(2012) Increased placental growth factor in cerebrospinal fluid of patients with epilepsy.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22172336	(2012) Blood vessel formation in the tissue-engineered bone with the constitutively active form of HIF-1alpha mediated BMSCs.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22174998	(2012) Antivascular endothelial growth factor agents for neovascular age-related macular degeneration.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22175024	(2012) Pathogenesis of preeclampsia: the genetic component.	3	40	2.09	0.0461	9606.ENSP00000276571,9606.ENSP00000451040,9606.ENSP00000478570	CRH,PGF,VEGFA
PMID:22175025	(2012) Prevention of vascular dysfunction after preeclampsia: a potential long-term outcome measure and an emerging goal for treatment.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22179104	(2012) Tolerability and pharmacokinetic profile of a sunitinib powder formulation in pediatric patients with refractory solid tumors: a Childrens Oncology Group study.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22187650	(2012) Signaling required for blood vessel maintenance: molecular basis and pathological manifestations.	3	60	1.91	0.0461	9606.ENSP00000334329,9606.ENSP00000451040,9606.ENSP00000478570	UNC5B,PGF,VEGFA
PMID:22190279	(2012) DCE and DW-MRI monitoring of vascular disruption following VEGF-Trap treatment of a rat glioma model.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22192729	(2012) Intravenous aflibercept for treatment of recurrent symptomatic malignant ascites in patients with advanced ovarian cancer: a phase 2, randomised, double-blind, placebo-controlled study.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22195275	(2012) Heme Oxygenase-1 Attenuates Hypoxia-Induced sFlt-1 and Oxidative Stress in Placental Villi through Its Metabolic Products CO and Bilirubin.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22210636	(2012) Cardiopulmonary function in individuals with HIV infection in the antiretroviral therapy era.	2	14	2.37	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:22215706	(2012) Transcriptionally active syncytial aggregates in the maternal circulation may contribute to circulating soluble fms-like tyrosine kinase 1 in preeclampsia.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22220269	(2012) Development of Anti-VEGF Therapies for Intraocular Use: A Guide for Clinicians.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22234787	(2012) Relationships among maternal nutrient intake and placental biomarkers during the 1st trimester in low-income women.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22244880	(2012) Oxygen-glucose deprivation (OGD) and interleukin-1 (IL-1) differentially modulate cathepsin BL mediated generation of neuroprotective perlecan LG3 by neurons.	2	8	2.61	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:22246794	(2012) The role of SPARC protein expression in the progress of gastric cancer.	2	3	3.04	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:22247820	(2012) The Impact of Magnesium Sulfate Therapy on Angiogenic Factors in Preeclampsia.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22258871	(2012) Cyclooxygenase isoenzyme-2 and vascular endothelial growth factor are associated with poor prognosis in esophageal adenocarcinoma.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22261192	(2012) Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22264850	(2012) A preclinical and clinical review of aflibercept for the management of cancer.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22273502	(2012) Biomarkers for antitumor activity of bevacizumab in gastric cancer models.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22283733	(2012) Serum neurotensin (NT) is increased in psoriasis and NT induces vascular endothelial growth factor release from human mast cells.	2	10	2.51	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:22302382	(2012) Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22311899	(2012) The role of angiogenic factors in the prediction and diagnosis of preeclampsia superimposed on chronic hypertension.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22322423	(2012) The balance of proangiogenic and antiangiogenic VEGFA isoforms regulate follicle development.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22333706	(2012) Second-line treatment for renal cell cancer.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22333707	(2012) A phase I, dose-escalation study of TB-403, a monoclonal antibody directed against PlGF, in patients with advanced solid tumours.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22340191	(2012) Effects of intravitreal injection of KH902, a vascular endothelial growth factor receptor decoy, on the retinas of streptozotocin-induced diabetic rats.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22346114	(2012) The past, present, and future of exudative age-related macular degeneration treatment.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22348624	(2012) The effect of maternal soluble FMS-like tyrosine kinase 1 during pregnancy on risk of preterm delivery.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22360979	(2012) Increased serum CRH levels with decreased skin CRHR-1 gene expression in psoriasis and atopic dermatitis.	2	9	2.56	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:22366328	(2012) VEGF signaling inside vascular endothelial cells and beyond.	3	44	2.05	0.0461	9606.ENSP00000334329,9606.ENSP00000451040,9606.ENSP00000478570	UNC5B,PGF,VEGFA
PMID:22369073	(2012) Acetylcholinesterase inhibitors attenuate angiogenesis.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22382594	(2012) Comparative analysis of the basement membrane composition of the human limbus epithelium and amniotic membrane epithelium.	2	9	2.56	0.0461	9606.ENSP00000231061,9606.ENSP00000363827	SPARC,HSPG2
PMID:22383980	(2012) Dilated thin-walled blood and lymphatic vessels in human endometrium: a potential role for VEGF-D in progestin-induced break-through bleeding.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22385653	(2012) Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease.	3	44	2.05	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:22385934	(2012) Vascular endothelial growth factor, as compared with placental growth factor, is increased in severe sepsis but not in organ failure.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22388551	(2012) The glomerular endothelium:  new insights on function and structure.	2	8	2.61	0.0461	9606.ENSP00000362524,9606.ENSP00000478570	ANGPTL2,VEGFA
PMID:22389705	(2012) Serum concentrations of soluble Flt-1 are decreased among women with a viable fetus and no symptoms of miscarriage destined for pregnancy loss.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22392532	(2012) Diabetic macular edema: therapeutic options.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22398973	(2012) The elevation in circulating anti-angiogenic factors is independent of markers of neutrophil activation in preeclampsia.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22400028	(2012) Microenvironment-centred dynamics in aggressive B-cell lymphomas.	3	63	1.89	0.0461	9606.ENSP00000231061,9606.ENSP00000451040,9606.ENSP00000478570	SPARC,PGF,VEGFA
PMID:22410175	(2012) Endothelial progenitor cells and integrins: adhesive needs.	3	53	1.97	0.0461	9606.ENSP00000363827,9606.ENSP00000451040,9606.ENSP00000478570	HSPG2,PGF,VEGFA
PMID:22413079	(2012) Stromal-cell-derived Factor 1-alpha Promotes Tumor Progression in Colorectal Cancer.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22428059	(2012) Differential expression of Vegfr-2 and its soluble form in preeclampsia.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22433027	(2012) Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22446028	(2012) Aflibercept (VEGF Trap-eye): the newest anti-VEGF drug.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22446996	(2012) Elevated concentration of placental growth factor (PlGF) and long term risk in patients with acute coronary syndrome in the PROVE IT-TIMI 22 trial.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22448651	(2012) Transcriptome landscape of the human placenta.	3	51	1.98	0.0461	9606.ENSP00000276571,9606.ENSP00000451040,9606.ENSP00000478570	CRH,PGF,VEGFA
PMID:22450332	(2012) Post-translational regulated and hypoxia-responsible VEGF plasmid for efficient secretion.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22462008	(2012) Genesis of preeclampsia: an epidemiological approach.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22470485	(2012) Ocular application of the kinin B1 receptor antagonist LF22-0542 inhibits retinal inflammation and oxidative stress in streptozotocin-diabetic rats.	2	11	2.47	0.0461	9606.ENSP00000450482,9606.ENSP00000478570	BDKRB2,VEGFA
PMID:22470568	(2012) Extract of Pleurotus pulmonarius suppresses liver cancer development and progression through inhibition of VEGF-induced PI3KAKT signaling pathway.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22474425	(2012) Emerging pharmacotherapies for diabetic macular edema.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22484977	(2012) VEGFR-1 expression levels predict occurrence of disseminated tumor cells in the bone marrow of patients with esophageal carcinoma.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22490165	(2012) [Enhancing effects of perlecan or vascular endothelial growth factor-165 on angiogenesis in mice].	2	2	3.21	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:22492468	(2012) Reversal of endothelial progenitor cell dysfunction in patients with type 2 diabetes using a conditioned medium of human embryonic stem cell-derived endothelial cells.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22495259	(2012) The vascular endothelial growth factor family in adverse pregnancy outcomes.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22508695	(2012) Anti-VEGFVEGFR therapy for cancer: reassessing the target.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22509290	(2012) Distinct effects of unfractionated heparin versus bivalirudin on circulating angiogenic peptides.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22510405	(2012) Vap (Vascular Associated Protein): a novel factor involved in erythropoiesis and angiogenesis.	2	14	2.37	0.0461	9606.ENSP00000362524,9606.ENSP00000478570	ANGPTL2,VEGFA
PMID:22523653	(2012) Anti-VEGF Treatment Strategies for Wet AMD.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22525430	(2012) Pathological crosstalk in vitro between T lymphocytes and lesional keratinocytes in psoriasis: necessity of direct cell-to-cell contact.	2	13	2.4	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:22531128	(2012) Tamoxifen modulates cell migration and expression of angiogenesis-related genes in human endometrial endothelial cells.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22537619	(2012) Differential expression of the angiogenesis growth factors in psoriasis vulgaris.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22539993	(2012) Mechanical strain regulates osteoblast proliferation through integrin-mediated ERK activation.	2	10	2.51	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:22545116	(2012) Differential modulation of retinal degeneration by Ccl2 and Cx3cr1 chemokine signalling.	2	11	2.47	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:22552373	(2012) Angiogenic factors in placentas from pregnancies complicated by fetal growth restriction (review).	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22555146	(2012) Mitochondria distinguish granule-stored from de novo synthesized tumor necrosis factor secretion in human mast cells.	2	12	2.43	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:22555639	(2012) The role of angiogenic, anti-angiogenic and vasoactive factors in pre-eclamptic African women: early- versus late-onset pre-eclampsia.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22570525	(2012) Quantitative proteomic (iTRAQ) analysis of 1st trimester maternal plasma samples in pregnancies at risk for preeclampsia.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22570554	(2012) The effect of anti-VEGF drugs (bevacizumab and aflibercept) on the survival of patients with metastatic colorectal cancer (mCRC).	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22582121	(2012) Bevacizumab-mediated interference with VEGF signaling is sufficient to induce a preeclampsia-like syndrome in nonpregnant women.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22593690	(2012) Assessment of control tissue for gene and protein expression studies: a comparison of three alternative lung sources.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22617589	(2012) First-trimester prediction of preeclampsia in nulliparous women at low risk.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22617817	(2012) Vascular development during distraction osteogenesis proceeds by sequential intramuscular arteriogenesis followed by intraosteal angiogenesis.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22617833	(2012) Cytokine concentration in aqueous humor of eyes with diabetic macular edema.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22627492	(2012) Fetal stress and programming of hypoxicischemic-sensitive phenotype in the neonatal brain: mechanisms and possible interventions.	3	70	1.84	0.0461	9606.ENSP00000006053,9606.ENSP00000276571,9606.ENSP00000478570	CX3CL1,CRH,VEGFA
PMID:22634070	(2012) Injectable system for spatio-temporally controlled delivery of hypoxia-induced angiogenic signalling.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22639743	(2012) The effect of human placental extract on rheumatoid arthritis in an animal model.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22643235	(2012) Perlecan domain V is upregulated in human brain arteriovenous malformation and could mediate the vascular endothelial growth factor effect in lesional tissue.	2	6	2.74	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:22645720	(2012) Aflibercept for the treatment of neovascular age-related macular degeneration.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22647886	(2012) Low placental growth factor across pregnancy identifies a subset of women with preterm preeclampsia: type 1 versus type 2 preeclampsia?	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22658411	(2012) Prevention of VEGF-induced growth and tube formation in human retinal endothelial cells by aldose reductase inhibition.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22666607	(2012) VEGF is involved in the increase of dermal microvascular permeability induced by tryptase.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22692562	(2012) Heterogeneity of the tumor vasculature: the need for new tumor blood vessel type-specific targets.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22692704	(2012) AMG 386 in combination with sorafenib in patients with metastatic clear cell carcinoma of the kidney: a randomized, double-blind, placebo-controlled, phase 2 study.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22696812	(2012) Vascular endothelial growth factors and their receptors and regulators in gestational trophoblastic diseases and normal placenta.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22701615	(2012) Phase I study of cetuximab, irinotecan, and vandetanib (ZD6474) as therapy for patients with previously treated metastastic colorectal cancer.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22707516	(2012) Efficacy, safety, and biomarkers of single-agent bevacizumab therapy in patients with advanced hepatocellular carcinoma.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22737191	(2012) Vascular endothelial growth factor-delivery systems for cardiac repair: an overview.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22740065	(2012) Renal evaluation in women with preeclampsia.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22750211	(2012) Effect of PACAP on MAP kinases, Akt and cytokine expressions in rat retinal hypoperfusion.	2	7	2.67	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:22753193	(2012) Elevated vascular endothelial growth factor receptor-2 abundance contributes to increased angiogenesis in vascular endothelial growth factor receptor-1-deficient mice.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22763474	(2012) Magnesium sulfate therapy of preeclampsia: an old tool with new mechanism of action and prospect in management and prophylaxis.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22764769	(2012) Influence of IL-8 on the epithelial-mesenchymal transition and the tumor microenvironment.	3	52	1.97	0.0461	9606.ENSP00000231061,9606.ENSP00000451040,9606.ENSP00000478570	SPARC,PGF,VEGFA
PMID:22772092	(2012) Inhibition of the placental growth factor decreases burden of cholangiocarcinoma and hepatocellular carcinoma in a transgenic mouse model.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22778495	(2012) Mast cells and histamine: do they influence placental vascular network and development in preeclampsia?	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22781936	(2012) Expression of angiogenic factors in placenta of stressed rats.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22791883	(2012) A phase I trial and pharmacokinetic study of aflibercept (VEGF Trap) in children with refractory solid tumors: a childrens oncology group phase I consortium report.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22796434	(2012) ADAMTS5 functions as an anti-angiogenic and anti-tumorigenic protein independent of its proteoglycanase activity.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22805331	(2012) A phase I dose-escalation study of aflibercept administered in combination with pemetrexed and cisplatin in patients with advanced solid tumours.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22815987	(2012) Prostate specific membrane antigen (PSMA) regulates angiogenesis independently of VEGF during ocular neovascularization.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22819041	(2012) Distal-less 3 haploinsufficiency results in elevated placental oxidative stress and altered fetal growth kinetics in the mouse.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22819145	(2012) Thrombin enhances soluble Fms-like tyrosine kinase 1 expression in trophoblasts; possible involvement in the pathogenesis of preeclampsia.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22825326	(2012) Protein expression changes during human triple negative breast cancer cell line progression to lymph node metastasis in a xenografted model in nude mice.	3	83	1.77	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:22828632	(2012) The role of heterodimerization between VEGFR-1 and VEGFR-2 in the regulation of endothelial cell homeostasis.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22840727	(2012) Endothelial microparticles and the antiangiogenic state in preeclampsia and the postpartum period.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22844419	(2012) Human tumor cells induce angiogenesis through positive feedback between CD147 and insulin-like growth factor-I.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22848831	(2012) Preeclampsia 2012.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22868393	(2012) Autoantibody-mediated complement C3a receptor activation contributes to the pathogenesis of preeclampsia.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22872523	(2012) Phase 1b dose-finding study of motesanib with docetaxel or paclitaxel in patients with metastatic breast cancer.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22875706	(2012) CT322, a VEGFR-2 antagonist, demonstrates anti-glioma efficacy in orthotopic brain tumor model as a single agent or in combination with temozolomide and radiation therapy.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22884349	(2012) Effects of lactation and pregnancy on gene expression of endometrium of Holstein cows at day 17 of the estrous cycle or pregnancy.	3	98	1.7	0.0461	9606.ENSP00000362524,9606.ENSP00000451040,9606.ENSP00000478570	ANGPTL2,PGF,VEGFA
PMID:22884851	(2012) Alcohol-induced premature permeability in mouse placenta-yolk sac barriers in vivo.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22887719	(2012) Ozone exposure during the early postnatal period alters the timing and pattern of alveolar growth and development in nonhuman primates.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22888169	(2012) Pravastatin does not prevent antiphospholipid antibody-mediated changes in human first trimester trophoblast function.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22888345	(2012) The effect of captopril on impaired wound healing in experimental diabetes.	2	8	2.61	0.0461	9606.ENSP00000450482,9606.ENSP00000478570	BDKRB2,VEGFA
PMID:22891044	(2012) Subclinical left ventricular dysfunction in preeclamptic women with preserved left ventricular ejection fraction: a 2D speckle-tracking imaging study.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22906984	(2012) VEGF, FLT3 ligand, PlGF and HGF can substitute for M-CSF to induce human osteoclast formation: implications for giant cell tumour pathobiology.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22908198	(2012) PlGF: a multitasking cytokine with disease-restricted activity.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22916133	(2012) Genetic and environmental factors influencing the Placental Growth Factor (PGF) variation in two populations.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22918697	(2012) An in vivo neovascularization assay for screening regulators of angiogenesis and assessing their effects on pre-existing vessels.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22921365	(2012) Determination of endothelial stalk versus tip cell potential during angiogenesis by H2.0-like homeobox-1.	2	10	2.51	0.0461	9606.ENSP00000334329,9606.ENSP00000478570	UNC5B,VEGFA
PMID:22922531	(2012) A phase II evaluation of aflibercept in the treatment of recurrent or persistent endometrial cancer: a Gynecologic Oncology Group study.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22922820	(2012) Air pollution exposure and markers of placental growth and function: the generation R study.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22925712	(2012) Placental growth factor and cardiac inflammation.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22927341	(2012) Endothelins reciprocally regulate VEGF-A and angiopoietin-1 production in cultured rat astrocytes: implications on astrocytic proliferation.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22930641	(2012) Safety profiles of current antiangiogenic therapies for metastatic colorectal cancer.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22952674	(2012) Hypoxia-inducible factor-1alpha regulates chemotactic migration of pancreatic ductal adenocarcinoma cells through directly transactivating the CX3CR1 gene.	2	9	2.56	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:22952728	(2012) Angiogenic factors in women ten years after severe very early onset preeclampsia.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22957090	(2012) Secreted protein acidic and rich in cysteine (SPARC) suppresses angiogenesis by down-regulating the expression of VEGF and MMP-7 in gastric cancer.	2	7	2.67	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:22962439	(2012) Pharmacokinetic and pharmacodynamic analysis of circulating biomarkers of anti-NRP1, a novel antiangiogenesis agent, in two phase I trials in patients with advanced solid tumors.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22962440	(2012) A phase I trial and pharmacokinetic study of sorafenib in children with refractory solid tumors or leukemias: a Childrens Oncology Group Phase I Consortium report.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22963500	(2012) Reverse translation of phase I biomarker findings links the activity of angiotensin-(1-7) to repression of hypoxia inducible factor-1alpha in vascular sarcomas.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22967000	(2012) Perlecan domain 1 recombinant proteoglycan augments BMP-2 activity and osteogenesis.	2	14	2.37	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:22973233	(2012) Airway responsiveness to psychological processes in asthma and health.	2	6	2.74	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:22975318	(2012) S1P1 bridges mechanotransduction and angiogenesis during vascular development.	2	10	2.51	0.0461	9606.ENSP00000450482,9606.ENSP00000478570	BDKRB2,VEGFA
PMID:22982464	(2012) Fibroblast growth factor-2 is required for vasa vasorum plexus stability in hypercholesterolemic mice.	2	11	2.47	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:22984218	(2012) Multitargeted tyrosine kinase inhibition produces discordant changes between 99mTc-MDP bone scans and other disease biomarkers: analysis of a phase II study of sunitinib for metastatic castration-resistant prostate cancer.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22994140	(2012) Inhibition of ocular neovascularization by a novel peptide derived from human placenta growth factor-1.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22994341	(2012) Fetal growth and risk of childhood asthma and allergic disease.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23021701	(2012) Systemic inflammatory stimulation by microparticles derived from hypoxic trophoblast as a model for inflammatory response in preeclampsia.	2	8	2.61	0.0461	9606.ENSP00000276571,9606.ENSP00000451040	CRH,PGF
PMID:23028880	(2012) The neuron-astrocyte-microglia triad in normal brain ageing and in a model of neuroinflammation in the rat hippocampus.	2	9	2.56	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:23056578	(2012) A role for Nrf2 in redox signalling of the invasive extravillous trophoblast in severe early onset IUGR associated with preeclampsia.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23060442	(2012) Endorepellin affects angiogenesis by antagonizing diverse vascular endothelial growth factor receptor 2 (VEGFR2)-evoked signaling pathways: transcriptional repression of hypoxia-inducible factor 1alpha and VEGFA and concurrent inhibition of ...	2	7	2.67	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:23061805	(2012) Potential anti-vascular endothelial growth factor therapies for central retinal vein occlusion.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23071422	(2012) Maternal serum endoglin as an early marker of pre-eclampsia in high-risk patients.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23074104	(2012) Spinal cord hemangioblastomas in von hippel-lindau disease: management of asymptomatic and symptomatic tumors.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23075146	(2012) Gene expression and release of growth factors during delayed wound healing: a review of studies in diabetic animals and possible combined laser phototherapy and growth factor treatment to enhance healing.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23077562	(2012) The role of VEGF and KDR polymorphisms in moyamoya disease and collateral revascularization.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23090773	(2012) Exercise training attenuates placental ischemia-induced hypertension and angiogenic imbalance in the rat.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23093230	(2012) Hypertensive diseases in pregnancy and subsequent lower risk of breast cancer: the common immune and antiangiogenic profile.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23098360	(2012) Mechanical strain promotes osteoblast ECM formation and improves its osteoinductive potential.	2	10	2.51	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:23110134	(2012) A New C-Xyloside induces modifications of GAG expression, structure and functional properties.	2	11	2.47	0.0461	9606.ENSP00000006053,9606.ENSP00000363827	CX3CL1,HSPG2
PMID:23139276	(2012) Inhibition of choroidal and corneal pathologic neovascularization by Plgf1-de gene transfer.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23145112	(2012) Mechanism of selective VEGF-A binding by neuropilin-1 reveals a basis for specific ligand inhibition.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23148666	(2012) Clinical procedure for colon carcinoma tissue sampling directly affects the cancer marker-capacity of VEGF family members.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23155356	(2012) VEGF -634CG genotype is predictive of long-term survival after treatment with a definitive 5-fluorouracilcisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23162702	(2012) Vixapatin (VP12), a c-type lectin-protein from Vipera xantina palestinae venom: characterization as a novel anti-angiogenic compound.	2	9	2.56	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:23166322	(2012) Laminin network formation studied by reconstitution of ternary nodes in solution.	2	6	2.74	0.0461	9606.ENSP00000231061,9606.ENSP00000363827	SPARC,HSPG2
PMID:23169339	(2012) VEGF directly suppresses activation of T cells from ascites secondary to ovarian cancer via VEGF receptor type 2.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23217102	(2012) The association of blood angioregulatory microRNA levels with circulating endothelial cells and angiogenic proteins in patients receiving dacarbazine and interferon.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23226527	(2012) Engineering of in vitro 3D capillary beds by self-directed angiogenic sprouting.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23233787	(2012) Overexpression of 15-lipoxygenase-1 in oxygen-induced ischemic retinopathy inhibits retinal neovascularization via downregulation of vascular endothelial growth factor-A expression.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23236461	(2012) Induction of osteogenic differentiation of adipose derived stem cells by microstructured nitinol actuator-mediated mechanical stress.	2	7	2.67	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:23272637	(2012) Adenovirus-mediated delivery of interferon-gamma gene inhibits the growth of nasopharyngeal carcinoma.	2	6	2.74	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:23285296	(2012) Recombinant human endostatin endostar suppresses angiogenesis and lymphangiogenesis of malignant pleural effusion in mice.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23342231	(2012) Aflibercept in wet age-related macular degeneration: a perspective review.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23346505	(2012) Finding a new prognostic biomarker for metastatic colorectal cancer.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23346511	(2012) Expression of placenta growth factor in colorectal carcinomas.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23383392	(2012) Microglial chemotactic signaling factors in Alzheimers disease.	2	5	2.81	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:23626629	(2012) The role of VEGF in melanoma progression.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24392297	(2012) Aflibercept: a Potent Vascular Endothelial Growth Factor Antagonist for Neovascular Age-Related Macular Degeneration and Other Retinal Vascular Diseases.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24843618	(2012) Endothelial impairment and bone marrow-derived CD34(+)133(+) cells in diabetic patients with erectile dysfunction.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26069810	(2012) Pre-eclampsia before 20-week gestation: diagnosis, investigation and management.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26105274	(2012) OS060. Exercise training promotes placental growth and development in an animal model of preeclampsia superimposed on chronic hypertension.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26105334	(2012) PP011. Increased placental expression of angiogenin inhibitor (Ribonuclease inhibitor), a novel gene in pre-eclampsia.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26105343	(2012) PP020 Association between renal dysfunction and angiogenic factors in preeclampsia.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26105365	(2012) PP042. Anti-hypertensive drugs hydralazine, clonidine and labetalol improve trophoblast integration into endothelial cellular networks in vitro.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26105464	(2012) PP143. Relationship between mid-pregnancy placenta growth factor and hemodynamics in the mother, fetus, and uterus.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20482334	(2011) Measurement of sVEGF R1 and PlGF in serum: comparing prototype assays from Beckman Coulter, Inc. to R&D Systems microplate assays.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20521248	(2011) Expression and prognostic significance of placental growth factor in hepatocellular carcinoma and peritumoral liver tissue.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20629995	(2011) Polyethylenimine-mediated gene delivery into human bone marrow mesenchymal stem cells from patients.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20632101	(2011) Corticosteroids modulate angiogenic soluble factors in ulcerative colitis patients.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20725052	(2011) Role of reactive oxygen species during hypertension in response to chronic antiangiogenic factor (sFlt-1) excess in pregnant rats.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20798152	(2011) Exploring relationships among psychosocial status, dietary quality, and measures of placental development during the first trimester in low-income women.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20804529	(2011) Changes of cytokine levels during granulocyte-colony-stimulating factor stem cell mobilization in healthy donors: association with mobilization efficiency and potential predictive significance.	2	11	2.47	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:20839998	(2011) Human marrow-isolated adult multilineage-inducible (MIAMI) cells protect against peripheral vascular ischemia in a mouse model.	2	9	2.56	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:20854168	(2011) SDF-1alpha secreted by human CD133-derived multipotent stromal cells promotes neural progenitor cell survival through CXCR7.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20920481	(2011) Antiangiogenic agents and targets: A perspective.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20932656	(2011) Phase II study of neoadjuvant bevacizumab and radiotherapy for resectable soft tissue sarcomas.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20935166	(2011) Up-regulation of soluble vascular endothelial growth factor receptor-1 prevents angiogenesis in hypertrophied myocardium.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20937289	(2011) Mutant hypoxia inducible factor-1alpha improves angiogenesis and tissue perfusion in ischemic rabbit skeletal muscle.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21047920	(2011) Placental growth factor: a promising diagnostic biomarker for tubal ectopic pregnancy.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21057529	(2011) Intracrine vascular endothelial growth factor signaling in survival and chemoresistance of human colorectal cancer cells.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21062661	(2011) Circulating angiogenic and antiangiogenic factors in women with eclampsia.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21071916	(2011) Characterization of dental pulp stem cells from impacted third molars cultured in low serum-containing medium.	2	9	2.56	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:21079047	(2011) Adenoviral delivery of VEGF121 early in pregnancy prevents spontaneous development of preeclampsia in BPH5 mice.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21088600	(2011) Expression of placental growth factor in regenerating livers after partial hepatectomy in the rat.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21095001	(2011) D2-40podoplanin expression in the human placenta.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21119072	(2011) Genetic variation in VEGF family genes and breast cancer risk: a report from the Shanghai Breast Cancer Genetics Study.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21135203	(2011) Molecular regulation of human placental growth factor (PlGF) gene expression in placental villi and trophoblast cells is mediated via the protein kinase a pathway.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21145529	(2011) Midpregnancy levels of angiogenic markers in relation to maternal characteristics.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21145589	(2011) Nicotine and cotinine affect the release of vasoactive factors by trophoblast cells and human umbilical vein endothelial cells.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21148423	(2011) Thrombospondin-1 is a plasmatic marker of peripheral arterial disease that modulates endothelial progenitor cell angiogenic properties.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21164078	(2011) Mitral valve endothelial cells with osteogenic differentiation potential.	2	13	2.4	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:21168500	(2011) Mesenchymal stem cell transplantation modulates neuroinflammation in focal cerebral ischemia: contribution of fractalkine and IL-5.	2	7	2.67	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:21172300	(2011) Novel antiangiogenic agents in dermatology.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21184108	(2011) Minimally invasive colon resection is associated with a persistent increase in plasma PlGF levels following cancer resection.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21184239	(2011) Role of the podocyte in proteinuria.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21187414	(2011) Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21199160	(2011) Rhinovirus infection induces expression of airway remodelling factors in vitro and in vivo.	2	4	2.91	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:21209384	(2011) Cholesterol regulates VEGFR-1 (FLT-1) expression and signaling in acute leukemia cells.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21216006	(2011) Review: Oxygen and trophoblast biology--a source of controversy.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21223248	(2011) Association of soluble fms-like tyrosine kinase-1 with pulmonary hypertension and haemolysis in sickle cell disease.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21224376	(2011) Evaluation of KRAS mutations, angiogenic biomarkers, and DCE-MRI in patients with advanced non-small-cell lung cancer receiving sorafenib.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21235296	(2011) Enhancement of wound healing by secretory factors of endothelial precursor cells derived from human embryonic stem cells.	2	8	2.61	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:21238923	(2011) Robo4 maintains vessel integrity and inhibits angiogenesis by interacting with UNC5B.	2	3	3.04	0.0461	9606.ENSP00000334329,9606.ENSP00000478570	UNC5B,VEGFA
PMID:21247755	(2011) Phase I trial of vandetanib and bevacizumab evaluating the VEGF and EGF signal transduction pathways in adults with solid tumours and lymphomas.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21251607	(2011) Polarization of tumor-associated macrophages: a novel strategy for vascular normalization and antitumor immunity.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21252283	(2011) sFLT01: a novel fusion protein with antiangiogenic activity.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21255566	(2011) Two distinct origins for Leydig cell progenitors in the fetal testis.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21266262	(2011) Emerging role of relaxin in the maternal adaptations to normal pregnancy: implications for preeclampsia.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21266264	(2011) Renin angiotensin signaling in normal pregnancy and preeclampsia.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21267661	(2011) Non-invasive bioluminescence imaging of myoblast-mediated hypoxia-inducible factor-1 alpha gene transfer.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21273368	(2011) Placental development during early pregnancy in sheep: cell proliferation, global methylation, and angiogenesis in the fetal placenta.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21292366	(2011) Lower urinary connective tissue growth factor levels and incident CKD stage 3 in the general population.	2	7	2.67	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:21300889	(2011) Jumonji domain-containing protein 6 (Jmjd6) is required for angiogenic sprouting and regulates splicing of VEGF-receptor 1.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21303226	(2011) Hypoxia preconditioning of tissue-engineered mucosa enhances its angiogenic capacity in vitro.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21304959	(2011) Epistasis between COMT and MTHFR in maternal-fetal dyads increases risk for preeclampsia.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21306888	(2011) Bioconjugation of hydrogels for tissue engineering.	2	8	2.61	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:21309731	(2011) Exogenous administration of vascular endothelial growth factor prior to human respiratory syncytial virus a2 infection reduces pulmonary pathology in neonatal lambs and alters epithelial innate immune responses.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21316642	(2011) Accreta complicating complete placenta previa is characterized by reduced systemic levels of vascular endothelial growth factor and by epithelial-to-mesenchymal transition of the invasive trophoblast.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21323568	(2011) Placental growth factor and soluble c-kit receptor dynamics characterize the cytokine signature of imatinib in prostate cancer and bone metastases.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21324460	(2011) VEGF-A-induced chemotaxis of CD16+ monocytes is decreased secondary to lower VEGFR-1 expression.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21330475	(2011) Distinct platelet packaging, release, and surface expression of proangiogenic and antiangiogenic factors on different platelet stimuli.	2	8	2.61	0.0461	9606.ENSP00000304767,9606.ENSP00000478570	P2RY1,VEGFA
PMID:21331165	(2011) Preeclampsia and Stroke: Risks during and after Pregnancy.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21333757	(2011) Mechanism of anti-angiogenic property of gold nanoparticles: role of nanoparticle size and surface charge.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21338327	(2011) Drug delivery strategies for therapeutic angiogenesis and antiangiogenesis.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21343374	(2011) Placental growth factor upregulation is a host response to antiangiogenic therapy.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21350285	(2011) Flare up of choroiditis and choroidal neovasculazation associated with punctate inner choroidopathy during early pregnancy.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21364963	(2011) Vascular endothelial growth factor-B gene transfer exacerbates retinal and choroidal neovascularization and vasopermeability without promoting inflammation.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21375491	(2011) Current Insights into the role of HIF-1 in cutaneous wound healing.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21375766	(2011) RNAi-mediated knockdown of cyclooxygenase2 inhibits the growth, invasion and migration of SaOS2 human osteosarcoma cells: a case control study.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21386840	(2011) Thymidine phosphorylase in cancer cells stimulates human endothelial cell migration and invasion by the secretion of angiogenic factors.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21394466	(2011) CKD-MBD after kidney transplantation.	2	12	2.43	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:21407219	(2011) Chronic exposure of colorectal cancer cells to bevacizumab promotes compensatory pathways that mediate tumour cell migration.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21414224	(2011) Polymorphisms in the hypoxia-inducible factor 1 alpha gene in Mexican patients with preeclampsia: A case-control study.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21435458	(2011) Circulating endothelial progenitor cells are up-regulated in a mouse model of endometriosis.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21444925	(2011) Plasma kallikrein mediates retinal vascular dysfunction and induces retinal thickening in diabetic rats.	2	10	2.51	0.0461	9606.ENSP00000450482,9606.ENSP00000478570	BDKRB2,VEGFA
PMID:21448460	(2011) Soluble Flt-1 and PlGF: new markers of early pregnancy loss?	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21464392	(2011) CD4+ T-helper cells stimulated in response to placental ischemia mediate hypertension during pregnancy.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21473705	(2011) Methylselenocysteine: a promising antiangiogenic agent for overcoming drug delivery barriers in solid malignancies for therapeutic synergy with anticancer drugs.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21486506	(2011) [New insights into the pathogenesis of pre-eclampsia: the role of angiogenesis-inhibiting factors].	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21494322	(2011) Renal involvement in preeclampsia: similarities to VEGF ablation therapy.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21497382	(2011) A phase II evaluation of nanoparticle, albumin-bound (nab) paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer: a Gynecologic Oncology Group study.	2	7	2.67	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:21501325	(2011) Effects of anti-beta2-glycoprotein I antibody on PlGF, VEGF and sVEGFR1 production from cultured choriocarcinoma cell line.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21504321	(2011) Potential role of soluble VEGFR-1 in antiangiogenesis therapy for cancer.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21505453	(2011) A role for nucleotides in support of breast cancer angiogenesis: heterologous receptor signalling.	2	10	2.51	0.0461	9606.ENSP00000304767,9606.ENSP00000478570	P2RY1,VEGFA
PMID:21507936	(2011) Proangiogenic factor PlGF programs CD11b(+) myelomonocytes in breast cancer during differentiation of their hematopoietic progenitors.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21510227	(2011) Placental growth factor: a tissue modelling factor with therapeutic potentials in neurology?	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21513467	(2011) Serum placental growth factor, vascular endothelial growth factor, soluble vascular endothelial growth factor receptor-1 and -2 levels in periodontal disease, and adverse pregnancy outcomes.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21520153	(2011) Active sonic hedgehog signaling between androgen independent human prostate cancer cells and normalbenign but not cancer-associated prostate stromal cells.	2	14	2.37	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:21532369	(2011) Amitriptyline and prochlorperazine inhibit proinflammatory mediator release from human mast cells: possible relevance to chronic fatigue syndrome.	2	6	2.74	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:21532964	(2011) The Role of Obesity in Preeclampsia.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21536992	(2011) Angiogenic growth factors are new and essential players in the sustained relaxin vasodilatory pathway in rodents and humans.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21541335	(2011) hHGF overexpression in myoblast sheets enhances their angiogenic potential in rat chronic heart failure.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21544229	(2011) Why integrin as a primary target for imaging and therapy.	3	57	1.93	0.0461	9606.ENSP00000231061,9606.ENSP00000451040,9606.ENSP00000478570	SPARC,PGF,VEGFA
PMID:21545366	(2011) Modulation of trophoblast angiogenic factor secretion by antiphospholipid antibodies is not reversed by heparin.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21558755	(2011) Involvement of Flt-1 (VEGF receptor-1) in cancer and preeclampsia.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21568945	(2011) A longitudinal study of plasma levels of soluble fms-like tyrosine kinase 1 (sFlt1), placental growth factor (PlGF), sFlt1: PlGF ratio and vascular endothelial growth factor (VEGF-A) in normal pregnancy.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21572784	(2011) Cow placenta extract promotes murine hair growth through enhancing the insulin - like growth factor-1.	2	7	2.67	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:21589847	(2011) Peripapillary Neovascular Membrane in a Young Pregnant Woman and Prompt Response to Ranibizumab Injections following Uneventful Delivery.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21601497	(2011) Expression and significance of Cyr61 in distant metastasis cells of human primary salivary adenoid cystic carcinoma.	2	4	2.91	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:21602894	(2011) IRX1 influences peritoneal spreading and metastasis via inhibiting BDKRB2-dependent neovascularization on gastric cancer.	2	14	2.37	0.0461	9606.ENSP00000450482,9606.ENSP00000478570	BDKRB2,VEGFA
PMID:21605699	(2011) Initial steps of metastasis: cell invasion and endothelial transmigration.	3	85	1.76	0.0461	9606.ENSP00000362524,9606.ENSP00000363827,9606.ENSP00000478570	ANGPTL2,HSPG2,VEGFA
PMID:21606416	(2011) Phase II study of aflibercept in recurrent malignant glioma: a North American Brain Tumor Consortium study.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21606594	(2011) Adenovirus-mediated HIF-1alpha gene transfer promotes repair of mouse airway allograft microvasculature and attenuates chronic rejection.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21619628	(2011) Binding of ATP to vascular endothelial growth factor isoform VEGF-A165 is essential for inducing proliferation of human umbilical vein endothelial cells.	2	11	2.47	0.0461	9606.ENSP00000304767,9606.ENSP00000478570	P2RY1,VEGFA
PMID:21621345	(2011) Comparison of the effects of carbon ion and photon irradiation on the angiogenic response in human lung adenocarcinoma cells.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21621825	(2011) Upregulation of hypoxia-inducible factor 1 alpha in local vein wall is associated with enhanced venous thrombus resolution.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21640761	(2011) Potential role of intermedinadrenomedullin 2 in early embryonic development in rats.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21649938	(2011) Levels of soluble fms-like tyrosine kinase one in first trimester and outcomes of pregnancy: a systematic review.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21668772	(2011) Impaired vascular permeability regulation caused by the VEGF165b splice variant in pre-eclampsia.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21674241	(2011) BMP-4 expression has prognostic significance in advanced serous ovarian carcinoma and is affected by cisplatin in OVCAR-3 cells.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21674706	(2011) VEGF164 isoform specific regulation of T-cell-dependent experimental colitis in mice.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21679003	(2011) Use of bevacizumab in metastatic colorectal cancer: report from the Mexican opinion and analysis forum on colorectal cancer treatment with bevacizumab (September 2009).	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21690570	(2011) Phase I and pharmacokinetic study of sunitinib in pediatric patients with refractory solid tumors: a childrens oncology group study.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21692205	(2011) Intravitreous high expression level of netrin-1 in patients with proliferative diabetic retinopathy.	2	5	2.81	0.0461	9606.ENSP00000334329,9606.ENSP00000478570	UNC5B,VEGFA
PMID:21703189	(2011) Regulation of placenta growth factor by microRNA-125b in hepatocellular cancer.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21715541	(2011) Soluble FMS-like tyrosine kinase-1 (sFlt-1) and serum placental growth factor (PlGF) as biomarkers for ectopic pregnancy and missed abortion.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21729304	(2011) Expression and prognostic value of circulating angiogenic cytokines in pancreatic cancer.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21732275	(2011) Signal transduction in vasculogenesis and developmental angiogenesis.	3	100	1.69	0.0461	9606.ENSP00000334329,9606.ENSP00000451040,9606.ENSP00000478570	UNC5B,PGF,VEGFA
PMID:21747167	(2011) Perlecan domain V is neuroprotective and proangiogenic following ischemic stroke in rodents.	2	2	3.21	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:21750610	(2011) Retinal vein occlusion and macular edema - critical evaluation of the clinical value of ranibizumab.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21751011	(2011) Suppression of neovascularization and experimental arthritis by D-form of anti-flt-1 peptide conjugated with mini-PEG((TM)).	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21752276	(2011) Autocrine activity of soluble Flt-1 controls endothelial cell function and angiogenesis.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21757116	(2011) The vascular marker soluble fms-like tyrosine kinase 1 is associated with disease severity and adverse outcomes in chronic heart failure.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21776283	(2011) Advances in cell transplantation therapy for diseased myocardium.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21778432	(2011) The VEGF165b ICE-o-form puts a chill on the VEGF story.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21780303	(2011) Extracellular matrix and matrix receptors in blood-brain barrier formation and stroke.	3	44	2.05	0.0461	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:21784979	(2011) VEGF is essential for hypoxia-inducible factor-mediated neovascularization but dispensable for endothelial sprouting.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21785732	(2011) Remodelling of membrane rafts expression in lung cells as an early sign of mechanotransduction-signalling in pulmonary edema.	2	10	2.51	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:21798099	(2011) Aberrant repair and fibrosis development in skeletal muscle.	3	76	1.81	0.0461	9606.ENSP00000363827,9606.ENSP00000451040,9606.ENSP00000478570	HSPG2,PGF,VEGFA
PMID:21827221	(2011) Maternal plasma concentrations of angiogenicanti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21833345	(2011) Safety, Efficacy, and Biomarker Exploration in a Phase II Study of Bevacizumab, Oxaliplatin, and Gemcitabine in Recurrent Mullerian Carcinoma.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21833584	(2011) Emerging functions of matricellular proteins.	2	13	2.4	0.0461	9606.ENSP00000231061,9606.ENSP00000363827	SPARC,HSPG2
PMID:21834229	(2011) Anti-angiogenic activity evaluation of secondary metabolites from Calycolpus moritzianus leaves.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21860391	(2011) Molecular control of endothelial cell behaviour during blood vessel morphogenesis.	3	92	1.73	0.0461	9606.ENSP00000334329,9606.ENSP00000451040,9606.ENSP00000478570	UNC5B,PGF,VEGFA
PMID:21873332	(2011) Subclinical gut inflammation in spondyloarthritis is associated with a pro-angiogenic intestinal mucosal phenotype.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21876459	(2011) Immunohistochemical expression of VEGF, HIF1-a, and PlGF in malignant melanomas and dysplastic nevi.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21885854	(2011) Dysregulated selectin expression and monocyte recruitment during ischemia-related vascular remodeling in diabetes mellitus.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21906811	(2011) Monoclonal antibody TB-403: a first-in-human, Phase I, double-blind, dose escalation study directed against placental growth factor in healthy male subjects.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21931477	(2011) Berberine hydrochloride: anticancer activity and nanoparticulate delivery system.	2	12	2.43	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:21937680	(2011) Tumor-surrogate blood vessel subtypes exhibit differential susceptibility to anti-VEGF therapy.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21947778	(2011) Associations of pregnancy characteristics with maternal and cord steroid hormones, angiogenic factors, and insulin-like growth factor axis.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21950485	(2011) Two-photon fluorescence vascular bioimaging with new bioconjugate probes selective toward the vascular endothelial growth factor receptor 2.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21962211	(2011) Elevated placenta growth factor predicts pneumonia in patients with chronic obstructive pulmonary disease under inhaled corticosteroids therapy.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21963217	(2011) Nitric oxide generation affects pro- and anti-angiogenic growth factor expression in primary human trophoblast.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21976540	(2011) Phase III and pharmacodynamic study of dovitinib (TKI258), an inhibitor of fibroblast growth factor receptors and VEGF receptors, in patients with advanced melanoma.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21980135	(2011) Lysosomal sequestration of sunitinib: a novel mechanism of drug resistance.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21982053	(2011) Tannin extracts from immature fruits of Terminalia chebula Fructus Retz. promote cutaneous wound healing in rats.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21983520	(2011) Therapeutic siRNA silencing in inflammatory monocytes in mice.	2	10	2.51	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:21986503	(2011) Midgestation maternal serum 25-hydroxyvitamin D level and soluble fms-like tyrosine kinase 1placental growth factor ratio as predictors of severe preeclampsia.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21992853	(2011) Phase 1-2 study of docetaxel plus aflibercept in patients with recurrent ovarian, primary peritoneal, or fallopian tube cancer.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21996013	(2011) Study of gastric fluid induced cytokine and chemokine expression in airway smooth muscle cells and airway remodeling.	2	8	2.61	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:22015869	(2011) Aspirin and heparin effect on basal and antiphospholipid antibody modulation of trophoblast function.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22018452	(2011) A critical review of early-onset and late-onset preeclampsia.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22035487	(2011) Abnormal vascular endothelial growth factor expression in mesenchymal stem cells from both osteonecrotic and osteoarthritic hips.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22077464	(2011) Improving delivery and efficacy of nanomedicines in solid tumors: role of tumor priming.	2	9	2.56	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:22082677	(2011) Heparin elevates circulating soluble fms-like tyrosine kinase-1 immunoreactivity in pregnant women receiving anticoagulation therapy.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22084722	(2011) Potential Agents against Plasma Leakage.	3	41	2.08	0.0461	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:22087332	(2011) A two-compartment model of VEGF distribution in the mouse.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22092404	(2011) Unexplained fetal death has a biological signature of maternal anti-fetal rejection: chronic chorioamnionitis and alloimmune anti-human leucocyte antigen antibodies.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22103490	(2011) An unexpected tail of VEGF and PlGF in pre-eclampsia.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22104283	(2011) Pharmacokinetics and pharmacodynamics of VEGF-neutralizing antibodies.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22114497	(2011) Intramyocardial sustained delivery of placental growth factor using nanoparticles as a vehicle for delivery in the rat infarct model.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22129087	(2011) Neuro-inflammation, blood-brain barrier, seizures and autism.	2	8	2.61	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:22130231	(2011) Vascular endothelial growth factor (VEGF), VEGF receptors and their inhibitors for antiangiogenic tumor therapy.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22144472	(2011) The evolution of endothelial regulatory paradigms in cancer biology and vascular repair.	2	7	2.67	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:22145143	(2011) Hypertension in pregnancy: The endocrine and metabolic aspect.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22162938	(2011) Challenges posed to the maternal circulation by pregnancy.	2	12	2.43	0.0461	9606.ENSP00000450482,9606.ENSP00000478570	BDKRB2,VEGFA
PMID:22172041	(2011) Recent progress in understanding molecular mechanisms of cartilage degeneration during osteoarthritis.	3	45	2.04	0.0461	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:22211145	(2011) Lasting controversy on ranibizumab and bevacizumab.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22295206	(2011) Neoadjuvant treatment in rectal cancer: actual status.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22346777	(2011) Blockade of Vascular Endothelial Growth Factor (VEGF) Aggravates the Severity of Acute Graft-versus-host Disease (GVHD) after Experimental Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT).	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22384440	(2011) Hormonal regulation of uterine chemokines and immune cells.	3	53	1.97	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:22902069	(2011) Placental growth factor as a protective paracrine effector in the heart.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24213109	(2011) Tumor-associated macrophages as incessant builders and destroyers of the cancer stroma.	3	53	1.97	0.0461	9606.ENSP00000231061,9606.ENSP00000451040,9606.ENSP00000478570	SPARC,PGF,VEGFA
PMID:19336420	(2010) Severe fibrotic changes and altered expression of angiogenic factors in maternal scleroderma: placental findings.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19538465	(2010) Reduction of circulating soluble Flt-1 alleviates preeclampsia-like symptoms in a mouse model.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19620132	(2010) Immaturity of microvessels in haemorrhagic plaques is associated with proteolytic degradation of angiogenic factors.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19639355	(2010) The effects of oxygen stresses on the development of features of severe retinopathy of prematurity: knowledge from the 5010 OIR model.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19720604	(2010) Flt-1 expression influences apoptotic susceptibility of vascular smooth muscle cells through the NF-kappaBIAP-1 pathway.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19761875	(2010) Structure-function analysis of VEGF receptor activation and the role of coreceptors in angiogenic signaling.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19762001	(2010) Automated assays for sVEGF R1 and PlGF as an aid in the diagnosis of preterm preeclampsia: a prospective clinical study.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19808712	(2010) Vascular metallomics: copper in the vasculature.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19840194	(2010) A systems biology perspective on sVEGFR1: its biological function, pathogenic role and therapeutic use.	2	12	2.43	0.0461	9606.ENSP00000363827,9606.ENSP00000451040	HSPG2,PGF
PMID:19852986	(2010) Corticotropin-releasing hormone attenuates vascular endothelial growth factor release from human HaCaT keratinocytes.	2	4	2.91	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:19853072	(2010) HO-1 expression increases mesenchymal stem cell-derived osteoblasts but decreases adipocyte lineage.	2	12	2.43	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:19876833	(2010) Critical growth factors and signalling pathways controlling human trophoblast invasion.	3	87	1.75	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:19882518	(2010) VEGF Trap(R1R2) suppresses experimental corneal angiogenesis.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19887303	(2010) Markers of haemostasis and angiogenesis in placentae from gestational vascular complications: impairment of mechanisms involved in maintaining intervillous blood flow.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19891735	(2010) Multi-targeted neuroprotection by the HSV-2 gene ICP10PK includes robust bystander activity through PI3-KAkt andor MEKERK-dependent neuronal release of vascular endothelial growth factor and fractalkine.	2	12	2.43	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:19924815	(2010) Estrogen-induced angiogenic factors derived from stromal and cancer cells are differently regulated by enterolactone and genistein in human breast cancer in vivo.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19931247	(2010) Human neural progenitor cells promote photoreceptor survival in retinal explants.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19944696	(2010) Hepatitis C virus infection reduces hepatocellular polarity in a vascular endothelial growth factor-dependent manner.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19952000	(2010) Short-term delivery of anti-PlGF antibody delays progression of atherosclerotic plaques to vulnerable lesions.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19996067	(2010) Progress toward identifying potential markers for preeclampsia: role of agonistic autoantibody to the angiotensin II type I receptor.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20004943	(2010) Quantitative expression of VEGF, VEGF-R1, VEGF-R2, and VEGF-R3 in melanoma tissue microarrays.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20005890	(2010) Anti-SPARC oligopeptide inhibits laser-induced CNV in mice.	2	5	2.81	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:20006475	(2010) VEGF-mediated signal transduction in lymphatic endothelial cells.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20022538	(2010) New insights in synovial angiogenesis.	3	77	1.8	0.0461	9606.ENSP00000006053,9606.ENSP00000231061,9606.ENSP00000478570	CX3CL1,SPARC,VEGFA
PMID:20026761	(2010) Inching towards a targeted therapy for preeclampsia.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20026764	(2010) Recombinant vascular endothelial growth factor 121 infusion lowers blood pressure and improves renal function in rats with placentalischemia-induced hypertension.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20038229	(2010) Chemokine polymorphisms and lymphoma: a pooled analysis.	2	8	2.61	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:20043119	(2010) PGF isoforms, PLGF-1 and PGF-2 and the PGF receptor, neuropilin, in human breast cancer: prognostic significance.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20069664	(2010) Maternal plasma and amniotic fluid angiogenic factors and their receptors in monochorionic twin pregnancies complicated by twin-to-twin transfusion syndrome.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20074343	(2010) Neurokinin B and pre-eclampsia: a decade of discovery.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20074690	(2010) Defining normal and abnormal fetal growth: promises and challenges.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20080567	(2010) HOXB9, a gene overexpressed in breast cancer, promotes tumorigenicity and lung metastasis.	2	9	2.56	0.0461	9606.ENSP00000362524,9606.ENSP00000478570	ANGPTL2,VEGFA
PMID:20080765	(2010) VEGFR1-mediated pericyte ablation links VEGF and PlGF to cancer-associated retinopathy.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20087061	(2010) The metal-responsive transcription factor-1 protein is elevated in human tumors.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20100589	(2010) Novel aspects of corneal angiogenic and lymphangiogenic privilege.	3	97	1.7	0.0461	9606.ENSP00000363827,9606.ENSP00000451040,9606.ENSP00000478570	HSPG2,PGF,VEGFA
PMID:20101671	(2010) Maternal plasma soluble fms-like tyrosine kinase-1 and free vascular endothelial growth factor at 11 to 13 weeks of gestation in preeclampsia.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20130818	(2010) Targeted therapy in ovarian cancer.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20132409	(2010) Mechanisms in the loss of capillaries in systemic sclerosis: angiogenesis versus vasculogenesis.	3	44	2.05	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:20133349	(2010) Arterial and venous thrombosis is associated with different angiogenic cytokine patterns in patients with antiphospholipid syndrome.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20142801	(2010) Absence of placental growth factor blocks dextran sodium sulfate-induced colonic mucosal angiogenesis, increases mucosal hypoxia and aggravates acute colonic injury.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20145150	(2010) A placental growth factor variant unable to recognize vascular endothelial growth factor (VEGF) receptor-1 inhibits VEGF-dependent tumor angiogenesis via heterodimerization.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20149453	(2010) Review: The placenta is a programming agent for cardiovascular disease.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20158393	(2010) Evidence in support of a role for anti-angiogenic factors in preterm prelabor rupture of membranes.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20158394	(2010) Serum and plasma determination of angiogenic and anti-angiogenic factors yield different results: the need for standardization in clinical practice.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20158395	(2010) Fetal death: a condition with a dissociation in the concentrations of soluble vascular endothelial growth factor receptor-2 between the maternal and fetal compartments.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20181085	(2010) Efficacy of thalidomide in a girl with inflammatory calcinosis, a severe complication of juvenile dermatomyositis.	2	8	2.61	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:20181837	(2010) SDF-1CXCR4 contributes to the activation of tip cells and microglia in retinal angiogenesis.	2	6	2.74	0.0461	9606.ENSP00000334329,9606.ENSP00000478570	UNC5B,VEGFA
PMID:20186736	(2010) An improved collagen scaffold for skeletal regeneration.	2	6	2.74	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:20195855	(2010) Comparison of endothelial biomarkers according to reversibility of pulmonary hypertension secondary to congenital heart disease.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20201838	(2010) Corticotropin-releasing hormone-receptor 2 is required for acute stress-induced bladder vascular permeability and release of vascular endothelial growth factor.	2	4	2.91	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:20223446	(2010) Nicotine restores endothelial dysfunction caused by excess sFlt1 and sEng in an in vitro model of preeclamptic vascular endothelium: a possible therapeutic role of nicotinic acetylcholine receptor (nAChR) agonists for preeclampsia.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20224572	(2010) Circulating angiogenic factors and their association with birth outcomes in preeclampsia.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20228380	(2010) Dysregulation of promyelocytic leukemia (PML) protein expression in preeclamptic placentae.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20298529	(2010) Notch regulates the angiogenic response via induction of VEGFR-1.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20360595	(2010) Maternal circulating CD34+VEGFR-2+ and CD133+VEGFR-2+ progenitor cells increase during normal pregnancy but are reduced in women with preeclampsia.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20371353	(2010) Further pharmacological and genetic evidence for the efficacy of PlGF inhibition in cancer and eye disease.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20374484	(2010) Tumor microvasculature and microenvironment: novel insights through intravital imaging in pre-clinical models.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20376344	(2010) HSPG-binding peptide corresponding to the exon 6a-encoded domain of VEGF inhibits tumor growth by blocking angiogenesis in murine model.	2	6	2.74	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:20382155	(2010) Establishment of culturing system for ex-vivo expansion of angiogenic immature erythroid cells, and its application for treatment of patients with chronic severe lower limb ischemia.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20385595	(2010) Alternate processing of Flt1 transcripts is directed by conserved cis-elements within an intronic region of FLT1 that reciprocally regulates splicing and polyadenylation.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20393507	(2010) Increased perfusion and angiogenesis in a hindlimb ischemia model with plasmid FGF-2 delivered by noninvasive electroporation.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20398289	(2010) Potent inhibition of tumoral hypoxia-inducible factor 1alpha by albendazole.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20407440	(2010) Issues on fit-for-purpose validation of a panel of ELISAs for application as biomarkers in clinical trials of anti-Angiogenic drugs.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20409151	(2010) Molecular mechanisms of enhanced wound healing by copper oxide-impregnated dressings.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20414842	(2010) Proinflammatory and profibrotic mediators: principal effectors of leiomyoma development as a fibrotic disorder.	3	107	1.66	0.0461	9606.ENSP00000231061,9606.ENSP00000451040,9606.ENSP00000478570	SPARC,PGF,VEGFA
PMID:20414975	(2010) Isolation of a novel basic FGF-binding peptide with   potent antiangiogenetic activity.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20417554	(2010) Biofunctionalization of electrospun PCL-based scaffolds with perlecan domain IV peptide to create a 3-D pharmacokinetic cancer model.	2	9	2.56	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:20425299	(2010) Gene expression studies in major depression.	2	13	2.4	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:20427725	(2010) Maternal obesity and overnutrition alter fetal growth rate and cotyledonary vascularity and angiogenic factor expression in the ewe.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20428821	(2010) The ratio of serum placenta growth factor to soluble vascular endothelial growth factor receptor-1 predicts the prognosis of hepatocellular carcinoma.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20431529	(2010) The effect of immune factors, tumor necrosis factor-alpha, and agonistic autoantibodies to the angiotensin II type I receptor on soluble fms-like tyrosine-1 and soluble endoglin production in response to hypertension during pregnancy.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20458050	(2010) Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20459642	(2010) Elevated IGFIR expression regulating VEGF and VEGF-C predicts lymph node metastasis in human colorectal cancer.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20462508	(2010) Green tea polyphenol epigallocatechin-3-gallate: inflammation and arthritis. [corrected].	3	53	1.97	0.0461	9606.ENSP00000006053,9606.ENSP00000220166,9606.ENSP00000478570	CX3CL1,CTSH,VEGFA
PMID:20473029	(2010) Cancer-associated retinopathy: a new mechanistic insight on vascular remodeling.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20473593	(2010) Circulating endothelial cells in essential thrombocythemia and polycythemia vera: correlation with JAK2-V617F mutational status, angiogenic factors and coagulation activation markers.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20484123	(2010) Plasma soluble VEGFR-1 is a potential dual biomarker of response and toxicity for bevacizumab with chemoradiation in locally advanced rectal cancer.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20488538	(2010) Inhibition of the PI3K-Akt pathway suppresses sFlt1 expression in human placental hypoxia models in vitro.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20491879	(2010) Urinary albumin excretion is associated with pulmonary hypertension in sickle cell disease: potential role of soluble fms-like tyrosine kinase-1.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20497994	(2010) Unveiling the vasodilatory actions and mechanisms of relaxin.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20503389	(2010) Postnatal development of the lamina reticularis in primate airways.	2	10	2.51	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:20514290	(2010) Inhibitory effects of anti-VEGF antibody on the growth and angiogenesis of estrogen-induced pituitary prolactinoma in Fischer 344 Rats: animal model of VEGF-targeted therapy for human endocrine tumors.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20525313	(2010) Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors.	2	9	2.56	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:20526760	(2010) Deterioration of glomerular endothelial surface layer induced by oxidative stress is implicated in altered permeability of macromolecules in Zucker fatty rats.	2	12	2.43	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:20531376	(2010) VEGF-B: a thing of beauty.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20565704	(2010) Relationship and prognostic significance of SPARC and VEGF protein expression in colon cancer.	2	3	3.04	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:20565712	(2010) Circulating levels of matrix proteases and their inhibitors in pregnant women with and without a history of recurrent pregnancy loss.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20571857	(2010) MCP-1 promotes mural cell recruitment during angiogenesis in the aortic ring model.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20575469	(2010) Utility of placental growth factor for prediction of 30-day adverse event in emergency department population with non-ST elevation acute coronary syndrome.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20587404	(2010) Antiangiogenic therapies in early-stage breast cancer.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20587530	(2010) Premetastatic lung niche: is vascular endothelial growth factor receptor 1 activation required?	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20593550	(2010) A multicenter, phase 2 study of vascular endothelial growth factor trap (Aflibercept) in platinum- and erlotinib-resistant adenocarcinoma of the lung.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20601535	(2010) Do anti-angiogenic or angiogenic factors contribute to the protection of birth weight at high altitude afforded by Andean ancestry?	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20615083	(2010) Plasma levels of angiogenic factors and circulating endothelial cells in essential thrombocythemia: correlation with cytoreductive therapy and JAK2-V617F mutational status.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20624307	(2010) Tocopherol induced angiogenesis in placental vascular network in late pregnant ewes.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20631824	(2010) Evolving refractory major depressive disorder diagnostic and treatment paradigms: toward closed-loop therapeutics.	2	10	2.51	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:20646741	(2010) Phase II study of Aflibercept (VEGF-Trap) in patients with recurrent or metastatic urothelial cancer, a California Cancer Consortium Trial.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20649935	(2010) Angiogenesis and biomarkers of cardiovascular risk in adults with metabolic syndrome.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20651234	(2010) Antibody treatment promotes compensation for human cytomegalovirus-induced pathogenesis and a hypoxia-like condition in placentas with congenital infection.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20659441	(2010) New markers in preeclampsia.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20679350	(2010) Impact of serum hepatocyte growth factor on treatment response to epidermal growth factor receptor tyrosine kinase inhibitors in patients with non-small cell lung adenocarcinoma.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20683032	(2010) Levels of elevated circulating endothelial cell decline after tumor resection in patients with pancreatic ductal adenocarcinoma.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20697002	(2010) Association of retinal vascular endothelial growth factor with avascular retina in a rat model of retinopathy of prematurity.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20699413	(2010) Synthetic progestins differentially promote or prevent 7,12-dimethylbenz(a)anthracene-induced mammary tumors in sprague-dawley rats.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20704762	(2010) Myocardial late gadolinium enhancement cardiovascular magnetic resonance in patients with cirrhosis.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20722022	(2010) CD248 and its cytoplasmic domain: a therapeutic target for arthritis.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20725100	(2010) Blood outgrowth endothelial cell-based systemic delivery of antiangiogenic gene therapy for solid tumors.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20727157	(2010) Kinetics of angiogenic changes in a new mouse model for hepatocellular carcinoma.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20739388	(2010) Biomarkers as predictors of response to treatment with motesanib in patients with progressive advanced thyroid cancer.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20826160	(2010) Effects of neuropeptide Y on collateral development in a swine model of chronic myocardial ischemia.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20828410	(2010) Similarity of recombinant human perlecan domain 1 by alternative expression systems bioactive heterogenous recombinant human perlecan D1.	2	13	2.4	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:20886389	(2010) Gene therapy from the perspective of systems biology.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20920154	(2010) Periodic assessment of plasma sFlt-1 and PlGF concentrations and its association with placental morphometry in gestational hypertension (GH) - a prospective follow-up study.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20924209	(2010) Hypoxia-inducible factor 1, hepatocellular carcinoma and angiogenesis.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20925202	(2010) Circulating angiogenic factors in pregnancies complicated by pre-eclampsia.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20951261	(2010) Spliced stromal cell-derived factor-1alpha analog stimulates endothelial progenitor cell migration and improves cardiac function in a dose-dependent manner after myocardial infarction.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20954461	(2010) Aetiology and physiopathology of preeclampsia and related forms.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20956209	(2010) Vascular dysfunction in women with a history of preeclampsia and intrauterine growth restriction: insights into future vascular risk.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20961309	(2010) Soluble VEGFR-2: an antilymphangiogenic variant of VEGF receptors.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20962354	(2010) Sorafenib prevents human retinal pigment epithelium cells from light-induced overexpression of VEGF, PDGF and PlGF.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20967275	(2010) Effect of smoking on circulating angiogenic factors in high risk pregnancies.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20978198	(2010) Differential effects of VEGFR-1 and VEGFR-2 inhibition on tumor metastases based on host organ environment.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20981316	(2010) Interleukin-6 as a potential therapeutic target for pulmonary arterial hypertension.	2	11	2.47	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:21047416	(2010) Soluble perlecan domain I enhances vascular endothelial growth factor-165 activity and receptor phosphorylation in human bone marrow endothelial cells.	2	13	2.4	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:21050477	(2010) Angiotensin II and angiotensin-(1-7) decrease sFlt1 release in normal but not preeclamptic chorionic villi: an in vitro study.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21103027	(2010) Pregnancy-induced hypertension and preeclampsia: levels of angiogenic factors in malaysian women.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21118571	(2010) Clinicopathological significance of platelet-derived growth factor (PDGF)-B and vascular endothelial growth factor-A expression, PDGF receptor-beta phosphorylation, and microvessel density in gastric cancer.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21118974	(2010) Increase of plasma VEGF after intravenous administration of bevacizumab is predicted by a pharmacokinetic model.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21126357	(2010) CCL2CCR2 and CX3CL1CX3CR1 chemokine axes and their possible involvement in age-related macular degeneration.	2	10	2.51	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:21146124	(2010) Hypertension induced by vascular endothelial growth factor signaling pathway inhibition: mechanisms and potential use as a biomarker.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21150016	(2010) Role of biomarkers in risk stratification of acute coronary syndrome.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21170149	(2010) Recent insights into the pathophysiology of preeclampsia.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21179485	(2010) Profiling of VEGFs and VEGFRs as prognostic factors in soft tissue sarcoma: VEGFR-3 is an independent predictor of poor prognosis.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21194438	(2010) Circulating endothelial cells are an early predictor in renal cell carcinoma for tumor response to sunitinib.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21226415	(2010) Specific role of lymphatic marker podoplanin in retinal pigment epithelial cells.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21234108	(2010) Enhanced healing of diabetic wounds by topical administration of adipose tissue-derived stromal cells overexpressing stromal-derived factor-1: biodistribution and engraftment analysis by bioluminescent imaging.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21278842	(2010) Neurological surgery at the National Institutes of Health.	2	6	2.74	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:21317448	(2010) Antiangiogenic agents in advanced gastrointestinal malignancies: past, present and a novel future.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21484030	(2010) [Preeclampsia: oxidative stress, inflammation and endothelial dysfunction].	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21505557	(2010) Myeloid cells in cancer progression: unique subtypes and their roles in tumor growth, vascularity, and host immune suppression.	3	43	2.06	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:21528105	(2010) Rosuvastatin counteracts vessel arterialisation and sinusoid capillarisation, reduces tumour growth, and prolongs survival in murine hepatocellular carcinoma.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23861616	(2010) Bevasiranib for the treatment of wet, age-related macular degeneration.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24179386	(2010) Circulating Natural IgM Antibodies Against Angiogenin in the Peripheral Blood Sera of Patients with Osteosarcoma as Candidate Biomarkers and Reporters of Tumorigenesis.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18192038	(2009) Elevation of plasma placental growth factor in the patients with ischemic cardiomyopathy.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18652540	(2009) Angiogenic capacity of human adipose-derived stromal cells during adipogenic differentiation: an in vitro study.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18665014	(2009) Investigation and characterization of the duct cell-enriching process during serum-free suspension and monolayer culture using the human exocrine pancreas fraction.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18816248	(2009) Vascular endothelial growth factor acts through novel, pregnancy-enhanced receptor signalling pathways to stimulate endothelial nitric oxide synthase activity in uterine artery endothelial cells.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18927470	(2009) Potential role for plasma placental growth factor in predicting coronary heart disease risk in women.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18952179	(2009) Bioengineering strategies to generate vascularized soft tissue grafts with sustained shape.	2	4	2.91	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:19028053	(2009) Limb ischemia after iliac ligation in aged mice stimulates angiogenesis without arteriogenesis.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19032146	(2009) Angiogenic factors and pre-eclampsia: an early marker is needed.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19050968	(2009) Identification of calreticulin as a prognosis marker and angiogenic regulator in human gastric cancer.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19075036	(2009) Regression of progestin-accelerated 7,12-dimethylbenz[a]anthracene-induced mammary tumors in Sprague-Dawley rats by p53 reactivation and induction of massive apoptosis: a pilot study.	2	5	2.81	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:19087223	(2009) Vascular biology of preeclampsia.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19115257	(2009) Cell surface heparan sulfate released by heparanase promotes melanoma cell migration and angiogenesis.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19118364	(2009) SufA - a bacterial enzyme that cleaves fibrinogen and blocks fibrin network formation.	2	10	2.51	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:19124387	(2009) Pre-eclampsia: the pivotal role of the placenta in its pathophysiology and markers for early detection.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19125649	(2009) Dual delivery of placental growth factor and vascular endothelial growth factor from poly(hydroxyethyl methacrylate-co-methyl methacrylate) microcapsules containing doubly transfected luciferase-expressing L929 cells.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19130404	(2009) Canonical and non-canonical pathways of osteoclast formation.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19147189	(2009) There are no estrogen and progesterone receptors in cerebral cavernomas: a preliminary immunohistochemical study.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19148474	(2009) Vascular endothelial growth factor blockade rapidly elicits alternative proangiogenic pathways in neuroblastoma.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19168169	(2009) Circulating angiogenic factors in gestational proteinuria without hypertension.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19174166	(2009) Fit-for-purpose validation of SearchLight multiplex ELISAs of angiogenesis for clinical trial use.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19175804	(2009) Oxygen, the Janus gas; its effects on human placental development and function.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19176215	(2009) Retinal vascular repair and neovascularization are not dependent on CX3CR1 signaling in a model of ischemic retinopathy.	2	10	2.51	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:19177163	(2009) Novel biochemical markers of psychosocial stress in women.	2	14	2.37	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:19201345	(2009) Hypoxia increases placenta growth factor expression in human myocardium and cultured neonatal rat cardiomyocytes.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19207011	(2009) Generation of a mouse monoclonal antibody recognizing both the native and denatured forms of human VEGF.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19215236	(2009) Effects of anti-hypertensive drugs on production of soluble fms-like tyrosine kinase 1 and soluble endoglin from human normal and pre-eclamptic placentas in vitro.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19230644	(2009) VEGFs and receptors involved in angiogenesis versus lymphangiogenesis.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19259624	(2009) Tumor stroma derived biomarkers in cancer.	2	9	2.56	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:19268361	(2009) Down-regulation of growth signaling pathways linked to a reduced cotyledonary vascularity in placentomes of over-nourished, obese pregnant ewes.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19275959	(2009) Vascular endothelial growth factors synthesized by human lung mast cells exert angiogenic effects.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19276301	(2009) Circulating endothelial cells and angiogenic proteins in patients with systemic lupus erythematosus.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19293668	(2009) Increased circulating placental growth factor during percutaneous coronary intervention is associated with applied radiocontrast agent.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19327525	(2009) Direct epicardial shock wave therapy improves ventricular function and induces angiogenesis in ischemic heart failure.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19333381	(2009) Blockade of VEGFR2 and not VEGFR1 can limit diet-induced fat tissue expansion: role of local versus bone marrow-derived endothelial cells.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19336729	(2009) Sunitinib prolongs survival in genetically engineered mouse models of multistep lung carcinogenesis.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19337591	(2009) Tumor associated stromal cells play a critical role on the outcome of the oncolytic efficacy of conditionally replicative adenoviruses.	2	11	2.47	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:19346489	(2009) G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19356732	(2009) Inhibitory effect of atractylenolide I on angiogenesis in chronic inflammation in vivo and in vitro.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19357774	(2009) Hypoxia induces dilated cardiomyopathy in the chick embryo: mechanism, intervention, and long-term consequences.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19365030	(2009) Suppression and regression of choroidal neovascularization by the multitargeted kinase inhibitor pazopanib.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19373690	(2009) Retinopathy of prematurity: current concepts in molecular pathogenesis.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19393057	(2009) Salivary VEGF: a non-invasive angiogenic and lymphangiogenic proxy in head and neck cancer prognostication.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19396960	(2009) Hepatic fibrosis.	3	48	2.01	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:19404922	(2009) Levels of cathepsins S and H in pleural fluids of inflammatory and neoplastic origin.	2	9	2.56	0.0461	9606.ENSP00000220166,9606.ENSP00000478570	CTSH,VEGFA
PMID:19415738	(2009) The function of vascular endothelial growth factor.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19418489	(2009) Association between color doppler vascularity index, angiogenesis-related molecules, and clinical outcomes in gastric cancer.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19420768	(2009) Evaluation of the antiangiogenic effects of 2-aryl-3-bromoquinolin-4(1H)-ones and a NCH3-4-oxo derivative.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19426483	(2009) Hypoxia upregulates angiogenesis and synovial cell migration in rheumatoid arthritis.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19435449	(2009) Amniotic fluid angiopoietin-2 in term and preterm parturition, and intra-amniotic infectioninflammation.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19437022	(2009) Urocortin and corticotropin-releasing factor receptor 2 in human renal cell carcinoma: disruption of an endogenous inhibitor of angiogenesis and proliferation.	2	9	2.56	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:19470735	(2009) Antimyeloangiogenic therapy for cancer by inhibiting PlGF.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19470921	(2009) Efficacy, safety, and biomarkers of neoadjuvant bevacizumab, radiation therapy, and fluorouracil in rectal cancer: a multidisciplinary phase II study.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19474289	(2009) Expression of angiogenesis-related genes in the cellular component of the blood of preeclamptic women.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19482180	(2009) Neuropeptides regulate expression of angiogenic growth factors in human dental pulp fibroblasts.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19498340	(2009) Maternal endothelial progenitor colony-forming units with macrophage characteristics are reduced in preeclampsia.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19505323	(2009) In vivo properties of the proangiogenic peptide QK.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19505392	(2009) Placenta growth factor is a survival factor for human malignant mesothelioma cells.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19505653	(2009) BK virus and human cancer: innocent until proven guilty.	2	5	2.81	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:19508152	(2009) Endothelial differentiation of amniotic fluid-derived stem cells: synergism of biochemical and shear force stimuli.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19509023	(2009) Regulation of the fibrosis and angiogenesis promoter SPARCosteonectin in human adipose tissue by weight change, leptin, insulin, and glucose.	2	13	2.4	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:19513111	(2009) Tumor vascular permeability to a nanoprobe correlates to tumor-specific expression levels of angiogenic markers.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19513511	(2009) Antiangiogenic versus cytotoxic therapeutic approaches in a mouse model of pancreatic cancer: an experimental study with a multitarget tyrosine kinase inhibitor (sunitinib), gemcitabine and radiotherapy.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19519199	(2009) Aflibercept in epithelial ovarian carcinoma.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19524720	(2009) Intestinal resection induces angiogenesis within adapting intestinal villi.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19530067	(2009) Autonomic circulatory control during pregnancy in humans.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19536308	(2009) Vascular endothelial growth factor upregulates expression of annexin A2 in vitro and in a mouse model of ischemic retinopathy.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19536709	(2009) Studies of placental vasculogenesis: a way to understand pregnancy pathology?	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19553699	(2009) Crystal structure of the LG1-3 region of the laminin alpha2 chain.	2	11	2.47	0.0461	9606.ENSP00000231061,9606.ENSP00000363827	SPARC,HSPG2
PMID:19553700	(2009) Angioinhibitory action of NK4 involves impaired extracellular assembly of fibronectin mediated by perlecan-NK4 association.	2	9	2.56	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:19558314	(2009) Regulation of osteogenesis-angiogenesis coupling by HIFs and VEGF.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19564554	(2009) Diabetic monocyte and vascular endothelial growth factor signaling impairment.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19564559	(2009) Diabetes mellitus activates signal transduction pathways resulting in vascular endothelial growth factor resistance of human monocytes.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19565563	(2009) miR-29 suppression of osteonectin in osteoblasts: regulation during differentiation and by canonical Wnt signaling.	2	10	2.51	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:19571580	(2009) Early signaling by vascular endothelial growth factor and placental growth factor in human bone marrow-derived endothelial cells is mediated by superoxide.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19576214	(2009) Reduction in endothelial tip cell filopodia corresponds to reduced intravitreous but not intraretinal vascularization in a model of ROP.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19584312	(2009) Lung parenchymal mechanics in health and disease.	2	13	2.4	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:19597474	(2009) The role of SPARC in the TRAMP model of prostate carcinogenesis and progression.	2	2	3.21	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:19602778	(2009) Treatment with recombinant placental growth factor (PlGF) enhances both angiogenesis and arteriogenesis and improves survival after myocardial infarction.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19608284	(2009) The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19632388	(2009) Placenta growth factor expression has prognostic value in malignant pleural mesothelioma.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19633554	(2009) Outcome of pregnancy in patients with isolated proteinuria.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19652083	(2009) Vascular endothelial growth factor inhibitors and hypertension: a central role for the kidney and endothelial factors?	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19653712	(2009) Anterior diffuse retinoblastoma: mutational analysis and immunofluorescence staining.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19657323	(2009) The biology of preeclampsia.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19668560	(2009) Age-related macular degeneration: current treatments.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19672468	(2009) Psychoneuroimmunology: application to ocular diseases.	2	13	2.4	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:19690493	(2009) Preoperative serum placenta growth factor level is a prognostic biomarker in colorectal cancer.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19706021	(2009) Maternal circulating TNF-alpha levels are highly correlated with IL-10 levels, but not IL-6 and IL-8 levels, in women with pre-eclampsia.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19716119	(2009) Placental gene transfer: transgene screening in mice for trophic effects on the placenta.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19719453	(2009) Angiogenesis inhibition in the treatment of prostate cancer.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19720393	(2009) Involvement of human decidual cell-expressed tissue factor in uterine hemostasis and abruption.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19723623	(2009) Pigment epithelium-derived factor maintains retinal pigment epithelium function by inhibiting vascular endothelial growth factor-R2 signaling through gamma-secretase.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19725916	(2009) The aortic ring model of angiogenesis: a quarter century of search and discovery.	3	101	1.69	0.0461	9606.ENSP00000334329,9606.ENSP00000451040,9606.ENSP00000478570	UNC5B,PGF,VEGFA
PMID:19754361	(2009) Increased tumor oxygenation and drug uptake during anti-angiogenic weekly low dose cyclophosphamide enhances the anti-tumor effect of weekly tirapazamine.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19759568	(2009) VEGFR1-activity-independent metastasis formation.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19769948	(2009) Prolactin induces Egr-1 gene expression in cultured hypothalamic cells and in the rat hypothalamus.	2	11	2.47	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:19786649	(2009) Effect of recombinant placental growth factor 2 on hypertension induced by full-length mouse soluble fms-like tyrosine kinase 1 adenoviral vector in pregnant mice.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19826039	(2009) Direct evidence that bevacizumab, an anti-VEGF antibody, up-regulates SDF1alpha, CXCR4, CXCL6, and neuropilin 1 in tumors from patients with rectal cancer.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19838361	(2009) Low-intensity pulsed ultrasound: Fracture healing.	2	7	2.67	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:19843006	(2009) Exogenous soluble VEGF receptor-1 (sFlt-1) regulates Th1Th2 cytokine production from normal placental explants via intracellular calcium.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19853925	(2009) Dysregulation of anti-angiogenic agents (sFlt-1, PLGF, and sEndoglin) in preeclampsia--a step forward but not the definitive answer.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19863375	(2009) Angiogenesis in rheumatoid arthritis.	3	76	1.81	0.0461	9606.ENSP00000231061,9606.ENSP00000451040,9606.ENSP00000478570	SPARC,PGF,VEGFA
PMID:19881969	(2009) Soluble and membranous vascular endothelial growth factor receptor-2 in pregnancies complicated by pre-eclampsia.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19900040	(2009) A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19914541	(2009) Issues regarding improving the impact of antiangiogenic drugs for the treatment of breast cancer.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19919522	(2009) Fetal and maternal angiogenicanti-angiogenic factors in normal and preeclamptic pregnancy.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19920106	(2009) Phase I and pharmacokinetic study of angiotensin-(1-7), an endogenous antiangiogenic hormone.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19924235	(2009) Selective inhibition of retinal angiogenesis by targeting PI3 kinase.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19924818	(2009) Collagen type IV and Perlecan exhibit dynamic localization in the Allantoic Core Domain, a putative stem cell niche in the murine allantois.	2	7	2.67	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:19930612	(2009) Prevention of elastase-induced emphysema in placenta growth factor knock-out mice.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19932778	(2009) Usefulness of soluble Fms-like tyrosine kinase-1 as a biomarker of acute severe heart failure in patients with acute myocardial infarction.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19944839	(2009) Neuroprotection in the newborn infant.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19962493	(2009) Pathophysiology of fibromyalgia.	2	9	2.56	0.0461	9606.ENSP00000006053,9606.ENSP00000276571	CX3CL1,CRH
PMID:19996864	(2009) The perinatal implications of angiogenic factors.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19997510	(2009) Distinct patterns of HIV-1 evolution within metastatic tissues in patients with non-Hodgkins lymphoma.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20025737	(2009) The effect of proteoglycans inhibited by RNA interference on metastatic characters of human salivary adenoid cystic carcinoma.	2	9	2.56	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:20041209	(2009) The presence of VEGF receptors on the luminal surface of endothelial cells affects VEGF distribution and VEGF signaling.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20046843	(2009) Erratum: Psychoneuroimmunology: application to ocular diseases.	2	13	2.4	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:20092749	(2009) [Down-regulated expression of UNC5b related to hepatocellular carcinoma angiogenesis].	2	3	3.04	0.0461	9606.ENSP00000334329,9606.ENSP00000478570	UNC5B,VEGFA
PMID:20161589	(2009) Sources of Urinary Proteins and their Analysis by Urinary Proteomics for the Detection of Biomarkers of Disease.	2	10	2.51	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:20352067	(2009) Novel Pharmacologic Approaches for the Management of Diabetic Retinopathy.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20616890	(2009) Targeted therapies in the management of colorectal carcinoma: role of bevacizumab.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21212834	(2009) Lessons from the Niche for Generation and Expansion of Hematopoietic Stem Cells.	2	8	2.61	0.0461	9606.ENSP00000362524,9606.ENSP00000478570	ANGPTL2,VEGFA
PMID:21556250	(2009) VEGF 936C > T Polymorphism and Association of BI-RADS Score in Women with Suspected Breast Cancer.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23198057	(2009) Vascular endothelial growth factors and their inhibitors in ocular neovascular disorders.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17553534	(2008) Molecular mechanisms of preeclampsia.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17692341	(2008) Regulation of multiple angiogenic pathways by Dll4 and Notch in human umbilical vein endothelial cells.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17879276	(2008) Role of vascular endothelial growth factor and angiopoietin systems in serum of Crohns disease patients.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17986606	(2008) Effects of visual experience on vascular endothelial growth factor expression during the postnatal development of the rat visual cortex.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17991885	(2008) 15-lipoxygenase-1 prevents vascular endothelial growth factor A- and placental growth factor-induced angiogenic effects in rabbit skeletal muscles via reduction in growth factor mRNA levels, NO bioactivity, and downregulation of VEGF receptor ...	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18006432	(2008) Activation of fractalkineCX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-AKDR and reverses hindlimb ischaemia.	2	4	2.91	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:18042800	(2008) alpha2beta1 integrin expression in the tumor microenvironment enhances tumor angiogenesis in a tumor cell-specific manner.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18097059	(2008) Chemokine receptor CX3CR1 mediates skin wound healing by promoting macrophage and fibroblast accumulation and function.	2	3	3.04	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:18156140	(2008) Enhanced functional response of CD133+ circulating progenitor cells in patients early after acute myocardial infarction.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18175241	(2008) A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver ...	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18175242	(2008) The maternal plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated in SGA and the magnitude of the increase relates to Doppler abnormalities in the maternal and fetal circulation.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18199827	(2008) HIF-1alpha regulates epithelial inflammation by cell autonomous NFkappaB activation and paracrine stromal remodeling.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18202163	(2008) Increased expression of placenta growth factor in COPD.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18230134	(2008) Cheiradone: a vascular endothelial cell growth factor receptor antagonist.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18258238	(2008) VEGF function for upregulation of endogenous PlGF expression during FGF-2-mediated therapeutic angiogenesis.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18264952	(2008) Physiological distribution of placental growth factor and soluble Flt-1 in early pregnancy.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18293205	(2008) Placental growth factor (PlGF) is a surrogate marker in preeclamptic hypertension.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18300957	(2008) Genetic markers of osteogenesis and angiogenesis are altered in processed lipoaspirate cells when cultured on three-dimensional scaffolds.	2	5	2.81	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:18322241	(2008) Protective roles of the fractalkineCX3CL1-CX3CR1 interactions in alkali-induced corneal neovascularization through enhanced antiangiogenic factor expression.	2	5	2.81	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:18328501	(2008) HMGB1-stimulated human primary cardiac fibroblasts exert a paracrine action on human and murine cardiac stem cells.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18330824	(2008) Whole-genome microarray and targeted analysis of angiogenesis-regulating gene expression (ENG, FLT1, VEGF, PlGF) in placentas from pre-eclamptic and small-for-gestational-age pregnancies.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18343373	(2008) Regulation of vascular endothelial growth factor-A and its soluble receptor sFlt-1 by luteinizing hormone in vivo: implication for ovarian follicle angiogenesis.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18350569	(2008) SPARC-induced increase in glioma matrix and decrease in vascularity are associated with reduced VEGF expression and secretion.	2	5	2.81	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:18404701	(2008) Perlecan, the jack of all trades proteoglycan of cartilaginous weight-bearing connective tissues.	2	3	3.04	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:18413304	(2008) Hypoxia is responsible for soluble vascular endothelial growth factor receptor-1 (VEGFR-1) but not for soluble endoglin induction in villous trophoblast.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18421240	(2008) PlGF-1 and VEGFR-1 pathway regulation of the external epithelial hemato-ocular barrier. A model for retinal edema.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18425358	(2008) p53-related apoptosis resistance and tumor suppression activity in UVB-induced premature senescent human skin fibroblasts.	2	7	2.67	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:18443332	(2008) Decidual cell-expressed tissue factor in human pregnancy and its involvement in hemostasis and preeclampsia-related angiogenesis.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18446652	(2008) The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18469803	(2008) Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18484196	(2008) Effects of corticotropin-releasing hormone and stresscopin on vascular endothelial growth factor mRNA expression in cultured early human extravillous trophoblasts.	2	5	2.81	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:18490835	(2008) Circulating leptin and angiogenic factors in preeclampsia patients.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18506785	(2008) Age-dependent impairment of HIF-1alpha expression in diabetic mice: Correction with electroporation-facilitated gene therapy increases wound healing, angiogenesis, and circulating angiogenic cells.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18507859	(2008) Expression of novel extracellular sulfatases Sulf-1 and Sulf-2 in normal and osteoarthritic articular cartilage.	2	14	2.37	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:18546869	(2008) Role of prorenin in the pathogenesis of retinal neovascularization.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18568405	(2008) The discovery of the placental growth factor and its role in angiogenesis: a historical review.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18593993	(2008) In vivo optical molecular imaging of vascular endothelial growth factor for monitoring cancer treatment.	2	6	2.74	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:18611064	(2008) Pro-angiogenic cytokines as cardiovascular therapeutics: assessing the potential.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18631405	(2008) Dinucleotide repeat polymorphism in Fms-like tyrosine kinase-1 (Flt-1) gene is not associated with preeclampsia.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18644991	(2008) Thymoquinone inhibits tumor angiogenesis and tumor growth through suppressing AKT and extracellular signal-regulated kinase signaling pathways.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18652948	(2008) Plasma levels of soluble Tie2 and vascular endothelial growth factor distinguish critical limb ischemia from intermittent claudication in patients with peripheral arterial disease.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18665074	(2008) Serum vascular endothelial growth factorsoluble vascular endothelial growth factor receptor 1 ratio is an independent prognostic marker in pancreatic cancer.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18669461	(2008) Antitumor activity and biomarker analysis of sunitinib in patients with bevacizumab-refractory metastatic renal cell carcinoma.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18669928	(2008) Fine-tuning the angiogenic response to vascular endothelial growth factor.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18677231	(2008) Dry eye and designer ophthalmics.	3	93	1.72	0.0461	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:18680722	(2008) VEGF receptor protein-tyrosine kinases: structure and regulation.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18682734	(2008) Three-dimensional analysis of vascular development in the mouse embryo.	2	13	2.4	0.0461	9606.ENSP00000334329,9606.ENSP00000478570	UNC5B,VEGFA
PMID:18682809	(2008) A reproducible and quantifiable model of choroidal neovascularization induced by VEGF A165 after subretinal adenoviral gene transfer in the rabbit.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18694994	(2008) Vascular endothelial growth factor receptor-1 contributes to resistance to anti-epidermal growth factor receptor drugs in human cancer cells.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18706274	(2008) Melanoma and the tumor microenvironment.	3	52	1.97	0.0461	9606.ENSP00000231061,9606.ENSP00000451040,9606.ENSP00000478570	SPARC,PGF,VEGFA
PMID:18708617	(2008) Drug delivery to posterior intraocular tissues: third Annual ARVOPfizer Ophthalmics Research Institute Conference.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18713470	(2008) A compartment model of VEGF distribution in blood, healthy and diseased tissues.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18719102	(2008) Netrin-4 inhibits angiogenesis via binding to neogenin and recruitment of Unc5B.	2	8	2.61	0.0461	9606.ENSP00000334329,9606.ENSP00000478570	UNC5B,VEGFA
PMID:18722574	(2008) Blood pressure augmentation and maternal circulating concentrations of angiogenic factors at delivery in preeclamptic and uncomplicated pregnancies.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18755139	(2008) Angiogenesis and growth factor modulation induced by alternagin C, a snake venom disintegrin-like, cysteine-rich protein on a rat skin wound model.	2	3	3.04	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:18757827	(2008) Overexpression of vascular endothelial growth factor-B in mouse heart alters cardiac lipid metabolism and induces myocardial hypertrophy.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18758911	(2008) Matrix vesicles are carriers of bone morphogenetic proteins (BMPs), vascular endothelial growth factor (VEGF), and noncollagenous matrix proteins.	2	9	2.56	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:18772115	(2008) Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18776949	(2008) Essential contribution of CCL3 to alkali-induced corneal neovascularization by regulating vascular endothelial growth factor production by macrophages.	2	12	2.43	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:18778566	(2008) The osteogenic-angiogenic interface: novel insights into the biology of bone formation and fracture repair.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18786179	(2008) VEGFR-2-mediated increased proliferation and survival in response to oxygen and glucose deprivation in PlGF knockout astrocytes.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18790389	(2008) Novel biomarkers for predicting preeclampsia.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18791178	(2008) A nonautonomous role for retinal frizzled-5 in regulating hyaloid vitreous vasculature development.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18792924	(2008) Gene expression in chorionic villous samples at 11 weeks gestation from women destined to develop preeclampsia.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18794121	(2008) Flt-1 signaling in macrophages promotes glioma growth in vivo.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18802023	(2008) Vascular endothelial growth factor-A specifies formation of native collaterals and regulates collateral growth in ischemia.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18839312	(2008) Control of growth factor networks by heparan sulfate proteoglycans.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18842520	(2008) Pathophysiology of cancer-related fatigue.	2	9	2.56	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:18845336	(2008) Vasoactivity to and endogenous release of vascular endothelial growth factor in the in vitro perfused human placental lobule from pregnancies complicated by preeclampsia.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18852292	(2008) Elevated levels of placental growth factor represent an adaptive host response in sepsis.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18922791	(2008) Modulation of angiogenesis by a tetrameric tripeptide that antagonizes vascular endothelial growth factor receptor 1.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18928341	(2008) Antiangiogenic therapy in brain tumors.	3	47	2.02	0.0461	9606.ENSP00000006053,9606.ENSP00000451040,9606.ENSP00000478570	CX3CL1,PGF,VEGFA
PMID:18948626	(2008) Vascular endothelial growth factor and the collateral circulation: the story continues.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18980226	(2008) HIPRPL29 antagonizes VEGF and FGF2 stimulated angiogenesis by interfering with HS-dependent responses.	2	10	2.51	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:19001927	(2008) Vascular endothelial growth factors in cardiovascular medicine.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19010294	(2008) Placental growth factor attenuates suppression of erythroid colony formation by interferon.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19010837	(2008) Vascular endothelial growth factor C stimulates progression of human gastric cancer via both autocrine and paracrine mechanisms.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19011671	(2008) Stress-induced senescence predominates in endothelial cells isolated from atherosclerotic chronic smokers.	2	4	2.91	0.0461	9606.ENSP00000362524,9606.ENSP00000478570	ANGPTL2,VEGFA
PMID:19018690	(2008) Placental ischemia and cardiovascular dysfunction in preeclampsia and beyond: making the connections.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19037039	(2008) Long-term blood pressure changes measured from before to after pregnancy relative to nonparous women.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19258657	(2008) Training-induced vascular adaptations to ischemic muscle.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19668729	(2008) Current and emerging therapies for the treatment of age-related macular degeneration.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20108480	(2008) Progress in obstetrics or the road to the promised land.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21221192	(2008) Ranibizumab: the evidence of its therapeutic value in neovascular age-related macular degeneration.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21918608	(2008) A network biology approach evaluating the anticancer effects of bortezomib identifies SPARC as a therapeutic target in adult T-cell leukemia cells.	2	14	2.37	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:16928195	(2007) Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17024106	(2007) Human blood late outgrowth endothelial cells for gene therapy of cancer: determinants of efficacy.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17082487	(2007) Therapeutic angiogenesis using novel vascular endothelial growth factor-Ehuman placental growth factor chimera genes.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17086423	(2007) Vascular endothelial growth factor inhibits the function of human mature dendritic cells mediated by VEGF receptor-2.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17110422	(2007) Analysis of the gene regulatory program induced by the homeobox transcription factor distal-less 3 in mouse placenta.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17115409	(2007) Vascular permeability induced by VEGF family members in vivo: role of endogenous PAF and NO synthesis.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17127249	(2007) Angiogenic factors and preeclampsia.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17127408	(2007) Corticotropin-releasing hormone and the blood-brain-barrier.	2	6	2.74	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:17137709	(2007) Placenta growth factor not vascular endothelial growth factor A or C can predict the early recurrence after radical resection of hepatocellular carcinoma.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17187248	(2007) Placental growth factor-1 and epithelial haemato-retinal barrier breakdown: potential implication in the pathogenesis of diabetic retinopathy.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17194893	(2007) Chimeric VEGF-ENZ7PlGF specifically binding to VEGFR-2 accelerates skin wound healing via enhancement of neovascularization.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17208447	(2007) Potential roles of the prokineticins in reproduction.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17221843	(2007) Vascular endothelial growth factor and angiopoietin are required for prostate regeneration.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17240241	(2007) Contrasting effects of chronic hypoxia and nitric oxide synthase inhibition on circulating angiogenic factors in a rat model of growth restriction.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17297258	(2007) The levels of circulating vascular endothelial growth factor and soluble Flt-1 in pregnancies complicated by preeclampsia.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17307732	(2007) Crystal structure and cell surface anchorage sites of laminin alpha1LG4-5.	2	8	2.61	0.0461	9606.ENSP00000231061,9606.ENSP00000363827	SPARC,HSPG2
PMID:17308051	(2007) Role of placenta growth factor in malignancy and evidence that an antagonistic PlGFFlt-1 peptide inhibits the growth and metastasis of human breast cancer xenografts.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17324579	(2007) Vascular endothelial growth factor (VEGF) signaling in tumor progression.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17330322	(2007) Angiogenic growth factor levels in maternal and fetal blood: correlation with Doppler ultrasound parameters in pregnancies complicated by pre-eclampsia and intrauterine growth restriction.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17344076	(2007) Vascular endothelial growth factor family of ligands and receptors: review.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17353919	(2007) Prognostic significance of vascular endothelial cell growth factors -A, -C and -D in breast cancer and their relationship with angio- and lymphangiogenesis.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17371983	(2007) Genetic deletion of placenta growth factor in mice alters uterine NK cells.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17383647	(2007) Different degrees of vascularization and their relationship to the expression of vascular endothelial growth factor, placental growth factor, angiopoietins, and their receptors in first-trimester decidual tissues.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17389231	(2007) Linker molecules between laminins and dystroglycan ameliorate laminin-alpha2-deficient muscular dystrophy at all disease stages.	2	12	2.43	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:17389265	(2007) Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17392818	(2007) VEGFPLGF induces leukemia cell migration via P38ERK12 kinase pathway, resulting in Rho GTPases activation and caveolae formation.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17420664	(2007) Preeclampsia: new insights.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17426083	(2007) Correlation between soluble endoglin, vascular endothelial growth factor receptor-1, and adipocytokines in preeclampsia.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17452111	(2007) Antigen expression of cord blood derived stem cells under osteogenic stimulation in vitro.	2	12	2.43	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:17459228	(2007) [Regulation of axon guidance cue netrin-1 on angiogenesis].	2	3	3.04	0.0461	9606.ENSP00000334329,9606.ENSP00000478570	UNC5B,VEGFA
PMID:17460297	(2007) Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin.	2	9	2.56	0.0461	9606.ENSP00000450482,9606.ENSP00000478570	BDKRB2,VEGFA
PMID:17462098	(2007) Global gene expression analysis and regulation of the principal genes expressed in bovine placenta in relation to the transcription factor AP-2 family.	3	60	1.91	0.0461	9606.ENSP00000231061,9606.ENSP00000276571,9606.ENSP00000478570	SPARC,CRH,VEGFA
PMID:17466267	(2007) A critical role of vascular endothelial growth factor D in zebrafish embryonic vasculogenesis and angiogenesis.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17486129	(2007) Identification of the high-risk group for metastasis of gastric cancer cases by vascular endothelial growth factor receptor-1 overexpression in peripheral blood.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17535974	(2007) Distinct vascular endothelial growth factor signals for lymphatic vessel enlargement and sprouting.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17545583	(2007) Human tumor xenografts recurring after radiotherapy are more sensitive to anti-vascular endothelial growth factor receptor-2 treatment than treatment-naive tumors.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17550303	(2007) Vascular endothelial growth factor mediates intracrine survival in human breast carcinoma cells through internally expressed VEGFR1FLT1.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17554150	(2007) The continuous erythropoietin receptor activator affects different pathways of diabetic renal injury.	2	5	2.81	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:17581219	(2007) Hypoxia-induced astrocytes promote the migration of neural progenitor cells via vascular endothelial factor, stem cell factor, stromal-derived factor-1alpha and monocyte chemoattractant protein-1 upregulation in vitro.	2	4	2.91	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:17615151	(2007) Erythropoietin inhibits basal and stimulated corticotropin-releasing hormone release from the rat hypothalamus via a nontranscriptional mechanism.	2	3	3.04	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:17634279	(2007) Lymphocyte contributions to altered endometrial angiogenesis during early and midgestation fetal loss.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17646268	(2007) Fluid shear stress upregulates vascular endothelial growth factor gene expression in osteoblasts.	2	7	2.67	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:17651752	(2007) Expression and function of vascular endothelial growth factor receptors (Flt-1 and Flk-1) in vascular adventitial fibroblasts.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17671153	(2007) Vascular endothelial growth factor trap in non small cell lung cancer.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17674262	(2007) Unexplained fetal death: another anti-angiogenic state.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17704140	(2007) Down-regulation of placenta growth factor by promoter hypermethylation in human lung and colon carcinoma.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17714938	(2007) Poly(ADP-ribose) polymerase (PARP) inhibition or PARP-1 gene deletion reduces angiogenesis.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17760831	(2007) Concepts of scaffold-based tissue engineering--the rationale to use solid free-form fabrication techniques.	2	10	2.51	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:17845154	(2007) Placental anomalies in children with infantile hemangioma.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17848952	(2007) Marrow angiogenesis-associated factors as prognostic biomarkers in patients with acute myelogenous leukaemia.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17890669	(2007) VEGF: an essential mediator of both angiogenesis and endochondral ossification.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17915218	(2007) VEGF modulation of retinal pigment epithelium resistance.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17923588	(2007) Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17942672	(2007) Multiple circulating proangiogenic factors induced by sunitinib malate are tumor-independent and correlate with antitumor efficacy.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17950332	(2007) Uniaxial mechanical strain: an in vitro correlate to distraction osteogenesis.	2	5	2.81	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:17951402	(2007) Normalization of the ovarian cancer microenvironment by SPARC.	2	5	2.81	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:17951895	(2007) Introduction, mechanism of action and rationale for anti-vascular endothelial growth factor drugs in age-related macular degeneration.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17964973	(2007) Circulating proangiogenic molecules PIGF, SDF-1 and sVCAM-1 in patients with systemic lupus erythematosus.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17970705	(2007) Altered angiogenesis in preeclampsia: evaluation of a new test system for measuring placental growth factor.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17980128	(2007) Analysis of soluble angiogenic factors in Crohns disease: a preliminary study.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17981115	(2007) Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17982238	(2007) Increased sFlt-1 to PlGF ratio in women who subsequently develop preeclampsia.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17991452	(2007) VEGF in physiological process and thyroid disease.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17997858	(2007) Increased lymphangiogenesis in joints of mice with inflammatory arthritis.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18006829	(2007) Placental growth factor-1 attenuates vascular endothelial growth factor-A-dependent tumor angiogenesis during beta cell carcinogenesis.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18021404	(2007) Therapeutic angiogenesis in cardiovascular disease.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18047998	(2007) [New insights in the pathophysiology of preeclampsia and potential therapeutic implications].	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18070938	(2007) Dual GPCR and GAG mimicry by the M3 chemokine decoy receptor.	2	13	2.4	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:18083934	(2007) Proteomic analysis of hydroxyapatite interaction proteins in bone.	2	12	2.43	0.0461	9606.ENSP00000231061,9606.ENSP00000363827	SPARC,HSPG2
PMID:18089720	(2007) Zoledronic acid inhibits osteosarcoma growth in an orthotopic model.	2	4	2.91	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:18154519	(2007) Angiogenesis in day-30 bovine pregnancies derived from nuclear transfer.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18160989	(2007) Impact of placental Plasmodium falciparum malaria on pregnancy and perinatal outcome in sub-Saharan Africa: I: introduction to placental malaria.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18200969	(2007) [Maternal serum concentration of angiogenic factors: PIGF, VEGF and VEGFR-1 and placental volume in pregnancies complicated by intrauterine growth restriction].	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18306920	(2007) [Maternal serum concentration of placental growth factor (PIGF) and endothelial growth factor (VEGF) in pregnancies complicated by preeclampsia].	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16155924	(2006) Elevated expression of hypoxia inducible factor-2alpha in terminally differentiating growth plate chondrocytes.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16187087	(2006) Multiple myeloma in a murine syngeneic model:modulation of growth and angiogenesis by a monoclonal antibody to kininogen.	2	6	2.74	0.0461	9606.ENSP00000450482,9606.ENSP00000478570	BDKRB2,VEGFA
PMID:16189273	(2006) Redundant roles of VEGF-B and PlGF during selective VEGF-A blockade in mice.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16216466	(2006) The placenta growth factor in skin angiogenesis.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16242694	(2006) Placental growth factor in the cerebrospinal fluid of women with preeclampsia.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16249383	(2006) VEGFR-1 (FLT-1) activation modulates acute lymphoblastic leukemia localization and survival within the bone marrow, determining the onset of extramedullary disease.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16278208	(2006) Cross-species vascular endothelial growth factor (VEGF)-blocking antibodies completely inhibit the growth of human tumor xenografts and measure the contribution of stromal VEGF.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16310040	(2006) Differential expression of vascular endothelial growth factor, placenta growth factor and their receptors in placentae from pregnancies complicated by placenta accreta.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16329123	(2006) Vascular endothelial growth factor stimulates neurite outgrowth from cerebral cortical neurons via Rho kinase signaling.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16332390	(2006) The anti-angiogenesis agent, AG-013736, has minimal activity in elderly patients with poor prognosis acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16341703	(2006) Human retinal epithelium produces and responds to placenta growth factor.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16403091	(2006) Granulocytemacrophage colony-stimulating factor treatment of human chronic ulcers promotes angiogenesis associated with de novo vascular endothelial growth factor transcription in the ulcer bed.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16428272	(2006) Pleiotropic role of VEGF-A in regulating fetal pulmonary mesenchymal cell turnover.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16458660	(2006) Circulating angiogenic factors in preeclampsia, gestational proteinuria, and preeclampsia superimposed on chronic glomerulonephritis.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16461039	(2006) Relation of various plasma growth factor levels in patients with stable angina pectoris and total occlusion of a coronary artery to the degree of coronary collaterals.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16472200	(2006) VEGF, a mediator of the effect of experience on hippocampal neurogenesis.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16479590	(2006) Human endothelial cells inhibit BMSC differentiation into mature osteoblasts in vitro by interfering with osterix expression.	2	6	2.74	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:16487969	(2006) Cervical sympathectomy regulates expression of key angiogenic factors in the rat choroid.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16511996	(2006) In vivo rat model of preeclampsia.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16520007	(2006) Angiogenic gene therapy as a potential therapeutic agent in chronic osteomyelitis.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16520388	(2006) Orphan nuclear receptor TR3Nur77 regulates VEGF-A-induced angiogenesis through its transcriptional activity.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16574650	(2006) Expression of vascular endothelial growth factor receptor 1 in bone marrow-derived mesenchymal cells is dependent on hypoxia-inducible factor 1.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16586492	(2006) Insulin-like growth factor binding protein-4 (IGFBP-4) is a novel anti-angiogenic and anti-tumorigenic mediator secreted by dibutyryl cyclic AMP (dB-cAMP)-differentiated glioblastoma cells.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16603182	(2006) Erythroid cells play essential roles in angiogenesis by bone marrow cell implantation.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16608872	(2006) Plgf--eNos-- mice show defective angiogenesis associated with increased oxidative stress in response to tissue ischemia.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16614757	(2006) Placental growth factor mediates mesenchymal cell development, cartilage turnover, and bone remodeling during fracture repair.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16616097	(2006) Human embryo-conditioned medium stimulates in vitro endometrial angiogenesis.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16618713	(2006) Placenta growth factor overexpression inhibits tumor growth, angiogenesis, and metastasis by depleting vascular endothelial growth factor homodimers in orthotopic mouse models.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16648417	(2006) Fractional excretion of angiogenic factors in women with severe preeclampsia.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16685275	(2006) Vascular endothelial growth factor receptor-1 mediates migration of human colorectal carcinoma cells by activation of Src family kinases.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16685460	(2006) Comparative integromics on VEGF family members.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16754748	(2006) VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16769024	(2006) Hypoadiponectinemia and circulating angiogenic factors in overweight patients complicated with pre-eclampsia.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16794222	(2006) Chimeric VEGF-E(NZ7)PlGF promotes angiogenesis via VEGFR-2 without significant enhancement of vascular permeability and inflammation.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16803577	(2006) Serum levels of angiogenic factors indicate a pro-angiogenic state in adults with sickle cell disease.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16814647	(2006) Atorvastatin increases plasma soluble Fms-like tyrosine kinase-1 and decreases vascular endothelial growth factor and placental growth factor in association with improvement of ventricular function in acute myocardial infarction.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16816146	(2006) Expression of angiogenic growth factors by uterine natural killer cells during early pregnancy.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16822315	(2006) Gene identification and analysis of transcripts differentially regulated in fracture healing by EST sequencing in the domestic sheep.	3	83	1.77	0.0461	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:16839256	(2006) Iodide inhibits vascular endothelial growth factor-A expression in cultured human thyroid follicles: a microarray search for effects of thyrotropin and iodide on angiogenesis factors.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16839420	(2006) Endostatin inhibits VEGF-A induced osteoclastic bone resorption in vitro.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16843105	(2006) A translocation involving the placental growth factor gene is identified in an epithelioid hemangioendothelioma.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16877362	(2006) Increased melanoma growth and metastasis spreading in mice overexpressing placenta growth factor.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16890727	(2006) Acute stress and intravesical corticotropin-releasing hormone induces mast cell dependent vascular endothelial growth factor release from mouse bladder explants.	2	3	3.04	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:16923853	(2006) Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16955048	(2006) Absence of tight junctions between microvascular endothelial cells in human cerebellar hemangioblastomas.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16964430	(2006) Role of bone morphogenetic protein 2 in the crosstalk between endothelial progenitor cells and mesenchymal stem cells.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16979977	(2006) Expression of fractalkine, CX3CR1, and vascular endothelial growth factor in human chronic renal allograft rejection.	2	3	3.04	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:16995949	(2006) In vivo glioblastoma growth is reduced by apyrase activity in a rat glioma model.	2	12	2.43	0.0461	9606.ENSP00000304767,9606.ENSP00000478570	P2RY1,VEGFA
PMID:17003476	(2006) Placenta growth factor in diabetic wound healing: altered expression and therapeutic potential.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17023682	(2006) Tissue factor pathway inhibitor-2 is upregulated by vascular endothelial growth factor and suppresses growth factor-induced proliferation of endothelial cells.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17031284	(2006) Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17047543	(2006) Osteogenic protein-1 induced gene expression: evaluation in a posterolateral spinal pseudarthrosis model.	2	5	2.81	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:17051153	(2006) Corneal avascularity is due to soluble VEGF receptor-1.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17065039	(2006) Circulating angiogenic factors and abnormal uterine artery Doppler velocimetry in the second trimester.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17065408	(2006) Localization of vascular endothelial growth factor (VEGF) receptors in normal and adenomatous pituitaries: detection of a non-endothelial function of VEGF in pituitary tumours.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17099328	(2006) First trimester screening for preeclampsia.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17102093	(2006) Expression of mRNAs for succinate dehydrogenase subunits and related genes in pheochromocytoma.	2	7	2.67	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:17105340	(2006) Hypertension and maternal-fetal conflict during placental malaria.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17108129	(2006) Inhibition of prostate tumor growth and bone remodeling by the vascular targeting agent VEGF121rGel.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17122145	(2006) Time-lapse imaging of vitreoretinal angiogenesis originating from both quiescent and mature vessels in a novel ex vivo system.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17159877	(2006) [Neoangiogenesis and coronary atherosclerosis: diagnostic value of a novel biochemical marker placenta growth factor in patients with ischemic heart disease].	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17173683	(2006) TRPV1 antagonists attenuate antigen-provoked cough in ovalbumin sensitized guinea pigs.	2	11	2.47	0.0461	9606.ENSP00000304767,9606.ENSP00000450482	P2RY1,BDKRB2
PMID:17183639	(2006) Short and long-term effects of hVEGF-A(165) in Cre-activated transgenic mice.	2	14	2.37	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17196035	(2006) Targeting neuropilin-1 to inhibit VEGF signaling in cancer: Comparison of therapeutic approaches.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17526946	(2006) Effects of estradiol-17beta on expression of mRNA for seven angiogenic factors and their receptors in the endometrium of ovariectomized (OVX) ewes.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:15297261	(2005) The gene transfer of soluble VEGF type I receptor (Flt-1) attenuates peritoneal fibrosis formation in mice but not soluble TGF-beta type II receptor gene transfer.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:15471974	(2005) VEGF receptor antagonism blocks arteriogenesis, but only partially inhibits angiogenesis, in skeletal muscle of exercise-trained rats.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:15572379	(2005) A novel role for vascular endothelial growth factor as an autocrine survival factor for embryonic stem cells during hypoxia.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:15591804	(2005) Isolated placental vessel response to vascular endothelial growth factor and placenta growth factor in normal and growth-restricted pregnancy.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:15611243	(2005) Differential roles of vascular endothelial growth factor receptors 1 and 2 in dendritic cell differentiation.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:15637071	(2005) Vascular endothelial growth factor (VEGF)-A165-induced prostacyclin synthesis requires the activation of VEGF receptor-1 and -2 heterodimer.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:15663401	(2005) Concentration of cord serum placenta growth factor in normal and diabetic pregnancies.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:15668800	(2005) Expression of mRNAs encoding for growth factors, ECM molecules, and MMP13 in mono-cultures and co-cultures of human periodontal ligament fibroblasts and alveolar bone cells.	2	5	2.81	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:15705190	(2005) Marked alveolar apoptosisproliferation imbalance in end-stage emphysema.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:15708122	(2005) Hypoxia-induced increase in soluble Flt-1 production correlates with enhanced oxidative stress in trophoblast cells from the human placenta.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:15710418	(2005) Upregulation of placental growth factor by vascular endothelial growth factor via a post-transcriptional mechanism.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:15717861	(2005) Maternal plasma VEGF, sVEGF-R1, and PlGF concentrations in preeclamptic and normotensive pregnant Zimbabwean women.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:15721752	(2005) Guidance of vascular and neural network formation.	2	4	2.91	0.0461	9606.ENSP00000334329,9606.ENSP00000478570	UNC5B,VEGFA
PMID:15746665	(2005) Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:15760768	(2005) Modulation of angiogenesis with siRNA inhibitors for novel therapeutics.	3	70	1.84	0.0461	9606.ENSP00000231061,9606.ENSP00000451040,9606.ENSP00000478570	SPARC,PGF,VEGFA
PMID:15788688	(2005) Vascular endothelial growth factor: a therapeutic target for tumors of the Ewings sarcoma family.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:15790923	(2005) Altered gene expression of angiogenic factors induced by calcium-mediated dissociation of retinal pigment epithelial cells.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:15795937	(2005) Enhanced angiogenesis characteristic of SPARC-null mice disappears with age.	2	2	3.21	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:15804781	(2005) Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:15807839	(2005) Placenta growth factor and vascular endothelial growth factor in the vitreous of patients with proliferative vitreoretinopathy.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:15814646	(2005) Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:15818117	(2005) Role of vascular endothelial growth factor receptor 1 and vascular endothelial growth factor receptor 2 in the vasodilator response to vascular endothelial growth factor in the neonatal piglet lung.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:15830105	(2005) [Promoting effects of serum-free murine bone marrow endothelial cell conditioned medium on the growth of bone marrow endothelial cells].	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:15831913	(2005) Placenta growth factor expression is correlated with survival of patients with colorectal cancer.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:15858091	(2005) Effect of thalidomide in hepatocellular carcinoma: assessment with power doppler US and analysis of circulating angiogenic factors.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:15886253	(2005) Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:15921668	(2005) Constitutively active HIF-1alpha improves perfusion and arterial remodeling in an endovascular model of limb ischemia.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:15935542	(2005) Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:15944267	(2005) Human mast cells express corticotropin-releasing hormone (CRH) receptors and CRH leads to selective secretion of vascular endothelial growth factor.	2	8	2.61	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:15960987	(2005) The role of mast cells in migraine pathophysiology.	2	7	2.67	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:15984940	(2005) Evolutionary analysis of human vascular endothelial growth factor, angiopoietin, and tyrosine endothelial kinase involved in angiogenesis and immunity.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:15987429	(2005) Muscarinic receptors participation in angiogenic response induced by macrophages from mammary adenocarcinoma-bearing mice.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:15987470	(2005) Laminin isoform expression in breast tumors.	2	10	2.51	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:16005848	(2005) VEGF-A and PlGF-1 stimulate chemotactic migration of human mesenchymal progenitor cells.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16020476	(2005) Modulation of angiogenesis during adipose tissue development in murine models of obesity.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16021053	(2005) Circulating levels of the antiangiogenic marker sFLT-1 are increased in first versus second pregnancies.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16061605	(2005) Excess soluble fms-like tyrosine kinase 1 and low platelet counts in premature neonates of preeclamptic mothers.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16104843	(2005) The vascular endothelial growth factor (VEGF)VEGF receptor system and its role under physiological and pathological conditions.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16105099	(2005) Serum levels of macrophage colony stimulating, vascular endothelial, and placenta growth factor in relation to later clinical onset of pre-eclampsia and a small-for-gestational age birth.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16118694	(2005) Targeting angiogenesis with antibodies for the treatment of cancer.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16131818	(2005) Expression of placenta growth factor mRNA in the rat placenta during mid-late pregnancy.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16146532	(2005) Placenta growth factor stimulates the growth of Philadelphia chromosome positive acute lymphoblastic leukemia cells by both autocrine and paracrine pathways.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16158464	(2005) Recent advances in understanding of preeclampsia.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16164411	(2005) NF-kappaB contributes to transcription of placenta growth factor and interacts with metal responsive transcription factor-1 in hypoxic human cells.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16193234	(2005) Patterns and localization of gene expression during intramembranous bone regeneration in the rat femoral marrow ablation model.	2	12	2.43	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:16194038	(2005) [Development and congenital malformations of the skeleton].	2	10	2.51	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:16205625	(2005) Influence of cyclical mechanical strain on extracellular matrix gene expression in human lamina cribrosa cells in vitro.	2	10	2.51	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:16223445	(2005) Expression of Placenta growth factor (PlGF) in non-small cell lung cancer (NSCLC) and the clinical and prognostic significance.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16229897	(2005) Lymphokine-activated killer cells induced from decidual lymphocytes reduce the angiogenic activity of trophoblasts by enhancing the release of soluble fms-like tyrosine kinase-1 from trophoblasts: an implication for the pathophysiology of ...	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16230516	(2005) Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16258196	(2005) Vascular endothelial growth factor and placenta growth factor in intrauterine growth-restricted fetuses and neonates.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16258339	(2005) Uterine artery Doppler screening for adverse pregnancy outcome.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16275058	(2005) Placenta growth factor is over-expressed and has prognostic value in human breast cancer.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16297527	(2005) Functions of alpha 2 macroglobulins in pregnancy.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16305657	(2005) A review of trafficking and activation of uterine natural killer cells.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16307652	(2005) Distribution and colocalization of markers for proliferation, invasion, motility and neoangiogenesis in benign melanocytic naevi and malignant melanomas.	2	7	2.67	0.0461	9606.ENSP00000220166,9606.ENSP00000478570	CTSH,VEGFA
PMID:16314484	(2005) Absence of host-secreted protein acidic and rich in cysteine (SPARC) augments peritoneal ovarian carcinomatosis.	2	2	3.21	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:16320832	(2005) Unique expression and regulatory mechanisms of EG-VEGFprokineticin-1 and its receptors in the corpus luteum.	2	6	2.74	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:16327548	(2005) Role of bovine bone morphogenetic proteins in bone matrix protein and osteoblast-related gene expression during rat bone marrow stromal cell differentiation.	2	7	2.67	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:16351462	(2005) Association between angiogenesis soluble factors and disease progression markers in chronic hepatitis C patients.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16390273	(2005) Adenovirus-mediated gene transfer of placental growth factor to perivascular tissue induces angiogenesis via upregulation of the expression of endogenous vascular endothelial growth factor-A.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18050423	(2005) Basement membranes.	2	3	3.04	0.0461	9606.ENSP00000231061,9606.ENSP00000363827	SPARC,HSPG2
PMID:12714333	(2004) Model of competitive binding of vascular endothelial growth factor and placental growth factor to VEGF receptors on endothelial cells.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:14633511	(2004) Vascular endothelial growth factor-induced secretion of fibronectin is ERK dependent.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:14644931	(2004) Overexpression of placenta growth factor contributes to the pathogenesis of pulmonary emphysema.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:14679134	(2004) Increased levels of viable circulating endothelial cells are an indicator of progressive disease in cancer patients.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:14684734	(2004) The crystal structure of placental growth factor in complex with domain 2 of vascular endothelial growth factor receptor-1.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:14704231	(2004) Localization of VEGFR-2 and PLD2 in endothelial caveolae is involved in VEGF-induced phosphorylation of MEK and ERK.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:14729679	(2004) Up-regulation of vascular endothelial growth factor-A by active membrane-type 1 matrix metalloproteinase through activation of Src-tyrosine kinases.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:14741347	(2004) Placental growth factor induces FosB and c-Fos gene expression via Flt-1 receptors.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:14747500	(2004) Prognostic value of placental growth factor in patients with acute chest pain.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:14764923	(2004) Circulating angiogenic factors and the risk of preeclampsia.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:14972444	(2004) Aspects of human fetoplacental vasculogenesis and angiogenesis. II. Changes during normal pregnancy.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:14984769	(2004) Genetic dissection of tumor angiogenesis: are PlGF and VEGFR-1 novel anti-cancer targets?	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:14985076	(2004) Coordinated activation of VEGFR-1 and VEGFR-2 is a potent arteriogenic stimulus leading to enhancement of regional perfusion.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:15017560	(2004) Biomolecular markers and involution of hemangiomas.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:15023891	(2004) Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:15072443	(2004) Functional significance of vascular endothelial growth factor receptor expression on human glioma cells.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:15083245	(2004) Expression of angiogenic factors and their receptors in postnatal mouse developing lung.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:15086970	(2004) Genomic and proteomic analyses of vascular endothelial growth factor and insulin-like growth factor-binding protein 3 in lung adenocarcinomas.	2	3	3.04	0.0461	9606.ENSP00000450482,9606.ENSP00000478570	BDKRB2,VEGFA
PMID:15126502	(2004) Anti-chemorepulsive effects of vascular endothelial growth factor and placental growth factor-2 in dorsal root ganglion neurons are mediated via neuropilin-1 and cyclooxygenase-derived prostanoid production.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:15131009	(2004) Vascular endothelial growth factor receptor-2-induced initial endothelial cell migration depends on the presence of the urokinase receptor.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:15183893	(2004) Vascular endothelial growth factor receptor-1 and receptor-2 initiate a phosphatidylinositide 3-kinase-dependent clonogenic response in acute myeloid leukemia cells.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:15184289	(2004) Circulating humoral factors and endothelial progenitor cells in patients with differing coronary collateral support.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:15184403	(2004) Integrin alphaVbeta6-mediated activation of latent TGF-beta requires the latent TGF-beta binding protein-1.	2	12	2.43	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:15192038	(2004) Blockage of VEGF-induced angiogenesis by preventing VEGF secretion.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:15212678	(2004) Determinants of placental vascularity.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:15236649	(2004) The placental problem: linking abnormal cytotrophoblast differentiation to the maternal symptoms of preeclampsia.	2	12	2.43	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:15258583	(2004) VEGF links hippocampal activity with neurogenesis, learning and memory.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:15271665	(2004) Time course of changes in collateral blood flow and isolated vessel size and gene expression after femoral artery occlusion in rats.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:15272021	(2004) Identification of placenta growth factor determinants for binding and activation of Flt-1 receptor.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:15277392	(2004) Diminished loss of proteoglycans and lack of albuminuria in protein kinase C-alpha-deficient diabetic mice.	2	5	2.81	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:15284201	(2004) Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:15284224	(2004) Decay-accelerating factor induction on vascular endothelium by vascular endothelial growth factor (VEGF) is mediated via a VEGF receptor-2 (VEGF-R2)- and protein kinase C-alphaepsilon (PKCalphaepsilon)-dependent cytoprotective signaling ...	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:15312686	(2004) The significance of placenta growth factor in angiogenesis and clinical outcome of human gastric cancer.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:15472115	(2004) Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:15472126	(2004) Essential role of vascular endothelial growth factor and Flt-1 signals in neointimal formation after periadventitial injury.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:15501243	(2004) Expression of placenta growth factor is regulated by both VEGF and hyperglycaemia via VEGFR-2.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:15509502	(2004) Vascular endothelial growth factor stimulates skeletal muscle regeneration in vivo.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:15516835	(2004) Bioinformatic analysis of primary endothelial cell gene array data illustrated by the analysis of transcriptome changes in endothelial cells exposed to VEGF-A and PlGF.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:15534089	(2004) Angiogenic profile of breast carcinoma determines leukocyte infiltration.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:15609082	(2004) Placenta growth factor is not required for exercise-induced angiogenesis.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:15613462	(2004) Distinct gene expression profiles in norepinephrine- and epinephrine-producing hereditary and sporadic pheochromocytomas: activation of hypoxia-driven angiogenic pathways in von Hippel-Lindau syndrome.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:12393422	(2003) A critical role of placental growth factor in the induction of inflammation and edema formation.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:12406876	(2003) Autocrine-paracrine VEGF loops potentiate the maturation of megakaryocytic precursors through Flt1 receptor.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:12511587	(2003) Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:12548214	(2003) Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:12551914	(2003) A set of loop-1 and -3 structures in the novel vascular endothelial growth factor (VEGF) family member, VEGF-ENZ-7, is essential for the activation of VEGFR-2 signaling.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:12556420	(2003) Role of vascular endothelial growth factor and placental growth factors during retinal vascular development and hyaloid regression.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:12581744	(2003) Inhibition of breast carcinoma and trophoblast cell invasiveness by vascular endothelial growth factor.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:12586442	(2003) A new role for corticotropin-releasing factor receptor-2: suppression of vascularization.	2	3	3.04	0.0461	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:12600898	(2003) VEGFR-1-selective VEGF homologue PlGF is arteriogenic: evidence for a monocyte-mediated mechanism.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:12610509	(2003) Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinoma.	2	10	2.51	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:12618519	(2003) Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:12670505	(2003) Vascular endothelial growth factor upregulates pigment epithelium-derived factor expression via VEGFR-1 in human retinal pigment epithelial cells.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:12673673	(2003) Altered tumor vessel maturation and proliferation in placenta growth factor-producing tumors: potential relationship to post-therapy tumor angiogenesis and recurrence.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:12678905	(2003) Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:12714517	(2003) Placenta growth factor activates monocytes and correlates with sickle cell disease severity.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:12740423	(2003) The relationship between transplacental O2 diffusion and placental expression of PlGF, VEGF and their receptors in a placental insufficiency model of fetal growth restriction.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:12744932	(2003) Vascular endothelial growth factor is a chemoattractant for trophoblast cells.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:12766907	(2003) Modulation of the angiogenesis response through Ha-ras control, placenta growth factor, and angiopoietin expression in mouse skin carcinogenesis.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:12796773	(2003) Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:12798535	(2003) Second-trimester maternal serum placental growth factor and vascular endothelial growth factor for predicting severe, early-onset preeclampsia.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:12823854	(2003) Upregulated hypoxia inducible factor-1alpha and -2alpha pathway in rheumatoid arthritis and osteoarthritis.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:12824270	(2003) Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:12871269	(2003) Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:12888864	(2003) Lymphangiogenic growth factors, receptors and therapies.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:12893832	(2003) Vascular endothelial growth factor up-regulates expression of receptor activator of NF-kappa B (RANK) in endothelial cells. Concomitant increase of angiogenic responses to RANK ligand.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:12898593	(2003) Quantitative analysis of colorectal tissue microarrays by immunofluorescence and in situ hybridization.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:12911439	(2003) Maternal plasma levels of cytokines in normal and preeclamptic pregnancies and their relationship with diastolic blood pressure and fibronectin levels.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:12937134	(2003) Survivin-dependent angiogenesis in ischemic brain: molecular mechanisms of hypoxia-induced up-regulation.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:12951850	(2003) [Angiogenic proteins: possible markers of physiopathological processes during fetal development].	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:12954624	(2003) A vascular endothelial growth factor high affinity receptor 1-specific peptide with antiangiogenic activity identified using a phage display peptide library.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:12965086	(2003) Angiogenesis and vasculogenesis in pregnancy.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:13678427	(2003) Adipocyte-derived leucine aminopeptidase genotype and response to antihypertensive therapy.	2	10	2.51	0.0461	9606.ENSP00000450482,9606.ENSP00000478570	BDKRB2,VEGFA
PMID:13678594	(2003) Transcriptional activation of placental growth factor by the forkheadwinged helix transcription factor FoxD1.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:13678785	(2003) Bone morphogenetic protein 2 induces placental growth factor in mesenchymal stem cells.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:13680354	(2003) VEGF and PlGF: two pleiotropic growth factors with distinct roles in development and homeostasis.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:14505757	(2003) Role of vascular endothelial growth factor and placental growth factor in basal adhesion formation and in carbon dioxide pneumoperitoneum-enhanced adhesion formation after laparoscopic surgery in transgenic mice.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:14515175	(2003) Role of c-kitKit ligand signaling in regulating vasculogenesis.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:14519482	(2003) Elevated serum concentrations of the angiogenesis inhibitor endostatin in preeclamptic women.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:14519649	(2003) Differential vascular and transcriptional responses to anti-vascular endothelial growth factor antibody in orthotopic human pancreatic cancer xenografts.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:14525795	(2003) Vascular endothelial growth factor-regulated gene expression in endothelial cells: KDR-mediated induction of Egr3 and the related nuclear receptors Nur77, Nurr1, and Nor1.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:14563949	(2003) Pediatric tumor cells express erythropoietin and a functional erythropoietin receptor that promotes angiogenesis and tumor cell survival.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:14568677	(2003) Evidence of a novel isoform of placenta growth factor (PlGF-4) expressed in human trophoblast and endothelial cells.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:14576200	(2003) Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:14580149	(2003) Effect of hypoxia on the expression of fractalkine in human endothelial cells.	2	5	2.81	0.0461	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:14602804	(2003) Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:14626450	(2003) Selective inhibition of vascular endothelial growth factor receptor-2 (VEGFR-2) identifies a central role for VEGFR-2 in human aortic endothelial cell responses to VEGF.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:14633857	(2003) Activation of vascular endothelial growth factor receptor-1 sustains angiogenesis and Bcl-2 expression via the phosphatidylinositol 3-kinase pathway in endothelial cells.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:14657382	(2003) Transforming growth factor beta1 induction of vascular endothelial growth factor receptor 1: mechanism of pericyte-induced vascular survival in vivo.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:14666676	(2003) Placental growth factor gene expression in human prostate cancer and benign prostate hyperplasia.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:14668430	(2003) Trophoblast expression of fms-like tyrosine kinase 1 is not required for the establishment of the maternal-fetal interface in the mouse placenta.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:14680729	(2003) Age-dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:14691306	(2003) VEGF(121) and VEGF(165) regulate blood vessel diameter through vascular endothelial growth factor receptor 2 in an in vitro angiogenesis model.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:14981951	(2003) Prognostic significance of plasma placental growth factor levels in renal cell cancer: an association with clinical characteristics and vascular endothelial growth factor levels.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:15041796	(2003) An engineered heparin-binding form of VEGF-E (hbVEGF-E). Biological effects in vitro and mobilizatiion of precursor cells.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:11786394	(2002) Human herpesvirus-8-transformed endothelial cells have functionally activated vascular endothelial growth factorvascular endothelial growth factor receptor.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:11943725	(2002) Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:11945079	(2002) Placental expression of VEGF, PlGF and their receptors in a model of placental insufficiency-intrauterine growth restriction (PI-IUGR).	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:11948135	(2002) Tumor-specific regulation of angiogenic growth factors and their receptors during recovery from cytotoxic therapy.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:11953816	(2002) Increased pre-therapeutic serum vascular endothelial growth factor in patients with early clinical relapse of osteosarcoma.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:11969343	(2002) Growth factor rescue of cytokine mediated trophoblast apoptosis.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:11986311	(2002) Neuropilin-1 binds vascular endothelial growth factor 165, placenta growth factor-2, and heparin via its b1b2 domain.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:11986782	(2002) Thymidine phosphorylase expression in normal, hyperplastic and neoplastic prostates: correlation with tumour associated macrophages, infiltrating lymphocytes, and angiogenesis.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:12007738	(2002) Role of placenta growth factor in cardiovascular health.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:12019148	(2002) Placental growth factor is a survival factor for tumor endothelial cells and macrophages.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:12032713	(2002) The pathogenesis of diabetic retinopathy: old concepts and new questions.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:12045226	(2002) Mice overexpressing placenta growth factor exhibit increased vascularization and vessel permeability.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:12052848	(2002) KDR (VEGF receptor 2) is the major mediator for the hypotensive effect of VEGF.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:12062723	(2002) Effect of hypoxia and endothelial loss on vascular smooth muscle cell responsiveness to VEGF-A: role of flt-1VEGF-receptor-1.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:12076096	(2002) Effects of angiogenic growth factor combinations on retinal endothelial cells.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:12086892	(2002) Placenta growth factor-1 antagonizes VEGF-induced angiogenesis and tumor growth by the formation of functionally inactive PlGF-1VEGF heterodimers.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:12091877	(2002) Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:12133823	(2002) Expression microarray analysis of brain tumors: what have we learned so far.	2	7	2.67	0.0461	9606.ENSP00000220166,9606.ENSP00000478570	CTSH,VEGFA
PMID:12150967	(2002) Loss of placental growth factor protects mice against vascular permeability in pathological conditions.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:12366396	(2002) Human vascular endothelial growth factor B: characterization of recombinant isoforms and generation of neutralizing monoclonal antibodies.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:12409656	(2002) Vascular endothelial growth factor as a target opportunity in hematological malignancies.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:12453985	(2002) Vitreous levels of placenta growth factor and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:12454810	(2002) Expression of vascular endothelial growth factor, placental growth factor, and their receptors Flt-1 and KDR in human placenta under pathologic conditions.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:12461084	(2002) Vascular permeability factorvascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis.	2	9	2.56	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:12470137	(2002) Correlation of increased vascular endothelial growth factor with neovascularization and permeability in ischemic central vein occlusion.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:12482580	(2002) Increased expression of vascular endothelial growth factor in placentas of p57(Kip2) null embryos.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:12489845	(2002) Antiangiogenic effect by SU5416 is partly attributable to inhibition of Flt-1 receptor signaling.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:12543719	(2002) Placental growth factor (PlGF) and its receptor Flt-1 (VEGFR-1): novel therapeutic targets for angiogenic disorders.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:12613542	(2002) Neuropilin-1 in the immune system.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:12708795	(2002) Vascular endothelial growth factor and placental growth factor release in cultured trophoblast cells under different oxygen tensions.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:12858539	(2002) Survival mechanisms of VEGF and PlGF during microvascular remodeling.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:11058594	(2001) Vascular endothelial growth factor KDR receptor signaling potentiates tumor necrosis factor-induced tissue factor expression in endothelial cells.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:11069911	(2001) The crystal structure of human placenta growth factor-1 (PlGF-1), an angiogenic protein, at 2.0 A resolution.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:11221852	(2001) Involvement of Flt-1 tyrosine kinase (vascular endothelial growth factor receptor-1) in pathological angiogenesis.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:11254400	(2001) Kinetics of placenta growth factorvascular endothelial growth factor synergy in endothelial hydraulic conductivity and proliferation.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:11257123	(2001) Oligomerization-dependent regulation of motility and morphogenesis by the collagen XVIII NC1endostatin domain.	2	14	2.37	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:11264160	(2001) Erythroblasts are a source of angiogenic factors.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:11289150	(2001) Placenta growth factor gene expression is induced by hypoxia in fibroblasts: a central role for metal transcription factor-1.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:11316953	(2001) Differential effects of vascular endothelial growth factor-C and placental growth factor-1 on the hydraulic conductivity of frog mesenteric capillaries.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:11329059	(2001) Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:11348872	(2001) VEGF protects against oxidized LDL toxicity to endothelial cells by an intracellular glutathione-dependent mechanism through the KDR receptor.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:11399883	(2001) Ontogenesis of villi and fetal vessels in the human placenta.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:11462155	(2001) Vascular localization of heparan sulfate proteoglycans in retinas of patients with diabetes mellitus and in VEGF-induced retinopathy using domain-specific antibodies.	2	4	2.91	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:11470864	(2001) Vascular endothelial growth factor and placenta growth factor concentrations in Downs syndrome and control pregnancies.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:11473363	(2001) Expression of vascular endothelial growth factor receptors in smooth muscle cells.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:11549592	(2001) Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:11554745	(2001) Induction of SPARC by VEGF in human vascular endothelial cells.	2	3	3.04	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:11559905	(2001) First trimester maternal serum placenta growth factor (PIGF)concentrations in pregnancies with fetal trisomy 21 or trisomy 18.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:11585724	(2001) Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:11689473	(2001) Human airway smooth muscle cells secrete vascular endothelial growth factor: up-regulation by bradykinin via a protein kinase C and prostanoid-dependent mechanism.	2	3	3.04	0.0461	9606.ENSP00000450482,9606.ENSP00000478570	BDKRB2,VEGFA
PMID:11720477	(2001) Identification of human renal cell carcinoma associated genes by suppression subtractive hybridization.	2	12	2.43	0.0461	9606.ENSP00000362524,9606.ENSP00000478570	ANGPTL2,VEGFA
PMID:11741095	(2001) VEGF receptor signal transduction.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:11750869	(2001) Vascular endothelial growth factor but not placental growth factor promotes trophoblast syncytialization in vitro.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:11896995	(2001) Increased fibrovascular invasion of subcutaneous polyvinyl alcohol sponges in SPARC-null mice.	2	2	3.21	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:10606981	(2000) Placenta growth factor (PlGF) induces vascular endothelial growth factor (VEGF) secretion from mononuclear cells and is co-expressed with VEGF in synovial fluid.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:10671553	(2000) Utilization of distinct signaling pathways by receptors for vascular endothelial cell growth factor and other mitogens in the induction of endothelial cell proliferation.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:10749582	(2000) Phenotypic alterations in Kaposis sarcoma cells by antisense reduction of perlecan.	2	2	3.21	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:10764269	(2000) Vascular endothelial growth factor, hepatocyte growth factorscatter factor, basic fibroblast growth factor, and placenta growth factor in human meningiomas and their relation to angiogenesis and malignancy.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:10780522	(2000) Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:10780661	(2000) Release and complex formation of soluble VEGFR-1 from endothelial cells and biological fluids.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:10831117	(2000) Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PIGF) and soluble Flt-1 by oxygen--a review.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:10871490	(2000) A study of the relationship between placenta growth factor and gestational age, parturition, rupture of membranes, and intrauterine infection.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:10919072	(2000) Recombinant production of PIGF-1 and its activity in animal models.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:10951273	(2000) Placenta growth factor is induced in human keratinocytes during wound healing.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:10961983	(2000) Vascular endothelial growth factor activates STAT proteins in aortic endothelial cells.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:10963684	(2000) Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:10986432	(2000) Development of the placental villous tree and its consequences for fetal growth.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:10987458	(2000) Cellular and extracellular markers of hemangioma.	2	6	2.74	0.0461	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:11006323	(2000) Expression of vascular endothelial growth factor (VEGF) and placental growth factor (PlGF) in conceptus and endometrium during implantation in the rhesus monkey.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:11036931	(2000) Vascular endothelial growth factor and the regulation of angiogenesis.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:11038171	(2000) A novel member of the netrin family, beta-netrin, shares homology with the beta chain of laminin: identification, expression, and functional characterization.	2	14	2.37	0.0461	9606.ENSP00000334329,9606.ENSP00000478570	UNC5B,VEGFA
PMID:11078637	(2000) Vascular endothelial growth factor fails to acutely modulate endothelial permeability during early angiogenesis in the chick chorioallantoic membrane.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:11106176	(2000) Purification and refolding of vascular endothelial growth factor-B.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:11120527	(2000) Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:11121133	(2000) Human melanoma cells secrete and respond to placenta growth factor and vascular endothelial growth factor.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:11147670	(2000) Tumor angiogenesis.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:11303624	(2000) Expression of vascular endothelial growth factor-b in human astrocytoma.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:10068204	(1999) Hypoxia down-regulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor expression: molecular evidence for placental hyperoxia in intrauterine growth restriction.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:10084962	(1999) Signal transduction and biological function of placenta growth factor in primary human trophoblast.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:10092882	(1999) Recombinant domain IV of perlecan binds to nidogens, laminin-nidogen complex, fibronectin, fibulin-2 and heparin.	2	7	2.67	0.0461	9606.ENSP00000231061,9606.ENSP00000363827	SPARC,HSPG2
PMID:10208873	(1999) Identification of receptor genes in renal cell carcinoma associated with angiogenesis by differential hybridization technique.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:10325292	(1999) Vascular endothelial growth factor is bound in amniotic fluid and maternal serum.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:10373449	(1999) Characterization of vascular endothelial cell growth factor interactions with the kinase insert domain-containing receptor tyrosine kinase. A real time kinetic study.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:10432291	(1999) Vascular endothelial growth factor can substitute for macrophage colony-stimulating factor in the support of osteoclastic bone resorption.	2	11	2.47	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:10435836	(1999) Basement membrane and growth factor gene expression in normal and diabetic human retinas.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:10451490	(1999) Expression and localization of placenta growth factor and PlGF receptors in human meningiomas.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:10462475	(1999) Expression of the VEGF gene family during retinal vaso-obliteration and hypoxia.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:10463618	(1999) Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:10519425	(1999) Selective deficit of angiogenic growth factors characterises pregnancies complicated by pre-eclampsia.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:10521504	(1999) Vascular endothelial growth factor effect on endothelial cell proliferation, migration, and platelet-activating factor synthesis is Flk-1-dependent.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:10527820	(1999) The effects of angiogenic growth factors on extravillous trophoblast invasion and motility.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:10544250	(1999) Tropoelastin binding to fibulins, nidogen-2 and other extracellular matrix proteins.	2	8	2.61	0.0461	9606.ENSP00000231061,9606.ENSP00000363827	SPARC,HSPG2
PMID:10574962	(1999) A mutant form of vascular endothelial growth factor (VEGF) that lacks VEGF receptor-2 activation retains the ability to induce vascular permeability.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:10575000	(1999) Placenta growth factor and vascular endothelial growth factor B and C expression in microvascular endothelial cells and pericytes. Implication in autocrine and paracrine regulation of angiogenesis.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:9886933	(1999) KDR activation is crucial for VEGF165-mediated Ca2+ mobilization in human umbilical vein endothelial cells.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:9949168	(1999) Maturation of embryonic stem cells into endothelial cells in an in vitro model of vasculogenesis.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:14987558	(1998) Functions of the VEGF receptor-1 (FLT-1) in the vasculature.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:9443437	(1998) Vascular endothelial growth factorvascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:9452434	(1998) Mapping the charged residues in the second immunoglobulin-like domain of the vascular endothelial growth factorplacenta growth factor receptor Flt-1 required for binding and structural stability.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:9461127	(1998) Increased expression of placenta growth factor in proliferative diabetic retinopathy.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:9467961	(1998) Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-gamma and migration of endothelial cells expressing Flt 1.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:9473412	(1998) Automated evaluation of angiogenic effects mediated by VEGF and PlGF homo- and heterodimers.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:9524110	(1998) Mice deficient for the secreted glycoprotein SPARCosteonectinBM40 develop normally but show severe age-onset cataract formation and disruption of the lens.	2	3	3.04	0.0461	9606.ENSP00000231061,9606.ENSP00000363827	SPARC,HSPG2
PMID:9570538	(1998) Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kappa B activation in hemopoietic progenitor cells.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:9588884	(1998) The basic residues of placenta growth factor type 2 retrieve sequestered angiogenic factors into a soluble form: implications for tumor angiogenesis.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:9621286	(1998) Receptors of vascular endothelial growth factorvascular permeability factor (VEGFVPF) in fetal and adult human kidney: localization and [125I]VEGF binding sites.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:9625748	(1998) Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:9692901	(1998) Mapping of the binding of platelet-derived growth factor to distinct domains of the basement membrane proteins BM-40 and perlecan and distinction from the BM-40 collagen-binding epitope.	2	3	3.04	0.0461	9606.ENSP00000231061,9606.ENSP00000363827	SPARC,HSPG2
PMID:9712843	(1998) Neuropilin-1 is a placenta growth factor-2 receptor.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:9778119	(1998) Role of placenta growth factor (PIGF) in human extravillous trophoblast proliferation, migration and invasiveness.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:9804796	(1998) Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3-kinaseAkt signal transduction pathway. Requirement for Flk-1KDR activation.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:9820123	(1998) Serum and tissue vascular endothelial growth factor levels in hydatidiform mole.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:9834463	(1998) Comparison of expression patterns for placenta growth factor, vascular endothelial growth factor (VEGF), VEGF-B and VEGF-C in the human placenta throughout gestation.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:9886308	(1998) Role of vascular endothelial growth factor (VEGF) and placenta-derived growth factor (PlGF) in regulating human haemopoietic cell growth.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:9892094	(1998) Placenta growth factor (PlGF) mRNA expression in brain tumors.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:10756725	(1997) [The role of the endothelium in angiogenesis].	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:9041202	(1997) Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in ...	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:9070853	(1997) Identification of the extracellular domains of Flt-1 that mediate ligand interactions.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:9111514	(1997) Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:9116151	(1997) Expression of vascular endothelial growth factor and placenta growth factor in human placenta.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:9226202	(1997) Expression patterns of extracellular matrix components in native and cultured normal human thyroid tissue and in human toxic adenoma tissue.	2	3	3.04	0.0461	9606.ENSP00000231061,9606.ENSP00000363827	SPARC,HSPG2
PMID:9245515	(1997) VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:9364601	(1997) Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:9369935	(1997) Characterization of the extracellular domain in vascular endothelial growth factor receptor-1 (Flt-1 tyrosine kinase).	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:9393770	(1997) Vascular endothelial growth factor up-regulates its receptor fms-like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:9400995	(1997) Upregulation of the angiogenic factors PlGF, VEGF and their receptors (Flt-1, Flk-1KDR) by TSH in cultured thyrocytes and in the thyroid gland of thiouracil-fed rats suggest a TSH-dependent paracrine mechanism for goiter hypervascularization.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:9401819	(1997) Placenta growth factor and vascular endothelial growth factor are co-expressed during early embryonic development.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:9426398	(1997) Expression and localization of the vascular endothelial growth factor family in ovarian epithelial tumors.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:9450544	(1997) Vascular endothelial growth factor stimulates prostacyclin production and activation of cytosolic phospholipase A2 in endothelial cells via p42p44 mitogen-activated protein kinase.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:8540853	(1996) Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:8602241	(1996) Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:8605350	(1996) Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:8621715	(1996) Heterodimers of placenta growth factorvascular endothelial growth factor. Endothelial activity, tumor cell expression, and high affinity binding to Flk-1KDR.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:8637916	(1996) Vascular endothelial growth factor B, a novel growth factor for endothelial cells.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:8663424	(1996) The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:8670141	(1996) Synthesis and physiological activity of heterodimers comprising different splice forms of vascular endothelial growth factor and placenta growth factor.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:8760299	(1996) Neovascularization in human germ cell tumors correlates with a marked increase in the expression of the vascular endothelial growth factor but not the placenta-derived growth factor.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:8764158	(1996) BM180: a novel basement membrane protein with a role in stimulus-secretion coupling by lacrimal acinar cells.	2	5	2.81	0.0461	9606.ENSP00000231061,9606.ENSP00000363827	SPARC,HSPG2
PMID:8774132	(1996) Vascular growth factors and receptors in capillary hemangioblastomas and hemangiopericytomas.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:8786112	(1996) Assignment of vascular endothelial growth factor (VEGF) and placenta growth factor (PLGF) genes to human chromosome 6p12-p21 and 14q24-q31 regions, respectively.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:8822205	(1996) Flt-1 but not KDRFlk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:8825127	(1996) Breast cancer angiogenesis--new approaches to therapy via antiangiogenesis, hypoxic activated drugs, and vascular targeting.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:8883582	(1996) Spindle cells isolated from Kaposis sarcoma-like lesions of BKVtat-transgenic mice co-express markers of different cell types.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:8890165	(1996) The second immunoglobulin-like domain of the VEGF tyrosine kinase receptor Flt-1 determines ligand binding and may initiate a signal transduction cascade.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:8903720	(1996) The placenta growth factor gene of the mouse.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:8906076	(1996) Chemiluminescence immunoassay for vascular endothelial growth factor (vascular permeability factor) in tumor-tissue homogenates.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:8919031	(1996) Localisation of placenta growth factor (PIGF) in human term placenta.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:8958213	(1996) In vivo angiogenic activity and hypoxia induction of heterodimers of placenta growth factorvascular endothelial growth factor.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:7478581	(1995) Upregulation of vascular endothelial growth factor (VEGF) and downregulation of placenta growth factor (PlGF) associated with malignancy in human thyroid tumors and cell lines.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:7500359	(1995) Binding of mouse and human fibulin-2 to extracellular matrix ligands.	2	7	2.67	0.0461	9606.ENSP00000231061,9606.ENSP00000363827	SPARC,HSPG2
PMID:7541940	(1995) Regulation of angiogenic growth factor expression by hypoxia, transition metals, and chelating agents.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:7543496	(1995) Platelet activating factor produced in vitro by Kaposis sarcoma cells induces and sustains in vivo angiogenesis.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:7706320	(1995) Purification and characterization of a naturally occurring vascular endothelial growth factor.placenta growth factor heterodimer.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:7856749	(1995) Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumors.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:8529674	(1995) Diphenylene iodonium inhibits the induction of erythropoietin and other mammalian genes by hypoxia. Implications for the mechanism of oxygen sensing.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:7518352	(1994) Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:7528359	(1994) Detection and quantification of vascular endothelial growth factorvascular permeability factor in brain tumor tissue and cyst fluid: the key to angiogenesis?	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:7734144	(1994) VEGF receptor subtypes KDR and FLT1 show different sensitivities to heparin and placenta growth factor.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:7929268	(1994) Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1KDR.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:8119973	(1994) Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells.	2	4	2.91	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:8126087	(1994) Differential expression of the two VEGF receptors flt and KDR in placenta and vascular endothelial cells.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:7681160	(1993) Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (PlGF), are transcribed from a single gene of chromosome 14.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:8148155	(1993) A heparin-binding form of placenta growth factor (PlGF-2) is expressed in human umbilical vein endothelial cells and in placenta.	2	3	3.04	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:8245783	(1993) The related FLT4, FLT1, and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:8466755	(1993) Translation of the placenta growth factor mRNA is severely affected by a small open reading frame localized in the 5 untranslated region.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:1924389	(1991) Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor.	2	2	3.21	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21969185	(....) a placenta growth factor 2 variant acts as dominant negative of vascular endothelial growth factor a by heterodimerization mechanism.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25114834	(....) linking tumor hypoxia with vegfr2 signaling and compensatory angiogenesis: glycans make the difference.	2	7	2.67	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26568652	(....) interpreggen: genetic studies of pre-eclampsia in three continents.	2	5	2.81	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26918199	(....) localization of c-fos-induced growth factor (figf) mrna expression in the mouse uterus during implantation.	2	13	2.4	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27570714	(....) ramucirumab for the treatment of gastroesophageal cancers.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27668980	(....) vegf-a and vegfr1 snps associate with preeclampsia in a philippine population.	2	8	2.61	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27739311	(....) [prognostic and predictive factors for pancreatic adenocarcinoma].	2	5	2.81	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:29225901	(....) immediate response in markers of inflammation and angiogenesis during exercise: a randomised cross-over study in heart transplant recipients.	2	13	2.4	0.0461	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:30650141	(....) retraction: placenta growth factor-1 exerts time-dependent stabilization of adherens junctions following vegf-induced vascular permeability.	2	6	2.74	0.0461	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31178971	(....) modulation of redox signaling in chronic diseases and regenerative medicine.	2	13	2.4	0.0461	9606.ENSP00000450482,9606.ENSP00000478570	BDKRB2,VEGFA
PMID:33990205	(2021) Role of lysosomes in physiological activities, diseases, and therapy.	3	116	1.62	0.0467	9606.ENSP00000220166,9606.ENSP00000451040,9606.ENSP00000478570	CTSH,PGF,VEGFA
PMID:34630033	(2021) NMDARs Drive the Expression of Neuropsychiatric Disorder Risk Genes Within GABAergic Interneuron Subtypes in the Juvenile Brain.	3	116	1.62	0.0467	9606.ENSP00000006053,9606.ENSP00000276571,9606.ENSP00000334329	CX3CL1,CRH,UNC5B
PMID:34738629	(2022) CD146 mediates the anti-apoptotic role of Netrin-1 in endothelial progenitor cells under hypoxic conditions.	2	15	2.34	0.0470	9606.ENSP00000334329,9606.ENSP00000478570	UNC5B,VEGFA
PMID:35088348	(2022) Pharmacokinetics, Safety, Efficacy, and Biomarker Profiles During Nemolizumab Treatment of Atopic Dermatitis in Adolescents.	2	15	2.34	0.0470	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:35140249	(2022) Mycobacterium vaccae immunization in rats ameliorates features of age-associated microglia activation in the amygdala and hippocampus.	2	15	2.34	0.0470	9606.ENSP00000006053,9606.ENSP00000276571	CX3CL1,CRH
PMID:35211625	(2022) Prognostic Significance of SPARC Expression in Breast Cancer: A Meta-Analysis and Bioinformatics Analysis.	2	15	2.34	0.0470	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:35345482	(2022) Preeclampsia and Venous Thromboembolism: Pathophysiology and Potential Therapy.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35408794	(2022) Thrombin-Activated Platelets Protect Vascular Endothelium against Tumor Cell Extravasation by Targeting Endothelial VCAM-1.	2	15	2.34	0.0470	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:35409211	(2022) Molecular Advances in Preeclampsia and HELLP Syndrome.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35411318	(2022) Hyperadhesive von Willebrand Factor Promotes Extracellular Vesicle-Induced Angiogenesis: Implication for LVAD-Induced Bleeding.	2	15	2.34	0.0470	9606.ENSP00000362524,9606.ENSP00000478570	ANGPTL2,VEGFA
PMID:35966095	(2022) Kisspeptin treatment improves fetal-placental development and blocks placental oxidative damage caused by maternal hypothyroidism in an experimental rat model.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33094607	(2021) Normalization of endometrial histopathology and endometrial NK cells concentration predict successful pregnancy in repeated implantation failure.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33259740	(2021) Maternal Morbidity and Mortality: Are We Getting to the Heart of the Matter?	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33450816	(2021) Epigallocatechin Gallate Ameliorates the Effects of Prenatal Alcohol Exposure in a Fetal Alcohol Spectrum Disorder-Like Mouse Model.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33578823	(2021) Role of Vascular Endothelial Growth Factor (VEGF) in Human Embryo Implantation: Clinical Implications.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33579739	(2021) Quantitative systems pharmacology model predictions for efficacy of atezolizumab and nab-paclitaxel in triple-negative breast cancer.	2	15	2.34	0.0470	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:33599733	(2021) Hypoxia Induces Galectin-1 Expression Via Autoinduction of Placental Growth Factor in Retinal Pigment Epithelium Cells.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33613290	(2021) Biodegradable Polymeric Nanoparticles for Drug Delivery to Solid Tumors.	2	15	2.34	0.0470	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:33647276	(2021) The ligand-bound state of a G protein-coupled receptor stabilizes the interaction of functional cholesterol molecules.	2	15	2.34	0.0470	9606.ENSP00000006053,9606.ENSP00000304767	CX3CL1,P2RY1
PMID:33796152	(2021) Immunotherapy as a treatment strategy in advanced stage and recurrent endometrial cancer: review of current phase III immunotherapy clinical trials.	2	15	2.34	0.0470	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:33804956	(2021) Role of Angiogenesis in the Pathogenesis of NAFLD.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33845913	(2021) Amine oxidase copper-containing 3 (AOC3) inhibition: a potential novel target for the management of diabetic retinopathy.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33850656	(2021) Ameliorative effect of apelin-13 against renal complications in L-NAME-induced preeclampsia in rats.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33879252	(2021) Characterisation of cardiac health in the reduced uterine perfusion pressure model and a 3D cardiac spheroid model, of preeclampsia.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33919199	(2021) Review of the Applications of Biomedical Compositions Containing Hydroxyapatite and Collagen Modified by Bioactive Components.	2	15	2.34	0.0470	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:33954115	(2021) Tyrosine Kinase Inhibitor Cabozantinib Inhibits Murine Renal Cancer by Activating Innate and Adaptive Immunity.	2	15	2.34	0.0470	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:34061117	(2021) Tumor Shrinkage by Metyrapone in Cushing Disease Exhibiting Glucocorticoid-Induced Positive Feedback.	2	15	2.34	0.0470	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:34067671	(2021) Anti-Vascular Endothelial Growth Factor C Antibodies Efficiently Inhibit the Growth of Experimental Clear Cell Renal Cell Carcinomas.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34082837	(2021) VEGFR1-tyrosine kinase signaling in pulmonary fibrosis.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34095164	(2021) Age and Interleukin-15 Levels Are Independently Associated With Intima-Media Thickness in Obesity-Related NAFLD Patients.	2	15	2.34	0.0470	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:34102753	(2021) Diagnostic and Prognostic Circulating MicroRNA in Acute Stroke: A Systematic and Bioinformatic Analysis of Current Evidence.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34108507	(2021) A high-throughput microfluidic bilayer co-culture platform to study endothelial-pericyte interactions.	2	15	2.34	0.0470	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:34318873	(2021) MicroRNAs targeting VEGF are related to vascular dysfunction in preeclampsia.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34657625	(2021) Curcumin upregulates transforming growth factor-beta1, its receptors, and vascular endothelial growth factor expressions in an in vitro human gingival fibroblast wound healing model.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34661176	(2021) Anxiety, depression, and asthma: New perspectives and approaches for psychoneuroimmunology research.	2	15	2.34	0.0470	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:34725557	(2021) Detection of Herbal Combinations and Pharmacological Mechanisms of Clinical Prescriptions for Coronary Heart Disease Using Data Mining and Network Pharmacology.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34884740	(2021) Proteomic Analysis of Mesenchymal Stromal Cell-Derived Extracellular Vesicles and Reconstructed Membrane Particles.	2	15	2.34	0.0470	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:35153764	(2021) Dioscin Reduces Vascular Damage in the Retina of dbdb Mice by Inhibiting the VEGFA Signaling Pathway.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35211027	(2021) How Soluble Fms-Like Tyrosine Kinase 1 Could Contribute to Blood-Brain Barrier Dysfunction in Preeclampsia?	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31718786	(2020) Exposure to airborne fine particulate matter is associated with impaired endothelial function and biomarkers of oxidative stress and inflammation.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31733011	(2020) Rapid stromal remodeling by short-term VEGFR2 inhibition increases chemotherapy delivery in esophagogastric adenocarcinoma.	2	15	2.34	0.0470	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:31754793	(2020) [(18)F]Fluciclatide PET as a biomarker of response to combination therapy of pazopanib and paclitaxel in platinum-resistantrefractory ovarian cancer.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32098270	(2020) Glioblastoma Cells Do Not Affect Axitinib-Dependent Senescence of HUVECs in a Transwell Coculture Model.	2	15	2.34	0.0470	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:32280836	(2020) Bioactive polymeric materials and electrical stimulation strategies for musculoskeletal tissue repair and regeneration.	2	15	2.34	0.0470	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:32343970	(2020) O-GlcNAc impairs endothelial function in uterine arteries from virgin but not pregnant rats: The role of GSK3beta.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32450219	(2020) Cancer associated fibroblast: Mediators of tumorigenesis.	2	15	2.34	0.0470	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:32642690	(2020) Eosinophil and lymphocyte counts predict bevacizumab response and survival in recurrent glioblastoma.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32655346	(2020) Ethanol-Induced Alterations in Placental and Fetal Cerebrocortical Annexin-A4 and Cerebral Cavernous Malformation Protein 3 Are Associated With Reductions in Fetal Cortical VEGF Receptor Binding and Microvascular Density.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32679703	(2020) Biomimetic Aspects of Restorative Dentistry Biomaterials.	2	15	2.34	0.0470	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:32708979	(2020) Podocytes-The Most Vulnerable Renal Cells in Preeclampsia.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32745373	(2020) Decreased ANGPTL4 impairs endometrial angiogenesis during peri-implantation period in patients with recurrent implantation failure.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32746939	(2020) Alleviation of acute radiation-induced bone marrow failure in mice with human fetal placental stromal cell therapy.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32747910	(2020) Injectable platelet-rich fibrin influences the behavior of gingival mesenchymal stem cells.	2	15	2.34	0.0470	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:32945843	(2020) VEGF-B Is an Autocrine Gliotrophic Factor for Muller Cells under Pathologic Conditions.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33000253	(2020) Long non-coding RNA PLK1S1 was associated with renal cell carcinoma progression by interacting with microRNA-653 and altering C-X-C chemokine receptor 5 expression.	2	15	2.34	0.0470	9606.ENSP00000304767,9606.ENSP00000478570	P2RY1,VEGFA
PMID:33014312	(2020) Appropriate Scaffold Selection for CNS Tissue Engineering.	2	15	2.34	0.0470	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:33065984	(2020) Activation of the VEGF-AERKPLA2 Axis Mediates Early Retinal Endothelial Cell Damage Induced by High Glucose: New Insight from an In Vitro Model of Diabetic Retinopathy.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33115414	(2020) Angiogenin, FGF-alpha, and IL-36beta have higher expression levels in aqueous humor of nAMD patients in comparison to cataract patients.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33150250	(2020) Neuroimmune Communication in the Kidney.	2	15	2.34	0.0470	9606.ENSP00000276571,9606.ENSP00000304767	CRH,P2RY1
PMID:33151982	(2020) High expression of Tie-2 predicts poor prognosis in primary high grade serous ovarian cancer.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33375253	(2020) Pregnancy-Induced High Plasma Levels of Soluble Endoglin in Mice Lead to Preeclampsia Symptoms and Placental Abnormalities.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29790398	(2019) Acute Inflammatory Biomarker Responses to Diffuse Traumatic Brain Injury in the Rat Monitored by a Novel Microdialysis Technique.	2	15	2.34	0.0470	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:30446828	(2019) Different effects of allergic rhinitis on nasal mucosa remodeling in chronic rhinosinusitis with and without nasal polyps.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30648518	(2019) Emergence of Three Dimensional Printed Cardiac Tissue: Opportunities and Challenges in Cardiovascular Diseases.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30651792	(2019) Glucose affects cell viability, migration, angiogenesis and cellular adhesion of human retinal capillary endothelial cells via SPARC.	2	15	2.34	0.0470	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:30702560	(2019) Cytokines concentrations in aqueous humor of eyes with uveal melanoma.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30761781	(2019) A literature review for the mechanisms of stress-induced liver injury.	2	15	2.34	0.0470	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:30967907	(2019) Angiogenesis of hepatocellular carcinoma: An immunohistochemistry study.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30972026	(2019) Hormonal Changes Associated With Intra-Uterine Growth Restriction: Impact on the Developing Brain and Future Neurodevelopment.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30993143	(2019) Advances in surgical applications of growth factors for wound healing.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31234528	(2019) Functional Protein-Based Bioinspired Nanomaterials: From Coupled Proteins, Synthetic Approaches, Nanostructures to Applications.	2	15	2.34	0.0470	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:31240219	(2019) Umbilical Cord Mesenchymal Stem Cell Transplantation Prevents Chemotherapy-Induced Ovarian Failure via the NGFTrkA Pathway in Rats.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31281401	(2019) Application of Herbal Medicines with Heat-Clearing Property to Anti-Microinflammation in the Treatment of Diabetic Kidney Disease.	2	15	2.34	0.0470	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:31413262	(2019) Intrabody against prolyl hydroxylase 2 promotes angiogenesis by stabilizing hypoxia-inducible factor-1alpha.	2	15	2.34	0.0470	9606.ENSP00000362524,9606.ENSP00000478570	ANGPTL2,VEGFA
PMID:31444620	(2019) A phase Ib study of the combination regorafenib with PF-03446962 in patients with refractory metastatic colorectal cancer (REGAL-1 trial).	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31578782	(2019) Novel human Ab against vascular endothelial growth factor receptor 2 shows therapeutic potential for leukemia and prostate cancer.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31602206	(2019) Cell sheets of co-cultured BMP-2-modified bone marrow stromal cells and endothelial progenitor cells accelerate bone regeneration in vitro.	2	15	2.34	0.0470	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:31649549	(2019) Examination of the Myokine Response in Pregnant and Non-pregnant Women Following an Acute Bout of Moderate-Intensity Walking.	2	15	2.34	0.0470	9606.ENSP00000006053,9606.ENSP00000231061	CX3CL1,SPARC
PMID:31673071	(2019) Non-proteolytic calpain-6 interacts with VEGFA and promotes angiogenesis by increasing VEGF secretion.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31790467	(2019) The efficacy of conditioned medium released by tonsil-derived mesenchymal stem cells in a chronic murine colitis model.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31843019	(2019) Human fetal skin-derived stem cell secretome enhances radiation-induced skin injury therapeutic effects by promoting angiogenesis.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31850373	(2019) Stratified Approaches to Antiplatelet Therapies Based on Platelet Reactivity Testing.	2	15	2.34	0.0470	9606.ENSP00000304767,9606.ENSP00000478570	P2RY1,VEGFA
PMID:31857774	(2019) Aberrant methylation of secreted protein acidic and rich in cysteine gene and its significance in gastric cancer.	2	15	2.34	0.0470	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:32009994	(2019) Editorial: Early Life Stress and Depression.	2	15	2.34	0.0470	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:33082659	(2019) Histological evaluation of pulpal response to direct pulp capping using statins with alpha-tricalcium phosphate and mineral trioxide aggregate in human teeth.	2	15	2.34	0.0470	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:28714140	(2018) Prevascularization of natural nanofibrous extracellular matrix for engineering completely biological three-dimensional prevascularized tissues for diverse applications.	2	15	2.34	0.0470	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:29132205	(2018)	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29329547	(2018) Microfluidic co-culture of pancreatic tumor spheroids with stellate cells as a novel 3D model for investigation of stroma-mediated cell motility and drug resistance.	2	15	2.34	0.0470	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:29399152	(2018) CITED2 attenuates macrophage recruitment concordant with the downregulation of CCL20 in breast cancer cells.	2	15	2.34	0.0470	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:29584759	(2018) Anti-inflammatory cytokine and angiogenic factors levels in vitreous samples of diabetic retinopathy patients.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29675110	(2018) Evaluation of Detection Methods and Values of Circulating Vascular Endothelial Growth Factor in Lung Cancer.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29756486	(2018) Osteonectin as a screening marker for pancreatic cancer: A prospective study.	2	15	2.34	0.0470	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:29785197	(2018) Applying Statistical and Complex Network Methods to Explore the Key Signaling Molecules of Acupuncture Regulating Neuroendocrine-Immune Network.	2	15	2.34	0.0470	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:29998195	(2018) Human brain gene expression profiles of the cathepsin V and cathepsin L cysteine proteases, with the PC13 and PC2 serine proteases, involved in neuropeptide production.	2	15	2.34	0.0470	9606.ENSP00000220166,9606.ENSP00000276571	CTSH,CRH
PMID:30077137	(2018) Customizable biomaterials as tools for advanced anti-angiogenic drug discovery.	2	15	2.34	0.0470	9606.ENSP00000363827,9606.ENSP00000451040	HSPG2,PGF
PMID:30212490	(2018) Treatment with placental growth factor attenuates myocardial ischemiareperfusion injury.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30224383	(2018) The BACE-1 inhibitor CNP520 for prevention trials in Alzheimers disease.	2	15	2.34	0.0470	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:30317225	(2018) Role of alternative splicing of VEGF-A in the development of atherosclerosis.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30369968	(2018) Therapeutic Apheresis in Metabolic Syndrome.	2	15	2.34	0.0470	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:30373628	(2018) Lentinan inhibits tumor angiogenesis via interferon gamma and in a T cell independent manner.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30603226	(2018) Nucleic acids and analogs for bone regeneration.	2	15	2.34	0.0470	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:30622436	(2018) Association between Brain-Derived Neurotrophic Factor (BDNF) Levels in 2(nd) Trimester Amniotic Fluid and Fetal Development.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27717848	(2017) Colon cancer-derived myofibroblasts increase endothelial cell migration by glucocorticoid-sensitive secretion of a pro-migratory factor.	2	15	2.34	0.0470	9606.ENSP00000362524,9606.ENSP00000478570	ANGPTL2,VEGFA
PMID:27737730	(2017) Spatiotemporal expression profile of proteases and immunological, angiogenic, hormonal and apoptotic mediators in rat placenta before and during intrauterine trophoblast migration.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27913439	(2017) Retinitis pigmentosa-associated cystoid macular oedema: pathogenesis and avenues of intervention.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28098884	(2017) Renin-angiotensin system activation accelerates atherosclerosis in experimental renal failure by promoting endoplasmic reticulum stress-related inflammation.	2	15	2.34	0.0470	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:28141765	(2017) Role of cytokines and treatment algorithms in retinopathy of prematurity.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28260032	(2017) Slit2 suppresses endothelial cell proliferation and migration by inhibiting the VEGF-Notch signaling pathway.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28285686	(2017) Pilot phase II study of metronomic chemotherapy in combination with bevacizumab in patients with advanced non-squamous non-small cell lung cancer.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28325294	(2017) Therapeutic Effect of Novel Single-Stranded RNAi Agent Targeting Periostin in Eyes with Retinal Neovascularization.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28761227	(2017) Acute Kidney Injury in Pregnancy-specific Disorders.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28829810	(2017) Extracellular overhydration linked with endothelial dysfunction in the context of inflammation in haemodialysis dependent chronic kidney disease.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29062792	(2017) Elevated Levels of Serum Vascular Endothelial Growth Factor-A Are Not Related to NK Cell Parameters in Recurrent IVF Failure.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29390367	(2017) Targeted therapy with apatinib in a patient with relapsed small cell lung cancer: A case report and literature review.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26686201	(2016) A phase I trial of ANG12-Tie2 inhibitor trebaninib (AMG386) and temsirolimus in advanced solid tumors (PJC008NCI#9041).	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26688332	(2016) Sciatic endometriosis induces mechanical hypersensitivity, segmental nerve damage, and robust local inflammation in rats.	2	15	2.34	0.0470	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:26811176	(2016) A survey of new oncology drug approvals in the USA from 2010 to 2015: a focus on optimal dose and related postmarketing activities.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26837315	(2016) miR-320a mediates doxorubicin-induced cardiotoxicity by targeting VEGF signal pathway.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26908652	(2016) Stabilin-1 and Stabilin-2 are specific receptors for the cellular internalization of phosphorothioate-modified antisense oligonucleotides (ASOs) in the liver.	2	15	2.34	0.0470	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:26981332	(2016) VEGF and Intraocular Neovascularization: From Discovery to Therapy.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27076594	(2016) Microarray analysis in pulmonary hypertension.	3	117	1.62	0.0470	9606.ENSP00000304767,9606.ENSP00000450482,9606.ENSP00000478570	P2RY1,BDKRB2,VEGFA
PMID:27127477	(2016) Contribution of purinergic receptors to spinal cord injury repair: stem cell-based neuroregeneration.	2	15	2.34	0.0470	9606.ENSP00000304767,9606.ENSP00000478570	P2RY1,VEGFA
PMID:27401257	(2016) Maitake Pro4X has anti-cancer activity and prevents oncogenesis in BALBc mice.	2	15	2.34	0.0470	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:27527865	(2016) The VEGF rise in blood of bevacizumab patients is not based on tumor escape but a host-blockade of VEGF clearance.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27618100	(2016) Early Activation of MAPK p4442 Is Partially Involved in DON-Induced Disruption of the Intestinal Barrier Function and Tight Junction Network.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27648727	(2016) A phase 2 study of dalantercept, an activin receptor-like kinase-1 ligand trap, in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27819042	(2016) Discovery of pan-VEGF inhibitory peptides directed to the extracellular ligand-binding domains of the VEGF receptors.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27833450	(2016) The era of anti-vascular endothelial growth factor (VEGF) drugs in ophthalmology, VEGF and anti-VEGF therapy.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28217210	(2016) Nanotechnology for Stimulating Osteoprogenitor Differentiation.	2	15	2.34	0.0470	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:29491917	(2016) Central monoaminergic systems are a site of convergence of signals conveying the experience of exercise to brain circuits involved in cognition and emotional behavior.	2	15	2.34	0.0470	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:25211383	(2015) Endocan, a putative endothelial cell marker, is elevated in preeclampsia, decreased in acute pyelonephritis, and unchanged in other obstetrical syndromes.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25597280	(2015) Genetic targeting of sprouting angiogenesis using Apln-CreER.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25683226	(2015) Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: a pooled analysis.	2	15	2.34	0.0470	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:26019750	(2015) The contribution of resident vascular stem cells to arterial pathology.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26106266	(2015) Combination of PAPPA, fhCGbeta, AFP, PlGF, sTNFR1, and Maternal Characteristics in Prediction of Early-onset Preeclampsia.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26133989	(2015) The Role of Vascular Endothelial Growth Factor Receptor-1 Signaling in the Recovery from Ischemia.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26190965	(2015) Brain fog, inflammation and obesity: key aspects of neuropsychiatric disorders improved by luteolin.	2	15	2.34	0.0470	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:26215324	(2015) Ramucirumab, another anti-angiogenic agent for metastatic colorectal cancer in second-line setting--its impact on clinical practice.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26347776	(2015) Involvement of the Androgen and Glucocorticoid Receptors in Bladder Cancer.	2	15	2.34	0.0470	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:26395479	(2015) Phenotypic analysis of mice completely lacking netrin 1.	2	15	2.34	0.0470	9606.ENSP00000334329,9606.ENSP00000478570	UNC5B,VEGFA
PMID:26462577	(2015) Proteoglycans regulate autophagy via outside-in signaling: an emerging new concept.	2	15	2.34	0.0470	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:26525902	(2015) Reprogramming energy metabolism and inducing angiogenesis: co-expression of monocarboxylate transporters with VEGF family members in cervical adenocarcinomas.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26543385	(2015) Biomarkers of Angiogenesis in Colorectal Cancer.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26719668	(2015) Aflibercept: a review of its use in the treatment of choroidal neovascularization due to age-related macular degeneration.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23775568	(2014) Paracrine signals from liver sinusoidal endothelium regulate hepatitis C virus replication.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24161166	(2014) Promotion of airway anastomotic microvascular regeneration and alleviation of airway ischemia by deferoxamine nanoparticles.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24641672	(2014) Heparin binding VEGF isoforms attenuate hyperoxic embryonic lung growth retardation via a FLK1-neuropilin-1-PKC dependent pathway.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24651804	(2014) Glycogen synthase kinase-3beta and cathepsin B in diabetic endothelial progenitor cell dysfunction: an old player finds a new partner.	2	15	2.34	0.0470	9606.ENSP00000220166,9606.ENSP00000478570	CTSH,VEGFA
PMID:24864163	(2014) Bevacizumab in combination with chemotherapy for the treatment of advanced ovarian cancer: a systematic review.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24988463	(2014) The transcription factor MEF2C negatively controls angiogenic sprouting of endothelial cells depending on oxygen.	2	15	2.34	0.0470	9606.ENSP00000334329,9606.ENSP00000478570	UNC5B,VEGFA
PMID:25153017	(2014) An update on cardio-oncology.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25278895	(2014) Physiological mechanisms of vascular response induced by shear stress and effect of exercise in systemic and placental circulation.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25540639	(2014) The effect of altering the mechanical loading environment on the expression of bone regenerating molecules in cases of distraction osteogenesis.	2	15	2.34	0.0470	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:22790418	(2013) Targeted nanoparticles in imaging: paving the way for personalized medicine in the battle against cancer.	2	15	2.34	0.0470	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:22948772	(2013) Alterations of circulating bone marrow-derived VEGFR-2+ progenitor cells in isolated limb perfusion with or without rhTNF-alpha.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23154403	(2013) Laminins and retinal vascular development.	2	15	2.34	0.0470	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:23364311	(2013) Competitive stem cell recruitment by multiple cytotactic cues.	2	15	2.34	0.0470	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:23383963	(2013) SPARC expression in CML is associated to imatinib treatment and to inhibition of leukemia cell proliferation.	2	15	2.34	0.0470	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:23475070	(2013) Vascular endothelial growth factors (VEGFs) and stroke.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23480364	(2013) Decreased levels of folate receptor-beta and reduced numbers of fetal macrophages (Hofbauer cells) in placentas from pregnancies with severe pre-eclampsia.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23610528	(2013) Critical appraisal of the use of regorafenib in the management of colorectal cancer.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23644659	(2013) Human antibodies targeting the C-type lectin-like domain of the tumor endothelial cell marker clec14a regulate angiogenic properties in vitro.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23711462	(2013) Magnetic resonance imaging of ischemia viability thresholds and the neurovascular unit.	2	15	2.34	0.0470	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:23876175	(2013) Molecular targeting of hepatocyte growth factor by an antagonist, NK4, in the treatment of rheumatoid arthritis.	2	15	2.34	0.0470	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:23935929	(2013) Downregulation of SPARC expression inhibits the invasion of human trophoblast cells in vitro.	2	15	2.34	0.0470	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:23945080	(2013) Double-antiangiogenic protein DAAP targeting vascular endothelial growth factor A and angiopoietins attenuates collagen-induced arthritis.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24058577	(2013) Chronic psychological stress induces the accumulation of myeloid-derived suppressor cells in mice.	2	15	2.34	0.0470	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:24391990	(2013) Hematopoietic stem cell cytokines and fibroblast growth factor-2 stimulate human endothelial cell-pericyte tube co-assembly in 3D fibrin matrices under serum-free defined conditions.	2	15	2.34	0.0470	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:33209651	(2013) Nanoformulation enhances anti-angiogenic efficacy of tunicamycin.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22089831	(2012) Substance P (SP) induces expression of functional corticotropin-releasing hormone receptor-1 (CRHR-1) in human mast cells.	2	15	2.34	0.0470	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:22287577	(2012) VEGF-induced endothelial cell migration requires urokinase receptor (uPAR)-dependent integrin redistribution.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22394267	(2012) VEGF levels in humans and animal models with RDS and BPD: temporal relationships.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22559745	(2012) Corticotropin-releasing hormone and extracellular mitochondria augment IgE-stimulated human mast-cell vascular endothelial growth factor release, which is inhibited by luteolin.	2	15	2.34	0.0470	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:22582844	(2012) Cathepsin H functions as an aminopeptidase in secretory vesicles for production of enkephalin and galanin peptide neurotransmitters.	2	15	2.34	0.0470	9606.ENSP00000220166,9606.ENSP00000276571	CTSH,CRH
PMID:22675625	(2012) The current state of targeted agents in rectal cancer.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22693640	(2012) Potential of host markers produced by infection phase-dependent antigen-stimulated cells for the diagnosis of tuberculosis in a highly endemic area.	2	15	2.34	0.0470	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:22713170	(2012) Targeted therapies in breast cancer: are heart and vessels also being targeted?	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22879735	(2012) Protein kinase C activation affects, via the mRNA-binding Hu-antigen RELAV protein, vascular endothelial growth factor expression in a pericyticendothelial coculture model.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22962618	(2012) Secretion of soluble vascular endothelial growth factor receptor 1 (sVEGFR1sFlt1) requires Arf1, Arf6, and Rab11 GTPases.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22994231	(2012) Aging and the neurovascular unit.	2	15	2.34	0.0470	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:23226202	(2012) Cerebrospinal fluid IL-12p40, CXCL13 and IL-8 as a combinatorial biomarker of active intrathecal inflammation.	2	15	2.34	0.0470	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:24213314	(2012) Remodeling of tumor stroma and response to therapy.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21139021	(2011) Soluble FLT1 sensitizes endothelial cells to inflammatory cytokines by antagonizing VEGF receptor-mediated signalling.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21188170	(2011) Placental leucine aminopeptidase- and aminopeptidase A- deficient mice offer insight concerning the mechanisms underlying preterm labor and preeclampsia.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21200283	(2011) Hyperbaric oxygen: its mechanisms and efficacy.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21264342	(2011) A two-way communication between microglial cells and angiogenic sprouts regulates angiogenesis in aortic ring cultures.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21306301	(2011) Neuropilin-1 mediates PDGF stimulation of vascular smooth muscle cell migration and signalling via p130Cas.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21330358	(2011) Capillary rarefaction, hypoxia, VEGF and angiogenesis in chronic renal disease.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21349998	(2011) CXCL12 (SDF1alpha)-CXCR4CXCR7 pathway inhibition: an emerging sensitizer for anticancer therapies?	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21370218	(2011) Decidual hemostasis, inflammation, and angiogenesis in pre-eclampsia.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21401497	(2011) The role of extracellular adenosine in chemical neurotransmission in the hippocampus and Basal Ganglia: pharmacological and clinical aspects.	2	15	2.34	0.0470	9606.ENSP00000006053,9606.ENSP00000304767	CX3CL1,P2RY1
PMID:21407216	(2011) Pharmacodynamic and pharmacogenetic angiogenesis-related markers of first-line FOLFOXIRI plus bevacizumab schedule in metastatic colorectal cancer.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21471210	(2011) The biflavonoid amentoflavone inhibits neovascularization preventing the activity of proangiogenic vascular endothelial growth factors.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21494568	(2011) Human dental pulp stem cells hook into biocoral scaffold forming an engineered biocomplex.	2	15	2.34	0.0470	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:21494642	(2011) Role of glomerular proteoglycans in IgA nephropathy.	2	15	2.34	0.0470	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:21559452	(2011) Resistance of renal cell carcinoma to sorafenib is mediated by potentially reversible gene expression.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21559523	(2011) TMEFF2 is a PDGF-AA binding protein with methylation-associated gene silencing in multiple cancer types including glioma.	2	15	2.34	0.0470	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:21622192	(2011) Cytokines as prognstic tool in breast carcinoma.	2	15	2.34	0.0470	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:21832157	(2011) A novel function of Tis11bBRF1 as a regulator of Dll4 mRNA 3-end processing.	2	15	2.34	0.0470	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:22125629	(2011) Antimycotic ciclopirox olamine in the diabetic environment promotes angiogenesis and enhances wound healing.	2	15	2.34	0.0470	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:22368352	(2011) Saliva: A diagnostic biomarker of periodontal diseases.	2	15	2.34	0.0470	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:19844198	(2010) Enhanced antitumor efficacy of vasculostatin (Vstat120) expressing oncolytic HSV-1.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20352456	(2010) A conceptual framework for the molecular pathogenesis of progressive kidney disease.	2	15	2.34	0.0470	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:20427084	(2010) Dysregulated complement activation as a common pathway of injury in preeclampsia and other pregnancy complications.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20551949	(2010) Placental growth factor (PlGF) enhances breast cancer cell motility by mobilising ERK12 phosphorylation and cytoskeletal rearrangement.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20603611	(2010) Cell delivery of Met docking site peptides inhibit angiogenesis and vascular tumor growth.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20722014	(2010) Intraarticular injection of heparin-binding insulin-like growth factor 1 sustains delivery of insulin-like growth factor 1 to cartilage through binding to chondroitin sulfate.	2	15	2.34	0.0470	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:20815916	(2010) Mtmr8 is essential for vasculature development in zebrafish embryos.	2	15	2.34	0.0470	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:21044213	(2010) Spatial and temporal coordination of bone marrow-derived cell activity during arteriogenesis: regulation of the endogenous response and therapeutic implications.	2	15	2.34	0.0470	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:21103392	(2010) 3D hepatic cultures simultaneously maintain primary hepatocyte and liver sinusoidal endothelial cell phenotypes.	2	15	2.34	0.0470	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:21351253	(2010) Aging-related alterations in the extracellular matrix modulate the microenvironment and influence tumor progression.	2	15	2.34	0.0470	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:22615629	(2010) Cloning and expression of human vascular endothelial growth factor gene and inhibition of its expression by antisense in prokaryotic system.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23199045	(2010) Characteristics of inflammation common to both diabetes and periodontitis: are predictive diagnosis and targeted preventive measures possible?	2	15	2.34	0.0470	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:25013705	(2010) Adhesion formation after laparoscopic surgery: what do we know about the role of the peritoneal environment?	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19276374	(2009) Identification of ligand-induced proteolytic cleavage and ectodomain shedding of VEGFR-1FLT1 in leukemic cancer cells.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19333978	(2009) Juvenile dermatomyositis calcifications selectively displayed markers of bone formation.	2	15	2.34	0.0470	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:19397781	(2009) Integrin alpha1beta1 is involved in the differentiation into myofibroblasts in adult reactive tissues in vivo.	2	15	2.34	0.0470	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:19434452	(2009) Coordinate loss of fragile gene expression in pancreatobiliary cancers: correlations among markers and clinical features.	2	15	2.34	0.0470	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:19435903	(2009) VEGF-A induces angiogenesis by perturbing the cathepsin-cysteine protease inhibitor balance in venules, causing basement membrane degradation and mother vessel formation.	2	15	2.34	0.0470	9606.ENSP00000220166,9606.ENSP00000478570	CTSH,VEGFA
PMID:19461051	(2009) Inhibition of VEGF or TGF-beta signaling activates endothelium and increases leukocyte rolling.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19672141	(2009) Development of sunitinib in hepatocellular carcinoma: rationale, early clinical experience, and correlative studies.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19672955	(2009) Vascular endothelial growth factor prevents G93A-SOD1-induced motor neuron degeneration.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19725228	(2009) Evaluation of molecular markers in a rat model of mammary carcinogenesis.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19763275	(2009) VEGFR1 activity modulates myeloid cell infiltration in growing lung metastases but is not required for spontaneous metastasis formation.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19796232	(2009) Functional heterogeneity of the bone marrow vascular niche.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19815827	(2009) Human studies of angiogenic gene therapy.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19816604	(2009) Vascular endothelial growth factor receptor-1 (VEGFR-1) expression in human corneal fibroblast decreased with age.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18414993	(2008) Clinical biomarkers of angiogenesis inhibition.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18438662	(2008) Anti-angiogenesis: making the tumor vulnerable to the immune system.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:18537159	(2008) Stromal cell-derived factor-1 stimulates vasculogenesis and enhances Ewings sarcoma tumor growth in the absence of vascular endothelial growth factor.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17980035	(2007) The Drosophila Perlecan gene trol regulates multiple signaling pathways in different developmental contexts.	2	15	2.34	0.0470	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:18159242	(2007) Up-regulation of intestinal vascular endothelial growth factor by AfaDr diffusely adhering Escherichia coli.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16671879	(2006) Profiling the cytokines in gingival crevicular fluid using a cytokine antibody array.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:16682252	(2006) Targeting the stromal microenvironment in chronic inflammation.	2	15	2.34	0.0470	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:16725035	(2006) Induction of antitumor immunity through xenoplacental immunization.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:15824137	(2005) Laminin-sulfatide binding initiates basement membrane assembly and enables receptor signaling in Schwann cells and fibroblasts.	2	15	2.34	0.0470	9606.ENSP00000231061,9606.ENSP00000363827	SPARC,HSPG2
PMID:12082085	(2002) Matrix assembly, regulation, and survival functions of laminin and its receptors in embryonic stem cell differentiation.	2	15	2.34	0.0470	9606.ENSP00000231061,9606.ENSP00000363827	SPARC,HSPG2
PMID:12235206	(2002) Lymphangiogenic gene therapy with minimal blood vascular side effects.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:12453314	(2002) Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers.	2	15	2.34	0.0470	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34909116	(2021) Epigenetic regulation of dental pulp stem cells and its potential in regenerative endodontics.	3	119	1.61	0.0475	9606.ENSP00000231061,9606.ENSP00000451040,9606.ENSP00000478570	SPARC,PGF,VEGFA
PMID:25701227	(2015) Proteoglycan form and function: A comprehensive nomenclature of proteoglycans.	3	119	1.61	0.0475	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:33262757	(2020) Immunomodulatory Role of the Extracellular Matrix Within the Liver Disease Microenvironment.	3	120	1.61	0.0486	9606.ENSP00000231061,9606.ENSP00000363827,9606.ENSP00000478570	SPARC,HSPG2,VEGFA
PMID:34992414	(2021) The Anti-Inflammatory Actions and Mechanisms of Acupuncture from Acupoint to Target Organs via Neuro-Immune Regulation.	3	121	1.61	0.0498	9606.ENSP00000006053,9606.ENSP00000276571,9606.ENSP00000478570	CX3CL1,CRH,VEGFA
PMID:35013714	(2022) NETME: on-the-fly knowledge network construction from biomedical literature.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35054929	(2022) G-Quadruplex Regulation of VEGFA mRNA Translation by RBM4.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35055804	(2022) The Effects of SARS-CoV-2 Infection on Female Fertility: A Review of the Literature.	2	16	2.31	0.0499	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:35103285	(2022) Placental trophoblast-specific overexpression of chemerin induces preeclampsia-like symptoms.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35140509	(2022) Treating Inflammation Associated with Pulmonary Hypertension: An Overview of the Literature.	2	16	2.31	0.0499	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:35160128	(2022) Pathogenesis, Diagnosis and Management of Obstetric Antiphospholipid Syndrome: A Comprehensive Review.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35203290	(2022) Angiogenesis Driven by the CEBPD-hsa-miR-429-VEGFA Signaling Axis Promotes Urothelial Carcinoma Progression.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35335547	(2022) Polymeric Hydrogels as Mesenchymal Stem Cell Secretome Delivery System in Biomedical Applications.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32090401	(2021) Progressive long-term spatial memory loss following repeat concussive and subconcussive brain injury in mice, associated with dorsal hippocampal neuron loss, microglial phenotype shift, and vascular abnormalities.	2	16	2.31	0.0499	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:33430842	(2021) The osteogenic differentiation of human dental pulp stem cells in alginate-gelatinNano-hydroxyapatite microcapsules.	2	16	2.31	0.0499	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:33495827	(2021) miR-140-5p regulates vascular smooth muscle cell viability, migration and apoptosis by targeting ROBO4 gene expression in atherosclerosis.	2	16	2.31	0.0499	9606.ENSP00000334329,9606.ENSP00000478570	UNC5B,VEGFA
PMID:33506602	(2021) Neurolysin substrates bradykinin, neurotensin and substance P enhance brain microvascular permeability in a human in vitro model.	2	16	2.31	0.0499	9606.ENSP00000450482,9606.ENSP00000478570	BDKRB2,VEGFA
PMID:33531677	(2021) Sexual dimorphisms in brain gene expression in the growth-restricted guinea pig can be modulated with intra-placental therapy.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33692847	(2021) Clinical significance of hypertension in patients with different types of cancer treated with antiangiogenic drugs.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33852994	(2021) Chemokine MCP1 is associated with cognitive flexibility in schizophrenia: A preliminary analysis.	2	16	2.31	0.0499	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:34062733	(2021) Concurrent Physiological and Pathological Angiogenesis in Retinopathy of Prematurity and Emerging Therapies.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34198773	(2021) Anti-Angiogenic Treatment in Pseudomyxoma Peritonei-Still a Strong Preclinical Rationale.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34344927	(2021) The COL-4A1 polypeptide destroy endothelial cells through the TGF-betaPI3KAKT pathway.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34381074	(2021) Hyperglycaemia up-regulates placental growth factor (PlGF) expression and secretion in endothelial cells via suppression of PI3 kinase-Akt signalling and activation of FOXO1.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34385934	(2021) Blockage of C-X-C Motif Chemokine Receptor 2 (CXCR2) Suppressed Uric Acid (UA)-Induced Cardiac Remodeling.	2	16	2.31	0.0499	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:34432025	(2021) Stanniocalcin-1 in the female reproductive system and pregnancy.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34462507	(2021) Spatial and temporal VEGF receptor intracellular trafficking in microvascular and macrovascular endothelial cells.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34527715	(2021) Angiogenic Secretion Profile of Valvular Interstitial Cells Varies With Cellular Sex and Phenotype.	2	16	2.31	0.0499	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:34625639	(2021) Stem cells from human exfoliated deciduous teeth attenuate mechanical allodynia in mice through distinct from the siglec-9MCP-1-mediated tissue-repairing mechanism.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:34777022	(2021) The Role of Vascular Endothelial Growth Factor in Tendon Healing.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:35069121	(2021) Glial Purinergic Signals and Psychiatric Disorders.	2	16	2.31	0.0499	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:35295158	(2021) Three-Dimensional in vitro Models of Healthy and Tumor Brain Microvasculature for Drug and Toxicity Screening.	2	16	2.31	0.0499	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:31158953	(2020) Stable Gastric Pentadecapeptide BPC 157, Roberts Stomach CytoprotectionAdaptive CytoprotectionOrganoprotection, and Selyes Stress Coping Response: Progress, Achievements, and the Future.	2	16	2.31	0.0499	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:31654589	(2020) Extracellular matrix alterations in low-grade lung adenocarcinoma compared with normal lung tissue by imaging mass spectrometry.	2	16	2.31	0.0499	9606.ENSP00000231061,9606.ENSP00000363827	SPARC,HSPG2
PMID:32070425	(2020) Conditioned medium derived from FGF-2-modified GMSCs enhances migration and angiogenesis of human umbilical vein endothelial cells.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32215270	(2020) CCAATEnhancer-Binding Protein beta Mediates Oxygen-Induced Retinal Neovascularization via Retinal Vascular Damage and Vascular Endothelial Growth Factor.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32368194	(2020) Pharmacological cancer treatment and venous thromboembolism risk.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32481647	(2020) miR-129-5p and miR-130a-3p Regulate VEGFR-2 Expression in Sensory and Motor Neurons during Development.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32678094	(2020) The Bartonella autotransporter BafA activates the host VEGF pathway to drive angiogenesis.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32685014	(2020) IGF-1C hydrogel improves the therapeutic effects of MSCs on colitis in mice through PGE2-mediated M2 macrophage polarization.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32802081	(2020) Medications for Hypertension Change the Secretome Profile from Marrow Stromal Cells and Peripheral Blood Monocytes.	2	16	2.31	0.0499	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:33114380	(2020) The HGFMetNF-kappaB Pathway Regulates RANKL Expression in Osteoblasts and Bone Marrow Stromal Cells.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33233863	(2020) Impact of Air Pollution and Weather on Dry Eye.	2	16	2.31	0.0499	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:33244116	(2020) In vitro model of distinct catabolic and inflammatory response patterns of endothelial cells to intervertebral disc cell degeneration.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:33361800	(2020) Pantoprazole impairs fracture healing in aged mice.	2	16	2.31	0.0499	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:33396962	(2020) Roles of beta-Endorphin in Stress, Behavior, Neuroinflammation, and Brain Energy Metabolism.	2	16	2.31	0.0499	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:33520706	(2020) A Correlative Study Between IVIM-DWI Parameters and the Expression Levels of Ang-2 and TKT in Hepatocellular Carcinoma.	2	16	2.31	0.0499	9606.ENSP00000362524,9606.ENSP00000478570	ANGPTL2,VEGFA
PMID:33553274	(2020) New Insights Into the Role of beta-NGFTrKA System in the Endometrium of Alpacas During Early Pregnancy.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30603797	(2019) Phase 1b trial of nintedanib in combination with bevacizumab in patients with advanced solid tumors.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30838453	(2019) Pancreatic kallikrein protects against diabetic retinopathy in KK Cg-A(y)J and high-fat dietstreptozotocin-induced mouse models of type 2 diabetes.	2	16	2.31	0.0499	9606.ENSP00000450482,9606.ENSP00000478570	BDKRB2,VEGFA
PMID:30845779	(2019) Bone Marrow CX3CL1Fractalkine is a New Player of the Pro-Angiogenic Microenvironment in Multiple Myeloma Patients.	2	16	2.31	0.0499	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:30897795	(2019) Downregulation of the Netrin-1 Receptor UNC5b Underlies Increased Placental Angiogenesis in Human Gestational Diabetes Mellitus.	2	16	2.31	0.0499	9606.ENSP00000334329,9606.ENSP00000478570	UNC5B,VEGFA
PMID:30968984	(2019) Fluorine-contained hydroxyapatite suppresses bone resorption through inhibiting osteoclasts differentiation and function in vitro and in vivo.	2	16	2.31	0.0499	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:31140727	(2019) MicroRNA-638 inhibits human aortic valve interstitial cell calcification by targeting Sp7.	2	16	2.31	0.0499	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:31236198	(2019) Plasma and wound fluid levels of eight proangiogenic proteins are elevated after colorectal resection.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31275860	(2019) Lipoxin-Induced Phenotypic Changes in CD115(+)LY6C(hi) Monocytes TAM Precursors Inhibits Tumor Development.	2	16	2.31	0.0499	9606.ENSP00000220166,9606.ENSP00000478570	CTSH,VEGFA
PMID:31285776	(2019) Development of a Biocompatible Copolymer Nanocomplex to Deliver VEGF siRNA for Triple Negative Breast Cancer.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31370007	(2019) Hormone receptor expression of colorectal cancer diagnosed during the peri-partum period.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31406128	(2019) VEGF mediates fat embolism-induced acute lung injury via VEGF receptor 2 and the MAPK cascade.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31419236	(2019) Batroxobin accelerated tissue repair via neutrophil extracellular trap regulation and defibrinogenation in a murine ischemic hindlimb model.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31421149	(2019) Hydrogel vehicles for sequential delivery of protein drugs to promote vascular regeneration.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31443707	(2019) The REVAMP study: research exploring various aspects and mechanisms in preeclampsia: study protocol.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31452940	(2019) Vegfcd-dependent regulation of the lymphatic vasculature during cardiac regeneration is influenced by injury context.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31546913	(2019) Dynamic Interplay between Pericytes and Endothelial Cells during Sprouting Angiogenesis.	2	16	2.31	0.0499	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:31645906	(2019) Two novel ligand-independent variants of the VEGFR-1 receptor are expressed in human testis and spermatozoa, one of them with the ability to activate SRC proto-oncogene tyrosine kinases.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:31717500	(2019) Bevacizumab Induces Upregulation of Keratin 3 and VEGFA in Human Limbal Epithelial Cells in Vitro.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32010144	(2019) Dysregulation of Complement Activation and Placental Dysfunction: A Potential Target to Treat Preeclampsia?	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:32082383	(2019) Bone Tissue Regeneration in the Oral and Maxillofacial Region: A Review on the Application of Stem Cells and New Strategies to Improve Vascularization.	2	16	2.31	0.0499	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:29257317	(2018) Crosstalk between human endometrial stromal cells and decidual NK cells promotes decidualization in vitro by upregulating IL-25.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29290825	(2018) Current Challenges of Cancer Anti-angiogenic Therapy and the Promise of Nanotherapeutics.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29316206	(2018) Inhibition of VEGF-dependent angiogenesis and tumor angiogenesis by an optimized antibody targeting CLEC14a.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29459325	(2018) Discontinuous Schedule of Bevacizumab in Colorectal Cancer Induces Accelerated Tumor Growth and Phenotypic Changes.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29547662	(2018) Individual and temporal variability of the retina after chronic bilateral common carotid artery occlusion (BCCAO).	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29615881	(2018) Age Dependent Hypothalamic and Pituitary Responses to Novel Environment Stress or Lipopolysaccharide in Rats.	2	16	2.31	0.0499	9606.ENSP00000006053,9606.ENSP00000276571	CX3CL1,CRH
PMID:29618333	(2018) The kallikrein-Kinin system modulates the progression of colorectal liver metastases in a mouse model.	2	16	2.31	0.0499	9606.ENSP00000450482,9606.ENSP00000478570	BDKRB2,VEGFA
PMID:29686307	(2018) Mousetap, a Novel Technique to Collect Uncontaminated Vitreous or Aqueous and Expand Usefulness of Mouse Models.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29708992	(2018) Genetic profiling of young and aged endothelial progenitor cells in hypoxia.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29867506	(2018) Current Therapeutic Strategies for Adipose Tissue DefectsRepair Using Engineered Biomaterials and Biomolecule Formulations.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29902349	(2018) Nab-paclitaxel interrupts cancer-stromal interaction through C-X-C motif chemokine 10-mediated interleukin-6 downregulation in vitro.	2	16	2.31	0.0499	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:29922218	(2018) Therapeutic Values of Human Urinary Kallidinogenase on Cerebrovascular Diseases.	2	16	2.31	0.0499	9606.ENSP00000450482,9606.ENSP00000478570	BDKRB2,VEGFA
PMID:29981574	(2018) Plasma levels of the proangiogenic protein CXCL16 remains elevated for 1 month after minimally invasive colorectal cancer resection.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30009886	(2018) Tumor targeting via EPR: Strategies to enhance patient responses.	2	16	2.31	0.0499	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:30132562	(2018) Cytoplasmic expression of SOX9 as a poor prognostic factor for oral squamous cell carcinoma.	2	16	2.31	0.0499	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:30235859	(2018) Platelet-Rich Plasma Prevents In Vitro Transforming Growth Factor-beta1-Induced Fibroblast to Myofibroblast Transition: Involvement of Vascular Endothelial Growth Factor (VEGF)-AVEGF Receptor-1-Mediated Signaling (+).	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30235918	(2018) Benzodiazepine-Associated Carcinogenesis: Focus on Lorazepam-Associated Cancer Biomarker Changes in Overweight Individuals.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30323672	(2018) Monitoring of tumor vascular normalization: the key points from basic research to clinical application.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30405914	(2018) Prediction of Preterm Birth: Maternal Characteristics, Ultrasound Markers, and Biomarkers: An Updated Overview.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:30557327	(2018) Angiopoietin-2 promotes osteogenic differentiation of thoracic ligamentum flavum cells via modulating the Notch signaling pathway.	2	16	2.31	0.0499	9606.ENSP00000362524,9606.ENSP00000478570	ANGPTL2,VEGFA
PMID:30564135	(2018) Crosstalk Between Nitric Oxide and Endocannabinoid Signaling Pathways in Normal and Pathological Placentation.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27865734	(2017) Vascular endothelial growth factor A is associated with the subsequent development of moderate or severe cardiac allograft vasculopathy in pediatric heart transplant recipients.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27873479	(2017) Cytokine and chemokine tear levels in patients with uveitis.	2	16	2.31	0.0499	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:28079884	(2017) Lack of collagen XV is protective after ischemic stroke in mice.	2	16	2.31	0.0499	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:28164137	(2017) Immune Responses to Tissue-Restricted Nonmajor Histocompatibility Complex Antigens in Allograft Rejection.	2	16	2.31	0.0499	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:28194096	(2017) Morphological Plasticity of Emerging Purkinje Cells in Response to Exogenous VEGF.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28257068	(2017) Effects of Ranibizumab and Aflibercept on Human Muller Cells and Photoreceptors under Stress Conditions.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28451171	(2017) Antiangiogenic platinum through glycan targeting.	2	16	2.31	0.0499	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:28736761	(2017) Phase II Study of Dovitinib in Patients Progressing on Anti-Vascular Endothelial Growth Factor Therapy.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28761141	(2017) Effects of pulpotomy using mineral trioxide aggregate on prostaglandin transporter and receptors in rat molars.	2	16	2.31	0.0499	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:28797294	(2017) The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cells.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28934120	(2017) Angiogenesis Inhibitors in NSCLC.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:28973330	(2017) Prehematopoietic Stem Cell Transplantation Tear Cytokines as Potential Susceptibility Biomarkers for Ocular Chronic Graft-Versus-Host Disease.	2	16	2.31	0.0499	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:29016599	(2017) Coronary collateralization shows sex and racial-ethnic differences in obstructive artery disease patients.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29021510	(2017) Treatment of rheumatoid arthritis with biological agents - as a typical and common immune-mediated inflammatory disease.	2	16	2.31	0.0499	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:29149082	(2017) The Biological Properties of OGI Surfaces Positively Act on Osteogenic and Angiogenic Commitment of Mesenchymal Stem Cells.	2	16	2.31	0.0499	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:29170520	(2017) Integrated Proteomic and Metabolomic prediction of Term Preeclampsia.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29276417	(2017) Bevacizumab in the treatment of NSCLC: patient selection and perspectives.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:29387052	(2017) Salmonella Typhi Bactericidal Antibodies Reduce Disease Severity but Do Not Protect against Typhoid Fever in a Controlled Human Infection Model.	2	16	2.31	0.0499	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:26117290	(2016) Angiogenic factors and inflammation in steroid-refractory acute graft-vs-host disease.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26666733	(2016) Animal Models of Maternal Immune Activation in Depression Research.	2	16	2.31	0.0499	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:26692348	(2016) Angiogenic and immune signatures in plasma of young relatives at familial high-risk for psychosis and first-episode patients: A preliminary study.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26732856	(2016) Lack of netrin-4 modulates pathologic neovascularization in the eye.	2	16	2.31	0.0499	9606.ENSP00000334329,9606.ENSP00000478570	UNC5B,VEGFA
PMID:26813606	(2016) Col4a1 mutations cause progressive retinal neovascular defects and retinopathy.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26877098	(2016) Extracellular Matrix Rigidity-dependent Sphingosine-1-phosphate Secretion Regulates Metastatic Cancer Cell Invasion and Adhesion.	2	16	2.31	0.0499	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:26880934	(2016) Mimicking Neural Stem Cell Niche by Biocompatible Substrates.	2	16	2.31	0.0499	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:26930285	(2016) A Switch in the Dynamics of Intra-Platelet VEGF-A from Cancer to the Later Phase of Liver Regeneration after Partial Hepatectomy in Humans.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26985430	(2016) A review of Vitamin D effects on common respiratory diseases: Asthma, chronic obstructive pulmonary disease, and tuberculosis.	2	16	2.31	0.0499	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:27017929	(2016) Ectodomain cleavage of FLT1 regulates receptor activation and function and is not required for its downstream intracellular cleavage.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27047772	(2016) Hepatopulmonary Syndrome and Liver Transplantation: A Recent Review of the Literature.	2	16	2.31	0.0499	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:27068016	(2016) The endothelial glycocalyx and its disruption, protection and regeneration: a narrative review.	2	16	2.31	0.0499	9606.ENSP00000006053,9606.ENSP00000363827	CX3CL1,HSPG2
PMID:27114434	(2016) Systemic Chemotherapy in Advanced Pancreatic Cancer.	2	16	2.31	0.0499	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:27119233	(2016) Expression and prognostic significance of CCL11CCR3 in glioblastoma.	2	16	2.31	0.0499	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:27142988	(2016) Markers for the progression of IgA nephropathy.	2	16	2.31	0.0499	9606.ENSP00000006053,9606.ENSP00000363827	CX3CL1,HSPG2
PMID:27362259	(2016) Profiling Analysis of Histone Modifications and Gene Expression in Lewis Lung Carcinoma Murine Cells Resistant to Anti-VEGF Treatment.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27386008	(2016) The Promising Applications of Stem Cells in the Oral Region: Literature Review.	2	16	2.31	0.0499	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:27617097	(2016) Glycocalyx and its involvement in clinical pathophysiologies.	2	16	2.31	0.0499	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:27645229	(2016) Expressions of VEGF-A and VEGFR-2 in placentae from GDM pregnancies.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27810736	(2016) Oxalomalate reduces expression and secretion of vascular endothelial growth factor in the retinal pigment epithelium and inhibits angiogenesis: Implications for age-related macular degeneration.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:27901020	(2016) Structural decoding of netrin-4 reveals a regulatory function towards mature basement membranes.	2	16	2.31	0.0499	9606.ENSP00000334329,9606.ENSP00000478570	UNC5B,VEGFA
PMID:25752908	(2015) Neoadjuvant and conversion treatment of patients with colorectal liver metastasis: the potential role of bevacizumab and other antiangiogenic agents.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25931788	(2015) The Effect of Umbilical Cord Blood Derived Mesenchymal Stem Cells in Monocrotaline-induced Pulmonary Artery Hypertension Rats.	2	16	2.31	0.0499	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:25932045	(2015) Repurposing Drugs in Oncology (ReDO)-itraconazole as an anti-cancer agent.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26056484	(2015) Regulation of indoleamine 2,3-dioxygenase in primary human saphenous vein endothelial cells.	2	16	2.31	0.0499	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:26058077	(2015) A Functional Role for VEGFR1 Expressed in Peripheral Sensory Neurons in Cancer Pain.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26059746	(2015) Multilayered, Hyaluronic Acid-Based Hydrogel Formulations Suitable for Automated 3D High Throughput Drug Screening of Cancer-Stromal Cell Cocultures.	2	16	2.31	0.0499	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:26107959	(2015) The identification of proteoglycans and glycosaminoglycans in archaeological human bones and teeth.	2	16	2.31	0.0499	9606.ENSP00000231061,9606.ENSP00000363827	SPARC,HSPG2
PMID:26155943	(2015) Requirement of novel amino acid fragments of orphan nuclear receptor TR3Nur77 for its functions in angiogenesis.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26239842	(2015) Genetically modified human placenta-derived mesenchymal stem cells with FGF-2 and PDGF-BB enhance neovascularization in a model of hindlimb ischemia.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26259585	(2015) IL-17A Contributes to the Pathogenesis of Endometriosis by Triggering Proinflammatory Cytokines and Angiogenic Growth Factors.	2	16	2.31	0.0499	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:26394830	(2015) Angiogenesis-related protein expression in bevacizumab-treated metastatic colorectal cancer: NOTCH1 detrimental to overall survival.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26492364	(2015) The RCAN1 inhibits NF-kappaB and suppresses lymphoma growth in mice.	2	16	2.31	0.0499	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:26635904	(2015) Biomarkers of cancer angioprevention for clinical studies.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:26673788	(2015) BEV-IP: Perioperative chemotherapy with bevacizumab in patients undergoing cytoreduction and intraperitoneal chemoperfusion for colorectal carcinomatosis.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24122122	(2014) Changes in plasma vascular endothelial growth factor at 8 weeks after sorafenib administration as predictors of survival for advanced hepatocellular carcinoma.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24412438	(2014) Intra- and inter-day variation of cytokines and chemokines in tears of healthy subjects.	2	16	2.31	0.0499	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:24434513	(2014) Osteolytic bone metastasis is hampered by impinging on the interplay among autophagy, anoikis and ossification.	2	16	2.31	0.0499	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:24551189	(2014) HIF-1alpha and HIF-2alpha: siblings in promoting angiogenesis of residual hepatocellular carcinoma after high-intensity focused ultrasound ablation.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24584737	(2014) Acute intravenous injection of serelaxin (recombinant human relaxin-2) causes rapid and sustained bradykinin-mediated vasorelaxation.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24592945	(2014) Impact of HIV co-infection on plasma level of cytokines and chemokines of pulmonary tuberculosis patients.	2	16	2.31	0.0499	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:24610034	(2014) Growth factor signaling: implications for disease & therapeutics.	2	16	2.31	0.0499	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:24646176	(2014) Treatment of medulloblastoma with oncolytic measles viruses expressing the angiogenesis inhibitors endostatin and angiostatin.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24812271	(2014) Netrin-1 promotes medulloblastoma cell invasiveness and angiogenesis, and demonstrates elevated expression in tumor tissue and urine of patients with pediatric medulloblastoma.	2	16	2.31	0.0499	9606.ENSP00000334329,9606.ENSP00000478570	UNC5B,VEGFA
PMID:24868139	(2014) The proliferation of malignant melanoma cells could be inhibited by ranibizumab via antagonizing VEGF through VEGFR1.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24886406	(2014) Role of spinal P2Y6 and P2Y11 receptors in neuropathic pain in rats: possible involvement of glial cells.	2	16	2.31	0.0499	9606.ENSP00000006053,9606.ENSP00000304767	CX3CL1,P2RY1
PMID:24900995	(2014) New progress in angiogenesis therapy of cardiovascular disease by ultrasound targeted microbubble destruction.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24932029	(2014) Osteosarcoma: Diagnostic dilemmas in histopathology and prognostic factors.	2	16	2.31	0.0499	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:24982709	(2014) Therapeutic approaches to skeletal muscle repair and healing.	2	16	2.31	0.0499	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:24991423	(2014) Advances in treating glioblastoma.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25013774	(2014) Influence of heating and cyclic tension on the induction of heat shock proteins and bone-related proteins by MC3T3-E1 cells.	2	16	2.31	0.0499	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:25244080	(2014) Hypoxia-inducible factor prolyl hydroxylase inhibitor prevents steroid-associated osteonecrosis of the femoral head in rabbits by promoting angiogenesis and inhibiting apoptosis.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:25610589	(2014) The extracellular matrix: Structure, composition, age-related differences, tools for analysis and applications for tissue engineering.	2	16	2.31	0.0499	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:23072875	(2013) Global analysis of the haematopoietic and endothelial transcriptome during zebrafish development.	2	16	2.31	0.0499	9606.ENSP00000334329,9606.ENSP00000478570	UNC5B,VEGFA
PMID:23238831	(2013) Rapid decrease in tumor perfusion following VEGF blockade predicts long-term tumor growth inhibition in preclinical tumor models.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23421942	(2013) Comparison of the diagnostic values of circulating steroid hormones, VEGF-A, PIGF, and ADAM12 in women with ectopic pregnancy.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23460876	(2013) Autoantibodies against muscarinic receptors in breast cancer: their role in tumor angiogenesis.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23483898	(2013) The expression and activity of cathepsins D, H and K in asthmatic airways.	2	16	2.31	0.0499	9606.ENSP00000220166,9606.ENSP00000478570	CTSH,VEGFA
PMID:23776453	(2013) Vascular endothelial growth factor receptor-1 activation promotes migration and invasion of breast cancer cells through epithelial-mesenchymal transition.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23814541	(2013) The Neuropeptide Systems and their Potential Role in the Treatment of Mammalian Retinal Ischemia: A Developing Story.	2	16	2.31	0.0499	9606.ENSP00000276571,9606.ENSP00000478570	CRH,VEGFA
PMID:23864770	(2013) Cytokine patterns in brain tumour progression.	2	16	2.31	0.0499	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:24101875	(2013) Vascular endothelial growth factor inhibitors: investigational therapies for the treatment of psoriasis.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24188108	(2013) Placental growth factor, pregnancy-associated plasma protein-A, soluble receptor for advanced glycation end products, extracellular newly identified receptor for receptor for advanced glycation end products binding protein and high mobility ...	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24244628	(2013) Predictive markers of efficacy for an angiopoietin-2 targeting therapeutic in xenograft models.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:24244720	(2013) Identification and expression analysis of zebrafish glypicans during embryonic development.	2	16	2.31	0.0499	9606.ENSP00000231061,9606.ENSP00000363827	SPARC,HSPG2
PMID:24312554	(2013) Bradykinin preconditioning improves therapeutic potential of human endothelial progenitor cells in infarcted myocardium.	2	16	2.31	0.0499	9606.ENSP00000450482,9606.ENSP00000478570	BDKRB2,VEGFA
PMID:24376772	(2013) Transcriptional targeting of primary and metastatic tumor neovasculature by an adenoviral type 5 roundabout4 vector in mice.	2	16	2.31	0.0499	9606.ENSP00000334329,9606.ENSP00000478570	UNC5B,VEGFA
PMID:24404454	(2013) Hepatobiliary diseases during pregnancy and their management: An update.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21880113	(2012) Angiostatic kinase inhibitors to sustain photodynamic angio-occlusion.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22253552	(2012) Aflibercept in the treatment of metastatic colorectal cancer.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22347360	(2012) Effects of sorafenib on intra-tumoral interstitial fluid pressure and circulating biomarkers in patients with refractory sarcomas (NCI protocol 6948).	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22363134	(2012) Identification of colorectal cancer metastasis markers by an angiogenesis-related cytokine-antibody array.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22419946	(2012) Hyaluronic Acid-Based Hydrogels: from a Natural Polysaccharide to Complex Networks.	2	16	2.31	0.0499	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:22525512	(2012) Bone matrix osteonectin limits prostate cancer cell growth and survival.	2	16	2.31	0.0499	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:22615958	(2012) Insufficient radiofrequency ablation promotes angiogenesis of residual hepatocellular carcinoma via HIF-1alphaVEGFA.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22622803	(2012) Pattern of expression of vascular endothelial growth factor and its receptors in the ovine choroid plexus during long and short photoperiods.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22685661	(2012) A comprehensive review of hypertension in pregnancy.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22708908	(2012) Novel biomarkers for risk stratification and identification of life-threatening cardiovascular disease: troponin and beyond.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:22805326	(2012) Cytokine and angiogenic factors associated with efficacy and toxicity of pazopanib in advanced soft-tissue sarcoma: an EORTC-STBSG study.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:23070965	(2012) A complex of alpha6 integrin and E-cadherin drives liver metastasis of colorectal cancer cells through hepatic angiopoietin-like 6.	2	16	2.31	0.0499	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:23177115	(2012) Spontaneous tumor regression in a syngeneic rat model of liver cancer: implications for survival studies.	2	16	2.31	0.0499	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:23203097	(2012) The role of vascular endothelial growth factor a polymorphisms in breast cancer.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20843836	(2011) Exploratory analysis of early toxicity of sunitinib in advanced hepatocellular carcinoma patients: kinetics and potential biomarker value.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21044967	(2011) Gene expression in first trimester preeclampsia placenta.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21074265	(2011) Protein composition of microparticles shed from human placenta during placental perfusion: Potential role in angiogenesis and fibrinolysis in preeclampsia.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21196204	(2011) In pursuit of new anti-angiogenic therapies for cancer treatment.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21284019	(2011) Mesothelium of the murine allantois exhibits distinct regional properties.	2	16	2.31	0.0499	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:21294050	(2011) The flavonoid quercetin modulates the hallmark capabilities of hamster buccal pouch tumors.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21301413	(2011) Pitavastatin-induced angiogenesis and arteriogenesis is mediated by Notch1 in a murine hindlimb ischemia model without induction of VEGF.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21378564	(2011) Inflammation and cardiac outcome.	2	16	2.31	0.0499	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:21422656	(2011) Characteristics of human EwingPNET sarcoma models.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21469981	(2011) Antiangiogenic agents in combination with chemotherapy in patients with advanced non-small cell lung cancer.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21487419	(2011) The biology of brain metastases-translation to new therapies.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21490965	(2011) Brain abnormalities and glioma-like lesions in mice overexpressing the long isoform of PDGF-A in astrocytic cells.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21494428	(2011) Supernatant of bone marrow mesenchymal stromal cells induces peripheral blood mononuclear cells possessing mesenchymal features.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21616972	(2011) Human neural stem cells enhance structural plasticity and axonal transport in the ischaemic brain.	2	16	2.31	0.0499	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:21704311	(2011) RahU: an inducible and functionally pleiotropic protein in Pseudomonas aeruginosa modulates innate immunity and inflammation in host cells.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21747968	(2011) Breast Tumor Angiogenesis and Tumor-Associated Macrophages: Histopathologists Perspective.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21906313	(2011) Serum leptin levels in relation to circulating cytokines, chemokines, adhesion molecules and angiogenic factors in normal pregnancy and preeclampsia.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21949719	(2011) ST2 and IL-33 in pregnancy and pre-eclampsia.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:21961998	(2011) Immunomodulatory factors in cervicovaginal secretions from pregnant and non-pregnant women: a cross-sectional study.	2	16	2.31	0.0499	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:21998328	(2011) CD4+ T cells and complement independently mediate graft ischemia in the rejection of mouse orthotopic tracheal transplants.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19934008	(2010) Engineered zinc finger protein-mediated VEGF-a activation restores deficient VEGF-a in sensory neurons in experimental diabetes.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20010945	(2010) Biomarkers of angiogenesis and their role in the development of VEGF inhibitors.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20054616	(2010) Sprouty1 inhibits angiogenesis in association with up-regulation of p21 and p27.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20087345	(2010) The role of MMP-9 in the anti-angiogenic effect of secreted protein acidic and rich in cysteine.	2	16	2.31	0.0499	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:20163569	(2010) Impaired angiogenesis and mobilization of circulating angiogenic cells in HIF-1alpha heterozygous-null mice after burn wounding.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20506383	(2010) Expression and function of CXCL16 in a novel model of gout.	2	16	2.31	0.0499	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:20629172	(2010) Concise review: Nanoparticles and cellular carriers-allies in cancer imaging and cellular gene therapy?	2	16	2.31	0.0499	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:20727171	(2010) Novel strategies in tendon and ligament tissue engineering: Advanced biomaterials and regeneration motifs.	2	16	2.31	0.0499	9606.ENSP00000334329,9606.ENSP00000478570	UNC5B,VEGFA
PMID:19671869	(2009) Tumor and host-mediated pathways of resistance and disease progression in response to antiangiogenic therapy.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19723501	(2009) Activation of mammalian Tolloid-like 1 expression by hypoxia in human neuroblastoma SH-SY5Y cells.	2	16	2.31	0.0499	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:19836839	(2009) Novel approaches for mechanistic understanding and predicting preeclampsia.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:20046875	(2009) Histidine-rich glycoprotein can prevent development of mouse experimental glioblastoma.	2	16	2.31	0.0499	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:18382683	(2008) In vivo isolation and characterization of stem cells with diverse phenotypes using growth factor impregnated biomatrices.	2	16	2.31	0.0499	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:18461618	(2008) Seoul virus enhances regulatory and reduces proinflammatory responses in male Norway rats.	2	16	2.31	0.0499	9606.ENSP00000006053,9606.ENSP00000478570	CX3CL1,VEGFA
PMID:19185813	(2008) Foxc2 transcription factor: a newly described regulator of angiogenesis.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:19308692	(2008) Sialyl Lewis X expression and lymphatic microvessel density in primary tumors of node-negative colorectal cancer patients predict disease recurrence.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17551577	(2007) Concave pit-containing scaffold surfaces improve stem cell-derived osteoblast performance and lead to significant bone tissue formation.	2	16	2.31	0.0499	9606.ENSP00000231061,9606.ENSP00000478570	SPARC,VEGFA
PMID:17761954	(2007) Placental growth factor down-regulates type 1 T helper immune response by modulating the function of dendritic cells.	2	16	2.31	0.0499	9606.ENSP00000451040,9606.ENSP00000478570	PGF,VEGFA
PMID:17927980	(2007) Characterization of extracellular matrix components in the limbal epithelial stem cell compartment.	2	16	2.31	0.0499	9606.ENSP00000231061,9606.ENSP00000363827	SPARC,HSPG2
PMID:16507112	(2006) Perlecan, a candidate gene for the CAPB locus, regulates prostate cancer cell growth via the Sonic Hedgehog pathway.	2	16	2.31	0.0499	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:16721359	(2006) Angiogenesis in a human neuroblastoma xenograft model: mechanisms and inhibition by tumour-derived interferon-gamma.	2	16	2.31	0.0499	9606.ENSP00000363827,9606.ENSP00000478570	HSPG2,VEGFA
PMID:32288774	(2006) The renin-angiotensin system in acute respiratory distress syndrome.	2	16	2.31	0.0499	9606.ENSP00000450482,9606.ENSP00000478570	BDKRB2,VEGFA
